Skip to main content

Παιδιατρική | Τόμος 71 • Τεύχος 6 • Νοέμβριος - Δεκέμβριος 2008

Page 1


¢ÈÌËÓÈ·›· ¤Î‰ÔÛË Ù˘

EÏÏËÓÈ΋˜ ¶·È‰È·ÙÚÈ΋˜ EÙ·ÈÚ›·˜

¶Úfi‰ÚÔ˜

∞. ∫ˆÓÛÙ·ÓÙfiÔ˘ÏÔ˜

™˘ÓÙ·ÎÙÈ΋ EÈÙÚÔ‹

¢È¢ı˘ÓÙ‹˜ ™‡ÓÙ·Í˘

∫. ™ÙÂÊ·Ó›‰Ë˜

M¤ÏË

™. ∞Ó‰ÚÔÓ›ÎÔ˘

ª. ∞ÓıÚ·ÎfiÔ˘ÏÔ˜

¶. ∞˘ÁÔ˘ÛÙ›‰Ô˘-™·‚‚ÔÔ‡ÏÔ˘

°. µ·ÚÏ¿Ì˘

∂. °·Ï·Ó¿Î˘

§. £ˆÌ·˝‰Ô˘

ª. ∫·Ó¿ÚÈÔ˘

A. K·ÙÙ¿Ì˘

™. K›ÙÛÈÔ˘-∆˙¤ÏË

∞. ¶··‰ÔÔ‡ÏÔ˘

µ. ¶··Â˘·ÁÁ¤ÏÔ˘

∞. ™È·ÌÔÔ‡ÏÔ˘-ª·˘Ú›‰Ô˘

∞. ™˘Ú›ÁÔ˘-¶··‚·ÛÈÏ›Ԣ

∂. ÷ÚÌ·Ó‰¿ÚË

ÀÔ‚ÔÏ‹ ∂ÚÁ·ÛÈÒÓ e-mail: hps@ath.forthnet.gr

√‰ËÁ›Â˜ ÚÔ˜ ÙÔ˘˜ Û˘ÁÁÚ·Ê›˜: http://www.e-child.gr/Instructions_ to_Authors_GR.pdf

ºÈÏÔÏÔÁÈ΋ EÈ̤ÏÂÈ·

∂È̤ÏÂÈ· ÂÏÏËÓÈÎÒÓ ÎÂÈÌ¤ÓˆÓ ∫. ¶··¯Ú‹ÛÙÔ˘

EÈ̤ÏÂÈ· ·ÁÁÏÈÎÒÓ ÎÂÈÌ¤ÓˆÓ ™. ¡¿ÎÔ˘

EΉfiÙ˘

K. °ÚÈ‚¤·˜

™˘ÓÙÔÓÈÛÙ‹˜ ∂ΉfiÛˆ˜ E¶I™THMONIKE™EK¢O™EI™E.¶.E. ¶ÈÂÚ›·˜ 1∞

144 51 MÂÙ·ÌfiÚʈÛË

TËÏ.: 210 87 78 810

Fax: 210 87 78 822

I‰ÈÔÎÙ‹Ù˘

EÏÏËÓÈ΋ ¶·È‰È·ÙÚÈ΋ EÙ·ÈÚ›·©

Mȯ·Ï·ÎÔÔ‡ÏÔ˘ 92

Aı‹Ó· 115 28

TËÏ.: 210 7771 140 210 7771 663

Fax: 210 7758 354

e-mail: hps@ath.forthnet.gr

EÙ‹ÛÈ· ™˘Ó‰ÚÔÌ‹: 40 €

¶·È‰È·ÙÚÈ΋

∆fiÌÔ˜ 71 ñ ∆‡¯Ô˜ 6 ñ ¡Ô¤Ì‚ÚÈÔ˜-¢ÂΤ̂ÚÈÔ˜ 2008

EȉÈ΢fiÌÂÓÔÈ, ºÔÈÙËÙ¤˜:20 € ¶ÂÚȯfiÌÂÓ· ∞¡∞™∫O¶∏™∂π™

∫ˆ‰ÈÎfi˜ ¢È‡ı˘ÓÛ˘ ∂ÔÙ›·˜ ªª∂: 3889

ISSN 0377-2551

£∂ª∞

ÙÔ˘ ‰È·‰ÈÎÙ‡Ô˘

∞. ∆Û›ÙÛÈη, ∂. ∫ÚÈÙÛ¤ÏË, ∂. ∫ˆÓÛÙ·ÓÙÔ˘Ï¿ÎË, °. ∫ÔÚÌ¿˜, ∞. ºÈÏÈÔÔ‡ÏÔ˘, ¢. ∆Ô˘ÓÈÛÛ›‰Ô˘, ∞. ºÚ¤ÛÎÔ˘, £. ™ËÏÈÔÔ‡ÏÔ˘, ∞. §Ô˘›˙Ô˘,

A. ∫ˆÓÛÙ·ÓÙfiÔ˘ÏÔ˜, ¢. ∫·ÊÂÙ˙‹˜ 449∏ ¯Ú‹ÛË ÙˆÓ ËÏÂÎÙÚÔÓÈÎÒÓ ˘ÔÏÔÁÈÛÙÒÓ

Î·È ÙÔ˘ ‰È·‰ÈÎÙ‡Ô˘ ·fi ·È‰È¿-ÂÊ‹‚Ô˘˜

ÛÙËÓ ÂÚÈÔ¯‹ Ù˘ ∞ı‹Ó·˜

∞. ¶··‰ÔÔ‡ÏÔ˘, °. ª›¯·˜, º. ª›¯·˜, ∞. ∑ÂÚ‚Ô˘‰¿ÎË, ∫. ∆ÛÔ˘Ì¿Î·˜, ¶. °ÂˆÚÁÈÔÔ‡ÏÔ˘-ª›¯·

458∞ÓȯÓ¢ÙÈ΋ ‰ÔÎÈÌ·Û›· Û¯ÔÏÈ΋˜ ÂÙÔÈÌfiÙËÙ·˜: ∞’ ∆∂™∆ ™. ª·ÓÙÔ‡‰Ë˜, §. £ˆÌ·˝‰Ô˘

469¶ÚfiÙ˘Ô ÚfiÁÚ·ÌÌ· ·ÁˆÁ‹˜ Î·È ÚÔ·ÁˆÁ‹˜ ˘Á›·˜ Û ·ÛÙÈ΋ ÎÔÈÓfiÙËÙ· ·fi

ÊÔÚ¤· ÚˆÙÔ‚¿ıÌÈ·˜ ÊÚÔÓÙ›‰·˜ ˘Á›·˜ ∞. •ÂηϿÎË, ¢. ª¤ÓÂÁ·˜, ∞ÈÎ. ∑ÔÏÒÙ·, ∑. ∏ÏÈÔ‰ÚÔÌ›ÙË, ∞. ¶Ú·ÛÔ‡ÏË, ∂. ∆˙›ÓË, ¶. ª·˘Ú›Î·, ∞ÈÎ. ¢ËÌÔÔ‡ÏÔ˘, ∞. ª¿ÚÁ·ÚË, π. ∞ÓÙˆÓÈ¿‰Ô˘-∫Ô˘Ì¿ÙÔ˘

475¢ÈÂÚ‡ÓËÛË Ù˘ ÂÊ·ÚÌÔÁ‹˜ Ù˘ ÓÔÌÔıÂÛ›·˜ ÁÈ· ÙËÓ ÂÈÛ‹Ì·ÓÛË ÎÔÈÓÒÓ

486M·ÛÙÔ΢ÙÙ¿ÚˆÛË ÛÙ· ·È‰È¿: ÂÚÈÁÚ·Ê‹ ‰‡Ô ÂÚÈÙÒÛÂˆÓ µ. ∞ÁÁÂÏ¿ÎÔ˘, ª. ∫Ô˘ÙÏ‹, ¡. ¶··‰fiÔ˘ÏÔ˜, ∂. ª·ÓÔ˘Û¿Î˘, ¶. •Â··‰¿ÎË, π. ÷ڈӛÙË, º. ™·ÍÒÓË-¶··ÁˆÚÁ›Ô˘

∫§π¡π∫√ ∫√Àπ∑

493 ª. ∫·ÏÏÈÒÚ·, ª. ª·˘Ú›ÎÔ˘ ™À¡∆√ª∞ ¶∞π¢π∞∆ƒπ∫∞ ¡∂∞

494K·Ù¢ı˘ÓÙ‹ÚȘ ÁÚ·Ì̤˜ 2008 E. °·Ï·Ó¿Î˘ ¡∂∞ ∞¶√ ∆√ ¢π∞¢π∫∆À√

496 πÛÙÔÛÂÏ›‰Â˜ ÁÂÓÂÙÈ΋˜ ∂. °È·ÓÓ¿ÙÔ˘, ™. ∫›ÙÛÈÔ˘-∆˙¤ÏË

501 ∂Àƒ∂∆∏ƒπ√ ∫ƒπ∆ø¡

502 ∂Àƒ∂∆∏ƒπ√ ™À°°ƒ∞º∂ø¡ ∆√À ∆√ª√À 71

505 ∂Àƒ∂∆∏ƒπ√ §∂•∂ø¡-∫§∂π¢πø¡ ∆√À ∆√ª√À 71

Bimonthly Publication of the Greek Paediatric Society

President

A. Constantopoulos

Editorial Board

Editor-in-Chief

C. Stefanidis

Members

S. Andronikou

ª. ∞nthracopoulos

P. Augoustides-Savvopoulou

G. Varlamis

∂. Galanakis

L. Thomaidou

M. Kanariou

A. Kattamis

S. Kitsiou-Tzeli

∞. Papadopoulou

V. Papaevagelou

A. Siamopoulou-Mavridou

A. Syrigou-Papavasiliou

E. Charmandari

Manuscript submission e-mail: hps@ath.forthnet.gr

Instructions to authors: http://www.e-child.gr/paediatriki/ iae.pdf

Manuscript Editing

Greek Editing

K. Papachristou

English Editing

S. Nakou

Publisher

K. Griveas

Publishing Coordinator SCIENTIFICPUBLICATIONSLtd.

1∞ Pierias St.

GR - 144 51, Metamorfossi

Tel.: +30 210 87 78 810

Fax: +30 210 87 78 822

Owner

Greek Paediatric Society© 92 Michalakopoulou St.

GR - 115 28, Athens

Tel.: +30 210 7771 140 +30 210 7771 663

Fax: +30 210 7758 354

e-mail: hps@ath.forthnet.gr

Annual Subscription

All foreign countries: US $ 50

Paediatriki

Volume 71 ñ Number 6 ñ November-December 2008

Contents

REVIEW ARTICLES

417Child health certificates: cardiovascular examination by the paediatricianguidelines

I. Germanakis, π. Papagiannis, G. Varlamis

426The effect of childhood epilepsy on cognitive function and behaviour

A. Prassouli, A. Attilakos, I. Antoniadou

434Internet addiction in adolescence

∞. Papadopoulou, P. Georgiopoulou-Micha

ORIGINAL ARTICLES

441Study on the use and misuse of internet among Greek adolescents

∞. Tsitsika, ∂. Kritseli, ∂. Konstantoulaki, G. Kormas, ∞. Filippopoulou, D. Tounissidou, ∞. Freskou, T. Spiliopoulou, ∞. Louizou, A. Constantopoulos, D. Kafetzis

449Computer and internet use by school age children in Athens

A. Papadopoulou, G. Michas, F. Michas, A. Zervoudakis, K. Tsoumakas, P. Georgiopoulou-Miha

458The A TEST; assessment of school readiness

S. Mantoudis, L. Thomaidis

469Model health promotion program in an urban community by a primary health care setting

A. Xekalaki, D. Menegas, K. Zolota, Z. Iliodromiti, A. Prasouli, E. Tzini, P. Mavrika, K. Dimopoulou, A. Margari, I. Antoniadou-Koumatou

475Application of the legislation on allergen labelling for selected food products in the Greek market

∞. Vassilopoulou, ∂. Stroumpi, ¡.G. Papadopoulos, V. Karathanos

PRACTICAL ISSUE

482Non-nutritive sucking habits: their influence on children’s health

G. Tsolas

CASE REPORT

486Mastocytosis in children: a report of two cases

V. Aggelakou, M. Koutli, N. Papadopoulos, E. Manoussakis, P. Xepapadaki, I. Charoniti

CLINICAL QUIZ

493 ª. Kalliora, ª. Mavrikou

PAEDIATRIC NEWS IN BRIEF

494 Guidelines 2008

E. Galanakis

NEWS FROM THE INTERNET

496 Genetics Sites

E. Giannatou, S. Kitsiou-Tzeli

501 REVIEWERS OF MANUSCRIPTS INDEX, VOLUME 71

502 AUTHORS INDEX, VOLUME 71

505 KEY WORDS INDEX, VOLUME 71

¢È¢ı˘ÓÙ‹˜ ™‡ÓÙ·Í˘

∫ˆÓÛÙ·ÓÙ›ÓÔ˜ ™ÙÂÊ·Ó›‰Ë˜, ∞ı‹Ó·

∂ȉÈÎÔ› ™˘ÓÙ¿ÎÙ˜

™Ù¤ÏÏ· ∞Ó‰ÚÔÓ›ÎÔ˘, ¡ÂÔÁÓÔÏÔÁ›·, πˆ¿ÓÓÈÓ·

ªÈ¯·‹Ï ∞ÓıÚ·ÎfiÔ˘ÏÔ˜, ¶Ó¢ÌÔÓÔÏÔÁ›·, ¶¿ÙÚ·

¶ÂÚÛÂÊfiÓË ∞˘ÁÔ˘ÛÙ›‰Ô˘-™·‚‚ÔÔ‡ÏÔ˘, MÂÙ·‚ÔÏÈο ÓÔÛ‹Ì·Ù·, £ÂÛÛ·ÏÔÓ›ÎË

°ÂÒÚÁÈÔ˜ µ·ÚÏ¿Ì˘, ∫·Ú‰ÈÔÏÔÁ›·, £ÂÛÛ·ÏÔÓ›ÎË

∂ÌÌ·ÓÔ˘‹Ï °·Ï·Ó¿Î˘, ∏ıÈ΋ Î·È ¢ÂÔÓÙÔÏÔÁ›·, ∏Ú¿ÎÏÂÈÔ

§ˆÚ¤ÙÙ· £ˆÌ·˝‰Ô˘, ∞Ó·Ù˘ÍȷΤ˜ ‰È·Ù·Ú·¯¤˜, ∞ı‹Ó·

ª·Ú›· ∫·Ó¿ÚÈÔ˘, ∞ÓÔÛÔÏÔÁ›·, ∞ı‹Ó·

∞ÓÙÒÓ˘ ∫·ÙÙ¿Ì˘, ∞ÈÌ·ÙÔÏÔÁ›· - OÁÎÔÏÔÁ›·, ∞ı‹Ó·

™ÔÊ›· ∫›ÙÛÈÔ˘-∆˙¤ÏË, °ÂÓÂÙÈ΋, ∞ı‹Ó·

∞ÏÂͿӉڷ ¶··‰ÔÔ‡ÏÔ˘, °·ÛÙÚÂÓÙÂÚÔÏÔÁ›· - ¢È·ÙÚÔÊ‹, ∞ı‹Ó·

µ·ÛÈÏÈ΋ ¶··Â˘·ÁÁ¤ÏÔ˘, §ÔÈ̈ÍÈÔÏÔÁ›·, ∞ı‹Ó·

∞ÓÙÈÁfiÓË ™È·ÌÔÔ‡ÏÔ˘-ª·˘Ú›‰Ô˘, ƒÂ˘Ì·ÙÔÏÔÁ›·, πˆ¿ÓÓÈÓ·

∞ÓÙÈÁfiÓË ™˘Ú›ÁÔ˘-¶··‚·ÛÈÏ›Ԣ, ¡Â˘ÚÔÏÔÁ›·, ∞ı‹Ó·

∂˘·ÁÁÂÏ›· ÷ÚÌ·Ó‰¿ÚË, ∂Ó‰ÔÎÚÈÓÔÏÔÁ›·, ∞ı‹Ó·

Editor-in-Chief

Constantinos Stefanidis, Athens

Section Editors

Stella Andronikou, Neonatology, Ioannina

Michael Anthracopoulos, Pneumonology, Patras

Persefoni Avgoustides-Savvopoulou, Metabolic Disorders, Thessaloniki

George Varlamis, Cardiology, Thessaloniki

Emmanouil Galanakis, Ethics and Deontology, Heraklion

Loretta Thomaidou, Developmental Pediatrics, Athens

Maria Kanariou, Immunology, Athens

Antonis Kattamis, Haematology - √ncology, Athens

Sophia Kitsiou-Tzeli, Genetics, Athens

Alexandra Papadopoulou, Gastroenterology - Nutrition, Athens

Vassiliki Papaevagelou, Infectious Diseases, Athens

Antigoni Siamopoulou-Mavridou, Rheumatology, Ioannina

Antigone Syrigou-Papavasiliou, Neurology, Athens

Evangelia Charmandari, Endocrinology, Athens

ª¤ÏË Ù˘ ¢ÈÂıÓÔ‡˜ ™˘ÓÙ·ÎÙÈ΋˜ ∂ÈÙÚÔ‹˜ ñ Members of the International Editorial Board

Alexis Arzimanoglou, Paris, France

Ellis D. Avner, Milwaukee, USA

Swati Bhave, New Delhi, India

Alberto Bissot, Panama, Panama

David Branski, Jerusalem, Israel

Francesco Chiarelli, Chieti, Italy

Chok-Wan Chan, Hong Kong, China

Denis Daneman, Toronto, Canada

Jochen Ehrich, Hannover, Germany

Demetrius Ellis, Pittsburgh, USA

Yoshikatsu Eto, Tokyo, Japan

Richard N. Fine, Stony Brook, USA

Margaret C. Fisher, Philadelphia, USA

Raif Geha, Boston, USA

Adenike Grange, Lagos, Nigeria

Judith G. Hall, Vancouver, Canada

Patricia Hamilton, London, UK

Enver Hasanoglu, Ankara, Turkey

Christer Holmberg, Helsinki, Finland

Lewis B. Holmes, Boston, USA

Peter Hoyer, Essen, Germany

Jan Janda, Prague, Czech Republic

Jan Kimpen, Ultrecht, Netherlands

Craig B. Langman, Chicago, USA

John Manis, Boston, USA

Manuel Moya, Alicante, Spain

Hugh O'Brodovich, Toronto, Canada

Ross Petty, Vancouver, Canada

Willem Proesmans, Leuven, Belgium

Jose Ramet, Antwerp, Belgium

Nikolai Shabalov, St. Petersburg, Russia

Alan Sinaiko, Minneapolis, USA

Nick J. Spencer, Coventry, UK

Alfred Tenore, Udine, Italy

Alkis Togias, Bethesda, USA

Eva Tsalikian, Iowa City, USA

Catherine Weil-Olivier, Paris, France

Max Zach, Graz, Austria

Zheng-Yan Zhao, Hangzhou, China

Johannes Zschocke, Heidelberg, Germany

∞Á·ËÙÔ› Û˘Ó¿‰ÂÏÊÔÈ,

∂Π̤ÚÔ˘˜ Ù˘ ™˘ÓÙ·ÎÙÈ΋˜ ∂ÈÙÚÔ‹˜ Ù˘ “¶·È‰È·ÙÚÈ΋˜” Û·˜ ‡¯ÔÌ·È Î·Ï¿ ÃÚÈÛÙÔ‡ÁÂÓÓ· ηÈ

¤Ó· ¯·ÚÔ‡ÌÂÓÔ Î·È ‰ËÌÈÔ˘ÚÁÈÎfi ηÈÓÔ‡ÚÁÈÔ ¯ÚfiÓÔ.

ªÂ ÙËÓ Â˘Î·ÈÚ›· ·˘Ù‹, ı· ı¤Ï·Ì ӷ Û·˜ ¢¯·ÚÈÛÙ‹ÛÔ˘ÌÂ

ÙÔ

ÂӉȷʤÚÔÓ Û·˜ ÁÈ· ÙÔ

ÂÚÈÔ‰ÈÎfi Î·È ÂÚÈ̤ÓÔ˘Ì ÙȘ ÚÔÙ¿ÛÂȘ Û·˜ ÁÈ· ÌÂÏÏÔÓÙÈΤ˜ ·ÏÏ·Á¤˜ Î·È ‚ÂÏÙÈÒÛÂȘ. π‰È·›ÙÂÚ·

¢¯·ÚÈÛÙԇ̠ÙÔ˘˜ Û˘ÁÁÚ·Ê›˜, ÙÔ˘˜ ÎÚÈÙ¤˜ ÙˆÓ ÂÚÁ·ÛÈÒÓ Î·È fiÏÔ˘˜ fiÛÔ˘˜ Û˘ÓÂÈÛ¤ÊÂÚ·Ó ÛÙËÓ

ÂÈÙ˘¯›· ÙÔ˘ ÂÚÈÔ‰ÈÎÔ‡.

∂›Ì·È Û›ÁÔ˘ÚÔ˜ fiÙÈ Ì ÙË ‰È΋ Û·˜ Û˘Ì‚ÔÏ‹ Î·È Ô ÂfiÌÂÓÔ˜ ¯ÚfiÓÔ˜ ı· Â›Ó·È ‰ËÌÈÔ˘ÚÁÈÎfi˜ ÁÈ· ÙËÓ “¶·È‰È·ÙÚÈ΋”. ªÂ ıÂÚÌÔ‡˜ ¯·ÈÚÂÙÈÛÌÔ‡˜, ∫ˆÓÛÙ·ÓÙ›ÓÔ˜ ™ÙÂÊ·Ó›‰Ë˜ ¢È¢ı˘ÓÙ‹˜ ™‡ÓÙ·Í˘

Dear colleagues,

On behalf of the Editorial Board of “Paediatriki”, I wish you Merry Christmas and a happy and creative new year.

On this occasion, we would like to thank you for your continuous participation to the journal and we look forward for your advice and feedback. We would especially like to thank the authors, the reviewers and each one of you who has contributed to the success of the journal.

I am sure that with your contributions the New Year will also prove to be creative for “Paediatriki”.

Warm greetings,

¶ÈÛÙÔÔÈËÙÈο

¤ÏÂÁ¯Ô˜ ·fi ·È‰›·ÙÚÔ

π. °ÂÚÌ·Ó¿Î˘1, I. ¶··ÁÈ¿ÓÓ˘2, °. µ·ÚÏ¿Ì˘3

ηډÈÔÏÔÁÈÎfi˜

¶ÂÚ›ÏË„Ë: √ ¤ÏÂÁ¯Ô˜ Î·È Ë ÈÛÙÔÔ›ËÛË Ù˘ ηډȷÁÁÂȷ΋˜ ˘Á›·˜ Â›Ó·È ˘Ô¯ÚˆÙÈ΋ ‰È·‰Èηۛ· ÛÙË ¯ÒÚ· Ì·˜ ÁÈ· fiÏ· Ù· ·È‰È¿ Û¯ÔÏÈ΋˜ ËÏÈΛ·˜, Ì ÛÙfi¯Ô ÙËÓ ·ÛÊ·Ï‹ ÙÔ˘˜ Û˘ÌÌÂÙÔ¯‹ ÛÙȘ Û¯ÔÏÈΤ˜ ‰Ú·ÛÙËÚÈfiÙËÙ˜, ÂÓÒ ÚfiÛıÂÙË ÈÛÙÔÔ›ËÛË ˙ËÙÂ›Ù·È ·fi ÔÚÁ·ÓˆÌ¤ÓÔ˘˜ ·ıÏËÙÈÎÔ‡˜ Û˘ÏÏfiÁÔ˘˜. ™ÙËÓ ·ÚÔ‡Û· ·Ó·ÛÎfiËÛË ·ÚÔ˘ÛÈ¿˙ÂÙ·È ÙfiÛÔ Ô ıÂÛÌÔıÂÙË̤ÓÔ˜ ηډȷÁÁÂÈ·Îfi˜ ¤ÏÂÁ¯Ô˜, ÛÙ· Ï·›ÛÈ· ÙÔ˘ ∞ÙÔÌÈÎÔ‡

¢ÂÏÙ›Ô˘ ÀÁ›·˜ ÙˆÓ Ì·ıËÙÒÓ, fiÛÔ Î·È Ë Û˘Ó‹ı˘ Ú·ÎÙÈ΋ ÚÔ-·ÁˆÓÈÛÙÈÎÔ‡ ÂϤÁ¯Ô˘ ÛÙ· Ï·›ÛÈ· Â͈ۯÔ-

ÏÈÎÒÓ ·ıÏËÙÈÎÒÓ ‰Ú·ÛÙËÚÈÔًوÓ. ªÂ ‚¿ÛË ÙȘ ÚfiÛÊ·Ù˜ ‰ÈÂıÓ›˜ ηÙ¢ı˘ÓÙ‹ÚȘ Ô‰ËÁ›Â˜, Ô ıÂÛÌÔıÂ-

ÙË̤ÓÔ˜ ¤ÏÂÁ¯Ô˜ ÌÔÚ› Ó· Á›ÓÂÈ ·ÔÙÂÏÂÛÌ·ÙÈÎfiÙÂÚÔ˜, Ì ÙËÓ ÚÔÛı‹ÎË ÂÚ·ÈÙ¤Úˆ ÏËÚÔÊÔÚÈÒÓ ÙÔ˘

·ÙÔÌÈÎÔ‡ ηÈ, ȉ›ˆ˜, ÔÈÎÔÁÂÓÂÈ·ÎÔ‡ ÈÛÙÔÚÈÎÔ‡, ÙË Û˘Ó˘¢ı˘ÓfiÙËÙ· ÙˆÓ ÎˉÂÌfiÓˆÓ ÛÙËÓ ÂÁ΢ÚfiÙËÙ· ÙˆÓ

ÏËÚÔÊÔÚÈÒÓ ÙÔ˘ ÈÛÙÔÚÈÎÔ‡, ÙËÓ ÚÔÙ˘ÔÔÈË̤ÓË ÎÏÈÓÈ΋ ÂͤٷÛË Î·È, Èı·ÓÒ˜, ÙËÓ ÂÈÙ¤ÏÂÛË ËÏÂÎÙÚÔηډÈÔÁڷʋ̷ÙÔ˜ Û ÂÚÈÙÒÛÂȘ Û˘ÌÌÂÙÔ¯‹˜ Û ÔÚÁ·ÓˆÌ¤ÓË ·ÓÙ·ÁˆÓÈÛÙÈ΋ ¿ıÏËÛË. ∫·ıÒ˜, fï˜, ηӤӷ Û‡ÛÙËÌ· ÂϤÁ¯Ô˘ ‰ÂÓ ÌÔÚ› Ó· ÂÍ·ÛÊ·Ï›ÛÂÈ Ìˉ·ÌÈÓfi ΛӉ˘ÓÔ Î·Ù¿ ÙË Û˘ÌÌÂÙÔ¯‹ Û ·ÓÙ·ÁˆÓÈÛÙÈ-

ο ·ıϋ̷ٷ ˘„ËÏ‹˜ ¤ÓÙ·Û˘, Ë ÏÂÙÔÌÂÚ‹˜ Ï‹„Ë ÙÔ˘ ÈÛÙÔÚÈÎÔ‡ Î·È Ë ÎÏÈÓÈ΋

ÛÈÎfi ̤ÛÔ ÂϤÁ¯Ô˘ ÙˆÓ ·È‰ÈÒÓ Ô˘ ·ıÏÔ‡ÓÙ·È,

Child health certificates: cardiovascular examination by the paediatrician - guidelines

I. Germanakis1, π. Papagiannis2, G. Varlamis3

Abstract: Preparticipation cardiovascular evaluation is obligatory for all children in Greece before participation in school athletic activities, while additional evaluation is requested by individual sports clubs. The current policy regarding preparticipation screening in Greece was reviewed. According to recent practice guidelines, the current screening practices could be improved by the addition of further details of the personal and family history, parental confirmation of the accuracy of the history provided, the use of a standardized physical evaluation and possibly the performance of an electrocardiogram before participation in competitive sports. However, as none of the current preparticipation screening systems can guarantee a ‘zero risk’ state during high intensity competitive sports, effective screening continues to be based on a detailed personal and family history and physical evaluation performed by a well trained general paediatrician.

Key words: Sports, child, preparticipation screening, cardiac evaluation, guidelines.

AÏÏËÏÔÁÚ·Ê›·:

1 Medical School, University of Crete, Crete, Greece

2 Pediatric Cardiologic Clinic, “Mitera” General, Maternity & Children’s Hospital

3 Medical School, Aristotelio University of Thessaloniki, Thessaloniki, Greece

Correspondence: Ioannis Germanakis germjohn@med.uoc.gr Paediatric Cardiology Unit, Department of Paediatrics, University Hospital of Heraklion, Crete, Greece

∏ ۈ̷ÙÈ΋ ¿ÛÎËÛË ·ÔÙÂÏ› ÛËÌ·ÓÙÈ΋ Û˘ÓÈÛÙÒÛ· οı ÂÎ·È‰Â˘ÙÈÎÔ‡ ÚÔÁÚ¿ÌÌ·ÙÔ˜, ‹‰Ë ·fi ÙËÓ ÎÏ·ÛÈ΋ ·Ú¯·ÈfiÙËÙ·. π‰Â҉˘ ÌÔÚÊ‹ ¿ıÏËÛ˘ ÁÈ· Ù· ·È‰È¿ Â›Ó·È Ë Û˘ÌÌÂÙÔ¯‹ ÙÔ˘˜ Û ‰Ú·ÛÙËÚÈfiÙËÙ˜ Û˘Ì‚·Ù¤˜ Ì ÙË ÛˆÌ·ÙÈ΋ Î·È Û˘Ó·ÈÛıËÌ·ÙÈ΋ ÙÔ˘˜ ·Ó¿Ù˘ÍË, Ì ÙË ÌÔÚÊ‹ ÂχıÂÚÔ˘ ·È¯ÓȉÈÔ‡, fiÔ˘ ÂȂڷ‚‡ÂÙ·È Ë ÚÔÛ¿ıÂÈ· Î·È Ë Û˘ÌÌÂÙÔ¯‹ (1). ¢˘ÛÙ˘¯Ò˜ Ô Û‡Á¯ÚÔÓÔ˜ ÙÚfiÔ˜ ˙ˆ‹˜ ¤¯ÂÈ ÛÙÂÚ‹ÛÂÈ ÛËÌ·ÓÙÈο ÙË ‰˘Ó·ÙfiÙËÙ· ÂχıÂÚ˘ „˘¯·-

Ó‡̷, ÌÂ

ÙËÓ ¿ÚÈÛÙË ·ıÏËÙÈ΋ Â›‰ÔÛË (competitive sports) (1-5). ŒÙÛÈ, Ô ÚÔ-·ÁˆÓÈÛÙÈÎfi˜ ¤ÏÂÁ¯Ô˜ Î·È Ë ÈÛÙÔÔ›ËÛË Ù˘ ˘Á›·˜ ÙˆÓ ·È‰ÈÒÓ ÁÈ· ÙË Û˘ÌÌÂÙÔ¯‹ ÙÔ˘˜ Û ۯÔÏÈΤ˜ Î·È Â͈ۯÔÏÈΤ˜ ·ıÏËÙÈΤ˜

ÁˆÁÈ΋˜ ¿ıÏËÛ˘ (recreational-leisure activities) Û Â›Â‰Ô ÁÂÈÙÔÓÈ¿˜ Î·È ˆ˜ ÌfiÓË ÂÓ·ÏÏ·ÎÙÈ΋ χÛË ÚÔ‚¿ÏÏÂÈ Ë Û˘ÌÌÂÙÔ¯‹ ÛÙË Û¯ÔÏÈ΋ Á˘ÌÓ·ÛÙÈ΋ ‹ Û ÔÚÁ·ÓˆÌ¤Ó˜ ·ıÏËÙÈΤ˜ ‰Ú·ÛÙËÚÈfiÙËÙ˜. √ÏÔ¤Ó· ÂÚÈÛÛfiÙÂÚ· ·È‰È¿, fiÏÔ Î·È ÌÈÎÚfiÙÂÚ˘ ËÏÈΛ·˜, Û˘ÌÌÂÙ¤¯Ô˘Ó Û ·ıÏËÙÈΤ˜ ‰Ú·ÛÙËÚÈfiÙËÙ˜, ·ÙÔÌÈΤ˜ ‹ ÔÌ·‰ÈΤ˜, ÔÈ Ôԛ˜ ·ÔÎÏ›ÓÔ˘Ó ·fi ÙË ÊÈÏÔÛÔÊ›· ÙÔ˘ „˘¯·ÁˆÁÈÎÔ‡ ·ÈÁÓȉÈÔ‡, ··ÈÙÒÓÙ·˜ Û˘ÛÙËÌ·ÙÈ΋

Î·Ú ‰È·ÁÁÂȷ΋ ÓfiÛÔ˜ (16,17). ∞ÓÙ›ıÂÙ·, Ë ‹È·

¿ıÏËÛË ÂÈÙÚ¤ÂÙ·È ·ÎfiÌ· Î·È Û ·ÛıÂÓ›˜ Ì ÁÂÓÂ-

ÙÈο ηډȷÁÁÂȷο ÓÔÛ‹Ì·Ù·, Ô˘ ÌÔÚÔ‡Ó Ó·

Û˘ÌÌÂÙ¿Û¯Ô˘Ó Ì ·ÛÊ¿ÏÂÈ· ÛÙËÓ ÏÂÈÔÓfiÙËÙ· ÙˆÓ

ÌË Û˘ÛÙËÌ·ÙÈÎÒÓ ÌÔÚÊÒÓ ¿ıÏËÛ˘ ‹È·˜ ¤ÓÙ·Û˘ (9). ∆¤ÏÔ˜, Ë Ê˘ÛÈ΋ ‰Ú·ÛÙËÚÈfiÙËÙ· ÛÙ· Ï·›ÛÈ·

Ù˘ ÁÂÈÙÔÓÈ¿˜ ‹ ÙÔ˘ ‰ËÌÔÙÈÎÔ‡ Û¯ÔÏ›Ԣ ıˆÚ›ٷÈ

ÁÂÓÈο ¯·ÌËÏÔ‡ ÎÈÓ‰‡ÓÔ˘ Î·È ˆ˜ Ù¤ÙÔÈ· Ú¤ÂÈ Ó·

ÂÈÙÚ¤ÂÙ·È ˆ˜ ¤Ó· Ù̷̋ ÙˆÓ Î·ıËÌÂÚÈÓÒÓ ‰Ú·ÛÙËÚÈÔًوÓ, ·ÎfiÌ· Î·È Û ·ÛıÂÓ›˜ Ì ÁÂÓÂÙÈο

ηډȷÁÁÂȷο ÓÔÛ‹Ì·Ù· (9,17).

¢ÈÂıÓ›˜ ηÙ¢ı˘ÓÙ‹ÚȘ Ô‰ËÁ›Â˜ ÁÈ· ÙÔÓ ¤ÏÂÁ¯Ô

Ù˘ ηډȷÁÁÂȷ΋˜ ˘Á›·˜ Ó¤ˆÓ ·ıÏËÙÒÓ

∫ÔÈÓ¿ ¯·Ú·ÎÙËÚÈÛÙÈο ÙˆÓ ‰ÈÂıÓÒÓ Ô‰ËÁÈÒÓ Â›-

Ó·È fiÙÈ ·ÊÔÚÔ‡Ó ·ÔÎÏÂÈÛÙÈο Û ·ıÏËÙ¤˜ Ô˘

Û˘ÌÌÂÙ¤¯Ô˘Ó Û ·ÓÙ·ÁˆÓÈÛÙÈο ·ıϋ̷ٷ (Û˘ÌÂ-

ÚÈÏ·Ì‚¿ÓÔÓÙ·È Î·È ÔÈ Û¯ÔÏÈÎÔ› ·ÁÒÓ˜) (18,19). ∆·

ÚÔÙÂÈÓfiÌÂÓ· Û˘ÛÙ‹Ì·Ù· Ì·˙ÈÎÔ‡ ÂϤÁ¯Ô˘ (screening) ‚·Û›˙ÔÓÙ·È ÛÙË ¯Ú‹ÛË ÚÔÙ˘ÔÔÈË̤ÓÔ˘ ·ÙÔÌÈÎÔ‡ Î·È ÔÈÎÔÁÂÓÂÈ·ÎÔ‡ ÈÛÙÔÚÈÎÔ‡ Î·È ÛÙË

ÏÂÙÔÌÂÚ‹ ÎÏÈÓÈ΋ ÂͤٷÛË ÙÔ˘ ηډȷÁÁÂÈ·ÎÔ‡ Û˘ÛÙ‹Ì·ÙÔ˜. ∂ÓÒ ˘¿Ú¯ÂÈ ‰È¯ÔÁӈ̛· Û¯ÂÙÈο Ì ÙË ¯ÚËÛÈÌfiÙËÙ· Ù˘ Ì·˙È΋˜ ¯Ú‹Û˘ ËÏÂÎÙÚÔηډÈÔÁڷʋ̷ÙÔ˜, Ô ˘ÂÚ˯ÔηډÈÔÁÚ·ÊÈÎfi˜ ¤ÏÂÁ-

¯Ô˜ ÙˆÓ ·ıÏËÙÒÓ ¯ˆÚ›˜ Ó· ˘¿Ú¯Ô˘Ó ÂӉ›ÍÂȘ ·fi

ÙÔ ÈÛÙÔÚÈÎfi Î·È ÙËÓ ÎÏÈÓÈ΋ ÂͤٷÛË ‰ÂÓ Û˘ÓÈÛٿٷÈ. ¶·Ú¿ÏÏËÏ·, ÙÔÓ›˙ÂÙ·È fiÙÈ, ÂÓÒ Ë ÌË Û˘ÌÌfiÚ-

ʈÛË ÙˆÓ È·ÙÚÒÓ Ì ÙȘ Ô‰ËÁ›Â˜ ‰ÂÓ ÛÙÔȯÂÈÔıÂÙ›

È·ÙÚÈ΋ ·Ì¤ÏÂÈ·, Ë ÂÊ·ÚÌÔÁ‹ ÙÔ˘˜ ·ÔÙÂÏ› ÛÙÔÈ-

¯Â›Ô ηϋ˜ È·ÙÚÈ΋˜ Ú·ÎÙÈ΋˜ Ô˘ Ú¤ÂÈ Ó· Ï·Ì-

‚¿ÓÂÙ·È

ıÂÙÈο ˘fi„Ë Û ÂΉ›Î·ÛË Û¯ÂÙÈÎÒÓ ˘Ô-

ı¤ÛÂˆÓ (18,19).

1.∞ÌÂÚÈηÓÈΤ˜Î·Ù¢ı˘ÓÙ‹ÚȘԉËÁ›Â˜ (∞∏∞,2007)

√È Î·Ù¢ı˘ÓÙ‹ÚȘ Ô‰ËÁ›Â˜ Ù˘ ∞ÌÂÚÈηÓÈ΋˜ ∫·Ú‰ÈÔÏÔÁÈ΋˜ ∂Ù·ÈÚ›·˜ (∞∏∞) ·ÊÔÚÔ‡Ó ÛÙÔÓ

¤ÏÂÁ¯Ô Ó¤ˆÓ >12 ÂÙÒÓ, ·ÏÏ¿ ÌÔÚÔ‡Ó Ó· ¤¯Ô˘Ó ÈÛ¯‡

Î·È ÁÈ· ÓÂfiÙÂÚ˜ ËÏÈ˘, ηıÒ˜ Î·È ÁÈ· ÌÂÌÔӈ̤Ó˜ ·ÍÈÔÏÔÁ‹ÛÂȘ Û ȷÙÚÂ›Ô (19). ™ÙȘ ∏¶∞ ‰ÂÓ

˘¿Ú¯ÂÈ ÓÔÌÈÎfi-ıÂÛÌÈÎfi Ï·›ÛÈÔ ÁÈ· ÙȘ ˘Ô¯ÚÂÒ-

ÛÂȘ ÙˆÓ ÛˆÌ·Ù›ˆÓ Û¯ÂÙÈο Ì ÙÔÓ ¤ÏÂÁ¯Ô ÙˆÓ

·ıÏËÙÒÓ, ÙÔ ÎfiÛÙÔ˜ ÙÔ˘ ÚÔ-·ÁˆÓÈÛÙÈÎÔ‡ ÂϤÁ¯Ô˘

‰ÂÓ Î·Ï‡ÙÂÙ·È ·fi ÙȘ ·ÛÊ·ÏÈÛÙÈΤ˜ ÂÙ·ÈÚ›˜, ÂÓÒ 35% ÙˆÓ ÂϤÁ¯ˆÓ Á›ÓÔÓÙ·È ·fi ÌË È·ÙÚÈÎfi ÚÔÛˆÈ-

Îfi (¯ÂÈÚÔÚ·ÎÙÈÎÔ› Î.Ù.Ï.). √È Ô‰ËÁ›Â˜ ·ÍÈÔÏÔÁÔ‡-

·ÈÊÓ›‰ÈÔ˘ ı·Ó¿ÙÔ˘ 1 ÂÚÈÛÙ·ÙÈÎfi ·Ó¿ 200.000 ·ıÏËÙ¤˜, Ë ÂÈÙ¤ÏÂÛË ËÏÂÎÙÚÔηÚ-

‰ÂÓ Û˘ÓÈÛٿٷÈ, ηıÒ˜ ÙÔ ÎfiÛÙÔ˜ ı·

·ÓÂÚ¯fiÙ·Ó Û 333.000 ‰ÔÏ¿ÚÈ· ÁÈ· οı ·ÓȯÓ¢fiÌÂÓÔ ·ıÏËÙ‹ Ì ηډÈÔ¿ıÂÈ·, ÌÂ Û˘ÓÔÏÈÎfi ÂÙ‹ÛÈÔ ÎfiÛÙÔ˜ ÁÈ· ÙÔÓ Û˘ÓÔÏÈÎfi ÏËı˘ÛÌfi 2 ‰ÈÛÂηÙÔÌ̇ÚÈ·

‰ÔÏ¿ÚÈ·, Ô˘ ıˆÚÂ›Ù·È ··ÁÔÚ¢ÙÈÎfi (19). √ Û˘ÓÈÛÙÒÌÂÓÔ˜ ¤ÏÂÁ¯Ô˜ ÂÚÈÏ·Ì‚¿ÓÂÈ 12 ÛËÌ›·: 8 ·fi ÙÔ

ÈÛÙÔÚÈÎfi (·ÙÔÌÈÎfi Î·È ÔÈÎÔÁÂÓÂÈ·Îfi) Î·È 4 ·fi ÙËÓ

ÎÏÈÓÈ΋ ÂͤٷÛË (¶›Ó·Î·˜ 1). ø˜ ˘Ô¯ÚˆÙÈ΋ ıˆÚÂ›Ù·È Ë ÂȂ‚·›ˆÛË ·fi ÙÔ˘˜ ÁÔÓ›˜ Ù˘ ÔÚıfiÙËÙ·˜

ÙˆÓ ··ÓÙ‹ÛÂˆÓ ÙÔ˘ ÈÛÙÔÚÈÎÔ‡ Û ·È‰È¿-·ıÏËÙ¤˜,

¶›Ó·Î·˜ 1. ∞ÌÂÚÈηÓÈΤ˜ ηÙ¢ı˘ÓÙ‹ÚȘ Ô‰ËÁ›Â˜ (2007) ÚÔ·ÁˆÓÈÛÙÈÎÔ‡ ÂϤÁ¯Ô˘ ÁÈ· Û˘ÌÌÂÙÔ¯‹ Û ·ÓÙ·ÁˆÓÈÛÙÈο ·ıϋ̷ٷ (19)

∞∆√ªπ∫√ π™∆√ƒπ∫√* (1-5)

1. £ˆÚ·ÎÈÎfi ¿ÏÁÔ˜-‰˘ÛÊÔÚ›· ÛÙËÓ ÎfiˆÛË

2. ∞ÓÂÍ‹ÁËÙË Û˘ÁÎÔ‹ - ·Ú’ ÔÏ›ÁÔÓ Û˘ÁÎÔ‹**

3. ∂‡ÎÔÏË ÎfiˆÛË / ‰‡ÛÓÔÈ· ηٿ ÙËÓ ¿ÛÎËÛË

4. ¶ÚÔËÁÔ‡ÌÂÓË ‰È·›ÛÙˆÛË Ê˘Û‹Ì·ÙÔ˜

5. °ÓˆÛÙ‹ ˘¤ÚÙ·ÛË

√π∫√°∂¡∂π∞∫√ π™∆√ƒπ∫√ (6-8)

6. ¶ÚÒÈÌÔ˜ ı¿Ó·ÙÔ˜ (·ÈÊÓ›‰ÈÔ˜) Û ËÏÈΛ· <50 ÂÙÒÓ ·fi ηډÈÔ¿ıÂÈ· Û ≥1 Û˘ÁÁÂÓ‹

7. ™Ô‚·Ú‹ ÓÔÛËÚfiÙËÙ·-·Ó·ËÚ›· ·fi ηډȷ΋ ÓfiÛÔ Û ÛÙÂÓfi Û˘ÁÁÂÓ‹ < 50 ÂÙÒÓ

8. °ÓÒÛË ‡·Ú͢ ÂȉÈÎfiÙÂÚˆÓ Î·Ú‰È·ÁÁÂÈ·ÎÒÓ

∞¡∆π∫∂πª∂¡π∫∏ ∂•∂∆∞™∏ (9-12)

9. ∫·Ú‰È·Îfi ʇÛËÌ·***

10. æËÏ·ÊËÙ¤˜ ÌËÚÈ·›Â˜

11. º·ÈÓÔÙ˘Èο ¯·Ú·ÎÙËÚÈÛÙÈο Û˘Ó‰ÚfiÌÔ˘ Marfan

12. ª¤ÙÚËÛË ·ÚÙËÚȷ΋˜

∞∆√ªπ∫√ π™∆√ƒπ∫√ (1-4)

Ô‰ËÁ›Â˜ (2005) ÚÔ·ÁˆÓÈÛÙÈÎÔ‡

1. £ˆÚ·ÎÈÎfi ¿ÏÁÔ˜-‰˘ÛÊÔÚ›· ÛÙËÓ ÎfiˆÛË

2. ∞ÓÂÍ‹ÁËÙË Û˘ÁÎÔ‹ - ·Ú’ ÔÏ›ÁÔÓ Û˘ÁÎÔ‹

3. ∂‡ÎÔÏË ÎfiˆÛË / ‰‡ÛÓÔÈ· ηٿ ÙËÓ ¿ÛÎËÛË

4. πÛÙÔÚÈÎfi ¿ÚÚ˘ıÌ˘ ηډȷ΋˜ ÏÂÈÙÔ˘ÚÁ›·˜ ‹ ·ÏÌÒÓ

√π∫√°∂¡∂π∞∫√ π™∆√ƒπ∫√ (5-6)

5. ¶ÚÒÈÌÔ Î·Ú‰È·Îfi ÂÂÈÛfi‰ÈÔ ‹ ı¿Ó·ÙÔ˜ (·ÈÊÓ›‰ÈÔ˜) Û ËÏÈΛ· <55 ÂÙÒÓ (¿Ó‰Ú˜) <65 ÂÙÒÓ (Á˘Ó·›Î˜)

6. °ÓÒÛË ‡·Ú͢ ÂȉÈÎfiÙÂÚˆÓ Î·Ú‰È·ÁÁÂÈ·ÎÒÓ ÚÔ‚ÏËÌ¿ÙˆÓ Û ̤ÏË Ù˘ ÔÈÎÔÁ¤ÓÂÈ·˜: ˘ÂÚÙÚÔÊÈ΋ ‹ ‰È·Ù·ÙÈ΋ Ì˘ÔηډÈÔ¿ıÂÈ·, Û‡Ó‰ÚÔÌÔ LQT ‹ Brugada, Marfan ‹ ÎÏÈÓÈο ÛËÌ·ÓÙÈΤ˜ ·ÚÚ˘ı̛˜ ‹ ÛÙÂÊ·ÓÈ·›· ÓfiÛÔ˜

∞¡∆π∫∂πª∂¡π∫∏ ∂•∂∆∞™∏ (7-13)

7. ∫·Ú‰È·Îfi ʇÛËÌ· (‰È·ÛÙÔÏÈÎfi ‹ Û˘ÛÙÔÏÈÎfi ¤ÓÙ·Û˘ > 2/6)

8. ™˘ÛÙÔÏÈο ÎÏÈΘ (ÌÂÛÔ-ÙÂÏÔÛ˘ÛÙÔÏÈο)

9. ªÔÓ‹Ú˘ ‹ ¢ڇ˜ Î·È ÛÙ·ıÂÚfi˜ ‰È¯·ÛÌfi˜ 2Ô˘ ηډȷÎÔ‡ ÙfiÓÔ˘

10. ∞ÚÚ˘ıÌ›·

11. æËÏ·ÊËÙ¤˜ ÌËÚÈ·›Â˜

12. º·ÈÓÔÙ˘Èο ¯·Ú·ÎÙËÚÈÛÙÈο Û˘Ó‰ÚfiÌÔ˘ Marfan

13. ª¤ÙÚËÛË ·ÚÙËÚȷ΋˜ ›ÂÛ˘

∏§∂∫∆ƒ√∫∞ƒ¢π√°ƒ∞º∏ª∞ (14)

ÂÓÒ ÔÈ ·ıÏËÙ¤˜ ıˆÚÔ‡ÓÙ·È Û˘Ó˘‡ı˘ÓÔÈ ·Ó·ÊÔÚÈ-

ο Ì ÙËÓ ·ÎÚ›‚ÂÈ· ÙˆÓ ··ÓÙ‹ÛˆÓ.

2.∂˘Úˆ·˚Τ˜Î·Ù¢ı˘ÓÙ‹ÚȘԉËÁ›Â˜ (ESC,2005)

∫‡ÚÈ· ‰È·ÊÔÚ¿ ÙˆÓ Ô‰ËÁÈÒÓ Ù˘ ∂˘Úˆ·˚΋˜

∫·Ú‰ÈÔÏÔÁÈ΋˜ ∂Ù·ÈÚ›·˜ (ESC) Â›Ó·È Ë Û‡ÛÙ·ÛË ÁÈ·

ÁÂÓÈÎÂ˘Ì¤ÓË ¯Ú‹ÛË ÙÔ˘ ËÏÂÎÙÚÔηډÈÔÁڷʋ̷ÙÔ˜

(∏∫°) 12 ··ÁˆÁÒÓ ÛÙÔÓ ¤ÏÂÁ¯Ô fiÏˆÓ ·ÓÂÍ·ÈÚ¤Ùˆ˜

ÙˆÓ ·ıÏËÙÒÓ (18). ∫˘Ú›·Ú¯Ë ı¤ÛË ÛÙË ‰È·ÌfiÚʈÛË

ÙˆÓ Â˘Úˆ·˚ÎÒÓ Ô‰ËÁÈÒÓ Â›¯Â Ë Ì·ÎÚÔ¯ÚfiÓÈ· ÂÌÂÈ-

Ú›· Ù˘ πÙ·Ï›·˜, ÛÙËÓ ÔÔ›· ¤¯ÂÈ ÂÈ‚ÏËı› ÓÔÌÔıÂÙÈ-

ο (·fi ÙÔ 1982) Ô ÚÔ-·ÁˆÓÈÛÙÈÎfi˜ ¤ÏÂÁ¯Ô˜ ÙˆÓ

·ıÏËÙÒÓ Û ·ÓÙ·ÁˆÓÈÛÙÈο ·ıϋ̷ٷ Ì ÙËÓ ÚÔ-

Ûı‹ÎË ∏∫°Ì·ÙÔ˜. √ Ì·˙ÈÎfi˜ ¤ÏÂÁ¯Ô˜ ÙˆÓ 6 ÂηÙÔÌ-

Ì˘Ú›ˆÓ ·ıÏËÙÒÓ (10% ÙÔ˘ ÏËı˘ÛÌÔ‡) ÂÙËÛ›ˆ˜ ›ӷÈ

ÂÊÈÎÙfi˜ ¯¿ÚË ÛÙËÓ Â·Ú΋ ÛÙÂϤ¯ˆÛË Ì ÂÍÂȉÈ΢-

̤ÓÔ˘˜ È·ÙÚÔ‡˜ Ô˘, ÌÂÙ¿ ·fi 4ÂÙ‹ Âȉ›Î¢ÛË ÛÙËÓ ∞ıÏËÙÈ·ÙÚÈ΋, Â›Ó·È ·ÔÎÏÂÈÛÙÈο ˘‡ı˘ÓÔÈ ÁÈ· ÙÔÓ

¤ÏÂÁ¯Ô ÙˆÓ ·ıÏËÙÒÓ. ∏ ·ÔÙÂÏÂÛÌ·ÙÈÎfiÙËÙ· ÙÔ˘ Û˘ÛÙ‹Ì·ÙÔ˜ ·Ó›¯Ó¢Û˘ ·ԉ›¯ıËΠ̠ÙË Ì›ˆÛË Î·Ù¿ 90% ÙˆÓ ÂÚÈÙÒÛÂˆÓ ·ÈÊÓ›‰ÈÔ˘ ηډȷÎÔ‡ ı·Ó¿ÙÔ˘ Û ·ıÏËÙ¤˜ 12-35 ÂÙÒÓ, ΢ڛˆ˜ ¯¿ÚË ÛÙËÓ ·Ó›¯Ó¢ÛË ÙˆÓ ÂÚÈÙÒÛÂˆÓ ˘ÂÚÙÚÔÊÈ΋˜ Ì˘ÔηډÈÔ¿ıÂÈ·˜ Ì ÙË ‚Ô‹ıÂÈ· ÙÔ˘ ∏∫°Ì·ÙÔ˜ (20,21).

3.ÕÏÏ·Û˘ÛÙ‹Ì·Ù·ÂϤÁ¯Ô˘Î·Ú‰È·ÁÁÂȷ΋˜ ˘Á›·˜·È‰ÈÒÓÛ¯ÔÏÈ΋˜ËÏÈΛ·˜ ªÔÏÔÓfiÙÈ ÏÈÁfiÙÂÚÔ ÁÓˆÛÙfi, ·fi ÙÔ 1973 ÛÙËÓ π·ˆÓ›· ¤¯ÂÈ ıÂÛÌÔıÂÙËı› ÚfiÁÚ·ÌÌ· Ì·˙ÈÎÔ‡ ÂϤÁ¯Ô˘ ηډȷÁÁÂȷ΋˜ ˘Á›·˜ Û fiÏ· Ù· ·È‰È¿ ηٿ ÙËÓ Â›ÛÔ‰fi ÙÔ˘˜ ÛÙÔ ‰ËÌÔÙÈÎfi Û¯ÔÏÂ›Ô (7 ÂÙÒÓ) Î·È ÛÙÔ Á˘ÌÓ¿ÛÈÔ (13 ÂÙÒÓ) (22-24). √ ¤ÏÂÁ¯Ô˜ ÂÚÈÏ·Ì‚¿ÓÂÈ ÏËÚÔÊÔڛ˜ ·fi ÙÔ ÈÛÙÔÚÈÎfi (Û˘ÌÂÚÈÏ·Ì‚·ÓÔ̤ÓÔ˘ ÙÔ˘ ÈÛÙÔÚÈÎÔ‡ ÓfiÛËÛ˘ ·fi ÓfiÛÔ Kawasaki ‹ ÚÂ˘Ì·ÙÈÎfi ˘ÚÂÙfi), ÂÈÙ¤ÏÂÛË ·ÏÔÔÈË̤ÓÔ˘ ∏∫°Ì·ÙÔ˜ (4 ··ÁˆÁÒÓ) Î·È ÊˆÓÔηډÈÔÁڷʋ̷ÙÔ˜ (Û ‰‡Ô ı¤ÛÂȘ ÛÙÔ ÚÔοډÈÔ). ªÂ ‚¿ÛË ÙÔ Û‡ÛÙËÌ· ·˘Ùfi, 10% ÙˆÓ ·È‰ÈÒÓ ·Ú·¤ÌÔÓÙ·È ÂÚ·ÈÙ¤Úˆ ÁÈ· ÂÍÂȉÈÎÂ˘Ì¤ÓÔ ˘ÂÚ˯ÔηډÈÔÁÚ¿ÊËÌ·, ÂÓÒ Ë Û˘¯ÓfiÙÂÚË Û˘ÁÁÂÓ‹˜ ηډÈÔ¿ıÂÈ· Ô˘ ·ÓȯÓ‡ÂÙ·È Â›Ó·È Ë ÌÂÛÔÎÔÏÈ΋ ÂÈÎÔÈÓˆÓ›· (0,02%) (24). ¶ÈÏÔÙÈ΋ ÂÊ·ÚÌÔÁ‹ ÚÔÁÚ¿ÌÌ·ÙÔ˜ ηډÈÔÏÔÁÈÎÔ‡ ÂϤÁ¯Ô˘ ·È‰ÈÒÓ Û¯ÔÏÈ΋˜ ËÏÈΛ·˜ Ì ¯Ú‹ÛË ÚÔÙ˘ÔÔÈË̤ÓÔ˘ ÈÛÙÔÚÈÎÔ‡, ËÏÂÎÙÚÔηډÈÔÁڷʋ̷ÙÔ˜ Î·È „ËÊÈ·ÎÔ‡ ʈÓÔηډÈÔÁڷʋ̷ÙÔ˜, Ì ÙËÓ ¤ÁÎÚÈÛË ÙÔ˘

¶·È‰·ÁˆÁÈÎÔ‡ πÓÛÙÈÙÔ‡ÙÔ˘ Î·È ÙÔ˘ ÀÔ˘ÚÁ›Ԣ ¶·È‰Â›·˜, ¤¯ÂÈ ‹‰Ë ÙÂı› Û ÂÊ·ÚÌÔÁ‹ ÛÙËÓ ¶ÂÚÈʤÚÂÈ· ∫Ú‹Ù˘. ™ÙËÚ›˙ÂÙ·È ÌÂٷ͇ ¿ÏÏˆÓ ÛÙËÓ ÂÍ ·ÔÛÙ¿ÛÂ-

ÙˆÓ Ë¯ÔÁÚ·ÊËÌ¤ÓˆÓ ‹¯ˆÓ ηډȷ΋˜

Ì ÈηÓfiÙËÙ· ·Ó›¯Ó¢Û˘ ÙˆÓ ·ÈÌÔ‰˘Ó·ÌÈο ÛËÌ·ÓÙÈÎÒÓ Î·Ú‰ÈÔ·ıÂÈÒÓ Î·Ù¿ 96% Î·È ÙˆÓ ÏÂÈÙÔ˘ÚÁÈÎÒÓ Ê˘ÛËÌ¿ÙˆÓ Î·Ù¿ 93-95%, ηٿ ÙËÓ ÈÏÔÙÈ΋ ·ÍÈÔÏfiÁËÛË Ù˘ ÌÂıfi‰Ô˘ (25).

À¶∂À£À¡√™ °π∞ ∆∏¡ ∞∫ƒπµ∂π∞ ∆√À π™∆√ƒπ∫√À

ñ √ È·ÙÚfi˜ (Î·È fi¯È ÔÈ ÁÔÓ›˜) ¤¯ÂÈ ÙËÓ Â˘ı‡ÓË Î·Ù·ÁÚ·Ê‹˜ ÙÔ˘ ·ÙÔÌÈÎÔ‡ ÈÛÙÔÚÈÎÔ‡

A∆√ªπ∫√ π™∆√ƒπ∫√

∞Ô˘ÛÈ¿˙Ô˘Ó Ù· ·ÎfiÏÔ˘ı· ÛÙÔȯ›·:

ñ ÚÔËÁÔ‡ÌÂÓË ‡·ÚÍË Ê˘Û‹Ì·ÙÔ˜ (∞∏∞)

ñ ÚÔËÁÔ‡ÌÂÓË ‰È·›ÛÙˆÛË ˘¤ÚÙ·Û˘ (∞∏∞)

ñ ÚÔËÁÔ‡ÌÂÓË ‰È·›ÛÙˆÛË ·ÚÚ˘ıÌ›·˜ (∂SC)

ñ ÏÈÔı˘Ì›· (Û˘ÁÎÔ‹) Î·È ·˘ÙfiÌ·Ù·, fi¯È ÌfiÓÔ ÌÂÙ¿ ·fi ¿ÛÎËÛË (ESC, AHA)

√π∫√°∂¡∂π∞∫√ π™∆√ƒπ∫√

∞Ô˘ÛÈ¿˙ÂÈ ϋڈ˜ οı ÏËÚÔÊÔÚ›· ÁÈ·:

ñ √ÈÎÔÁÂÓÂÈ·Îfi ÈÛÙÔÚÈÎfi ÚÒÈÌÔ˘ ı·Ó¿ÙÔ˘ (·ÈÊÓ›‰ÈÔ˘): Û ËÏÈΛ· <50 ÂÙÒÓ ·fi ηډÈÔ¿ıÂÈ· Û >1 Û˘ÁÁÂÓ‹ (AHA) / ı·Ó¿ÙÔ˘ ‹ ÚÒÈÌÔ˘ ηډȷÎÔ‡ ÂÂÈÛÔ‰›Ô˘ Û ËÏÈΛ· <55 ÂÙÒÓ (¿Ó‰Ú˜) <65 ÂÙÒÓ (Á˘Ó·›Î˜) (ESC)

ñ ™Ô‚·Ú‹ ÓÔÛËÚfiÙËÙ·-·Ó·ËÚ›· ·fi ηډȷ΋ ÓfiÛÔ Û ÛÙÂÓfi Û˘ÁÁÂÓ‹ <50 ÂÙÒÓ (AHA)

ñ °ÓÒÛË ‡·Ú͢ ÂȉÈÎfiÙÂÚˆÓ Î·Ú‰È·ÁÁÂÈ·ÎÒÓ ÚÔ‚ÏËÌ¿ÙˆÓ Û ̤ÏË Ù˘ ÔÈÎÔÁ¤ÓÂÈ·˜: ˘ÂÚÙÚÔÊÈ΋ ‹ ‰È·Ù·ÙÈ΋ Ì˘ÔηÚ-

‰ÈÔ¿ıÂÈ·, Û‡Ó‰ÚÔÌÔ LQT ‹ ¿ÏÏˆÓ Î·Ó·ÏÔ·ıÂÈÒÓ, Û‡Ó‰ÚÔÌÔ Marfan ‹ ÎÏÈÓÈο ÛËÌ·ÓÙÈΤ˜ ·ÚÚ˘ı̛˜ (AHA, ESC) ‹

ÛÙÂÊ·ÓÈ·›· ÓfiÛÔ˜ (ESC)

∞¡∆π∫∂πª∂¡π∫∏ ∂•∂∆∞™∏

∞Ô˘ÛÈ¿˙Ô˘Ó Ù· ·ÎfiÏÔ˘ı· ÛÙÔȯ›·:

ñ ∞ÍÈÔÏfiÁËÛË Ê˘Û‹Ì·ÙÔ˜ Û ‰È¿ÊÔÚ˜ ı¤ÛÂȘ (‡ÙÈ·, fiÚıÈ·) (∞∏∞)

ñ ¶ÂÚÈÁÚ·Ê‹ Ê˘Û‹Ì·ÙÔ˜ ˆ˜ ‰È·ÛÙÔÏÈÎfi ‹ ¤ÓÙÔÓÔ (> 2/6) Û˘ÛÙÔÏÈÎfi (∂SC)

ñ ¶ÂÚÈÁÚ·Ê‹ ÚfiÛıÂÙˆÓ ‹¯ˆÓ (ÎÏÈÎ) ‹ ·ÓˆÌ·ÏÈÒÓ 2Ô˘ ÙfiÓÔ˘ (∂SC)

ñ ¶ÂÚÈÁÚ·Ê‹ ·ÚÔ˘Û›·˜ ·ÚÚ˘ıÌ›·˜ (ESC)

ñ ¶ÂÚÈÁÚ·Ê‹ ·ÚÔ˘Û›·˜ Ê·ÈÓfiÙ˘Ô˘ Marfan (∂SC, ∞∏∞)

∏§∂∫∆ƒ√∫∞ƒ¢π√°ƒ∞º∏ª∞

ñ ¢ÂÓ ÂÚÈÏ·Ì‚¿ÓÂÙ·È (Ô‡ÙÂ Î·È ÛÙËÓ ·ıÏËÙÈ΋-Ì·ıËÙÈ΋ Ù·˘ÙfiÙËÙ·) (ESC)

Ù˘ ˘Á›·˜ ÙˆÓ Ì·ıËÙÒÓ ÛÙË ¯ÒÚ· Ì·˜ ·ÔÙÂÏ› ÛË-

Ì·ÓÙÈ΋ ÔÏÈÙÈ΋ ‰ËÌfiÛÈ·˜ ˘Á›·˜. ∆Ô ÁÂÁÔÓfi˜ fiÙÈ Ë

·ÍÈÔÏfiÁËÛË Á›ÓÂÙ·È ·ÔÎÏÂÈÛÙÈο ·fi È·ÙÚÔ‡˜ Ì ÙË

¯Ú‹ÛË ÚÔÙ˘ÔÔÈË̤ÓÔ˘ ÂÓÙ‡Ô˘ (∞.¢.À.) ·ÔÙÂÏ› ÂÚ·ÈÙ¤Úˆ ÂÁÁ‡ËÛË ÁÈ· ÙËÓ ·ÔÙÂÏÂÛÌ·ÙÈÎfiÙËÙ· ÙÔ˘ Û˘ÛÙ‹Ì·ÙÔ˜ ÂϤÁ¯Ô˘. ∫ÔÈÓ¿ Ì ÙȘ ‰ÈÂıÓ›˜ ηÙ¢ı˘ÓÙ‹ÚȘ Ô‰ËÁ›Â˜ Â›Ó·È Ù· 3 ÂÚˆÙ‹Ì·Ù· ·ÙÔÌÈÎÔ‡ ÈÛÙÔÚÈÎÔ‡ Î·È Ù· 3 ÎÏÈÓÈο ÛËÌ›· ÚÔ˜ ·ÍÈÔÏfiÁËÛË. ™˘ÁÎÚÈÙÈο, fï˜, Ì ٷ ·ÓÙ›ÛÙÔȯ· ÚÔÙ˘ÔÔÈË̤ӷ ‰ÈÂıÓ‹ ÂÚˆÙËÌ·ÙÔÏfiÁÈ·: ·) ·Ô˘ÛÈ¿˙Ô˘Ó ÛËÌ·ÓÙÈΤ˜ ÏËÚÔÊÔڛ˜ ÙÔ˘ ·ÙÔÌÈÎÔ‡ ÈÛÙÔÚÈÎÔ‡, ‚) ‰ÂÓ ˘¿Ú¯Ô˘Ó ηıfiÏÔ˘ ÏËÚÔÊÔڛ˜ ÙÔ˘ ÔÈÎÔÁÂÓÂÈ·ÎÔ‡ ÈÛÙÔÚÈÎÔ‡, Á) Ë ÂÚÈÁÚ·Ê‹ ÙˆÓ ÎÏÈÓÈÎÒÓ Â˘ÚËÌ¿ÙˆÓ ·fi ÙÔ Î·Ú‰È·ÁÁÂÈ·Îfi ‰ÂÓ Â›Ó·È ÏÂÙÔÌÂÚ‹˜, ÂÓÒ ‰) ÔÈ ÁÔÓ›˜ ‰ÂÓ Û˘Ó˘ÔÁÚ¿ÊÔ˘Ó ÁÈ· ÙËÓ ·ÎÚ›‚ÂÈ· ÙÔ˘ ÈÛÙÔÚÈÎÔ‡. ™ÙÔÓ ¶›Ó·Î· 3 ·ÚÔ˘ÛÈ¿˙ÂÙ·È Ë Û˘ÁÎÚÈÙÈ΋ ·ÍÈÔÏfiÁËÛË ÙÔ˘ ∞.¢.À. ·Ó·ÊÔÚÈο Ì ÙȘ ·ÓÙ›ÛÙÔȯ˜ Â˘Úˆ·˚Τ˜ (ESC) Î·È ·ÌÂÚÈηÓÈΤ˜ (∞∏∞) Ô‰ËÁ›Â˜. ¶·Ú¿ÏÏËÏ·, ¯ÚÂÈ¿˙ÔÓÙ·È ÙÚÔÔÔÈ‹ÛÂȘ Î·È ÚÔÛı‹Î˜, Èı·ÓÒ˜ Î·È Ù· ‰›· Ô˘ Û¯ÂÙ›˙ÔÓÙ·È Ì ÙËÓ ·ÍÈÔÏfiÁËÛË

·ÛÊ¿ÏÂÈ· ÙÔ˘ È·ÙÚÈÎÔ‡ ·ÔÚÚ‹ÙÔ˘, ÌÂ Û˘Ó·ÎfiÏÔ˘ıË

ÛÎfiÈÌË ·fiÎÚ˘„Ë ÏËÚÔÊÔÚÈÒÓ. ∏ ·ÎÚÈ‚‹˜ Û˘ÌϋڈÛË ÙÔ˘ ÔÈÎÔÁÂÓÂÈ·ÎÔ‡ ÈÛÙÔÚÈÎÔ‡ Èı·ÓfiÓ Â›Ó·È ·ÔÙÂÏÂÛÌ·ÙÈÎfiÙÂÚË Î·È ·ÛʷϤÛÙÂÚË Â¿Ó Û˘ÌÏËÚÒÓÂÙ·È ˘fi ÙËÓ Î·ıÔ‰‹ÁËÛË-Â›‚ÏÂ„Ë ÙÔ˘

ÔÈÎÔÁÂÓÂÈ·ÎÔ‡ ·È‰È¿ÙÚÔ˘, Ô ÔÔ›Ô˜ ı· Ú¤ÂÈ Ó· Â›Ó·È Î·È Ô ÌfiÓÔ˜ ˘‡ı˘ÓÔ˜ ÁÈ· ÙËÓ Ù‹ÚËÛË ÙÔ˘ È·ÙÚÈÎÔ‡

¢. ¶ÚÔÙ¿ÛÂȘ ÁÈ· ÙËÓ Ú·ÎÙÈ΋ ÂÊ·ÚÌÔÁ‹

·ÔÚÚ‹ÙÔ˘ (Â›Ó·È ·ÌÊ›‚ÔÏË Ë ÂÍ·ÛÊ¿ÏÈÛ‹ ÙÔ˘ Ì ÙË Ê‡Ï·Í‹ ÙˆÓ ÂÓÙ‡ˆÓ ÛÙÔ Û¯ÔÏ›Ô) Î·È Ì ÙË ÛˆÛÙ‹ ‰È·Ù‡ˆÛË ÙˆÓ ÂÚˆÙ‹ÛˆÓ. ªÂ ‚¿ÛË ÙËÓ ÚÔÛˆÈ΋ Ì·˜ ÂÌÂÈÚ›·, ˘¿Ú¯ÂÈ Û˘¯Ó¿ ·‰˘Ó·Ì›· ηٷÓfiËÛ˘ (.¯. Ë ˘ÂÚÙÚÔÊÈ΋ Ì˘ÔηډÈÔ¿ıÂÈ· ·Ó·Ê¤ÚÂÙ·È ˆ˜ ηډÈÔÌÂÁ·Ï›·) ‹ ¿ÁÓÔÈ· ‡·Ú͢ Û˘ÁÎÂÎÚÈÌ¤ÓˆÓ ‰È·ÁÓÒÛÂˆÓ ÛÙËÓ ÔÈÎÔÁ¤ÓÂÈ· Î·È Î¿ÔÙ ÂÈʇϷÍË ÁÈ· ÙËÓ

(Û˘ÌÏËÚÒÓÂÙ·È ·fi ÁÔÓ›˜ ηÈ

·È‰›·ÙÚÔ - fi¯È ÛÙÔ Û¯ÔÏ›Ô)

¶ÚfiÙ˘Ô πÛÙÔÚÈÎfi (·ÙÔÌÈÎfi-ÔÈÎÔÁÂÓÂÈ·Îfi) ∞ÍÈÔÏfiÁËÛ˘ πηÓfiÙËÙ·˜ ™˘ÌÌÂÙÔ¯‹˜ ¶·È‰ÈÒÓ Û ∞ıÏËÙÈΤ˜ ¢Ú·ÛÙËÚÈfiÙËÙ˜

¶·Ú·Î·ÏÒ, ··ÓÙ‹ÛÂÙ ¡∞π ‹ √Ãπ ÛÙ· ÂÚˆÙ‹Ì·Ù· Ô˘ ·ÎÔÏÔ˘ıÔ‡Ó

∞∆√ªπ∫√ π™∆√ƒπ∫√

1.£ˆÚ·ÎÈÎfi¿ÏÁÔ˜-‰˘ÛÊÔÚ›·ÛÙËÓÎfiˆÛË Œ¯ÂÈ ÔÙ¤ ·Ú·ÔÓÂı› ÙÔ ·È‰› Û·˜ ÁÈ· fiÓÔ ‹ ‰˘ÛÊÔÚ›· ÛÙÔÓ ıÒڷη ηٿ ÙË ‰È¿ÚÎÂÈ· ۈ̷ÙÈ΋˜ ¿ÛÎËÛ˘ ‹ Û‡ÓÙÔÌ· ÌÂÙ¿ ·fi ·˘Ù‹Ó; ¡∞π√Ãπ

2.∞ÓÂÍ‹ÁËÙËÛ˘ÁÎÔ‹-·Ú’ÔÏ›ÁÔÓÛ˘ÁÎÔ‹ Œ¯ÂÈ ÔÙ¤ ÙÔ ·È‰› Û·˜ ÏÈÔı˘Ì‹ÛÂÈ, ¯¿ÛÂÈ ÙȘ ·ÈÛı‹ÛÂȘ ÙÔ˘ ‹ ÂÌÊ·Ó›ÛÂÈ ÂÂÈÛfi‰ÈÔ Û·ÛÌÒÓ; ¡∞π√Ãπ

3.∂‡ÎÔÏËÎfiˆÛË/‰‡ÛÓÔȷηٿÙËÓ¿ÛÎËÛË ∫Ô˘Ú¿˙ÂÙ·È Â˘ÎÔÏfiÙÂÚ· ÙÔ ·È‰› Û·˜ ηٿ ÙËÓ ¿ÛÎËÛË, Û˘ÁÎÚÈÙÈο Ì ٷ ¿ÏÏ· ·È‰È¿, ‹ ¤¯ÂÈ ·Ú·ÔÓÂı› ÁÈ· ‰‡ÛÓÔÈ· Î·È ·‰˘Ó·Ì›· Ó· ¿ÚÂÈ ·¤Ú· ηٿ ÙËÓ ¿ÛÎËÛË; ¡∞π√Ãπ

4.πÛÙÔÚÈÎfi¿ÚÚ˘ıÌ˘ηډȷ΋˜ÏÂÈÙÔ˘ÚÁ›·˜‹·ÏÌÒÓ Œ¯ÂÈ ÔÙ¤ ÙÔ ·È‰› Û·˜ ·Ú·ÔÓÂı› ÁÈ· “¯Ù˘‹Ì·Ù·”

ÏÂÈÙÔ˘ÚÁ›· Ù˘ ηډȿ˜ ÙÔ˘; Œ¯ÂÈ ÂÏÂÁ¯ı› ÔÙ¤ ÁÈ· ·ÚÚ˘ıÌ›·; ¡∞π√Ãπ

5.¶ÚÔËÁÔ‡ÌÂÓˉȷ›ÛÙˆÛËÊ˘Û‹Ì·ÙÔ˜ °ÓˆÚ›˙ÂÙÂ Â¿Ó ¤¯ÂÈ ‰È·ÈÛÙˆı› ·ÚÔ˘Û›· ηډȷÎÔ‡

·fi ÙÔÓ ·È‰›·ÙÚÔ ‹ οÔÈÔ ÁÈ·ÙÚfi ÛÙÔ ·È‰› Û·˜; ¡∞π√Ãπ Œ¯ÂÈ ÂÏÂÁ¯ı› ·fi ηډÈÔÏfiÁÔ ÙÔ

¡∞π√Ãπ

6.πÛÙÔÚÈÎfi˘¤ÚÙ·Û˘ Œ¯ÂÈ ÙÔ ·È‰› Û·˜ ÁÓˆÛÙ‹ ˘¤ÚÙ·ÛË; ¡∞π√Ãπ

√π∫√°∂¡∂π∞∫√ π™∆√ƒπ∫√

7.¶ÚÒÈÌÔηډȷÎfiÂÂÈÛfi‰ÈÔ‹ı¿Ó·ÙÔ˜(·ÈÊÓ›‰ÈÔ˜)ÛÂËÏÈΛ·ÌÈÎÚfiÙÂÚËÙˆÓ55ÂÙÒÓ(¿Ó‰Ú˜)ηÈÙˆÓ65ÂÙÒÓ(Á˘Ó·›Î˜) À¿Ú¯ÂÈ ÛÙËÓ ÔÈÎÔÁ¤ÓÂÈ¿ Û·˜ (ÁÔÓ›˜, ·Ô‡‰Â˜, ·‰¤ÚÊÈ·) ÈÛÙÔÚÈÎfi ηډȷÎÔ‡ ÂÂÈÛÔ‰›Ô˘ ‹ ηډȷÎÔ‡ (·ÈÊÓ›‰ÈÔ˘) ı·Ó¿ÙÔ˘ Û ¿ÙÔÌ· ÌÈÎÚfiÙÂÚ· ÙˆÓ ËÏÈÎÈÒÓ ·˘ÙÒÓ; ¡∞π√Ãπ

8.°ÓÒÛˇ·Ú͢ÂȉÈÎfiÙÂÚˆÓηډȷÁÁÂÈ·ÎÒÓÚÔ‚ÏË̿وÓÛÂ̤ÏËÙ˘ÔÈÎÔÁ¤ÓÂÈ·˜,fiˆ˜˘ÂÚÙÚÔÊÈ΋‹‰È·Ù·ÙÈ΋ Ì˘ÔηډÈÔ¿ıÂÈ·,Û‡Ó‰ÚÔÌÔLQT‹Brugada,Marfan‹ÎÏÈÓÈοÛËÌ·ÓÙÈΤ˜·ÚÚ˘ı̛˜‹ÛÙÂÊ·ÓÈ·›·ÓfiÛÔ˜ ¶¿Û¯ÂÈ Î¿ÔÈÔ ·fi Ù· ̤ÏË Ù˘ ÔÈÎÔÁ¤ÓÂÈ¿˜ Û·˜ ·fi οÔÈÔ ·fi Ù· ·Ú·¿Óˆ ÓÔÛ‹Ì·Ù·; ¡∞π√Ãπ

¢ËÏÒÓˆ ˘‡ı˘Ó· fiÙÈ ÔÈ ·ÓˆÙ¤Úˆ ÏËÚÔÊÔڛ˜ Â›Ó·È ·ÏËı›˜.

√ ÎˉÂÌfiÓ·˜∏ÌÂÚÔÌËÓ›·: √ÓÔÌ·ÙÂÒÓ˘ÌÔ - ÀÔÁÚ·Ê‹∆ËϤʈÓÔ ÂÈÎÔÈÓˆÓ›·˜ ÁÔÓ¤ˆÓ:

‰˘Ó·ÙfiÙËÙ· ¯ÚËÌ·ÙÔ‰fiÙËÛ˘, Ô Û·Ê‹˜ ηıÔÚÈÛÌfi˜

ÙˆÓ ·ÓȯÓ¢ÙÈÎÒÓ ÌÂıfi‰ˆÓ Ô˘ ı· ¯ÚËÛÈÌÔÔÈËıÔ‡Ó, Ë ‰È·ıÂÛÈÌfiÙËÙ· ÁÈ· ÙÔÓ ÛÎÔfi ·˘Ùfi ÂÍÂȉÈÎÂ˘Ì¤ÓˆÓ È·ÙÚÒÓ ÙfiÛÔ ÁÈ· ÙÔÓ ÚˆÙÔ‚¿ıÌÈÔ fiÛÔ Î·È ÁÈ· ÙÔÓ ‰Â˘ÙÂÚÔ‚¿ıÌÈÔ ¤ÏÂÁ¯Ô (·È‰ÔηډÈÔÏfiÁˆÓ), ηıÒ˜ Î·È Ë ÔÚÁ¿ÓˆÛË Û˘ÛÙ‹Ì·ÙÔ˜

(101.823

ÏÈÎÒÓ Ù¿ÍˆÓ, Ô‰ËÁ› ÛÙËÓ ·Ó¿ÁÎË ÂϤÁ¯Ô˘ 600.000

ÙÔ˘Ï¿¯ÈÛÙÔÓ ·È‰ÈÒÓ ÛÙËÓ ·Ú¯‹ οı ۯÔÏÈÎÔ‡

¤ÙÔ˘˜. ªÂ ‚¿ÛË ÙË ‰È·ıÂÛÈÌfiÙËÙ· ÂÚ›Ô˘ 3.000

·È‰È¿ÙÚˆÓ ÛÙË ¯ÒÚ· Ì·˜ (2.700 ÙÔ 2000), ·ÓÙÈÛÙÔÈ-

¯Ô‡Ó 200 ·ÍÈÔÏÔÁ‹ÛÂȘ ·Ó¿ ·È‰›·ÙÚÔ. ¶·Ú¿ÏÏËÏ·, Ì ‰Â‰Ô̤ÓË ÙËÓ ·Ú·ÔÌ‹ ÙÔ˘Ï¿¯ÈÛÙÔÓ 10% ÙˆÓ ·È‰ÈÒÓ (26), ÚÔ·ÙÂÈ Ë ÂÚ·ÈÙ¤Úˆ ·Ó¿ÁÎË ‰Â˘ÙÂÚÔ‚¿ıÌÈÔ˘ ÂϤÁ¯Ô˘ 60.000 ·È‰ÈÒÓ ÂÙËÛ›ˆ˜. ∆ËÓ Â˘ı‡ÓË (Î·È ÔÈÎÔÓÔÌÈ΋ ÂÈ‚¿Ú˘ÓÛË) ÙÔ˘ ÂϤÁ¯Ô˘ ¤¯Ô˘Ó ˆ˜ ÙÒÚ· ÔÈ ÁÔÓ›˜, ÂÓÒ Û ÂÚÈÙÒÛÂȘ ·Ó·ÛÊ¿ÏÈÛÙˆÓ, ·ÏÏÔ‰·ÒÓ Î·È ·fiÚˆÓ, ÚԂϤÂÙ·È Ô

∂. ∞Ó¿ÁÎË ÂÓÈ·›Ô˘ ıÂÛÌÈÎÔ‡ Ï·ÈÛ›Ô˘

·ÓÙ·ÁˆÓÈÛÙÈ΋˜ ¿ıÏËÛ˘ ¢˘ÛÙ˘¯Ò˜, Û ·ÓÙ›ıÂÛË Ì ÙË ıÂÛÌÔıÂÙË̤ÓË

·ÍÈÔÏfiÁËÛË ÁÈ· ÙË Û˘ÌÌÂÙÔ¯‹ ÛÙȘ Û˘Ó‹ıÂȘ (¯·ÌËÏÔ‡ ÎÈÓ‰‡ÓÔ˘) Û¯ÔÏÈΤ˜ ‰Ú·ÛÙËÚÈfiÙËÙ˜ Î·È ÙȘ ·È-

ÛÈfi‰Ô͘ ÚÔÔÙÈΤ˜ ÂÚ·ÈÙ¤Úˆ ‚ÂÏÙ›ˆÛ‹˜ Ù˘, Ë

(˘„ËÏfiÙÂÚÔ˘ ÎÈÓ‰‡ÓÔ˘) Û˘ÌÌÂÙÔ¯‹ ÙfiÛÔ Û ۯÔÏÈ-

ο fiÛÔ Î·È Û Â͈ۯÔÏÈο ·ÓÙ·ÁˆÓÈÛÙÈο ·ıϋ̷-

Ù· ‰ÂÓ Î·Ï‡ÙÂÙ·È ·fi ÂÓÈ·›Ô ıÂÛÌÈÎfi Ï·›ÛÈÔ ÌÂ

‚¿ÛË ÙȘ ‰ÈÂıÓ›˜ Ô‰ËÁ›Â˜. ∏ ¤ÏÏÂÈ„Ë ·˘Ù‹ Ô‰ËÁ›

ÛÙÔÓ ·˘ÙÔۯ‰ȷÛÌfi ÙˆÓ ÛˆÌ·Ù›ˆÓ, Ô˘, ·ÔÛÎÔ-

ÒÓÙ·˜ ΢ڛˆ˜ ÛÙË ÓÔÌÈ΋ ÙÔ˘˜ ÚÔÛÙ·Û›·, ÂÚÈÔ-

Ú›˙ÔÓÙ·È Û ·Ó·˙‹ÙËÛË ÂÓ˘fiÁÚ·ÊˆÓ ‚‚·ÈÒÛˆÓ

“ÌˉÂÓÈÎÔ‡ ÎÈÓ‰‡ÓÔ˘”, ¯ˆÚ›˜ Ó· ÚÔÛ‰ÈÔÚ›˙ÔÓÙ·È

Ô‡Ù ÙÔ Â›‰Ô˜ Î·È Ë ¤ÎÙ·ÛË ÙÔ˘ ··ÈÙÔ‡ÌÂÓÔ˘

ÂϤÁ¯Ô˘ Ô‡ÙÂ Î·È Ë ÂȉÈÎfiÙËÙ· ÙÔ˘ È·ÙÚÔ‡. ∏ ·ÍÈÔ-

ÏfiÁËÛË ÙˆÓ Ó¤ˆÓ ·ıÏËÙÒÓ Ú¤ÂÈ Î·È Û ·˘Ù‹ ÙËÓ

ÂÚ›ÙˆÛË Ó· ‚·Û›˙ÂÙ·È ÛÙȘ ‰ÈÂıÓ›˜ Ô‰ËÁ›Â˜, Ë

Èı·ÓfiÙËÙ· ·Ú¿ÓÔÌ˘ Ï‹„˘ Ê·Ú̷΢ÙÈÎÒÓ Ô˘-

ÛÈÒÓ Î·È ÔÈ Û¯ÂÙÈ˙fiÌÂÓÔÈ Ì ·˘Ù‹Ó ΛӉ˘ÓÔÈ Ú¤ÂÈ

Ó· Ï·Ì‚¿ÓÔÓÙ·È ˘fi„Ë (32,33), ÂÓÒ Ë ·Ó¿ÁÎË ÂÈ-

Ù¤ÏÂÛ˘ Î·È ∏∫°Ì·ÙÔ˜ ÛÙÔÓ ·Ú¯ÈÎfi ¤ÏÂÁ¯Ô Ê·›ÓÂ-

Ù·È ÂȂ‚ÏË̤ÓË, ȉ›ˆ˜ Û ÌÂÁ·Ï‡ÙÂÚ˘ ËÏÈΛ·˜

·È‰È¿ (>12 ÂÙÒÓ) (18). ∫·È ÛÙËÓ ÂÚ›ÙˆÛË ·˘Ù‹

Ô ÁÂÓÈÎfi˜ ·È‰›·ÙÚÔ˜ ÔÊ›ÏÂÈ Ó· ¤¯ÂÈ ÚˆÙ·Ú¯ÈÎfi

Î·È ÎÔÌ‚ÈÎfi ÚfiÏÔ ÛÙÔ Û‡ÛÙËÌ· ÚÔ-·ÁˆÓÈÛÙÈÎÔ‡

ÂϤÁ¯Ô˘, ÂÓÒ Ë ÎÏÈÓÈ΋ ÙÔ˘ ÈηÓfiÙËÙ· ÛÙËÓ Î·Ú‰È·Î‹ ·ÎÚfi·ÛË Î·È ÛÙË ‰È¿ÁÓˆÛË ÙÔ˘ ·È‰ÈÎÔ‡

∏∫°Ì·ÙÔ˜ ηıÔÚ›˙Ô˘Ó Î·È ÙËÓ ÂÈÙ˘¯›· ÙÔ˘ Û˘ÛÙ‹-

Ì·ÙÔ˜ ÂϤÁ¯Ô˘.

™˘ÌÂÚ¿ÛÌ·Ù·

√ ıÂÛÌÔıÂÙË̤ÓÔ˜ ¤ÏÂÁ¯Ô˜ ·È‰ÈÒÓ Û¯ÔÏÈ΋˜

ËÏÈΛ·˜ ÛÙË ¯ÒÚ· Ì·˜ Â›Ó·È È‰È·›ÙÂÚ· ÛËÌ·ÓÙÈÎfi

̤ÙÚÔ ÚÔÛÙ·Û›·˜ Ù˘ ˙ˆ‹˜ Î·È Ù˘ ˘Á›·˜ ÙˆÓ

·È‰ÈÒÓ, Ì ÛËÌ·ÓÙÈο fï˜ ÂÚÈıÒÚÈ· ‚ÂÏÙ›ˆ-

Û˘. ¶·Ú¿ÏÏËÏ· ‰È·ÈÛÙÒÓÂÙ·È ¤ÏÏÂÈ„Ë ÂÓÈ·›·˜

ÔÏÈÙÈ΋˜ Û¯ÂÙÈο Ì ÙÔÓ ¤ÏÂÁ¯Ô ·È‰ÈÒÓ Ô˘ Û˘Ì-

ÌÂÙ¤¯Ô˘Ó Û ·ÓÙ·ÁˆÓÈÛÙÈο ·ıϋ̷ٷ. ∏ ‚ÂÏÙ›ˆ-

ÛË Ù˘ ÂÎ·›‰Â˘Û˘ ÙˆÓ ·È‰È¿ÙÚˆÓ ÛÙËÓ ·ÍÈÔÏfiÁËÛË ÙÔ˘ ηډȷÁÁÂÈ·ÎÔ‡ Û˘ÛÙ‹Ì·ÙÔ˜, Ë Â·Ú΋˜ ÛÙÂϤ¯ˆÛË

1. Washington RL, Bernhardt DT, Gomez J, Johnson MD, Martin TJ, Rowland TW, et al. Organized sports for children and preadolescents. Pediatrics 2001;107:1459-1462.

2. American Academy of Pediatrics. Committee on Pediatric Aspects of Physical Fitness, Recreation, and Sports. Competitive athletics for children of elementary school age. Pediatrics 1981;67:927-928.

3. American Academy of Pediatrics. Committee on Sports Medicine and Committee on School Health: Organized athletics for preadolescent children. Pediatrics 1989;84: 583-584.

4. American Academy of Pediatrics. Committee on Sports Medicine and Fitness. Intensive training and sports specialization in young athletes. Pediatrics 2000;106:154-157.

5. American Academy of Pediatrics. Committee on Sports Medicine and Fitness. Participation in boxing by children, adolescents, and young adults. Pediatrics 1997; 99:134-135.

6. American Academy of Pediatrics. Committee on Sports Medicine and Fitness. Medical conditions affecting sports participation. Pediatrics 1994;94:757-760.

7. Campbell RM, Berger S. Preventing pediatric sudden cardiac death: where do we start; Pediatrics 2006;118:802-804.

8. Maron BJ, Thompson PD, Puffer JC, McGrew CA, Strong WB, Douglas PS, et al. Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American Heart Association. Circulation 1996; 94:850-856.

9. Maron BJ, Chaitman BR, Ackerman MJ, Bayes de Luna A, Corrado D, Crosson JE, et al. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation 2004;109:2807-2816.

10. Thompson PD, Franklin BA, Balady GJ, Blair SN, Corrado D, Estes NA, et al. Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology. Circulation 2007;115:2358-2368.

11. Maron BJ, Shirani J, Poliac LC, Mathenge R, Roberts WC, Mueller FO. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA 1996;276:199-204.

12. Basso C, Maron BJ, Corrado D, Thiene G. Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes. J Am Coll Cardiol 2000;35:1493-1501.

13. Corrado D, Basso C, Rizzoli G, Schiavon M, Thiene G. Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol 2003;42: 1959-1963.

14. Van Camp SP, Bloor CM, Mueller FO, Cantu RC, Olson HG. Nontraumatic sports death in high school and college athletes. Med Sci Sports Exerc 1995;27:641-647.

15. Basso C, Corrado D, Thiene G. Arrhythmogenic right ventricular cardiomyopathy in athletes: diagnosis, management, and recommendations for sport activity. Cardiol Clin 2007;25:415-422.

16. Maron BJ, Isner JM, McKenna WJ. 26th Bethesda

conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 3: hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse. Med Sci Sports Exerc 1994;26(10 S): S261-267.

17. Pelliccia A, Corrado D, Bjornstad HH, PanhuyzenGoedkoop N, Urhausen A, Carre F, et al. Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditis. Eur J Cardiovasc Prev Rehabil 2006;13:876-885.

18. Corrado D, Pelliccia A, Bjornstad HH, Vanhees L, Biffi A, Borjesson M, et al. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2005;26:516-524.

19. Maron BJ, Thompson PD, Ackerman MJ, Balady G, Berger S, Cohen D, et al. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation 2007;115:1643-1455.

20. Pelliccia A, Di Paolo FM, Corrado D, Buccolieri C, Quattrini FM, Pisicchio C, et al. Evidence for efficacy of the Italian national pre-participation screening programme for identification of hypertrophic cardiomyopathy in competitive athletes. Eur Heart J 2006;27:2196-2200.

21. Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA 2006;296:1593-1601.

22. Niwa K, Warita N, Sunami Y, Shimura A, Tateno S, Sugita K. Prevalence of arrhythmias and conduction disturbances in large population-based samples of children. Cardiol Young 2004;14:68-74.

23. Ninova PP, Dascalov IK, Dimitrova MI. Automated phonocardiographic screening for heart disease in children. Cardiology 1978;63:5-13.

24. Muta H, Akagi T, Egami K, Furui J, Sugahara Y, Ishii M, et al. Incidence and clinical features of asymptomatic atrial septal defect in school children diagnosed by heart disease screening. Circ J 2003;7:112-115.

25. Germanakis I, Dittrich S, Perakaki R, Kalmanti M. Digital phonocardiography as a screening tool for heart disease in childhood. Acta Paediatr 2008;51:327-333.

26. Okuni M, Kusakawa S, Hozaki J, Hirayama T, Osano M, Murakami M, et al. Development of a heart disease screening system for school children and its results in the Tokyo area in 1980. Jpn Circ J 1982;46:1250-1254.

27. Tavel ME. Cardiac auscultation. A glorious past - but does it have a future? Circulation 1996;93:1250-1253.

28. McFee RB, Boykan R. Clinical auscultation skills in pediatric residents. Pediatrics 2001;108:1388-1389.

29. Yi MS, Kimball TR, Tsevat J, Mrus JM, Kotagal UR. Evaluation of heart murmurs in children: cost-effectiveness and practical implications. J Pediatr 2002;141:504-511.

30. Mahnke CB, Nowalk A, Hofkosh D, Zuberbuhler JR, Law YM. Comparison of two educational interventions on pediatric resident auscultation skills. Pediatrics 2004;113: 1331-1335.

31. Hatzisevastou-Loukidou H, Badouraki M, Kambouridou P, Sotiridou E. Risks of sports activities in individuals with Down syndrome and atlantoaxial instability. Paediatriki 2005;68:365.

32. Antoniadis S. Doping in children, adolescents and young adults. Paediatriki 2006;69:317-322.

33. Calfee R, Fadale P. Popular ergogenic drugs and supplements in young athletes. Pediatrics 2006;117:e577-589.

¢È‡ı˘ÓÛË ∫ÔÈÓˆÓÈ΋˜ ηÈ

∞Ó·Ù˘Íȷ΋˜ ¶·È‰È·ÙÚÈ΋˜,

πÓÛÙÈÙÔ‡ÙÔ ÀÁ›·˜ ÙÔ˘

¶·È‰ÈÔ‡, ¡ÔÛÔÎÔÌ›Ô

¶·›‰ˆÓ “∞Á›· ™ÔÊ›·”,

∞ı‹Ó·

AÏÏËÏÔÁÚ·Ê›·:

∞ÏÂÍ›· ¶Ú·ÛÔ‡ÏË

prasouli@hotmail.com

¢È‡ı˘ÓÛË ∫ÔÈÓˆÓÈ΋˜ ηÈ

∞Ó·Ù˘Íȷ΋˜ ¶·È‰È·ÙÚÈ΋˜, πÓÛÙÈÙÔ‡ÙÔ ÀÁ›·˜ ÙÔ˘

¶·È‰ÈÔ‡, ¡ÔÛÔÎÔÌ›Ô

¶·›‰ˆÓ “∞Á›· ™ÔÊ›·”

£Ë‚ÒÓ Î·È §Â‚·‰Â›·˜, 115 27, ∞ı‹Ó·

∞. ¶Ú·ÛÔ‡ÏË, ∞. ∞ÙÙÈÏ¿ÎÔ˜, π. ∞ÓÙˆÓÈ¿‰Ô˘

¶ÂÚ›ÏË„Ë: ∏ ÂÈÏË„›· Â›Ó·È Ì›· ·fi ÙȘ ÈÔ Û˘¯Ó¤˜ Ó¢ÚÔÏÔÁÈΤ˜ ·ı‹ÛÂȘ Ù˘ ·È‰È΋˜ ËÏÈΛ·˜. ∆· ·È‰È¿ Ì ÂÈÏË„›· ‚Ú›ÛÎÔÓÙ·È Û ·˘ÍË̤ÓÔ Î›Ó‰˘ÓÔ Ó· ÂÌÊ·Ó›ÛÔ˘Ó ÁÓˆÛÙÈΤ˜ ‰È·Ù·Ú·¯¤˜ Î·È ÚԂϋ̷ٷ Û˘ÌÂÚÈÊÔÚ¿˜, Û ۇÁÎÚÈÛË ÙfiÛÔ Ì ÙÔÓ ÁÂÓÈÎfi ÏËı˘ÛÌfi fiÛÔ Î·È Ì ٷ ·È‰È¿ Ô˘

·fi ¿ÏÏ· ¯ÚfiÓÈ· ÓÔÛ‹Ì·Ù· Ô˘ ‰ÂÓ ·ÊÔÚÔ‡Ó ÙÔ ÎÂÓÙÚÈÎfi Ó¢ÚÈÎfi Û‡ÛÙËÌ·. √È ÁÓˆÛÙÈΤ˜ ‰È·Ù·Ú·¯¤˜ Î·È Ù· ÚԂϋ̷ٷ Û˘ÌÂÚÈÊÔÚ¿˜ ÌÔÚ› Ó· ÚÔËÁËıÔ‡Ó Ù˘ ‰È¿ÁÓˆÛË Ù˘ ÂÈÏË„›·˜, Ó· ÂÌÊ·ÓÈÛıÔ‡Ó Ù·˘Ùfi¯ÚÔÓ· Ì ·˘Ù‹Ó ‹ Ó· ÙËÓ ·ÎÔÏÔ˘ı‹ÛÔ˘Ó . ¶ÔÏÏÔ› ÂÚ¢ÓËÙ¤˜ ¤¯Ô˘Ó ÚÔÛ·ı‹ÛÂÈ Ó· ·Ó·ÁÓˆÚ›ÛÔ˘Ó ÂȉÈÎÔ‡˜ ·ÈÙÈÔÏÔÁÈÎÔ‡˜ Î·È ÚÔÁÓˆÛÙÈÎÔ‡˜ ·Ú¿ÁÔÓÙ˜ ÁÈ· ÙËÓ ÂÌÊ¿ÓÈÛË ÁÓˆÛÙÈÎÒÓ Î·È Û˘ÌÂÚÈÊÔÚÈÎÒÓ ‰È·Ù·Ú·¯ÒÓ Û ÂÈÏËÙÈο ·È‰È¿, Ì ·ÓÙÈÎÚÔ˘fiÌÂÓ· fï˜ ·ÔÙÂϤÛÌ·Ù·. ∞˘Ùfi Û˘Ì‚·›ÓÂÈ ÂÂȉ‹ Ë ¤Ú¢ӷ Û¯ÂÙÈο Ì ÙËÓ ·ÎÚÈ‚‹ Û˘Û¯¤ÙÈÛË

ÔÏϤ˜ ÌÂÙ·‚ÏËÙ¤˜, fiˆ˜ Ë ‡·ÚÍË Û·ÛÌÒÓ ‰È·ÊfiÚˆÓ Ù‡ˆÓ, ÙÔ ·ıÔÊ˘ÛÈÔÏÔÁÈÎfi ˘fiÛÙڈ̷

ÏË„›·˜, Ë ˘ÔΛÌÂÓË ÂÁÎÂÊ·ÏÈ΋ ‚Ï¿‚Ë, Ë ÂÌÊ¿ÓÈÛË ˘ÔÎÏÈÓÈÎÒÓ ÂÈÏËÙÈÎÒÓ ÂÎÊÔÚÙ›ÛˆÓ, Ë Â›‰Ú·ÛË ÙˆÓ ·ÓÙÈÂÈÏËÙÈÎÒÓ Ê·ÚÌ¿ÎˆÓ Î·È ·Ú¿ÁÔÓÙ˜

ÚÔÎÂÈ̤ÓÔ˘ Ó· ÂÍ·ÛÊ·ÏÈÛı›

The effect of childhood epilepsy on cognitive function and behaviour

Department of Social and Developmental Paediatrics, Institute of Child Health, “Aghia Sophia” Children’s Hospital, Athens

Correspondence: Alexia Prassouli prasouli@hotmail.com

Department of Social and Developmental Paediatrics, Institute of Child Health, “Aghia Sophia” Children’s Hospital

Thivon & Levadias St., 115 27, Athens

Prassouli,

Abstract: Epilepsy is one of the most common neurological disorders in childhood. Children with epilepsy are at increased risk of cognitive dysfunction and behavioural problems, compared with normal children or children with other chronic diseases not involving the central nervous system. Cognitive dysfunction and behavioural problems may precede, coincide with or follow the diagnosis of childhood epilepsy. Numerous investigators have attempted to identify specific factors contributing to or predictive of cognitive and behavioural impairment in epileptic children, with conflicting results. The investigation of the precise relationship between epilepsy and cognitive/behavioural dysfunction is confounded by several variables, including the type of seizures, the pathophysiology of the epilepsy, the underlying brain damage, the occurrence of subclinical epileptiform discharges, the effect of antiepileptic drug treatment and family-related parameters. Epilepsy type, age at onset, seizure frequency, and subclinical epileptiform disharges have been associated with the occurrence of cognitive impairment, while additional neurological deficits, drug-resistant epilepsy, and family-related factors have been associated with the occurrence of behavioural disturbance in epileptic children. In any case, the neurological monitoring of children with epilepsy should include evaluation of cognitive and behavioural functions, and provision of appropriate intervention when needed.

Key words: Childhood epilepsy, cognitive function, behaviour.

ÔÍηڂ·Ì· ˙Â›ÓË Ê·›ÓÂÙ·È ˆ˜ ‰ÂÓ ÂËÚ¿˙ÂÈ ·Ú-

ÓËÙÈο ÙȘ ÁÓˆÛÙÈΤ˜ ÏÂÈÙÔ˘ÚÁ›Â˜, ÂÓÒ ÁÈ· ÙÔ ‚·Ï-

ÚÔ˚Îfi Ó¿ÙÚÈÔ ÔÈ ÂȉڿÛÂȘ ‰Â›¯ÓÔ˘Ó Ó· Â›Ó·È ‰ÔÛÔ-

ÂÍ·ÚÙÒÌÂÓ˜ (64-67). ™Â fiÙÈ ·ÊÔÚ¿ Ù· ÓÂfiÙÂÚ· ∞∂º, ÔÈ Û¯ÂÙÈΤ˜ ÌÂϤÙ˜ Â›Ó·È ÂÚÈÔÚÈṲ̂Ó˜. ™ÙË ÌfiÓË

ηϿ ۯ‰ȷṲ̂ÓË ÌÂϤÙË Û ·È‰È¿, ÔÈ Pressler ηÈ

Û˘Ó. (67) ‰ÂÓ ‚Ú‹Î·Ó ÛËÌ·ÓÙÈ΋ Â›‰Ú·ÛË Ù˘ Ï·ÌÔ-

ÙÚÈÁ›Ó˘ ÛÙȘ ÁÓˆÛÙÈΤ˜ ÏÂÈÙÔ˘ÚÁ›Â˜. ∆¤ÏÔ˜, Ë ÔÏ˘ıÂÚ·›· Ê·›ÓÂÙ·È ˆ˜ Â›Ó·È ·Ú¿ÁÔÓÙ·˜ ÎÈÓ‰‡ÓÔ˘, ÂÓÒ Ë ÌÔÓÔıÂÚ·›· Û ̤ÙÚȘ ‰fiÛÂȘ ‰ÂÓ Ê·›ÓÂÙ·È

Ó· ÂËÚ¿˙ÂÈ ÙȘ Û˘Ó‹ıˆ˜ ÌÂÙÚÔ‡ÌÂÓ˜ ·Ú·Ì¤-

ÙÚÔ˘˜ Ù˘ ÁÓˆÛÙÈ΋˜ ÏÂÈÙÔ˘ÚÁ›·˜ (7,68,69).

¶Ú¤ÂÈ, ¿ÓÙˆ˜, Ó· ÙÔÓÈÛÙ› fiÙÈ ÔÈ ÂÚÈÛÛfiÙÂ-

Ú˜ ÌÂϤÙ˜ Ô˘ ·ÊÔÚÔ‡Ó ÙȘ ÁÓˆÛÙÈΤ˜ ÂȉڿÛÂȘ ÙˆÓ ∞∂º ÛÙ· ·È‰È¿ Ì ÂÈÏË„›· ÂÚÈÔÚ›˙ÔÓÙ·È ÛÙË Ì¤ÙÚËÛË ÙÔ˘ ‰Â›ÎÙË ÓÔËÌÔÛ‡Ó˘ (πQ) ηÈ

‰ÂÓ ÂÎÙÈÌÔ‡Ó ÂȉÈΤ˜ Ó¢ÚÔ„˘¯ÔÏÔÁÈΤ˜ ·Ú·Ì¤-

ÙÚÔ˘˜, ÛËÌ·ÓÙÈΤ˜ ÁÈ· ÙË ‰È·‰Èηۛ· Ù˘ Ì¿ıËÛ˘, fiˆ˜ Ë ÚÔÛÔ¯‹ Î·È Ë ÓÔËÙÈ΋ ÎfiˆÛË. ∏ ‰˘ÛÎÔÏ›· ÂÎÙ›ÌËÛ˘ Ù˘ ‰Ú¿Û˘ ÙˆÓ ∞∂º Ê·›ÓÂÙ·È ÛÙÔ Û˘Ì¤Ú·ÛÌ· Ù˘ ÌÂϤÙ˘ ÙˆÓ Vermeulen Î·È Û˘Ó. (70). √È Û˘ÁÁÚ·Ê›˜, ·ÊÔ‡ ·Ó·ÛÎfiËÛ·Ó 90 ÌÂϤÙ˜ Ô˘ ¤ÁÈÓ·Ó Û ¯ÚÔÓÈÎfi ‰È¿ÛÙËÌ· ÌÂÁ·Ï‡ÙÂÚÔ

ÙˆÓ 25 ¯ÚfiÓˆÓ, Û¯ÂÙÈο Ì ÙËÓ Â›‰Ú·ÛË ÙˆÓ ∞∂º

ÛÙȘ ÁÓˆÛÙÈΤ˜ ÏÂÈÙÔ˘ÚÁ›Â˜, η٤ÏËÍ·Ó fiÙÈ ‰ÂÓ

‹Ù·Ó ÛÂ ı¤ÛË Ó· ··ÓÙ‹ÛÔ˘Ó ¿ÌÂÛ· ÛÙÔ ÈÔ ÎÚ›ÛÈ-

ÌÔ ÂÚÒÙËÌ·, ‰ËÏ. Â¿Ó Ù· ∞∂º ¤¯Ô˘Ó ıÂÙÈΤ˜ ‹ ·Ú-

ÓËÙÈΤ˜ ÁÓˆÛÙÈΤ˜ ÂȉڿÛÂȘ ÛÙȘ Û˘Ó‹ıÂȘ ıÂÚ·-

¢ÙÈΤ˜ ‰fiÛÂȘ.

∆¤ÏÔ˜, Ù· ∞∂º ¤¯Ô˘Ó Û˘Û¯ÂÙÈÛÙ› Ì ¤Ó· ÌÂÁ¿ÏÔ

‡ÚÔ˜ ÚÔ‚ÏËÌ¿ÙˆÓ Û˘ÌÂÚÈÊÔÚ¿˜. ∫·Ù¿ıÏÈ„Ë, Ì·Ó›·, „‡¯ˆÛË, ¢ÂÚÂıÈÛÙfiÙËÙ·, ÂÈıÂÙÈÎfiÙËÙ·, ˘ÂÚ-

ÎÈÓËÙÈÎfiÙËÙ· Î·È ·ÚÔÚÌËÙÈÎfiÙËÙ· ¤¯Ô˘Ó ·Ó·ÊÂÚ-

ı› ÛÂ Û˘Ó‰˘·ÛÌfi Ì ÙË ¯ÔÚ‹ÁËÛË ·Ï·ÈfiÙÂÚˆÓ ‹

ÓÂfiÙÂÚˆÓ ∞∂º (4,6). ¶·Ú¿ÁÔÓÙ˜ ÎÈÓ‰‡ÓÔ˘ ÁÈ· ÙËÓ

ÂÌÊ¿ÓÈÛË ÙˆÓ ·Ú·¿Óˆ ‰È·Ù·Ú·¯ÒÓ Ê·›ÓÂÙ·È ˆ˜

Â›Ó·È Ë ÔÏ˘ıÂÚ·›·, ÔÈ ˘„ËϤ˜ ‰fiÛÂȘ ÙˆÓ ∞∂º

Î·È ÙÔ ÔÈÎÔÁÂÓÂÈ·Îfi ÈÛÙÔÚÈÎfi „˘¯Ô·ıÔÏÔÁ›·˜ (4).

™˘Ì¤Ú·ÛÌ·

∞fi Ù· ·Ú·¿Óˆ ÚÔ·ÙÂÈ fiÙÈ Ù· ·È‰È¿ ÌÂ

ÂÈÏË„›· ·ÚÔ˘ÛÈ¿˙Ô˘Ó ‰È·Ù·Ú·¯¤˜ ÙˆÓ ÁÓˆÛÙÈÎÒÓ

ηÈ

Î·È Ù˘ Û˘ÌÂÚÈÊÔÚ¿˜, ÚÔÎÂÈ̤ÓÔ˘

µÈ‚ÏÈÔÁÚ·Ê›·

1. Cowan LD. The epidemiology of the epilepsies in children. Ment Retard Dev Disabil Res Rev 2002;8:171-181.

2. Beghi M, Cornaggia CM, Frigeni B, Beghi E. Learning Disorders in Epilepsy. Epilepsia 2006;47 (Suppl 2):14-18.

3. Williams J. Learning and behavior in children with epilepsy. Epilepsy Behav. 2003;4:107-111.

4. Austin JK, Caplan R. Behavioral and psychiatric comorbidities in pediatric epilepsy: toward an integrative model. Epilepsia 2007;48:1639-1651.

5. Ott D, Siddarth P, Gurbani S, Koh S, Tournay A, Shields WD, et al. Behavioral disorders in pediatric epilepsy: unmet psychiatric need. Epilepsia 2003;44:591-597.

6. Bourgeois BF. Antiepileptic drugs, learning, and behavior in childhood epilepsy. Epilepsia 1998;39:913-921.

7. Ortinski P, Meador KJ. Cognitive side effects of antiepileptic drugs. Epilepsy Behav 2004;5 (Suppl 1):S60-65.

8. Holmes GL, Ben-Ari Y. The neurobiology and consequences of epilepsy in the developing brain. Pediatr Res 2001;49:320-325.

9. Grigonis AM, Murphy EH. The effects of epileptic cortical activity on the development of callosal projections. Brain Res Dev Brain Res 1994;77:251-255.

10. Bourgeois BF, Prensky AL, Palkes HS, Talent BK, Busch SG. Intelligence in epilepsy: a prospective study in children. Ann Neurol 1983;14:438-444.

11. Gündüz E, Demirbilek V, Korkmaz B. Benign rolandic epilepsy: neuropsychological findings. Seizure 1999;8: 246-249.

12. Bailet LL, Turk WR. The impact of childhood epilepsy on neurocognitive and behavioral performance: a prospective longitudinal study. Epilepsia 2000;41:426-431.

13. Bulteau C, Jambaque I, Viguier D, Kieffer V, Dellatolas G, Dulac O. Epileptic syndromes, cognitive assessment and school placement: a study of 251 children. Dev Med Child Neurol 2000;42:319-327.

14. Neville BG. Reversible disability associated with epilepsy. Brain Dev 1999;21:82-85.

15. Berg AT, Langfitt JT, Testa FM, Levy SR, DiMario F, Westerveld M, et al. Global cognitive function in children with epilepsy: a community-based study. Epilepsia 2008;49: 608-614.

16. Rodin EA, Schmaltz S, Twitty G. Intellectual functions of patients with childhood-onset epilepsy. Dev Med Child Neurol 1986;28:25-33.

17. Piccirilli M, D'Alessandro P, Sciarma T, Cantoni C, Dioguardi MS, Giuglietti M, et al. Attention problems in epilepsy: possible significance of the epileptogenic focus. Epilepsia 1994;35:1091-1096.

18. Massa R, de Saint-Martin A, Carcangiu R, Rudolf G, Seegmuller C, Kleitz C, et al. EEG criteria predictive of complicated evolution in idiopathic rolandic epilepsy. Neurology. 2001;57:1071-1079.

19. Nieuwenhuis L, Nicolai J. The pathophysiological mechanisms of cognitive and behavioral disturbances in children with

Landau-Kleffner syndrome or epilepsy with continuous spikeand-waves during slow-wave sleep. Seizure 2006; 15:249-258.

20. Aldenkamp AP, Alpherts WC, Dekker MJ, Overweg J. Neuropsychological aspects of learning disabilities in epilepsy. Epilepsia 1990;31 (Suppl 4):S9-20.

21. Gordon N. Cognitive functions and epileptic activity. Seizure 2000;9:184-188.

22. Cohen M. Auditory/verbal and visual/spatial memory in children with complex partial epilepsy of temporal lobe origin. Brain Cogn 1992;20:315-326.

23. Reid IC, Stewart CA. Seizures, memory and synaptic plasticity. Seizure 1997;6:351-359.

24. Aldenkamp AP, Bodde N. Behaviour, cognition and epilepsy. Acta Neurol Scand Suppl 2005;182:19-25.

25. Dunn DW, Kronenberger WG. Childhood epilepsy, attention problems, and ADHD: review and practical considerations. Semin Pediatr Neurol 2005;12:222-228.

26. Liégeois F, Connelly A, Salmond CH, Gadian DG, VarghaKhadem F, Baldeweg T. A direct test for lateralization of language activation using fMRI: comparison with invasive assessments in children with epilepsy. Neuroimage 2002; 17:1861-1867.

27. Camfield PR, Gates R, Ronen G, Camfield C, Ferguson A, MacDonald GW. Comparison of cognitive ability, personality profile, and school success in epileptic children with pure right versus left temporal lobe EEG foci. Ann Neurol 1984;15:122-126.

28. Aldenkamp AP, Beitler J, Arends J, van der Linden I, Diepman L. Acute effects of subclinical epileptiform EEG discharges on cognitive activation. Funct Neurol 2005;20: 23-28.

29. Aldenkamp AP, Arends J. Effects of epileptiform EEG discharges on cognitive function: is the concept of“transient cognitive impairment” still valid? Epilepsy Behav 2004;5 (Suppl 1):S25-34.

30. Kasteleijn-Nolst Trenité DG. Transient cognitive impairment during subclinical epileptiform electroencephalographic discharges. Semin Pediatr Neurol 1995;2:246-53.

31. Schouten A, Oostrom KJ, Pestman WR, Peters AC, JennekensSchinkel A; Dutch Study Group of Epilepsy in Childhood. Learning and memory of school children with epilepsy: a prospective controlled longitudinal study. Dev Med Child Neurol 2002;44:803-811.

32. Austin JK, Dunn DW. Progressive behavioral changes in children with epilepsy. Prog Brain Res 2002;135:419-427.

33. Cornaggia CM, Beghi M, Provenzi M, Beghi E. Correlation between cognition and behavior in epilepsy. Epilepsia 2006;47 (2 Suppl):34-39.

34. Aldenkamp AP, Overweg-Plandsoen WC, Arends J. An open, nonrandomized clinical comparative study evaluating the effect of epilepsy on learning. J Child Neurol 1999;14: 795-800.

35. Hertz-Pannier L, Chiron C, Véra P, Van de Morteele PF, Kaminska A, Bourgeois M, et al. Functional imaging in the work-up of childhood epilepsy. Childs Nerv Syst 2001;17: 223-228.

36. Westerveld M, Sass KJ, Chelune GJ, Hermann BP, Barr WB, Loring DW, et al. Temporal lobectomy in children: cognitive outcome. J Neurosurg 2000;92:24-30.

37. Austin JK. Comparison of child adaptation to epilepsy and asthma. J Child Adolesc Psychiatr Ment Health Nurs 1989; 2:139-144.

38. Lambert MV. Seizures, hormones and sexuality. Seizure. 2001;10:319-340.

39. Austin JK, Harezlak J, Dunn DW, Huster GA, Rose DF, Ambrosius WT. Behavior problems in children before first recognized seizures. Pediatrics 2001;107:115-122.

40. Dunn DW, Austin JK, Huster GA. Behavior problems in children with new-onset epilepsy. Seizure 1997;6:283-287.

41. Jokeit H, Schacher M. Neuropsychological aspects of type of epilepsy and etiological factors in adults. Epilepsy Behav 2004;5 (Suppl 1):S14-20.

42. McDermott S, Mani S, Krishnaswami S. A population-based analysis of specific behavior problems associated with childhood seizures. J Epilepsy 1995;8:110-118.

43. Semrud-Clikeman M, Wical B. Components of attention in children with complex partial seizures with and without ADHD. Epilepsia 1999;40:211-215.

44. Noeker M, Haverkamp-Krois A, Haverkamp F. Development of mental health dysfunction in childhood epilepsy. Brain Dev 2005;27:5-16.

45. Levisohn PM. The autism-epilepsy connection. Epilepsia 2007;48 (Suppl 9):33-35.

46. Caplan R, Arbelle S, Guthrie D, Komo S, Shields WD, Hansen R, et al. Formal thought disorder and psychopathology in pediatric primary generalized and complex partial epilepsy. J Am Acad Child Adolesc Psychiatry 1997;36:1286-1294.

47. Dunn DW, Austin JK, Huster GA. Symptoms of depression in adolescents with epilepsy. J Am Acad Child Adolesc Psychiatry 1999;38:1132-1138.

48. Oguz A, Kurul S, Dirik E. Relationship of epilepsy-related factors to anxiety and depression in epileptic children. J Child Neurol 2002;17:37-40.

49. Devinsky O, Vazquez B. Behavioral changes associated with epilepsy. Neurol Clin 1993;11:127-149.

50. Besag FM. Childhood epilepsy in relation to mental handicap and behavioural disorders. J Child Psychol Psychiatry 2002; 43:103-131.

51. Cendes F, Andermann F, Gloor P, Gambardella A, LopesCendes I, Watson C, et al. Relationship between atrophy of the amygdala and ictal fear in temporal lobe epilepsy. Brain 1994;117:739-746.

52. Hariri AR, Bookheimer SY, Mazziotta JC. Modulating emotional responses: effects of a neocortical network on the limbic system. Neuroreport 2000;11:43-48.

53. Hoare P. The quality of life of children with chronic epilepsy and their families. Seizure 1993;2:269-275.

54. Williams J, Steel C, Sharp GB, DelosReyes E, Phillips T, Bates S, et al. Parental anxiety and quality of life in children with epilepsy. Epilepsy Behav 2003;4:483-486.

55. Austin JK, Risinger MW, Beckett LA. Correlates of behaviour problems in children with epilepsy. Epilepsia 1992;33:11151122.

56. Stores G. School-children with epilepsy at risk for learning and behaviour problems. Dev Med Child Neurol 1978;20: 502-508.

57. Nuffield EJ. Neuro-physiology and behaviour disorders in epileptic children. J Ment Sci 1961;107:438-458.

58. Caplan R, Arbelle S, Magharious W, Guthrie D, Komo S, Shields WD, et al. Psychopathology in pediatric complex partial and primary generalized epilepsy. Dev Med Child Neurol 1998;40:805-811.

59. Prassouli A, Attilakos A, Katsarou E, Sarafidou J, Mastroyianni S, Voudris K, et al. Behavioural and emotional

problems in children with idiopathic generalized epilepsy and well-controlled seizures. Paediatriki 2008;71:210-214.

60. Jacoby A, Austin JK. Social stigma for adults and children with epilepsy. Epilepsia 2007;48 (Suppl 9):6-9.

61. Saccomani L, Cordella E, Cirrincione M. Children and adolescents with epilepsy. Cognitive abilities, learning disorders and depression. Minerva Pediatr 1991;43:383-388.

62. Kaindl AM, Asimiadou S, Manthey D, Hagen MV, Turski L, Ikonomidou C. Antiepileptic drugs and the developing brain. Cell Mol Life Sci 2006;63:399-413.

63. Bittigau P, Sifringer M, Ikonomidou C. Antiepileptic drugs and apoptosis in the developing brain. Ann N Y Acad Sci 2003;993:103-114.

64. Loring DW, Meador KJ. Cognitive side effects of antiepileptic drugs in children. Neurology. 2004;62:872-877.

65. ∆˙ËÙËÚ›‰Ô˘ ª, ¶¿ÓÔ˘ £, ¶·˘Ï›‰Ô˘ ∂, ÕÚÛÔ˜ °, ª·Î·‚fi˜ ∞, ªÈ¯·Ï¤ÙÔ˘ ∂, Î·È Û˘Ó. °ÓˆÛÙÈΤ˜ ÏÂÈÙÔ˘ÚÁ›Â˜ ÛÂ

Ì ÂÛÙȷΤ˜ ÂÈÏË„›Â˜ Î·È Ì·ÎÚÔ¯ÚfiÓÈ· ıÂÚ·›·

ÔÍηڂ·˙Â›ÓË. ¶·È‰È·ÙÚÈ΋ 2005;68:112-119.

66. Hirsch E, Schmitz B, Carren~o M. Epilepsy, antiepileptic drugs (AEDs) and cognition. Acta Neurol Scand Suppl 2003;180:23-32.

67. Pressler RM, Binnie CD, Coleshill SG, Chorley GA, Robinson RO. Effect of lamotrigine on cognition in children with epilepsy. Neurology 2006;66:1495-1499.

68. Aldenkamp AP, Alpherts WC, Blennow G, Elmqvist D, Heijbel J, Nilsson HL, et al. Withdrawal of antiepileptic medication in children - effects on cognitive function: the Multicenter Holmfrid Study. Neurology 1993;43:41-50.

69. Chen Y, Chi Chow J, Lee I. Comparison the cognitive effect of anti-epileptic drugs in seizure-free children with epilepsy before and after drug withdrawal. Epilepsy Res 2001;44:65-70.

70. Vermeulen J, Aldenkamp AP. Cognitive side-effects of chronic antiepileptic drug treatment: a review of 25 years of research. Epilepsy Res 1995;22:65-95.

¶·È‰È·ÙÚÈÎfi

AÏÏËÏÔÁÚ·Ê›·:

∞ıËÓ¿ ¶··‰ÔÔ‡ÏÔ˘ athinapap@yahoo.com

¶·È‰È·ÙÚÈÎfi ∆̷̋, °ÂÓÈÎfi

¡ÔÛÔÎÔÌÂ›Ô ∫∞∆, ∞ı‹Ó·

Department of Pediatrics, “KAT” General Hospital, Athens, Greece

Correspondence: Athina Papadopoulou athinapap@yahoo.com

Department of Pediatrics, “KAT” General Hospital, Athens, Greece

∞. ¶··‰ÔÔ‡ÏÔ˘, ¶. °ÂˆÚÁÈÔÔ‡ÏÔ˘-ª›¯·

¶ÂÚ›ÏË„Ë: √ ‰È·‰ÈÎÙ˘·Îfi˜ ÂıÈÛÌfi˜, ÓfiÛËÌ· ÂÍ¿ÚÙËÛ˘ Ù˘ ÙÂÏÂ˘Ù·›·˜ ‰ÂηÂÙ›·˜, ¤¯ÂÈ ·Ó·ÁÓˆÚÈÛÙ› ÛÂ

ÛËÌ·ÓÙÈÎfi ·ÚÈıÌfi ÂÊ‹‚ˆÓ ÛÙȘ ·ÓÂÙ˘Á̤Ó˜ ¯ÒÚ˜. ÷ڷÎÙËÚ›˙ÂÙ·È ·fi ˘ÂÚ‚ÔÏÈ΋ ¯Ú‹ÛË Î·È ÂÍ·ÚÙÒÌÂÓË Û˘ÌÂÚÈÊÔÚ¿, Ë ÔÔ›· ÂËÚ¿˙ÂÈ ·ÚÓËÙÈο ÙË ÛˆÌ·ÙÈ΋, ·Î·‰ËÌ·˚΋, ÎÔÈÓˆÓÈ΋, ÔÈÎÔÓÔÌÈ΋ Î·È Â·ÁÁÂÏÌ·ÙÈ΋ ˙ˆ‹ ÙÔ˘ ¯Ú‹ÛÙË. √ ÂÚÈÔÚÈÛÌfi˜ Ù˘ ¯Ú‹Û˘ ÚÔηÏ› Û˘ÌÙÒÌ·Ù· ÛÙ¤ÚËÛ˘, fiˆ˜ ·ÓËÛ˘¯›·, ¢ÂÚÂıÈÛÙfiÙËÙ·, ÙÚfiÌÔ, ¿Á¯Ô˜, Ê·ÓÙ·ÛÈÒÛÂȘ Î·È ÂÈıÂÙÈÎfiÙËÙ·, Ù· ÔÔ›· ˘Ô¯ˆÚÔ‡Ó ÌÂÙ¿ ·fi Ó¤· ¯Ú‹ÛË. √Ê›ÏÂÙ·È ÛÂ Û˘Ó‰˘·ÛÌfi ÎÔÈÓˆÓÈÎÒÓ ·Ú·ÁfiÓÙˆÓ Î·È ÚÔÛˆÈÎÒÓ ¯·Ú·ÎÙËÚÈÛÙÈÎÒÓ Î·È Û˘¯Ó¿ Û˘Ó‰˘¿˙ÂÙ·È Ì ηٿıÏÈ„Ë. ∏ Â›ÙˆÛË ÙÔ˘ ‰È·‰ÈÎÙ˘·ÎÔ‡ ÂıÈÛÌÔ‡ ÛÙÔ˘˜ ÂÊ‹‚Ô˘˜ Î˘Ì·›ÓÂÙ·È ·fi 1% ¤ˆ˜ 9% Î·È ¤¯Ô˘Ó ‰ËÌÈÔ˘ÚÁËı› ÂȉÈο ΤÓÙÚ· ·ÂÍ¿ÚÙËÛ˘ Ì ÛÎÔfi ÙËÓ ·ÏÏ·Á‹ ÙÔ˘ ÙÚfiÔ˘ ˙ˆ‹˜ ÙˆÓ ·Û¯fiÓÙˆÓ Î·È ÙËÓ ·Ó¿Ù˘ÍË ¿ÏÏˆÓ ‰Ú·ÛÙËÚÈÔًوÓ, ÂËÚ¿˙ÔÓÙ·˜ ÚˆÙ›ÛÙˆ˜ ÙÔ ÔÈÎÔÁÂÓÂÈ·Îfi ÂÚÈ‚¿ÏÏÔÓ. ∆Ô ‰È·‰›ÎÙ˘Ô ·ÔÙÂÏ› ÌÈ· ‚È‚ÏÈÔı‹ÎË ÛÙÔ Û›ÙÈ, ¤Ó· ·Ú¿ı˘ÚÔ ÛÙÔÓ ÎfiÛÌÔ Î·È, ȉȷ›ÙÂÚ· ÁÈ· ¤Ó· ·È‰›, ·ÔÙÂÏ› ÙÔÓ ÙÚfiÔ Ì ÙÔÓ ÔÔ›Ô ı· ·Ó·Ù‡ÍÂÈ ÔÏϤ˜ ·fi ÙȘ ‰ÂÍÈfiÙËÙ¤˜ ÙÔ˘. °È· ÙÔ ÏfiÁÔ ·˘Ùfi, Ë ¯Ú‹ÛË ı· Ú¤ÂÈ Ó· Â›Ó·È ÏÔÁÈ΋, ÌÂ Û˘ÁÎÂÎÚÈ̤ÓÔ ÛÎÔfi Î·È ÁÈ· Û˘ÁÎÂÎÚÈ̤ÓÔ ¯ÚfiÓÔ, Ì ÂÈÙ‹ÚËÛË, ÂÓÒ fiÏÔÈ ÔÈ ·ÚÌfi‰ÈÔÈ ÊÔÚ›˜ ÔÈ ÔÔ›ÔÈ ÂÌϤÎÔÓÙ·È

Internet addiction in adolescence

Abstract: Internet addiction has been diagnosed increasingly in the last decade and it is a recognized phenomenon in adolescence in developed countries. It is characterized by compulsive use and addictive behaviour, to a degree which interrupts personal, social, academic, economic and occupational activities and is associated with withdrawal symptoms, such as anxiety, trembling, tremors, aggressiveness and fantasies, which are relieved by re-use of the internet. Internet addiction is the combined result of many social factors and personal characteristics and is often associated with depression. Its prevalence in adolescence ranges from 1% to 9%. A few internet addiction recovery centres have been organized, with their main task that of changing the subjects’ everyday life, encouraging them to create other activities and trying to influence the family environment in a positive way. The internet offers an on-line updated library in the home, an open window to the world knowledge, and a means for children to improve their talents. However, for children and adolescents its use must be logical, with specific purposes and for certain time periods, supervised by adults; all persons responsible for children’s biopsychosocial development (parents, teachers, paediatricians, mental health professionals) should be aware of the problem of internet addiction and be able to identify prodromal symptoms and recognize children and adolescents who are at risk.

Key words: Internet addiction, adolescence.

ÂÍ¿ÚÙËÛË ·fi Ù˘¯ÂÚ¿ ·È¯Ó›‰È·, Ô˘, Û ·ÓÙ›ıÂÛË Ì ÙËÓ Â·ÁÁÂÏÌ·ÙÈ΋ Î·È ÚÔÛˆÈ΋ ÚÔÛÊÔÚ¿ ÙˆÓ ËÏÂÎÙÚÔÓÈÎÒÓ ˘ÔÏÔÁÈÛÙÒÓ, ‹Ù·Ó ÌÈ· ·ÓÙÈÎÔÈÓˆÓÈ΋ Ú¿ÍË (2). °Ú‹ÁÔÚ·, fï˜, Ë Û˘Ó¯Ҙ ·˘Í·ÓfiÌÂÓË ·Ó¿ÁÎË Ù˘ on line ËÁ‹˜ ÏËÚÔÊfiÚËÛ˘ Î·È Ë ¯Ú‹ÛË ÛÙËÓ ·ÓÒÚÈÌË ·È‰È΋ ËÏÈΛ· ·Ó¤‰ÂÈÍ ¿ÙÔÌ· Ô˘ ·ÚÔ˘Û›·˙·Ó ÂıÈÛÌfi ÌÂ Û˘ÌÙÒÌ·Ù· ÛÙ¤ÚËÛ˘

∞ÙÔÌÈο ¯·Ú·ÎÙËÚÈÛÙÈο

∞ÁfiÚȢȷٷڷ¯‹ ÛÙËÓ ÔÈÎÔÁÂÓÂȷ΋ Û˘ÓÔ¯‹

¡ÙÚÔ·Ïfi ªÔÓÔÁÔÓÂ˚΋ ÔÈÎÔÁ¤ÓÂÈ·

¢˘ÛÎÔÏ›· ÛÙËÓ ·fiÎÙËÛË Ê›ÏˆÓ∂ÏÏÈ‹˜ ÔÈÎÔÁÂÓÂȷ΋ ÛÙ‹ÚÈÍË

÷ÌËÏ‹ ·˘ÙÔÂÎÙ›ÌËÛË∂ÏÏÈ‹˜ ÂÔÙ›·

∫·Ù¿ıÏÈ„Ë∂χıÂÚË ¯Ú‹ÛË, ¯ˆÚ›˜ ¯ÚÔÓÈÎÔ‡˜ Î·È ÔÈÔÙÈÎÔ‡˜ ÂÚÈÔÚÈÛÌÔ‡˜

∫·Î‹ Û¯¤ÛË Ì ÙÔ˘˜ ÁÔÓ›˜ÀÂÚÚÔÛٷ٢ÙÈÎfi ‹ ·˘ÛÙËÚfi ÂÚÈ‚¿ÏÏÔÓ

∞Á¯Ò‰Ë˜ Î·È Â˘·›ÛıËÙË ÚÔÛˆÈÎfiÙËÙ·¶·ÚÔ˘Û›· ËÏÂÎÙÚÔÓÈÎÔ‡ ˘ÔÏÔÁÈÛÙ‹ ÛÙÔ ‰ˆÌ¿ÙÈÔ ÙÔ˘ ·È‰ÈÔ‡

ÀÂÚÎÈÓËÙÈÎfiÙËÙ· ªÂȈ̤Ó˜ ‰Ú·ÛÙËÚÈfiÙËÙ˜ ÂÎÙfi˜ ÛÈÙÈÔ‡ ¢È·Ù·Ú·¯¤˜ Û˘ÁΤÓÙÚˆÛ˘™˘¯Ó¤˜ ÂÈÛΤ„ÂȘ Û internet café

∞Ó·˙‹ÙËÛË Û˘Ó¯Ҙ ÙÔ˘ ηÈÓÔ‡ÚÁÈÔ˘

∆¿ÛË ˘¤Ú‚·Û˘ ÙˆÓ ÔÚ›ˆÓ

∫·Î‹ ·ÓÙ›ÏË„Ë ÙÔ˘ ¯ÚfiÓÔ˘

æ˘¯·Ó·ÁηÛÙÈ΋ ÚÔÛˆÈÎfiÙËÙ·

·˘Í¿ÓÂÈ ÙËÓ ·ÔÌfiÓˆÛË (19). ¶ÔÏϤ˜ ¤Ú¢Ó˜ ¤‰ÂÈÍ·Ó fiÙÈ ·È‰È¿ Ì „˘¯È·ÙÚÈΤ˜ ‰È·Ù·Ú·¯¤˜, fiˆ˜ ηٿıÏÈ„Ë, „˘¯·Ó·ÁηÛÙÈÎfiÙËÙ·-ηٷӷÁηÛÙÈÎfiÙËÙ·, ÊÔ‚›Â˜, ·Ó·Ù‡ÛÛÔ˘Ó Â˘ÎÔÏfiÙÂÚ· ÂıÈÛÙÈ΋ Û˘ÌÂÚÈÊÔÚ¿ Î·È ÛÙËÓ ÏÂÈÔÓfiÙËÙ· ÙˆÓ ·È‰ÈÒÓ ÚÔ¸¿Ú¯ÂÈ Î¿ÔÈÔ˘ ‚·ıÌÔ‡ ηٿıÏÈ„Ë (20-22). ∞Ó¿ÏÔÁ· ·ÔÙÂϤÛÌ·Ù· ·Ú·ÙËÚ‹ıËÎ·Ó Û ·È‰È¿ Ì ‰È·Ù·Ú·¯¤˜ Û˘ÁΤÓÙÚˆÛ˘ Î·È ˘ÂÚÎÈÓËÙÈÎfiÙËÙ·, ¯ˆÚ›˜ fï˜ Ó· ‰È¢ÎÚÈÓÈÛÙ› ·Ó ÙÔ ¤Ó· Â›Ó·È ·ÈÙ›·

ÙÔ˘ ¿ÏÏÔ˘ ‹ ·ÓÙ›ÛÙÚÔÊ· (23,24).

√ ÎÔÈÓˆÓÈÎfi˜ ÂÚ›Á˘ÚÔ˜ ‰Ú· Û˘ÓÂÚÁÈο Û ÂÊ‹‚Ô˘˜ Ì ¯·Ú·ÎÙËÚÈÛÙÈο Ô˘ ‰ËÌÈÔ˘ÚÁÔ‡Ó ÚԉȿıÂÛË. ∏ ‰ÔÌ‹ Ù˘ Û‡Á¯ÚÔÓ˘ ÎÔÈÓˆÓ›·˜ ·ÚÔÙÚ‡ÓÂÈ

Ù· ·È‰È¿ ÛÙË ¯Ú‹ÛË ÙˆÓ ËÏÂÎÙÚÔÓÈÎÒÓ ˘ÔÏÔÁÈ-

ÛÙÒÓ ˆ˜ ·ÛÊ·Ï‹ ÙÚfiÔ ··Û¯fiÏËÛ˘ Î·È „˘¯·ÁˆÁ›·˜ ÛÙÔ Û›ÙÈ, ‰Â‰Ô̤ÓÔ˘ fiÙÈ ÔÈ ÂÎÙfi˜ ÛÈÙÈÔ‡ ‰Ú·ÛÙËÚÈfiÙËÙ˜, fi¯È ÌfiÓÔ Â›Ó·È ÂÈΛӉ˘Ó˜, ·ÏÏ¿ ··ÈÙÔ‡Ó Î·È ÙËÓ ·ÚÔ˘Û›· ÙˆÓ ÁÔÓ¤ˆÓ Ô˘, ÏfiÁˆ ÔχˆÚ˘ Â·ÁÁÂÏÌ·ÙÈ΋˜ ÂÚÁ·Û›·˜, Û˘¯Ó¿ ‰ÂÓ Û˘ÌÌÂÙ¤¯Ô˘Ó ÛÙËÓ Î·ıËÌÂÚÈÓfiÙËÙ· ÙˆÓ ÂÊ‹‚ˆÓ Î·È ‰ÂÓ ‚ÔËıÔ‡Ó ÛÙËÓ ÂÎÙfiÓˆÛË Ù˘ ÂÓ¤ÚÁÂÈ·˜ Î·È ‰ËÌÈÔ˘Ú-

ÁÈÎfiÙËÙ·˜ Ô˘ ‰È·ı¤ÙÔ˘Ó. ∂ÈϤÔÓ, Ë ·Ô˘Û›· ÙˆÓ ÁÔÓ¤ˆÓ ‹ ÔÈ ·ÛÙ·ı›˜ ÔÈÎÔÁÂÓÂȷΤ˜ ‰Ô̤˜ (‰È·˙‡ÁÈÔ, ηٿ¯ÚËÛË ·ÏÎÔfiÏ Î·È Î·Ó›ÛÌ·ÙÔ˜) Ô‰ËÁÔ‡Ó

Û˘¯Ó¿ Û ηΤ˜ Û¯¤ÛÂȘ ·È‰ÈÔ‡-ÁÔÓ¤·, ÁÂÁÔÓfi˜ Ô˘

·ÔÙÂÏ› ÛÔ‚·Úfi ÂÈ‚·Ú˘ÓÙÈÎfi ·Ú¿ÁÔÓÙ· ÁÈ· ·Ó¿-

Ù˘ÍË ÂıÈÛÌÔ‡ ÛÙÔ˘˜ ÂÊ‹‚Ô˘˜ (25-26). ∆· ›ÓÙÂÚÓÂ٠ηʤ Î·È Ë ·ÚÔ˘Û›· ÙÔ˘ ËÏÂÎÙÚÔÓÈÎÔ‡ ˘ÔÏÔÁÈÛÙ‹ Û ÌË ÎÔÈÓfi¯ÚËÛÙÔ˘˜ ¯ÒÚÔ˘˜ ÛÙÔ Û›ÙÈ (.¯. ˘ÓÔ-

ÙËÓ Î·Ù·ÁÚ·Ê‹ Ù˘ Â›ÙˆÛ˘. √È ÂÚÈÛ-

ηٷÛ΢‹˜ Ù˘ ËÏÂÎÙÚÔÓÈ΋˜ Ù¯ÓÔÏÔÁ›·˜, fiˆ˜ Ë ∫›Ó· Î·È Ë ∫ÔÚ¤·. ™ÙÔÓ ¶›Ó·Î· 3 ·ÚÔ˘ÛÈ¿˙ÂÙ·È Ë Â›ÙˆÛË ÛÙÔ˘˜ ÂÊ‹‚Ô˘˜. À„ËÏfiÙÂÚ· ÔÛÔÛÙ¿ ¤¯Ô˘Ó ·Ó·ÊÂÚı› ÛÙË °ÂÚÌ·Ó›· Î·È ÛÙȘ ∏¶∞, ÂÓÒ ¯·ÌËÏfiÙÂÚ· ÛÙËÓ ∂ÏÏ¿‰·. ∂›Û˘, ·Ú·ÙËÚÂ›Ù·È ˘ÂÚÔ¯‹ ÙˆÓ ·ÁÔÚÈÒÓ ¤Ó·ÓÙÈ ÙˆÓ ÎÔÚÈÙÛÈÒÓ (20,23,27-35). ∞·ÈÙÔ‡ÓÙ·È, fï˜, ÂÚÈÛÛfiÙÂÚ˜ ÌÂϤÙ˜ ÚÔÎÂÈ̤ÓÔ˘ Ó· ·ÔÎÙËı› ÌÈ· ÛÊ·ÈÚÈ΋ ÂÈÎfiÓ· ÙÔ˘ ÚԂϋ̷ÙÔ˜.

™˘ÓÔ‰¤˜ ÂÈÏÔΤ˜

∏ ‰È¿ÁÓˆÛË Û˘¯Ó¿ ηı˘ÛÙÂÚ› ›Ù ÁÈ·Ù› Ô ‰È·‰ÈÎÙ˘·Îfi˜ ÂıÈÛÌfi˜ ‰‡ÛÎÔÏ· ·Ó·ÁÓˆÚ›˙ÂÙ·È ·fi ÙÔ˘˜

ÁÔÓ›˜ Î·È ÙÔ˘˜ ÂÊ‹‚Ô˘˜ ›Ù ÁÈ·Ù› ÔÈ ËÏÂÎÙÚÔÓÈÎÔ› ˘ÔÏÔÁÈÛÙ¤˜ ·ÔÙÂÏÔ‡Ó Â˘ÂÚÁÂÛ›· ÛÙË ˙ˆ‹ Ù˘ Û‡Á-

¯ÚÔÓ˘ ÎÔÈÓˆÓ›·˜ (36,37). ø˜ ÂÎ ÙÔ‡ÙÔ˘, ÔÏÏÔ›

¤ÊË‚ÔÈ ‰È·ÁÈÁÓÒÛÎÔÓÙ·È fiÙ·Ó ·ÚÔ˘ÛÈ¿ÛÔ˘Ó ÛÔ‚·Ú¤˜ ÂÈÏÔΤ˜ ÔÈ Ôԛ˜ ÚÔηÏÔ‡Ó ·ÓËÛ˘¯›· ÛÙÔ

ÔÈÎÔÁÂÓÂÈ·Îfi ÂÚÈ‚¿ÏÏÔÓ, fiˆ˜ ·ÓÙÈÎÔÈÓˆÓÈ΋ Û˘ÌÂÚÈÊÔÚ¿, ·fiÚÚÈ„Ë Ù˘ Ú·ÁÌ·ÙÈÎfiÙËÙ·˜, ·‰È·ÊÔÚ›· ÁÈ· ÙË Ì¿ıËÛË Î·È ÙËÓ Â·ÁÁÂÏÌ·ÙÈ΋ ·Ôη-

Û οıÂ

Ì›ˆÛ˘ Ù˘ ¯Ú‹Û˘ (38-39). °Ú‹ÁÔÚ·

Î·È Û˘¯Ó¿

Yoo (Korea)5359-15140,9

Hur MH (Korea)24011-15502

Jang KS (Korea)91214-18304,3

June KJ (Korea)152915-1820-

Deng YX (China)576012-15-5,5

Cao F (China)262012-18-2

Nalwa K (India)10016-1818Stefanescu C (Romania)6911-18-1,4

Johansson A (Norway)323712-188,61,9

Grusser SM (Germany)32311-14-9,3

MÔÓ¿‰· EÊË‚È΋˜ ÀÁ›·˜ (∞ı‹Ó·)52915181

ÂÚÈÛÛfiÙÂÚ˜ ·fi 60 ÂÚÈÙÒÛÂȘ ‰È·‰ÈÎÙ˘·Î‹˜ ·˘-

ÙÔÎÙÔÓ›·˜ (net suicide) (45), ÂÓÒ ÛÙËÓ πÓ‰›· ÚÔ ‰ÈÂ-

Ù›·˜ ··ÁÔÚ‡ÙËÎÂ Ë ¯Ú‹ÛË ÙÔ˘ ‰È·‰ÈÎÙ‡Ô˘ ÛÙÔ˘˜

ÎÔÈÙÒÓ˜ ÙˆÓ ÊÔÈÙËÙÒÓ, ÌÂÙ¿ ÙËÓ ·˘ÙÔÎÙÔÓ›· ÊÔÈ-

ÙËÙ‹ (6). ∆ÂÏÈο, ÙÔ Û‡Ó‰ÚÔÌÔ ÙÔ˘ ηÚÈ·›Ô˘ ۈϋ-

Ó· ›Ûˆ˜ Â›Ó·È Ë ÈÔ ·Ï‹ ÂÈÏÔ΋, Ô˘ ‡ÎÔÏ· ·Ôηı›ÛٷٷÈ.

£ÂÚ·›·

£ÂÚ·¢ÙÈΤ˜ ·ÚÂÌ‚¿ÛÂȘ Á›ÓÔÓÙ·È ÌfiÓÔ Û ÂÈ-

‰Èο ΤÓÙÚ·, Ì ÂȉÈÎÔ‡˜ „˘¯È΋˜ ˘Á›·˜ (·È‰Ô„˘-

¯›·ÙÚÔ˘˜, ·È‰Ô„˘¯ÔÏfiÁÔ˘˜ Î·È „˘¯oıÂÚ·Â˘Ù¤˜),

ÁÓÒÛÙ˜ ÙÔ˘ ‰È·‰ÈÎÙ˘·ÎÔ‡ ÂıÈÛÌÔ‡ (46). ∏ ıÂÚ·-

›· ·ÚÔ˘ÛÈ¿˙ÂÈ È‰È·ÈÙÂÚfiÙËÙ˜, Û ۯ¤ÛË Ì ¿ÏÏ·

›‰Ë ÂıÈÛÌÔ‡. µ·ÛÈ΋ ‰È·ÊÔÚ¿ ·ÔÙÂÏ› ÙÔ ÁÂÁÔÓfi˜

fiÙÈ ‰ÂÓ ÂÓÔ¯ÔÔÈÂ›Ù·È Î¿ÔÈ· ÙÔÍÈ΋ Ô˘Û›· ·ÏÏ¿ ο-

ÔÈÔ˜ ÙÚfiÔ˜ ˙ˆ‹˜ Î·È Ë ·Ú¤Ì‚·ÛË ı· Ú¤ÂÈ Ó·

ÂÛÙÈ¿˙ÂÙ·È ÛÙËÓ ·ÏÏ·Á‹ Ù˘ ηıËÌÂÚÈÓfiÙËÙ·˜ ÙÔ˘

¿Û¯ÔÓÙÔ˜. √È ‹Ș ÂÚÈÙÒÛÂȘ ·Ú·ÎÔÏÔ˘ıÔ‡-

ÓÙ·È Ì ÛÂÈÚ¿ Û˘Ó‰ÚÈÒÓ Û ٷÎÙ¿ ¯ÚÔÓÈο ‰È·ÛÙ‹-

Ì·Ù·, ÂÓÒ ÔÈ ÛÔ‚·Ú¤˜ ··ÈÙÔ‡Ó “ÓÔÛËÏ›·”Û ÂȉÈο ΤÓÙÚ· ÛÙ· ÔÔ›· ÂÊ·ÚÌfi˙ÂÙ·È Ë ÁÓˆÛȷ΋ Û˘-

ÌÂÚÈÊÔÚÈ΋ ıÂÚ·›· (47). ∆Ô ÚÒÙÔ Î¤ÓÙÚÔ Ô˘

‰ÈÔÚÁ·ÓÒıËΠ̠ÙË ÌÔÚÊ‹ ηٷÛ΋ӈÛ˘ ÁÈ· ÂÊ‹-

‚Ô˘˜ Â›Ó·È ÛÙËÓ ·Ú·Ïȷ΋ ΈÌfiÔÏË Boltenhagen

ÛÙËÓ ÂÚÈÔ¯‹ Mecklenburg ÛÙË ¢˘ÙÈ΋ Pomerania

(°ÂÚÌ·Ó›·), ÙÔ ÔÔ›Ô ÂȉÈÒÎÂÈ Ó· ‚ÔËı‹ÛÂÈ Ù· ·È-

‰È¿ Ó· ‚ÂÏÙÈÒÛÔ˘Ó ÙȘ Û¯¤ÛÂȘ Ì ʛÏÔ˘˜, Ó· ÂÈϤ-

‰È·ÊÔÚÂÙÈΤ˜ ‰Ú·ÛÙËÚÈfiÙËÙ˜

ÙËÏÂfiÚ·Û˘, ÔÈ ·ÙÂÏ›ˆÙ˜ ÒÚ˜ ÔÌÈÏ›·˜ ÛÙÔ ÙËϤʈÓÔ, ÙÔ ˘ÂÚ‚ÔÏÈÎfi ‰È¿‚·ÛÌ· ‹ Ë „˘¯·Ó·ÁηÛÙÈ΋ ÂÚÁ·Û›·, Û˘ÌÂÚÈÊÔÚ¤˜ ηٿ ÙȘ Ôԛ˜ Ù· ¿ÙÔÌ· ·ÔÔÈÔ‡ÓÙ·È ÔÈÎÔÁÂÓÂȷΤ˜ ·Ó¿ÁΘ, Ê›ÏÔ˘˜ ‹ ÎÔÈÓˆÓÈΤ˜ ÂΉËÏÒÛÂȘ (50). ∏ ¢¯·Ú›ÛÙËÛË ·fi ÙË ¯Ú‹ÛË ÙÔ˘ ‰È·‰ÈÎÙ‡Ô˘ ‰ÂÓ ÌÔÚ› Ó· Û˘ÁÎÚÈı› Ô‡Ù ÛÙÔ ÂÏ¿¯ÈÛÙÔ Ì ÙË ¯Ú‹ÛË ÎÔη˝Ó˘ ‹ ËÚˆ›Ó˘. √‡Ù ÌÔÚ› Ó· Û˘ÁÎÚÈı› Ì ÙËÓ ·ıÔÏÔÁÈ΋ ÂÍ¿ÚÙËÛË ·fi Ù˘¯ÂÚ¿ ·È¯Ó›‰È·, Ë ÔÔ›· ·ÔÙÂÏ› ÌÂÌÔӈ̤ÓË ·ÓÙÈÎÔÈÓˆÓÈ΋ Û˘ÌÂÚÈÊÔÚ¿. ∞ÓÙ›ıÂÙ·, ÙÔ ‰È·‰›ÎÙ˘Ô ¤¯ÂÈ Ì¤ÁÈÛÙÔ ·ÙÔÌÈÎfi Î·È ÎÔÈÓˆÓÈÎfi fiÊÂÏÔ˜. ∞ÔÙÂÏ› ÙÔ ··Ú·›ÙËÙÔ Ì¤ÛÔ ÏÂÈÙÔ˘ÚÁ›·˜ ÔÏÏÒÓ ÂȯÂÈÚ‹ÛÂˆÓ Î·È ¿ÌÂÛ˘ ÚfiÛ‚·Û˘ Û Ï›ÛÙ· ˘ÏÈο ·Á·ı¿, ÚÔÛʤÚÂÈ ÙÔÓ ÙÚfiÔ Â‡ÎÔÏ˘ Â·ÁÁÂÏÌ·ÙÈ΋˜ ‹ ÚÔÛˆÈ΋˜ ÂÈÎÔÈÓˆÓ›·˜ Î·È ÏÂÈ-

ÙÔ˘ÚÁ› ˆ˜ ÙÔ ·Ú¿ı˘ÚÔ ÚfiÛ‚·Û˘ ÛÙËÓ ÔÏÔÎÏËڈ̤ÓË Î·È ·ÁÎfiÛÌÈ· ÁÓÒÛË. ø˜ ÂÎ ÙÔ‡ÙÔ˘, ˘ÔÛÙËÚ›˙ÂÈ Ô Grohol, Ë Ù¯ÓÔÏÔÁ›· ·˘Ù‹ ηı·˘Ù‹ ‰ÂÓ Â›Ó·È ˘‡ı˘ÓË ÁÈ· ÙËÓ ÂÁηٿÛÙ·ÛË ÂıÈÛÌÔ‡, ·ÏÏ¿

¿ÙÔÌ· ÌÂ Û˘ÁÎÂÎÚÈ̤Ó˜ Û˘ÌÂÚÈÊÔÚ¤˜ ÌÔÚÔ‡Ó Ó·

ÂÚÈ¤ÛÔ˘Ó Û ˘ÂÚ‚ÔÏÈ΋ ¯Ú‹ÛË (50).

∆Ô ÂÚÒÙËÌ· Ô˘ Ù›ıÂÙ·È Â›Ó·È ÙÈ ÚÔηÏ› ·ÏÏ·Á¤˜ ÛÙËÓ ÈÛÔÚÚÔ›· Ù˘ ·ÓıÚÒÈÓ˘ „˘¯ÔÛ‡ÓıÂÛ˘. ∂›Ó·È ÁÂÁÔÓfi˜ fiÙÈ ÔÈ ÎÔÈÓˆÓÈΤ˜ Î·È Â·ÁÁÂÏÌ·ÙÈΤ˜ ··ÈÙ‹ÛÂȘ ‰ËÌÈÔ˘ÚÁÔ‡Ó ÚÔÛˆÈÎfiÙËÙ˜ ÌÔÓ·¯ÈΤ˜, ÊÔ‚ÈṲ̂Ó˜, ·Ó·ÛÊ·Ï›˜, ηٷıÏÈÙÈΤ˜, ¯ˆÚ›˜ ηÏÏȤÚÁÂÈ· Î·È ÛÙ·ıÂÚfiÙËÙ·, Ì ·ÔÙ¤ÏÂÛÌ· ÙÔ ‰È·‰›ÎÙ˘Ô

·ÔÌÔӈ̤ÓÔ˘˜ ·ÓıÚÒÔ˘˜, ÔÈ ÔÔ›ÔÈ ¤¯Ô˘Ó ·Ó¿-

ÁÎË Ó· ·ÊÔÛȈıÔ‡Ó ‹ Ó· ÂÍ·ÚÙËıÔ‡Ó ·fi οÙÈ Ô˘

ı· ‰ÒÛÂÈ ÂӉȷʤÚÔÓ ÛÙË ˙ˆ‹ ÙÔ˘˜.

ªÂ ·˘Ù¿ Ù· ‰Â‰Ô̤ӷ, Ê·›ÓÂÙ·È fiÙÈ Ë ÚfiÏË„Ë

Ù˘ ·Ó¿Ù˘Í˘ ÂıÈÛÌÔ‡ ÛÙËÚ›˙ÂÙ·È ÛÙË ÛˆÛÙ‹ Û¯¤ÛË Ô˘ ı· ¤¯Ô˘Ó ÔÈ ¤ÊË‚ÔÈ Ì ÙÔ˘˜ ÁÔÓ›˜ Î·È ÙÔ˘˜

Ê›ÏÔ˘˜ ÙÔ˘˜. ∏ ÛˆÛÙ‹ Û¯¤ÛË Û˘Ó›ÛÙ·Ù·È Û ÛÙÂÓ‹,

Ì ηٷÓfiËÛË Î·È ·Á¿Ë, ·Ú·ÎÔÏÔ‡ıËÛË Ù˘ ηıËÌÂÚÈÓfiÙËÙ¿˜ ÙÔ˘˜, ÛˆÛÙ‹ ·ÍÈÔÏfiÁËÛË ÙˆÓ ·Ó·-

ÁÎÒÓ ÙÔ˘˜, Û˘ÓÂÙ¤˜ Â·ÁÁÂÏÌ·ÙÈΤ˜ ··ÈÙ‹ÛÂȘ

·Ó¿ÏÔÁ· Ì ÙȘ ÈηÓfiÙËÙ˜ Î·È ÙËÓ ÚÔÛˆÈÎfiÙËÙ¿ ÙÔ˘˜ Î·È ·˘ÍË̤Ó˜ ‰Ú·ÛÙËÚÈfiÙËÙ˜ ÂÎÙfi˜ ÛÈÙÈÔ‡.

¶ÈÛÙ‡ԢÌ fiÙÈ ÔÈ ·ÏËıÈÓ¤˜ Û¯¤ÛÂȘ-ÊÈϛ˜ Î·È Ë

Â·Ó-Â·Ê‹ ÙˆÓ ÂÊ‹‚ˆÓ Ì ÙË Ê‡ÛË Î·È ÙË ¢ËÌÈ-

Ô˘ÚÁ›· ı· ·ÔÙÚ¤„Ô˘Ó ÂıÈÛÙÈΤ˜ Û˘ÌÂÚÈÊÔÚ¤˜ ηÈ

ı· Ô‰ËÁ‹ÛÔ˘Ó Û ÈÛÔÚÚÔË̤Ó˜ Û¯¤ÛÂȘ Ì ÙÔ˘˜

Á‡Úˆ Û˘Ó·ÓıÚÒÔ˘˜ ÙÔ˘˜ Î·È ÙÔÓ £Âfi. ÿÛˆ˜ ÙfiÙ ٷ

Taiwan: an interview study. Cyberpsychol Behav 2003;6: 649-652.

13. Simkova B, Cincera J. Internet addiction disorder and chatting in the Czech Republic. Cyberpsychol Behav 2004;7: 536-539.

14. Donovan DM, Marlatt GA. Assessment of Addictive Behaviors. 2nd ed. New York: Guilford Press; 2008.

15. Cho YR, Lee HJ. A study on a model for internet addiction of adolescents. Taehan Kanho Hakhoe Chi 2004;34:541-551.

16. Chak K, Leung L. Shyness and locus of control as predictors of internet addiction and internet use. Cyberpsychol Behav 2004;7:559-570.

17. Caplan SE. Relations among loneliness, social anxiety, and problematic Internet use. Cyberpsychol Behav 2007;10: 234-242.

18. Campbell AJ, Cumming SR, Hughes I. Internet use by the socially fearful: addiction or therapy? Cyberpsychol Behav 2006;9:69-81.

19. Seepersad S. Coping with loneliness: adolescent online and offline behavior. Cyberpsychol Behav 2004;7:35-39.

20. Jang KS, Hwang SY, Choi JY. Internet addiction and psychiatric symptoms among Korean adolescents. J Sch Health 2008;78:165-171.

21. Ha JH, Kim SY, Bae SC, Bae S, Kim H, Sim M, et al. Depression and Internet addiction in adolescents. Psychopathology 2007;40:424-430.

1. O’Reilly M. Internet addiction: a new disorder enters the medical lexicon. CMAJ 1996;154:1882-1883.

2. Belluck P. Net addiction: true disorder or just a cyberpsycho-fad? The New York Times [Internet]. 1996 Dec: Webpage: http://search.nytimes.com/search/daily/bin/ fastweb?search

3. Yang DJ. Craving your next Web fix. Internet addiction is no laughing matter. US News World Rep 2000;128:41.

4. Block JJ. Issues for DSM-V: internet addiction [Editorial]. Am J Psychiatry 2008;165:306-307.

5. Young KS. πnternet addiction: the emergence of a new clinical disorder. Paper presented at the 104th annual meeting of the American Psychological Association, Toronto, Canada, August 15, 1996. Center for Internet Addiction Recovery [Internet]. Webpage: http://www. netaddiction.com/ articles/newdisorder.pdf

6. What is Internet addiction? Center for Internet Addiction Recovery [Internet]. 2008: Webpage: http://www. netaddiction.com/whatis.htm

7. Tuleya LG. Thesaurus of Psychological Index Terms. 11th ed. Washington, American Psychological Association; 2007.

8. Nichols LA, Nicki R. Development of a psychometrically sound internet addiction scale: a preliminary step. Psychol Addict Behav 2004;18:381-384.

9. Ko CH, Yen JY, Chen CC, Chen SH, Yen CF. Proposed diagnostic criteria of Internet addiction for adolescents. J Nerv Ment Dis 2005;193:728-733.

0. Ko CH, Yen JY, Yen CF, Chen CC, Yen CN, Chen SH. Screening for Internet addiction: an empirical study on cut-off points for the Chen Internet Addiction Scale. Kaohsiung J Med Sci 2005;21:545-551.

11. Young K. Internet Addiction Test (IAT). Center for Internet Addiction Recovery [Internet]. Webpage: htpp://www. netaddiction.com/resources/internet_addiction_test.htm

12. Tsai CC, Lin SS. Internet addiction of adolescents in

22. Kratzer S, Hegerl U. Is “Internet Addiction” a Disorder of its Own? Psychiatr Prax 2008;35:80-83.

23. Yoo HJ, Cho SC, Ha J, Yune SK, Kim SJ, Hwang J, et al. Attention deficit hyperactivity symptoms and internet addiction. Psychiatry Clin Neurosci 2004;58:487-494.

24. Yen JY, Ko CH, Yen CF, Wu HY, Yang MJ. The comorbid psychiatric symptoms of Internet addiction: attention deficit and hyperactivity disorder (ADHD), depression, social phobia, and hostility. J Adolesc Health 2007;41:93-98.

25. Yen JY, Yen CF, Chen CC, Chen SH, Ko CH. Family factors of internet addiction and substance use experience in Taiwanese adolescents. Cyberpsychol Behav 2007;10: 323-329.

26. Liu CY, Kuo FY. A study of Internet addiction through the lens of the interpersonal theory. Cyberpsychol Behav 2007; 10:799-804.

27. Cao F, Su L. Internet addiction among Chinese adolescents: prevalence and psychological features. Child Care Health Dev 2007;33:275-281.

28. Hur MH. Demographic, habitual, and socioeconomic determinants of Internet addiction disorder: an empirical study of Korean teenagers. Cyberpsychol Behav 2006;9: 514-525.

29. June KJ, Sohn SY, So AY, Yi GM, Park SH. A study of factors that influence Internet addiction, smoking, and drinking in high school students. Taehan Kanho Hakhoe Chi 2007;37:872-882.

30. Deng YX, Hu M, Hu GQ, Wang LS, Sun ZQ. An investigation on the prevalence of internet addiction disorder in middle school students of Hunan province. Zhonghua Liu Xing Bing Xue Za Zhi 2007;28:445-448.

31. Nalwa K, Anand AP. Internet addiction in students: a cause of concern. Cyberpsychol Behav 2003;6:653-656.

32. Stefanescu C, Chele G, Chirit , a V, Chirit , a R, Mavros M, Macarie G, et al. The effects of computer-use on adolescents. Rev Med Chir Soc Med Nat Iasi 2005;109:871-877.

33. Johansson A, Götestam KG. Internet addiction: characteristics of a questionnaire and prevalence in Norwegian youth (12-18 years). Scand J Psychol 2004;45: 223-229.

34. Grüsser SM, Thalemann R, Griffiths MD. Excessive computer game playing: evidence for addiction and aggression? Cyberpsychol Behav 2007;10:290-292.

35.∆Û›ÙÛÈη ∞. ÃÚ‹ÛË Î·È Î·Ù¿¯ÚËÛË ‰È·‰ÈÎÙ‡Ô˘. ∂ÈÛ‹ÁËÛË

ÛÙÔ 1Ô ∂ÓÙ·ÙÈÎfi ™ÂÌÈÓ¿ÚÈÔ ÛÙËÓ ∂ÊË‚È΋ π·ÙÚÈ΋. ªÔÓ¿‰· ∂ÊË‚È΋˜ ÀÁ›·˜. ¡ÔÛÔÎÔÌÂ›Ô ¶·›‰ˆÓ “¶. & ∞. ∫˘ÚÈ·ÎÔ‡”. [Internet]. ∞Ú›ÏÈÔ˜ 2008: Webpage: http://www. youth-health.gr/gr/index.php?I=6&J=2&K=42

36. Subrahmanyam K, Kraut RE, Greenfield PM, Gross EF. The impact of home computer use on children's activities and development. Future Child 2000;10:123-144.

37. Beard KW. Internet addiction: a review of current assessment techniques and potential assessment questions. Cyberpsychol Behav 2005;8:7-14.

38. Meenan AL. Internet Gaming: A Hidden Addiction. Am Fam Physician 2007;76:1116-1117.

39. Wu CS, Cheng FF. Internet café addiction of Taiwanese adolescents. Cyberpsychol Behav 2007;10:220-225.

40. Subrahmanyam K, Lin G. Adolescents on the net: Internet use and well-being. Adolescence 2007;42:659-677.

41. Olson CK, Kutner LA, Warner DE, Almerigi JB, Baer L, Nicholi AM 2nd, et al. Factors correlated with violent video game use by adolescent boys and girls. Adolesc Health 2007;41:77-83.

42. Ng BD, Wiemer-Hastings P. Addiction to the internet and online gaming. Cyberpsychol Behav 2005;8:110-113.

43. Van den Bulck J. Television viewing, computer game playing, and Internet use and self-reported time to bed and time out of bed in secondary-school children. Sleep 2004;27:101-104.

44. Kim K, Ryu E, Chon MY, Yeun EJ, Choi SY, Seo JS, et al. Internet addiction in Korean adolescents and its relation to depression and suicidal ideation: a questionnaire survey. Int J Nurs Stud 2006;43:185-192.

45. Naito A. Internet suicide in Japan: implications for child and adolescent mental health. Clin Child Psychol Psychiatry 2007;12:583-597.

46. Stein DJ. Internet addiction, Internet psychotherapy. Am J Psychiatry 1997;154:890.

47. Young KS. Cognitive behavior therapy with Internet addicts: treatment outcomes and implications. Cyberpsychol Behav 2007;10:671-679.

48. Widyanto L, Griffiths M. ‘Internet Addiction’: A Critical Review. Int J Mental Health and Addiction 2006;4:31-51.

49. Chien C, Linda C, Belland JC. A Review of the Research on Internet Addiction. Educational Psychology Review 2005; 17:363-388.

50. Grohol JM. Internet addiction guide. Psychcentral [Internet]. 2005 Apr: Webpage: http://psychcentral.com/ netaddiction

ªÂϤÙË Ù˘ ¯Ú‹Û˘ Î·È Î·Ù¿¯ÚËÛ˘ ÙÔ˘ ‰È·‰ÈÎÙ‡Ô˘ ÛÂ

ŒÏÏËÓ˜ ÂÊ‹‚Ô˘˜

∞. ∆Û›ÙÛÈη1, ∂. ∫ÚÈÙÛ¤ÏË2, ∂. ∫ˆÓÛÙ·ÓÙÔ˘Ï¿ÎË1, °. ∫ÔÚÌ¿˜1, ∞. ºÈÏÈÔÔ‡ÏÔ˘1, ¢. ∆Ô˘ÓÈÛÛ›‰Ô˘1, ∞. ºÚ¤ÛÎÔ˘1, £. ™ËÏÈÔÔ‡ÏÔ˘1, ∞. §Ô˘›˙Ô˘1, A. ∫ˆÓÛÙ·ÓÙfiÔ˘ÏÔ˜1, ¢. ∫·ÊÂÙ˙‹˜2

¶ÂÚ›ÏË„Ë

∂ÈÛ·ÁˆÁ‹: ∆Ô ‰È·‰›ÎÙ˘Ô ·ÔÙÂÏ› ϤÔÓ ·Ó·Áη›Ô ÂÚÁ·ÏÂ›Ô ÂÓË̤ڈÛ˘, ÎÔÈÓˆÓÈ΋˜ Â·Ê‹˜ Î·È „˘¯·ÁˆÁ›·˜ ÁÈ· ÙÔ˘˜ ÂÊ‹‚Ô˘˜. øÛÙfiÛÔ, Ë ˘ÂÚ‚ÔÏÈ΋ ÂÓ·Û¯fiÏËÛË Ì ÙÔ Ì¤ÛÔ ·˘Ùfi ‰ËÌÈÔ˘ÚÁ› ÎÈÓ‰‡ÓÔ˘˜ ·Ó¿Ù˘Í˘ ·ÎÚ·›ˆÓ Û˘ÌÂÚÈÊÔÚÒÓ Û¯ÂÙÈο Ì ÙË ¯Ú‹ÛË ÙÔ˘. √È ÛÙfi¯ÔÈ Ù˘ ÌÂϤÙ˘ ›ӷÈ: (1) Ó· ÂÎÙÈÌËı› Ë ¤ÎÙ·ÛË Ù˘ ¯Ú‹Û˘ ÙÔ˘ ‰È·‰ÈÎÙ‡Ô˘ (2) Ó· ·ÍÈÔÏÔÁËıÔ‡Ó Ù· ÔÈÔÙÈο ¯·Ú·ÎÙËÚÈÛÙÈο ·˘Ù‹˜ Ù˘ ¯Ú‹Û˘ Î·È (3) Ó· ˘ÔÏÔÁÈÛÙ› Ë Â›ÙˆÛË ·ıÔÏÔÁÈ΋˜ ¯Ú‹Û˘.

ÀÏÈÎfi Î·È Ì¤ıÔ‰ÔÈ: √ ÏËı˘ÛÌfi˜ Ô˘ ÌÂÏÂÙ‹ıËΠ(¡=897) ‹Ù·Ó Ù˘¯·›Ô ‰Â›ÁÌ· ÂÊ‹‚ˆÓ Ô˘ ηÙÔÈÎÔ‡Ó

ÛÙËÓ ∞ı‹Ó·, Ì ‰È·ÛÙڈ̿وÛË Û‡Ìʈӷ Ì ÙËÓ ÏËı˘ÛÌȷ΋ ˘ÎÓfiÙËÙ·. ÃÚËÛÈÌÔÔÈ‹ıËÎ·Ó ·ÓÒÓ˘-

Ì· ÂÚˆÙËÌ·ÙÔÏfiÁÈ·, Ù· ÔÔ›· ·ÊÔÚÔ‡Û·Ó ÛÙ· ¯·Ú·ÎÙËÚÈÛÙÈο Ù˘ ÚfiÛ‚·Û˘ ÛÙÔ ‰È·‰›ÎÙ˘Ô, ηıÒ˜ ηÈ

ÙÔ ÂÚÁ·ÏÂ›Ô ·ÍÈÔÏfiÁËÛ˘ Ù˘ ηٿ¯ÚËÛ˘ Young Internet Addiction Score (YIAS).

∞ÔÙÂϤÛÌ·Ù·: ∏ ÌÂϤÙË ·Ó¤‰ÂÈÍ fiÙÈ ÔÈ ÈÔ ÛËÌ·ÓÙÈÎÔ› ·Ú¿ÁÔÓÙ˜

Û¯ÂÙ›˙ÔÓÙ·È Ì ÙËÓ ·Ó¿Ù˘ÍË ·-

ıÔÏÔÁÈ΋˜ ¯Ú‹Û˘ ‹Ù·Ó Ë ÚfiÛ‚·ÛË ·fi ÙÔ Û›ÙÈ, Ë Û˘ÌÌÂÙÔ¯‹ Û ‰È·‰ÈÎÙ˘·Î¿ ·È¯Ó›‰È·, ηıÒ˜ Î·È ÏfiÁÔÈ ÎÔÈÓˆÓÈÎÔÔ›ËÛ˘ (.¯. e-mail, chat rooms). ∏ ÚfiÛ‚·ÛË ÛÙÔ ‰È·‰›ÎÙ˘Ô Ì¤Ûˆ Û¯ÔÏÈÎÒÓ ÚÔÁÚ·ÌÌ¿ÙˆÓ ·ÔÙ¤ÏÂÛ ÛËÌ·ÓÙÈÎfi ·Ú¿ÁÔÓÙ· ÚÔÛÙ·Û›·˜ ¤Ó·ÓÙÈ Ù˘ ˘ÂÚ‚ÔÏÈ΋˜ ¯Ú‹Û˘, ÂÓÒ Ë ÚfiÛ‚·ÛË Ì¤-

Ûˆ ÙˆÓ ›ÓÙÂÚÓÂ٠ηʤ Û˘Û¯ÂÙ›ÛÙËΠ̠ÔχˆÚË ¯Ú‹ÛË (11-20 ÒÚ˜/‚‰ÔÌ¿‰·). ™‡Ìʈӷ Ì ÙÔ YIAS, 1% ÙˆÓ ÂÊ‹‚ˆÓ ÙÔ˘ ‰Â›ÁÌ·ÙÔ˜ ›¯Â Û˘ÌÂÚÈÊÔÚ¿ ÂıÈÛÌÔ‡, ÂÓÒ 12,8% ·ÚÔ˘Û›·˙ ÔÚȷ΋ ¯Ú‹ÛË (ÚԂϋ̷ٷ Ô˘ ‰˘ÓËÙÈο ı· ÌÔÚÔ‡Û·Ó Ó· Ô‰ËÁ‹ÛÔ˘Ó Û ÂıÈÛÌfi). ™˘ÌÂÚ¿ÛÌ·Ù·: ∏ ηٿ¯ÚËÛË ÙÔ˘ ‰È·‰ÈÎÙ‡Ô˘ Â›Ó·È ÂÌÊ·Ó‹˜ ÛÙÔ˘˜ ŒÏÏËÓ˜ ÂÊ‹‚Ô˘˜ Î·È ··ÈÙ› ·Ú¤Ì-

Î·È ÚÔÁÚ¿ÌÌ·Ù· ÚfiÏ˄˘. §¤ÍÂȘ ÎÏÂȉȿ: ∂Ê˂›·, ‰È·‰›ÎÙ˘Ô, ηٿ¯ÚËÛË

Study on the use and misuse of internet among Greek adolescents

∞. Tsitsika1, ∂. Critselis2, ∂. Konstantoulaki1, G. Kormas1, ∞. Filippopoulou1, D. Tounissidou1, ∞. Freskou1, T. Spiliopoulou1, ∞. Louizou1, A. Constantopoulos1, D. Kafetzis2

Abstract

Background: The internet is an integral tool for information, social communication, and entertainment among adolescents. However, the risk of adopting pathological internet use behaviour is inherent. The aim of this study was: (1) to evaluate the prevalence and (2) to assess the characteristics and predictors of internet use, and (3) to measure the prevalence of pathological internet use among Greek adolescents.

Methods: A cross-sectional study design was applied. The source population (N=897) consisted of a random sample, stratified according to locality and population density, of adolescents residing in Athens, Greece. Self-completed questionnaires, pertaining to internet access characteristics, and the Young Internet Addiction Score (YIAS) were utilized in order to assess the predictors of internet use and the prevalence of pathological internet use.

Results: Multivariate logistic regression analysis indicated that the most significant predictors of all categories of internet use included accessing the internet via one’s own home portal and internet access for on-line games and social interaction (i.e. e-mail and chat room use). Internet access via the school environment was a significant protective factor against the development of misuse. Access via internet cafés was a significant predictor for high (11-20 hours/week) internet users. According to the YIAS, 1% of the study population reported Addictive Internet Use and 12.8% recorded problems of use that could potentially lead to future pathology (Borderline Internet Use).

Conclusions: Internet misuse is apparent among Greek adolescents and calls for intervention and preventive public health programmes.

Key words: Adolescence, internet use, internet misuse, internet addiction.

AÏÏËÏÔÁÚ·Ê›·:

1 Adolescent Health Unit (AHU), 2nd Department of Paediatrics, Medical School, University of Athens, “P. & A. Kyriakou” Children’s Hospital, Athens, Greece 2 2nd Department of Paediatrics, Medical School, University of Athens, “P. & A. Kyriakou” Children’s Hospital, Athens, Greece

Correspondence: Artemis Tsitsika info@youth-health.gr Adolescent Health Unit (AHU), 2nd Department of Paediatrics, Medical School, University of Athens, “P. & A. Kyriakou” Children’s Hospital, Athens, Greece

∏ÏÈΛ·

0-1 ÒÚ·/ ‚‰ÔÌ¿‰· 1-3 ÒÚ˜/‚‰ÔÌ¿‰· 4-10 ÒÚ˜/‚‰ÔÌ¿‰· 11-20 ÒÚ˜/‚‰ÔÌ¿‰· >20 ÒÚ˜/‚‰ÔÌ¿‰· (N=277) (N=318) (N=191) (N=55) (N=56) N (%) N (%) OR 95% CI N (%) OR 95% CI N (%) OR 95% CI N (%) OR 95% CI

<15 ¤ÙË193 (69,7)207 (65,1)0,710,49-1,03112 (58,6)0,590,39-0,9031 (56,4)0,480,26-0,9031 (55,4)0,600,31-1,15 15-15,9 ¤ÙË63 (22,7)104 (32,7)--62 (32,5)--21 (38,2)--17 (30,4)->16 ¤ÙË8 (2,9)7 (2,2)0,580,20-1,688 (4,2)1,020,36-2,881 (1,8)0,380,04-3,183 (5,4)1,390,33-5,81

º‡ÏÔ

ÕÚÚÂÓ98 (35,4)132 (41,5)--107 (56,0)--38 (69,1)--48 (85,7)-£‹Ï˘177 (63,9)183 (57,5)0,770,55-1,0784 (44,0)0,430,30-0,6318 (32,7)0,270,14-0,508 (14,3)0,090,04-0,20

BMI

<18,5 kg/m2 169 (61,0)194 (61,0)0,950,66-1,36104 (54,4)0,710,48-1,0627 (49,1)0,690,36-1,3126 (46,4)0,520,28-0,97 18,5-24,9 kg/m2 82 (29,6)99 (31,1)--71 (37,2)--19 (34,5)--24 (42,8)->25,0 kg/m2 5 (1,8)5 (1,6)0,830,23-2,964 (2,1)0,920,24-3,574 (7,3)3,450,85-14,093 (5,4)2,050,46-9,20

ª√µ

<C+74 (26,7)83 (26,1)--51 (26,7)--15 (27,3)--16 (28,6)--

B- - B+116 (41,9)131 (41,2)1,010,67-1,5079 (41,4)0,990,62-1,5624 (43,6)1,020,50-2,0727 (48,2)1,080,54-2,13

A- - A+70 (25,3)87 (27,4)1,110,71-1,7351 (26,7)1,060,64-1,7613 (23,6)0,920,41-2,069 (16,1)0,590,25-1,43

πÛÙÔÚÈÎfi ¯Ú‹Û˘ ‰È·‰ÈÎÙ‡Ô˘

0-6 ̋Ә181 (65,3)101 (31,8)--30 (15,7)--5 (9,1)--3 (5,4)-6-12 ̋Ә18 (6,5)50 (15,7)4,982,76-8,9934 (17,8)11,405,72-22,715 (9,1)10,062,66-38,054 (7,1)13,412,78-64,66 >12 ̋Ә 72 (26,0)163 (51,2)4,062,80-5,87127 (66,5)10,646,57-17,2445 (81,8)22,628,63-59,2948 (85,7)40,2212,14-133,27

OR: Unadjusted Odds Ratio, 95% CI: 95% Confidence Interval for Unadjusted Odds Ratio

Û˘Û¯ÂÙ›˙ÂÙ·È ÛËÌ·ÓÙÈο Ì ÙÔ ÈÛÙÔÚÈÎfi ¯Ú‹Û˘

›ÓÙÂÚÓÂÙ. √È ¯Ú‹ÛÙ˜ Â›Ó·È Èı·ÓfiÙÂÚÔ Ó· ¤¯Ô˘Ó

ÚfiÛ‚·ÛË ·fi ÙÔ Û›ÙÈ ÙÔ˘˜ (OR: 2,90, 95% CI: 2,06-4,10) ‹ Ù· ›ÓÙÂÚÓÂ٠ηʤ (OR: 1,49, 95% CI: 1,05-2,10). ∞Ó·ÊÔÚÈο Ì ÙÔ Â›‰Ô˜ ÙˆÓ ÈÛÙÔÛÂÏ›‰ˆÓ, Ë ¯·ÌËÏ‹ ¯Ú‹ÛË Û¯ÂÙ›˙ÂÙ·È Ì ÈÛÙfiÙÔÔ˘˜ Ô˘ ·ÊÔÚÔ‡Ó ·ÏÏËÏÔÁÚ·Ê›· Î·È chat rooms (¶›Ó·Î·˜ 2).

™¯ÂÙÈο Ì ÙÔ YIAS, Ë ÔÌ¿‰· 1 Û¯ÂÙ›˙ÂÙ·È ÌÂ

√Úȷ΋ ÃÚ‹ÛË (OR: 2,58, 95% CI: 1,13-5,86), ¯ˆÚ›˜

ˆÛÙfiÛÔ Ó· ηٷÁÚ·Ê› ÂıÈÛÌfi˜ (¶›Ó·Î·˜ 2).

™‡Ìʈӷ Ì ÙËÓ ·Ï›Ó‰ÚÔÌË ·Ó¿Ï˘ÛË ÔÏÏ·-

ÏÒÓ ÌÂÙ·‚ÏËÙÒÓ (¶∞¶ª), ÔÈ ÈÔ ÛËÌ·ÓÙÈÎÔ› ·-

Ú¿ÁÔÓÙ˜ Ô˘ Û¯ÂÙ›˙ÔÓÙ·È Ì ÙËÓ ÔÌ¿‰· 1 Â›Ó·È Ë

ÚfiÛ‚·ÛË ÌÂ ÛÎÔfi ÙËÓ ·ÏÏËÏÔÁÚ·Ê›· (adjusted OR: 2,10, 95% CI: 1,37-3,23) ‹ ÙË ¯Ú‹ÛË chat rooms (adjusted OR: 1,91, 95% CI: 1,25-2,93), Ë ÚfiÛ‚·ÛË

·fi ÙÔ Û›ÙÈ (adjusted OR 1,22, 95% CI: 1,22-2,77)

Î·È ÙÔ ÈÛÙÔÚÈÎfi ÚÔËÁÔ‡ÌÂÓ˘ ¯Ú‹Û˘ ÙÔ˘ ‰È·‰ÈÎÙ‡Ô˘ (adjusted OR: 1,53, 95% CI: 1,23-1,89).

ª¤ÙÚÈ· ¯Ú‹ÛË ›ÓÙÂÚÓÂÙ (4-10 ÒÚ˜/‚‰ÔÌ¿‰·) –

√Ì¿‰· 2

H √Ì¿‰· 2 Û¯ÂÙ›˙ÂÙ·È ÙfiÛÔ Ì ÙÔ Ê‡ÏÔ (˘ÂÚÙÂÚÔ‡Ó Ù· ·ÁfiÚÈ·) fiÛÔ Î·È Ì ÙÔ ÈÛÙÔÚÈÎfi ¯Ú‹Û˘ ÙÔ˘

‰È·‰ÈÎÙ‡Ô˘ (¶›Ó·Î·˜ 1). ™ÙÔÓ ¶›Ó·Î· 2 Ê·›ÓÂÙ·È fiÙÈ ÔÈ Ì¤ÙÚÈÔÈ ¯Ú‹ÛÙ˜ Â›Ó·È Èı·ÓfiÙÂÚÔ Ó· ¤¯Ô˘Ó ÚfiÛ‚·ÛË ·fi ÙÔ Û›ÙÈ ÙÔ˘˜ (OR: 5,61, 95% CI: 3,588,80) ‹ ·fi ÙÔ ›ÓÙÂÚÓÂ٠ηʤ (OR: 1,77, 95% CI : 1,202,61). ∏ ÔÌ¿‰· 1 Û¯ÂÙ›˙ÂÙ·È ÛËÌ·ÓÙÈο Ì ÙË ¯Ú‹ÛË e-

mail (OR: 6,98, 95% CI: 4,57-10,67), ÙËÓ ·ÁÔÚ¿ ÚÔ˚fiÓÙˆÓ (OR: 4,28, 95% CI: 2,02-9,04), Ù· chat rooms (OR: 4,17, 95% CI: 2,76-6,30) Î·È ÙËÓ ·Ó·˙‹ÙËÛË ÏËÚÔÊÔÚÈÒÓ Û¯ÂÙÈÎÒÓ Ì ÙË ÛÂÍÔ˘·ÏÈ΋ ‰È··È‰·ÁÒÁËÛË (OR: 2,77, 95% CI: 1,40-5,48), ÂÓÒ ‰ÂÓ Û¯ÂÙ›˙ÂÙ·È

Ì ÙËÓ ·Ó·˙‹ÙËÛË ÏËÚÔÊÔÚÈÒÓ ÁÈ· ÂÚÁ·Û›· ‹ ÂÎ·›‰Â˘ÛË (OR: 0,59, 95% CI: 0,40-0,89) (¶›Ó·Î·˜ 2).

™‡Ìʈӷ Ì ÙÔ YIAS, ÔÈ Ì¤ÙÚÈÔÈ ¯Ú‹ÛÙ˜ ·ÚÔ˘ÛÈ¿˙Ô˘Ó ÂÓÓ¤· ÊÔÚ¤˜ ÌÂÁ·Ï‡ÙÂÚË Èı·ÓfiÙËÙ· Ó· Â›Ó·È ÔÚÈ·ÎÔ› ¯Ú‹ÛÙ˜ (OR: 8,96, 95% CI: 4,08-19,69), Û˘ÁÎÚÈÓfiÌÂÓÔÈ Ì ÙËÓ ÔÌ¿‰· ÂϤÁ¯Ô˘. ∂ÈϤÔÓ, Â›Ó·È ÂÓÙ˘ˆÛÈ·Îfi fiÙÈ 44,5% (n=4) ÙˆÓ ÂıÈṲ̂ӈÓ

¯ÚËÛÙÒÓ ·Ó‹ÎÔ˘Ó Û ·˘Ù‹ ÙËÓ ÔÌ¿‰· (¶›Ó·Î·˜ 2).

∏ ¶∞¶ª ÂȂ‚·›ˆÛ fiÙÈ ÔÈ ÛËÌ·ÓÙÈÎÔ› ·Ú¿ÁÔÓÙ˜ ÁÈ· ÙËÓ ÔÌ¿‰· 2 Â›Ó·È Ë ÚfiÛ‚·ÛË ÁÈ· ·ÏÏË-

ÏÔÁÚ·Ê›· (adjusted OR: 4,14, 95% CI: 2,39-7,19) ‹ chat rooms (adjusted OR: 2,80, 95% CI: 1,62-4,84), Ë

ÚfiÛ‚·ÛË ·fi ÙÔ Û›ÙÈ (adjusted OR: 2,74, 95% CI: 1,47-5,10) Î·È ÙÔ ÈÛÙÔÚÈÎfi ÚÔËÁÔ‡ÌÂÓ˘ ¯Ú‹Û˘ ÙÔ˘

‰È·‰ÈÎÙ‡Ô˘ (adjusted OR: 2,19, 95% CI: 1,63-2,93).

À„ËÏ‹ ¯Ú‹ÛË ›ÓÙÂÚÓÂÙ (11-20 ÒÚ˜/‚‰ÔÌ¿‰·) –

√Ì¿‰· 3

∏ ÔÌ¿‰· 3 Û˘Û¯ÂÙ›˙ÂÙ·È ·ÓÙÈÛÙÚfiʈ˜ ·Ó¿ÏÔÁ· Ì ÙÔ Á˘Ó·ÈÎÂ›Ô Ê‡ÏÔ (¶›Ó·Î·˜ 1), ÂÓÒ ÂÈÚÔÛı¤Ùˆ˜ ÔÈ ˘„ËÏÔ› ¯Ú‹ÛÙ˜ Â›Ó·È Èı·ÓfiÙÂÚÔ Ó· ¤¯Ô˘Ó

·fi ÙÔ Û›ÙÈ ÙÔ˘˜ (OR: 19,57, 95% CI: 5,96-64,24) ‹ Ù· ›ÓÙÂÚÓÂ٠ηʤ (OR: 3,45, 95% CI: 1,89-6,29).

(YIAS)

(N=897)

0-1 ÒÚ·/ ‚‰ÔÌ¿‰· 1-3 ÒÚ˜/‚‰ÔÌ¿‰· 4-10 ÒÚ˜/‚‰ÔÌ¿‰· 11-20 ÒÚ˜/‚‰ÔÌ¿‰· >20 ÒÚ˜/‚‰ÔÌ¿‰· (N=277) (N=318) (N=191) (N=55) (N=56) N (%) N (%) OR 95% CI N (%) OR 95% CI N (%) OR 95% CI N (%) OR 95% CI

¶ÚˆÙ·Ú¯ÈÎfi˜ ÙfiÔ˜ ÚfiÛ‚·Û˘

™›ÙÈ124 (44,8)229 (72,0)2,902,06-4,10159 (83,2)5,613,58-8,8052 (94,5)19,575,96-64,2450 (89,3)9,413,90-22,70

ºÈÏÈÎfi Û›ÙÈ63 (22,7)87 (27,4)1,200,82-1,7537 (19,4)0,770,48-1,2114 (25,4)1,090,56-2,1312 (21,4)0,870,43-1,75

™¯ÔÏ›Ô79 (28,5)49 (15,4)0,430,28-0,6425 (13,1)0,350,21-0,5810 (18,2)0,520,25-1,086 (10,7)0,280,12-0,68

µÈ‚ÏÈÔı‹ÎË14 (5,0)9 (2,8)0,520,22-1,221 (0,5)0,090,01-0,722 (3,6)0,670,15-3,053 (5,4)1,010,28-3,64

ÿÓÙÂÚÓÂ٠ηʤ80 (28,9)125 (39,3)1,491,05-2,1083 (43,4)1,771,20-2,6133 (60,0)3,451,89-6,2930 (53,6)2,651,48-4,77

¶ÚˆÙ·Ú¯ÈÎfi ·ÓÙÈΛÌÂÓÔ ÂӉȷʤÚÔÓÙÔ˜ ̤ۈ ¯Ú‹Û˘ ÙÔ˘ ‰È·‰ÈÎÙ‡Ô˘

E-mail52 (18,8)147 (46,2)3,462,38-5,04121 (63,4)6,984,57-10,6737 (67,3)8,664,52-16,5942 (75,0)11,946,07-23,50

ªª∂43 (15,5)51 (16,0)0,970,62-1,5138 (19,9)1,250,77-2,0210 (18,2)1,140,53-2,4411 (19,6)1,260,60-2,62

Chat room54 (19,5)118 (37,1)2,261,55-3,30100 (52,4)4,172,76-6,3037 (67,3)8,264,32-15,7935 (62,5)6,323,41-11,74

¶·È¯Ó›‰È·131 (47,3)181 (56,9)1,310,94-1,82113 (59,2)1,420,97-2,0641 (74,5)3,081,58-6,0252 (92,8)12,704,46-36,14

ÀËÚÂۛ˜51 (18,4)74 (23,3)1,250,83-1,8648 (25,1)1,370,87-2,1417 (30,9)1,870,98-3,5923 (41,1)2,841,54-5,25

∂ÚÁ·Û›· & 100 (36,1)103 (32,4)0,770,54-1,0852 (27,2)0,590,40-0,8912 (21,8)0,450,23-0,9018 (32,1)0,750,41-1,39

ÂÎ·›‰Â˘ÛË

™ÂÍÔ˘·ÏÈ΋ 14 (5,0)31 (9,7)1,880,97-3,6126 (13,6)2,771,40-5,488 (14,5)2,951,17-7,4515 (26,8)6,402,86-14,32

‰È··È‰·ÁÒÁËÛË

∞ÁÔÚ¤˜ 10 (3,6)24 (7,5)2,050,96-4,3628 (14,6)4,282,02-9,0410 (18,2)5,662,22-4,3914 (0,25)8,303,46-19,91

ÚÔ˚fiÓÙˆÓ Young Internet Addiction Score

º˘ÛÈÔÏ. ¯Ú‹ÛË251 (90,6)280 (88,0)--140 (73,3)--36 (65,4)--22 (39,3)--

√Úȷ΋ ¯Ú‹ÛË8 (2,9)23 (7,2)2,581,13-5,8640 (20,9)8,964,08-19,6918 (32,7)15,696,36-38,7026 (46,4)37,0815,01-91,60

∂ıÈÛÙÈ΋ ¯Ú‹ÛË0 (0)0 (0)--4 (2,1)0 (0)5 (8,9)

OR: Unadjusted Odds Ratio, 95% CI: 95% Confidence Interval for Unadjusted Odds Ratio

∞Ó·ÊÔÚÈο Ì ÙÔ Â›‰Ô˜ ÙˆÓ ÈÛÙÔÛÂÏ›‰ˆÓ, Ë ÔÌ¿‰· Û˘Û¯ÂÙ›˙ÂÙ·È ÛËÌ·ÓÙÈο Ì e-mail (OR: 8,66, 95% CI: 4,52-16,59), chat rooms (OR: 8,26, 4,32-15,79), ·ÁÔÚ¿ ÚÔ˚fiÓÙˆÓ (OR: 5,66, 95% CI: 2,22-4,39), ·È¯Ó›‰È· (OR: 3,08, 95% CI: 1,58-6,02) Î·È ·Ó·˙‹ÙËÛË ÏËÚÔÊÔÚÈÒÓ Û¯ÂÙÈÎÒÓ Ì ÙË ÛÂÍÔ˘·ÏÈ΋ ‰È··È‰·ÁÒÁËÛË (OR: 2,95, 95% CI: 1,17-7,45), ÁÂÁÔÓfi˜ Ô˘ ·Ó·‰ÂÈÎÓ‡ÂÈ ÙËÓ ÔÈÎÈÏÔ-

ÌÔÚÊ›· ÙˆÓ ÂӉȷÊÂÚfiÓÙˆÓ ÙˆÓ ¯ÚËÛÙÒÓ ·˘Ù‹˜ Ù˘ ÔÌ¿‰·˜.

∞fi Ù· Â˘Ú‹Ì·Ù· ÙÔ˘ YIAS, ÔÈ ˘„ËÏÔ› ¯Ú‹ÛÙ˜ ·ÚÔ˘ÛÈ¿˙Ô˘Ó ÈÛ¯˘Ú‹ Û˘Û¯¤ÙÈÛË Ì ÙËÓ ÔÚȷ΋ ¯Ú‹ÛË ›ÓÙÂÚÓÂÙ (OR: 15,69, 95% CI: 6,36-38,70), Û˘ÁÎÚÈÓfiÌÂÓÔÈ Ì ÙËÓ ÔÌ¿‰· ÂϤÁ¯Ô˘. ∫·Ì›· ÂÚ›ÙˆÛË ÂıÈÛÌÔ‡ ‰ÂÓ Î·Ù·ÁÚ¿ÊÂÙ·È Û’ ·˘Ù‹ ÙËÓ ÔÌ¿‰· (¶›Ó·Î·˜ 2).

¶›Ó·Î·˜ 3. Pearson Correlation Coefficients (r) ÁÈ· Ù· ‰ËÌÔÁÚ·ÊÈο ¯·Ú·ÎÙËÚÈÛÙÈο Î·È ÙÔ˘˜ ·Ú¿ÁÔÓÙ˜ ÎÈÓ‰‡ÓÔ˘ ÁÈ· ÙË ¯Ú‹ÛË ÙÔ˘ ‰È·‰ÈÎÙ‡Ô˘ ÛÙÔ˘˜ ŒÏÏËÓ˜ ÂÊ‹‚Ô˘˜, Û‡Ìʈӷ Ì ÙÔÓ Û˘ÓÔÏÈÎfi ·ÚÈıÌfi ˆÚÒÓ ¯Ú‹Û˘ ›ÓÙÂÚÓÂÙ ·Ó¿ ‚‰ÔÌ¿‰· (N=897) 1-3 ÒÚ˜/‚‰ÔÌ¿‰· 4-10 ÒÚ˜/‚‰ÔÌ¿‰· 11-20 ÒÚ˜/‚‰ÔÌ¿‰· >20 ÒÚ˜/‚‰ÔÌ¿‰· (N=318) (N=191) (N=55) (N=56)

¡ r ∆ÈÌ‹ p ¡ r ∆ÈÌ‹ p ¡ r ∆ÈÌ‹ p ¡ r ∆ÈÌ‹ p

∏ÏÈΛ·

<15 ¤ÙË (¤Ó·ÓÙÈ 15-15,9 ÂÙÒÓ)558-0,075740,0738430-0,11915 0,0134 308-0,13269 0,0198 304-0,08949 0,1195

>16 ¤ÙË (¤Ó·ÓÙÈ 15-15,9 ÂÙÒÓ)173-0,077000,31401410,002540,976293-0,096620,3569910,047410,6554

º‡ÏÔ

£‹Ï˘ (¤Ó·ÓÙÈ ÕÚÚÂÓÔ˜)590 -0,06412 0,1198 466-0,20197 <0,0001 330 -0,23980 <0,0001 331 -0,37813

¢ª™

<18,5 kg/m2 544-0,011840,7829426-0,081030,0948297 -0,065950,2572301-0,119460,0383

(¤Ó·ÓÙÈ 18,5-24,9 kg/m2)

>25,0 kg/m2 191-0,021000,7730162-0,009010,90941100,172760,07111140,089280,3449

(¤Ó·ÓÙÈ 18,5-24,9 kg/m2)

ª√µ

B- - B+ (¤Ó·ÓÙÈ <C+)404 0,00166 0,9734 320 -0,00285 0,9595 229 0,003750,9550 233 0,01385 0,8335

A- - A+ (¤Ó·ÓÙÈ <C+)3140,025570,65182460,013690,8309172-0,016120,8337169-0,089740,2459

πÛÙÔÚÈÎfi ¯Ú‹Û˘ ‰È·‰ÈÎÙ‡Ô˘

6-12 ̋Ә (¤Ó·ÓÙÈ 0-6 ÌËÓÒÓ)3500,30128<0,00012630,47491<0,00012090,27933<0,00012060,28215<0,0001 >12 ̋Ә (¤Ó·ÓÙÈ 0-6 ÌËÓÒÓ) 517 0,33415<0,00014100,50997<0,00013030,46921<0,00013040,50193<0,0001

¶›Ó·Î·˜ 4. Pearson Correlation Coefficients (r) ÁÈ·

(N=897)

>20 ÒÚ˜/‚‰ÔÌ¿‰· (N=318) (N=191) (N=55) (N=56)

¡ r ∆ÈÌ‹

¶ÚˆÙ·Ú¯ÈÎfi˜ ÙfiÔ˜ ÚfiÛ‚·Û˘

™›ÙÈ5820,25521<0,0001

4550,36922<0,0001

3190,36136 <0,0001

ºÈÏÈÎfi Û›ÙÈ5820,039780,3381455-0,053530,25443190,014040,8027320-0,021840,6971 ™¯ÔÏ›Ô582-0,17447<0,0001455-0,19786<0,0001319-0,098900,0778320-0,165260,0030 µÈ‚ÏÈÔı‹ÎË582-0,063190,1278455-0,132110,0048319-0,028840,60783200,000920,9870 ÿÓÙÂÚÓÂ٠ηʤ5820,093860,02364550,135380,00383190,23454<0,00013200,186150,0008

¶ÚˆÙ·Ú¯ÈÎfi ·ÓÙÈΛÌÂÓÔ ÂӉȷʤÚÔÓÙÔ˜ ̤ۈ ¯Ú‹Û˘ ÙÔ˘ ‰È·‰ÈÎÙ‡Ô˘

E-mail5750,27654 <0,0001 4490,44270<0,0001 3130,40574<0,0001 3150,45892 <0,0001

ªª∂575-0,006230,88154500,042360,36993130,019300,73373150,034220,5457 Chat room5750,17921<0,00014500,32822<0,00013130,39663<0,00013150,35368<0,0001 ¶·È¯Ó›‰È·5750,066910,10904500,085150,07113130,192480,00063150,32760<0,0001 ÀËÚÂۛ˜5750,044950,28194500,064900,16933130,108030,05623150,192810,0006

∂ÚÁ·Û›· & ÂÎ·›‰Â˘ÛË575-0,062620,1337450-0,118980,0115313-0,129170,0223315-0,051080,3662

™ÂÍÔ˘·ÏÈ΋ ‰È··È‰·ÁÒÁËÛË5400,081990,05694190,147990,00242930,138830,01742940,28998<0,0001

∞ÁÔÚ¤˜ ÚÔ˚fiÓÙˆÓ5750,078760,05914500,19195<0,00013130,22644<0,00013150,30463<0,0001 Young Internet Addiction Score

º˘ÛÈÔÏÔÁÈ΋ ¯Ú‹ÛË

√Úȷ΋ ¯Ú‹ÛË5610,098300,01984390,30156<0,00013130,41406<0,00013070,59113<0,0001

∂ıÈÛÙÈ΋ ¯Ú‹ÛË3950,133540,00792780,41263<0,0001

∏ ¶∞¶ª ηıfiÚÈÛ ÙÔ˘˜ ÛËÌ·ÓÙÈÎfiÙÂÚÔ˘˜ ·-

Ú¿ÁÔÓÙ˜ Û˘Û¯¤ÙÈÛ˘: ÚfiÛ‚·ÛË ·fi ÙÔ Û›ÙÈ (adjusted OR: 11,26, 95% CI: 2,60-48,73), ¯Ú‹ÛË chat rooms (adjusted OR: 4,30, 95% CI: 1,78-10,41), ¯Ú‹ÛË e-mail (adjusted OR: 3,96, 95% CI: 1,61-9,76),

ÚfiÛ‚·ÛË ·fi Ù· ›ÓÙÂÚÓÂ٠ηʤ (adjusted OR: 3,09, 95% CI: 1,22-7,78) Î·È ÈÛÙÔÚÈÎfi ÚÔËÁÔ‡ÌÂÓ˘ ¯Ú‹Û˘ ÙÔ˘ ‰È·‰ÈÎÙ‡Ô˘ (adjusted OR: 2,19, 95% CI: 1,30-3,71). ∆Ô ·Ó‰ÚÈÎfi ʇÏÔ ‹Ù·Ó Â›Û˘ ÈÛ¯˘Úfi˜ ÚÔÁÓˆÛÙÈÎfi˜ ·Ú¿ÁÔÓÙ·˜.

ÀÂÚ‚ÔÏÈ΋ ¯Ú‹ÛË ›ÓÙÂÚÓÂÙ (>20 ÒÚ˜/‚‰ÔÌ¿‰·) - √Ì¿‰· 4 ∏ ÔÌ¿‰· Û¯ÂÙ›˙ÂÙ·È ÛÙ·ÙÈÛÙÈÎÒ˜ ÛËÌ·ÓÙÈο Ì ÙÔ ¿ÚÚÂÓ Ê‡ÏÔ Î·È ÙÔ ÈÛÙÔÚÈÎfi ÚÔËÁÔ‡ÌÂÓ˘ ‰È·‰ÈÎÙ˘·Î‹˜ ¯Ú‹Û˘ (¶›Ó·Î·˜ 1). ∂ÈϤÔÓ, ÔÈ ¯Ú‹ÛÙ˜ Â›Ó·È Èı·ÓfiÙÂÚÔ Ó· ¤¯Ô˘Ó ÚfiÛ‚·ÛË ·fi ÙÔ Û›ÙÈ

ÙÔ˘˜ (OR: 9,41, 95% CI: 3,90-32,70) ‹ ·fi Ù· ›ÓÙÂÚÓÂ٠ηʤ (OR: 2,65, 95% CI: 1,48-4,77) (¶›Ó·Î·˜ 2).

∏ ÚfiÛ‚·ÛË ·fi ÙÔ Û¯ÔÏÂ›Ô Î·È/‹ ·fi ÙȘ ‚È‚ÏÈÔı‹Î˜ ‰ÂÓ Ê·›ÓÂÙ·È Ó· Û˘Û¯ÂÙ›˙ÂÙ·È ·ÚÓËÙÈο, ÙÔ˘Ï¿¯ÈÛÙÔÓ Û ÛÙ·ÙÈÛÙÈÎÒ˜ ÛËÌ·ÓÙÈÎfi ‚·ıÌfi, Ì ÙËÓ ÔÌ¿‰· ·˘Ù‹ (¶›Ó·Î·˜ 2). ™ÎÔfi˜ Ù˘ ÚfiÛ‚·Û˘ ‹Ù·Ó Ù· ·È¯Ó›‰È· (OR: 12,70, 95% CI: 4,46-36,14), Ë ·ÏÏËÏÔÁÚ·Ê›· (OR: 11,94, 95% CI: 6,07-23,50), Ë ·ÁÔÚ¿ ÚÔ˚fiÓÙˆÓ (OR: 8,30, 95% CI: 3,46-19,91), Ë ÛÂÍÔ˘·ÏÈ΋ ‰È··È‰·ÁÒÁËÛË (OR: 6,40, 95% CI: 2,86-14,32), Ù· chat rooms (OR: 6,32, 95% CI: 3,41-11,74) Î·È Ë ·Ó·˙‹ÙËÛË ˘ËÚÂÛÈÒÓ (OR: 2,84, 95% CI: 1,54-5,25).

ÔÚȷ΋ ¯Ú‹ÛË ›ÓÙÂÚÓÂÙ (OR: 37,08, 95% CI: 15,0191,60), Û˘ÁÎÚÈÓfiÌÂÓÔÈ Ì ÙËÓ ÔÌ¿‰· ÂϤÁ¯Ô˘. ∂ÈϤÔÓ, 55,5% (n=5) ÙˆÓ ÂÚÈÙÒÛÂˆÓ ÂıÈÛÌÔ‡ ·Ó‹ÎÔ˘Ó Û’ ·˘Ù‹Ó ÙËÓ ÔÌ¿‰· (¶›Ó·Î·˜ 2).

∏

¶∞¶ª ¤‰ÂÈÍ fiÙÈ ÔÈ ÈÔ ÛËÌ·ÓÙÈÎÔ› ·Ú¿ÁÔÓÙ˜ Â›Ó·È Ë ÚfiÛ‚·ÛË Ì ÛÎÔfi ÙË Û˘ÌÌÂÙÔ¯‹ ÛÂ

·È¯Ó›‰È· (adjusted OR: 8,26, 95% CI: 2,16-31,49), Ë

ÚfiÛ‚·ÛË ·fi ÙÔ Û›ÙÈ (adjusted OR: 6,96, 95% CI: 1,72-28,27), Ë ÚfiÛ‚·ÛË ÌÂ ÛÎÔfi ÙËÓ ·ÏÏËÏÔÁÚ·Ê›· (adjusted OR: 5,52, 95% CI: 2,01-15,21), Ë ¯Ú‹ÛË chat rooms (adjusted OR: 3,37, 95% CI: 1,24-9,12)

Î·È ÙÔ ÈÛÙÔÚÈÎfi ÚÔËÁÔ‡ÌÂÓ˘ ¯Ú‹Û˘ ÙÔ˘ ‰È·‰ÈÎÙ‡Ô˘ (adjusted OR: 3,63, 95% CI: 1,84-7,15). ∆Ô Á˘Ó·ÈÎÂ›Ô Ê‡ÏÔ ‹Ù·Ó ·ÚÓËÙÈÎfi˜ ÚÔÁÓˆÛÙÈÎfi˜ ·Ú¿ÁÔÓÙ·˜, fiˆ˜ Ê·›ÓÂÙ·È ÛÙÔÓ ¶›Ó·Î· 5.

™˘˙‹ÙËÛË ŸÛÔÓ ·ÊÔÚ¿ ÙȘ ‰È·ÊÔÚ¤˜ ÌÂٷ͇ ÙˆÓ ‰‡Ô ʇψÓ, ÙÔ ı‹Ï˘ ʇÏÔ Û˘Û¯ÂÙ›˙ÂÙ·È ·ÚÓËÙÈο Ì ÙË Ì¤-

ÛË, ˘„ËÏ‹ Î·È ˘ÂÚ‚ÔÏÈ΋ ¯Ú‹ÛË - ·ÚfiÌÔÈ· Â˘Ú‹Ì·Ù· ·Ó·Ê¤ÚÔÓÙ·È ÛÙË ‰ÈÂıÓ‹ ‚È‚ÏÈÔÁÚ·Ê›· (17,18).

ÚfiÛ‚·Û˘ ÛÙÔ ‰È·‰›ÎÙ˘Ô ·ÔÙÂÏ› ÛËÌ·ÓÙÈÎfi ÚÔÁÓˆÛÙÈÎfi

µ¿ÛÂÈ ÙˆÓ Â˘ÚËÌ¿ÙˆÓ ÙÔ˘ YIAS, ÔÈ ˘ÂÚ‚ÔÏÈÎÔ› ¯Ú‹ÛÙ˜ ·ÚÔ˘ÛÈ¿˙Ô˘Ó ÈÛ¯˘Ú‹ Û˘Û¯¤ÙÈÛË Ì ÙËÓ

(N=897) 1-3 ÒÚ˜/‚‰ÔÌ¿‰· (N=524) 4-10 ÒÚ˜/‚‰ÔÌ¿‰· (N=381) 11-20 ÒÚ˜/‚‰ÔÌ¿‰· (N=262) >20 ÒÚ˜/‚‰ÔÌ¿‰· (N=264) Maximum Wald CI Maximum Wald CI Maximum Wald CI Maximum Wald CI Likelihood for Likelihood for Likelihood for Likelihood for Estimates Adj OR Estimates Adj OR Estimates Adj OR Estimates Adj

(<0,0001)(<0,0001)(<0,0001)(<0,0001)

∏ÏÈΛ· -NS--NS--NS--NS-

0,423815,2940

ÃÚ‹Û˘ (<0,0001)(1,23-1,89)(<0,0001)(1,63-2,93)(0,0034)(1,30-3,71)(0,0002)(1,84-7,15)

¶ÚˆÙ·Ú¯ÈÎfi˜ ÙfiÔ˜ ÚfiÛ‚·Û˘ ÛÙÔ ¢È·‰›ÎÙ˘Ô

™›ÙÈ0,60698,3896 1,84 1,0081 10,0930 2,74 2,4214 10,4970 11,26 1,9409 -7,3744 6,96 (0,0038)(1,22-2,77)(0,0015)(1,47-5,10)(0,0012)(2,60-48,73)(0,0066)(1,72-28,27)

™¯ÔÏ›Ô-0,52964,8503 0,59 -NS--NS--NS(0,0276)(0,37-0,94)

µÈ‚ÏÈÔı‹ÎË-NE--NS--NS--NSÿÓÙÂÚÓÂ٠ηʤ-NS--NS-1,1267 5,7015 3,09 -NS(0,0170)(1,22-7,78)

¶ÚˆÙ·Ú¯ÈÎfi ·ÓÙÈΛÌÂÓÔ ÂӉȷʤÚÔÓÙÔ˜ ̤ۈ ¯Ú‹Û˘ ¢È·‰ÈÎÙ‡Ô˘

E-mail0,743811,6111

10,9370 5,52 (0,0007)(1,37-3,23)(<0,0001)(2,39-7,19)(0,0027)(1,61-9,76)(0,0009)(2,01-15,21) Chat room0,64898,9436 1,91

3,37 (0,0028)(1,25-2,93)(0,0002)(1,62-4,84)(0,0012)(1,78-10,41)(0,0169)(1,24-9,12)

¶·È¯Ó›‰È·-NE--NE--NS-2,1111 9,5530 8,26 (0,0020)(2,16-31,49)

∂ÚÁ·Û›· & -NE--0,6945 5,1862 0,50 -NS--NE-

ÂÎ·›‰Â˘ÛË(0,0228)(0,28-0,91)

™ÂÍ. ‰È··È‰.-NE--NS--NS--NS∞ÁÔÚ¤˜-NE--NS--NS--NSHosmerLemeshow 10,3217 (0,3251)8,0697 (0,4267)11,4314 (0,1209)3,8133 (0,9233) Goodness of Fit (p-value)

‚: Point Estimate, Wald x2: Wald x2 Test, Adj. OR: ¶ÚÔÛ·ÚÌÔṲ̂ÓÔ˜ ™¯ÂÙÈÎfi˜ ∫›Ó‰˘ÓÔ˜, 95% CI: 95% ŸÚÈ· ∞ÍÈÔÈÛÙ›·˜, NE: ∏ ÌÂÙ·‚ÏËÙ‹ ‰ÂÓ

Â›Ó·È ÛÙ·ÙÈÛÙÈο ÛËÌ·ÓÙÈ΋ (p-value < 0,0500) Î·È ‰ÂÓ Û˘ÌÂÚÈÏ‹ÊıËΠÛÙÔ ÌÔÓÙ¤ÏÔ ·ÏÈÓ‰ÚfiÌËÛ˘, NS: ∏ ÌÂÙ·‚ÏËÙ‹ Û˘ÌÂÚÈÏ‹ÊıËÎÂ

ÛÙÔ ÌÔÓÙ¤ÏÔ ·ÏÈÓ‰ÚfiÌËÛ˘, ·ÏÏ¿ ÏfiÁˆ ¤ÏÏÂȄ˘ ÛÙ·ÙÈÛÙÈ΋˜ ÛËÌ·ÓÙÈÎfiÙËÙ·˜ ‰ÂÓ ‰È·ÙËÚ‹ıËÎÂ.

√ Û¯ÂÙÈÎfi˜ ΛӉ˘ÓÔ˜ ÁÈ· Ù¤ÙÔÈ· ÚfiÛ‚·ÛË ·˘Í¿-

ÓÂÙ·È ÏÔÁ·ÚÈıÌÈο ·fi ÙȘ ¯·ÌËÏfiÙÂÚ˜ ÛÙȘ ˘„ËÏfi-

ÙÂÚ˜ ηÙËÁÔڛ˜ ¯ÚËÛÙÒÓ, ·ÚÔ˘ÛÈ¿˙ÔÓÙ·˜ ÎÔÚ˘-

Ê·›Â˜ ÙÈ̤˜ ÛÙËÓ ÔÌ¿‰· ˘„ËÏ‹˜ ¯Ú‹Û˘ ›ÓÙÂÚÓÂÙ.

∞˘Ù‹ Â›Ó·È Ë ÚÒÙË ÌÂϤÙË Ô˘ Û˘Û¯ÂÙ›˙ÂÈ ÙÔ Û›ÙÈ

ˆ˜ ¯ÒÚÔ ÚfiÛ‚·Û˘ Ì ÙËÓ Î·Ù¿¯ÚËÛË ÙÔ˘ ‰È·‰ÈÎÙ‡Ô˘, ÂÓÒ ÁÈ· Ù· ›ÓÙÂÚÓÂ٠ηʤ ˘¿Ú¯ÂÈ Û¯ÂÙÈ΋

ÛÙË ‰ÈÂıÓ‹ ‚È‚ÏÈÔÁÚ·Ê›· (19).

ηٷ‰ÂÈÎÓ‡Ô˘Ó

∞Ó·ÊÔÚÈο Ì ÙÔ Â›‰Ô˜ ÙˆÓ ÈÛÙÔÛÂÏ›‰ˆÓ Ô˘ ÂÈÛΤÙÔÓÙ·È ÔÈ ¤ÊË‚ÔÈ, ÔÈ ÈÛÙfiÙÔÔÈ Ô˘ Û¯ÂÙ›˙ÔÓÙ·È Ì ÂÈÎÔÈÓˆÓ›· (.¯. e-mail Î·È chat rooms) ·ÔÙÂÏÔ‡Ó ÛÙ·ıÂÚfi ·Ú¿ÁÔÓÙ· Û fiϘ ÙȘ ÔÌ¿‰Â˜ ¯ÚËÛÙÒÓ. øÛÙfiÛÔ, Ë ˘ÂÚ‚ÔÏÈ΋ ¯Ú‹ÛË Û¯ÂÙ›˙ÂÙ·È Î˘Ú›ˆ˜ ÌÂ Û˘ÌÌÂÙÔ¯‹ Û ·È¯Ó›‰È· Î·È ‰Â˘ÙÂÚ¢fiÓÙˆ˜ Ì ٷ sites Ô˘ Û¯ÂÙ›˙ÔÓÙ·È Ì ÎÔÈÓˆÓÈ΋ Â·Ê‹. º·›ÓÂÙ·È fiÙÈ Ù· ‰È·‰ÈÎÙ˘·Î¿ ·È¯Ó›‰È· -Î·È È‰È·›ÙÂÚ· ÂΛӷ Ô˘ ηÏÔ‡Ó ÙÔ˘˜ ¯Ú‹ÛÙ˜ Ó· ·Ó·Ï·Ì‚¿ÓÔ˘Ó ÚfiÏÔ˘˜ (20)- ·ÔÙÂÏÔ‡Ó ·ÓÂÍ¿ÚÙËÙÔ ·Ú¿ÁÔÓÙ· ·Ó¿Ù˘Í˘ ÂıÈÛÙÈ΋˜ Û˘ÌÂÚÈÊÔÚ¿˜ (21,22). ∆¤ÙÔÈ· Û˘ÌÂÚÈÊÔÚ¿ ÌÔÚ› Ó· ÂÈÙÂÏÂ›Ù·È Ì Ì˯·ÓÈÛÌfi ·ÚfiÌÔÈÔ ·˘ÙÔ‡ Ù˘ ·ıÔÏÔÁÈ΋˜ ÂÓ·Û¯fiÏËÛ˘ ÌÂ Ù˘¯ÂÚ¿ ·È¯Ó›‰È· (gambling) (23,24). ∞˘Ù‹ Ë Û˘Û¯¤ÙÈÛË ·Ú·ÙËÚÂ›Ù·È Î˘Ú›ˆ˜ Û ¿ÚÚÂÓ˜ ÂÊ‹‚Ô˘˜ (25,26),

√ ÈÔ ÚfiÛÊ·ÙÔ˜ ÔÚÈÛÌfi˜ ÙˆÓ Kaplan ηÈ

Sadock ÁÈ· ÙÔÓ ÂıÈÛÌfi ÛÙÔ ‰È·‰›ÎÙ˘Ô (27) ··ÈÙ›

¤ÓÙ ·fi Ù· ¤ÍÈ ·Ú·Î¿Ùˆ ÎÚÈÙ‹ÚÈ· ÁÈ· ÙË ‰È¿ÁÓˆ-

ÛË: 1) ·Ú·ÌÔÓ‹ on-line ÁÈ· fiÏÔ Î·È ÂÚÈÛÛfiÙÂÚÔ

¯ÚfiÓÔ, 2) ·ÔÙ˘¯›· ‰È·¯Â›ÚÈÛ˘ ÙÔ˘ ÂÂÚ¯fiÌÂÓÔ˘

·ÈÛı‹Ì·ÙÔ˜ ‰È¤ÁÂÚÛ˘ ‹/Î·È Î·Ù¿ıÏȄ˘, 3) ·Ú·-

ÌÔÓ‹ on-line ÁÈ· ÂÚÈÛÛfiÙÂÚÔ ·fi ÙÔ ÚÔÙÈı¤ÌÂÓÔ

¯ÚÔÓÈÎfi ‰È¿ÛÙËÌ·, 4) ΛӉ˘ÓÔ˜ ·ÒÏÂÈ·˜ Û¯¤Û˘ ‹

¢ηÈÚ›·˜ ÂÍ·ÈÙ›·˜ Ù˘ ¯Ú‹Û˘, 5) „‡‰Ë ÚÔÎÂÈ̤ÓÔ˘ Ó· Î·Ï˘Êı› Ë ·ÏËı‹˜ ¤ÎÙ·ÛË Ù˘ ¯Ú‹Û˘ ηÈ

6) ¯Ú‹ÛË ÚÔÎÂÈ̤ÓÔ˘ Ó· ÂÏÂÁ¯ıÔ‡Ó Ù· ·ÚÓËÙÈο

‚Ô˘˜, Ô˘ ı¤ÙÂÈ ˆ˜ fiÚÈ· ËÌÂÚ‹ÛÈ·˜ ¯Ú‹Û˘ ÔıfiÓ˘

(ÙËÏÂfiÚ·ÛË, ˘ÔÏÔÁÈÛÙ‹˜, ‰È·‰›ÎÙ˘Ô) ÙȘ 2 ÒÚ˜ (36). ªÂ ‚¿ÛË Ù· ·Ú·¿Óˆ ·ÔÙÂϤÛÌ·Ù·, ı· ‹Ù·Ó

ȉȷ›ÙÂÚ· ¯Ú‹ÛÈÌÔ˜ Ô Û¯Â‰È·ÛÌfi˜ Î·È Ë ÂÊ·ÚÌÔÁ‹

̤ÙÚˆÓ ‰ËÌfiÛÈ·˜ ˘Á›·˜, Ì ÛÙfi¯Ô ÙÔÓ ÂÚÈÔÚÈÛÌfi

Î·È ÙËÓ ÚfiÏË„Ë Ù˘ ˘ÂÚ‚ÔÏÈ΋˜ ¯Ú‹Û˘ ‰È·‰È-

ÎÙ‡Ô˘ ÛÙÔ˘˜ ŒÏÏËÓ˜ ÂÊ‹‚Ô˘˜.

∏ Û˘ÁÎÂÎÚÈ̤ÓË ¤Ú¢ӷ Â›Ó·È Ë ÚÒÙË (Û‡Ìʈӷ

Ì fiÛ· ¤ˆ˜ ÙÒÚ· ÁÓˆÚ›˙Ô˘ÌÂ) Ô˘ ‰ÈÂÍ‹¯ıË ÚÔÎÂÈ̤ÓÔ˘ Ó· ÂÎÙÈÌËıÔ‡Ó Î·È Ó· ÚÔÛ‰ÈÔÚÈÛÙÔ‡Ó ÔÈ ÚÔ-

ÁÓˆÛÙÈÎÔ› ·Ú¿ÁÔÓÙ˜ Ù˘ ¯Ú‹Û˘ ÙÔ˘ ‰È·‰ÈÎÙ‡Ô˘

Û ŒÏÏËÓ˜ ÂÊ‹‚Ô˘˜. §fiÁˆ Ù˘ Ù˘¯·ÈÔÔ›ËÛ˘ ÛÙË

fï˜ Ù· ··ÈÙÔ‡ÌÂÓ· ÁÈ· ÙË ‰È¿ÁÓˆÛË ÂıÈ-

Û˘Ó·ÈÛı‹Ì·Ù·. ∆· ¿ÙÔÌ· Ô˘ ·ÚÔ˘ÛÈ¿˙Ô˘Ó ÌÂÚÈο, fi¯È

ÛÌÔ‡ ÎÚÈÙ‹ÚÈ·, ·Ó‹ÎÔ˘Ó ÛÙËÓ Î·ÙËÁÔÚ›· √Úȷ΋˜

ÃÚ‹Û˘ (27) Î·È ÂÌ›ÙÔ˘Ó ÛÙËÓ ·ÓÙ›ÛÙÔÈ¯Ë Î·ÙËÁÔÚ›· ÙÔ˘ YIAS.

ŒÓ· ÛËÌ·ÓÙÈÎfi ÔÛÔÛÙfi Û˘ÌÌÂÙ¯fiÓÙˆÓ ·ÚÔ˘-

ÛÈ¿˙Ô˘Ó √Úȷ΋ ÃÚ‹ÛË, Û‡Ìʈӷ Ì ÙÔ YIAS, (n=115, 12,8%), Ë ÔÔ›· ·˘Í¿ÓÂÙ·È ÁˆÌÂÙÚÈο fiÛÔ ·˘Í¿ÓÂÙ·È Ô Û˘ÓÔÏÈÎfi˜ ·ÚÈıÌfi˜ ˆÚÒÓ ¯Ú‹Û˘ ›ÓÙÂÚ-

ÓÂÙ ·Ó¿ ‚‰ÔÌ¿‰·.

øÛÙfiÛÔ, ÂıÈÛÌfi˜ ·Ú·ÙËÚÂ›Ù·È Û 9 (1%) ÂÊ‹‚Ô˘˜ ÙÔ˘ ‰Â›ÁÌ·ÙÔ˜, ÛÙȘ ηÙËÁÔڛ˜ ̤ÙÚÈˆÓ (n=4)

Î·È ˘ÂÚ‚ÔÏÈÎÒÓ ¯ÚËÛÙÒÓ (n=5). ∂ÓÙ‡ˆÛË ÚÔη-

Ï› ÙÔ ÁÂÁÔÓfi˜ fiÙÈ ‰ÂÓ ·Ú·ÙËÚ‹ıËΠÂÚ›ÙˆÛË

ÂıÈÛÌÔ‡ ÛÙËÓ ÔÌ¿‰· 3 (˘„ËÏ‹˜ ¯Ú‹Û˘). ∞˘Ùfi ÂÓ‰¤-

¯ÂÙ·È Ó· ÔÊ›ÏÂÙ·È ÛÙÔ fiÙÈ Ë ÂıÈÛÙÈ΋ Û˘ÌÂÚÈÊÔÚ¿

‰ÂÓ ·ÊÔÚ¿ ·ÔÎÏÂÈÛÙÈο ÛÙË ‰È¿ÚÎÂÈ· ¯Ú‹Û˘, ·ÏÏ¿

ÛÙÔ Â›‰Ô˜ Ù˘ Û¯¤Û˘ Ô˘ ·Ó·Ù‡ÛÛÂÙ·È Ì ÙÔ ‰È·‰›-

ÎÙ˘Ô (.¯. οÔÈÔ˜ ¤Ê˂Ԙ Ì ÂıÈÛÌfi ÌÔÚ› Ó· ÌËÓ

·Û¯ÔÏÂ›Ù·È ÔÏϤ˜ ÒÚ˜, ˆÛÙfiÛÔ Ó· ¤¯ÂÈ ¤ÌÌÔÓË

ÛΤ„Ë ÁÈ· ÙÔ ›ÓÙÂÚÓÂÙ, ·Ú·ÌÂÏÒÓÙ·˜ ¿ÏÏÔ˘˜ ÙÔÌ›˜ Ù˘ ˙ˆ‹˜ ÙÔ˘) (11,27).

∏ Â›ÙˆÛË ÙÔ˘ ÂıÈÛÌÔ‡ ÛÙËÓ ∂ÏÏ¿‰· Â›Ó·È ¯·ÌËÏfiÙÂÚË ·fi fi,ÙÈ Û ¿ÏϘ Â˘Úˆ·˚Τ˜ [¡ÔÚ‚ËÁ›·: 1,98% (28), µÚÂÙ·Ó›·, Û ‰Â›ÁÌ· ÊÔÈÙËÙÒÓ ÙÔ˘ ¶·ÓÂÈÛÙËÌ›Ô˘ ÙÔ˘ Nottingham: 18,3% (29), ƒÔ˘Ì·Ó›·: 1,4% (30), πÙ·Ï›·-ºÏˆÚÂÓÙ›·: 5,4% (9)] Î·È ·ÛÈ·ÙÈΤ˜ ¯ÒÚ˜ [πÓ‰›·: 18% (31), ∫ÔÚ¤·: 18,4% (32), ∫›Ó·: 2,4% (33)]. øÛÙfiÛÔ, ı· Ú¤ÂÈ Ó· ÏËÊı› ˘fi„Ë fiÙÈ Ë ¯ÒÚ· Ì·˜ ¤¯ÂÈ Î·ı˘ÛÙÂÚ‹ÛÂÈ Û¯ÂÙÈο Ì ÙËÓ ·Ó¿Ù˘ÍË ÙˆÓ ‰Ú·ÛÙËÚÈÔÙ‹ÙˆÓ ÙÔ˘ ‰È·‰ÈÎÙ‡Ô˘, Û ۯ¤ÛË Ì ÙȘ ˘fiÏÔÈ˜ Â˘Úˆ·˚Τ˜ ¯ÒÚ˜ Î·È ‚¤‚·È· ÙȘ ·ÛÈ·ÙÈΤ˜ (34). ∆Ô Â›‰Ô˜ ÙˆÓ ÂÈÛÎÂÙfiÌÂ-

ÓˆÓ ÛÂÏ›‰ˆÓ Â›Ó·È ·ÚfiÌÔÈÔ Ì ·˘Ù¿ Ô˘ ·Ó·Ê¤ÚÔÓÙ·È ÛÙË ‚È‚ÏÈÔÁÚ·Ê›· (35). °›ÓÂÙ·È Û·Ê¤˜ ·fi ÙËÓ ¤Ú¢ӷ ·˘Ù‹ fiÙÈ ÔÈ ¯Ú‹ÛÙ˜

Û˘ÏÏÔÁ‹ ÙÔ˘ ‰Â›ÁÌ·ÙÔ˜ Î·È Ù˘ ·ÓÒÓ˘Ì˘ ÌÂıÔ‰ÔÏÔÁ›·˜ Ô˘ ÂÊ·ÚÌfiÛÙËÎÂ, ÔÈ Èı·ÓfiÙËÙ˜ Û˘ÛÙËÌ·ÙÈÎÔ‡ ÛÊ¿ÏÌ·ÙÔ˜ ÂÈÏÔÁ‹˜ Î·È ·Ó·ÊÔÚ¿˜ ÂÏ·¯ÈÛÙÔ-

ÔÈ‹ıËηÓ.

1. Süss D. Impacts of computer- and media usage on the personality development of children and young people. Ther Umsch 2007;64:103-108.

2. Paul B, Bryant JA. Adolescents and the internet. Adolesc Med Clin 2005;16:413-426.

3. Dannon PN, Iancu I. Internet addiction. Harefuah 2007; 146:549-553, 573, 572.

4. Bradley K. Internet lives: social context and moral domain in adolescent development. New Dir Youth Dev 2005;108: 11-12.

5. Valaitis RK. Computers and the internet: tools for youth empowerment. J Med Internet Res 2005;7:e51.

6. Bremer J. The internet and children: advantages and disadvantages. Child Adolesc Psychiatr Clin N Am 2005;14: 405-428.

7. Yan Z. What influences children’s and adolescents’ understanding of the complexity of the Internet? Dev Psychol 2006;42:418-428.

8. Caplan SE. Relations among loneliness, social anxiety, and problematic Internet use. Cyberpsychol Behav 2007;10: 234-242.

9. Pallanti S, Bernardi S, Quercioli L. The Shorter PROMIS Questionnaire and the Internet Addiction Scale in the assessment of multiple addictions in a high-school population: prevalence and related disability. CNS Spectr 2006;11: 966-974.

10. Leung L. Stressful life events, motives for Internet use, and social support among digital kids. Cyberpsychol Behav 2007;10:204-214.

11. Shapira NA, Goldsmith TD, Keck PE Jr, Khosla UM, McElroy SL. Psychiatric features of individuals with problematic internet use. J Affect Disord 2000;57:267-272.

12. Chak K, Leung L. Shyness and locus of control as predictors of internet addiction and internet use. Cyberpsychol Behav 2004;7:559-570.

13. Ng BD & Wiemer-Hastigs P. Addiction to the internet and online gaming. Cyberpsychol Behav 2005;8:110-113.

14. Suhail K, Bargees Z. Effects of excessive internet use on undergraduate students in Pakistan. Cyberpsychol Behav 2006;9:297-307.

15. Borzekowski DL. Adolescents’ use of the Internet: a controversial, coming of age resource. Adolesc Med Clin 2006;17:205-216.

16. Widyanto L, McMurran M. The psychometric properties of the internet addiction test. Cyberpsychol Behav 2004;7: 443-450.

17. Madell D, Muncer S. Back from the beach but hanging on the telephone? English adolescents’ attitudes and experiences of mobile phones and the internet. Cyberpsychol Behav 2004;7:359-367.

18. Rees H, Noyes JM. Mobile telephones, computers, and the internet: sex differences in adolescents’ use and attitudes. Cyberpsychol Behav 2007;10:482-484.

19. Wu CS, Cheng FF. Internet café addiction of Taiwanese adolescents. Cyberpsychol Behav 2007;10:220-225.

20. Lee MS, Ko YH, Song HS, Kwon KH, Lee HS, Nam M, et al. Characteristics of Internet use in relation to game genre in Korean adolescents. Cyberpsychol Behav 2007;10:278-285.

21. Griffiths MD, Hunt N. Dependence on computer games by adolescents. Psychol Rep 1998;82:475-480.

22. Grusser SM, Thalemann R, Albrecht U, Thalemann CN. Excessive computer usage in adolescents - results of a psychometric evaluation. Wien Klin Wochenschr 2005;117: 188-195.

23. Johansson A, Gotestam KG. Problems with computer games without monetary reward: similarity to pathological gambling. Psychol Rep 2004;95:641-650.

24. Skinner H, Biscope S, Murray M, Koru D. Dares to addiction: youth definitions and perspectives on gambling. Can J Public Health 2004;95:264-267.

25. Ko CH, Yen JY, Chen CC, Chen SH, Yen CF. Gender

differences and related factors affecting online gaming addiction among Taiwanese adolescents. J Nerv Ment Dis 2005; 193:273-277.

26. Wei R. Effects of playing violent videogames on Chinese adolescents’ pro-violence attitudes, attitudes towards others, and aggressive behaviour. Cyberpsychol Behav 2007; 10:371-380.

27. Telemedicine, Telepsychiatry, and Online Therapy. In: Sadock BJ, Sadock VA, editors. Kaplan and Sadock’s Comprehensive Textbook of Psychiatry. 8th ed. Lippincott Williams & Wilkins; 2004. p. 958.

28. Johansson A, Götestam KG. Internet addiction: characteristics of a questionnaire and prevalence in Norwegian youth (12-18 years). Scand J Psychol 2004;45:223-229.

29. Niemz K, Griffiths M, Banyard P. Prevalence of pathological internet use among university students and correlations with self-esteem, the General Health Questionnaire and disinhibition. Cyberpsychol Behav 2005;8:562-570.

30. Stefanescu C, Chele G, Chirita V, Chirita R, Mavros M, Macrie G, et al. The effects of computer use on adolescents. Rev Med Chir Soc Med Nat Iasi 2005;109:871-877.

31. Nalwa K, Anand AP. Internet addiction in students: a cause of concern. Cyberpsychol Behav 2003;6:653-656.

32. Whang LS, Lee S, Chang G. Internet over-users’ psychological profiles: a behaviour sampling analysis on internet addiction. Cyberpsychol Behav 2003;6:143-150.

33. Cao F, Su L. Internet addiction among Chinese adolescents: prevalence and psychological features. Child Care Health Dev 2007;33:275-281.

34. Halkias D, Harkiolakis N, Thurman P, Caracatsanis S. Internet use for health-related purposes among Greek consumers. Telemed J E Health 2008;14:255-260.

35. Dejoie JF. Internet addiction: a different kind of addiction? Rev Med Liege 2001;56:523-530.

36. Hagan JF Jr, Shaw JS, Duncan P. In: Health Supervision: Middle Adolescence (15 to 17 Year Visits). In: Bright Futures, Guidelines for Health Supervision of Infants, Children and Adolescents. 3rd ed. American Academy of Pediatrics; 2008. p. 539-557.

∏ ¯Ú‹ÛË ÙˆÓ ËÏÂÎÙÚÔÓÈÎÒÓ

˘ÔÏÔÁÈÛÙÒÓ Î·È ÙÔ˘ ‰È·‰ÈÎÙ‡Ô˘

·fi ·È‰È¿-ÂÊ‹‚Ô˘˜ ÛÙËÓ ÂÚÈÔ¯‹ Ù˘ ∞ı‹Ó·˜

∞. ¶··‰ÔÔ‡ÏÔ˘, °. ª›¯·˜, º. ª›¯·˜, ∞. ∑ÂÚ‚Ô˘‰¿ÎË, ∫. ∆ÛÔ˘Ì¿Î·˜, ¶. °ÂˆÚÁÈÔÔ‡ÏÔ˘-ª›¯·

¶ÂÚ›ÏË„Ë

∂ÈÛ·ÁˆÁ‹: ∆· ·È‰È¿ ·fi ÌÈÎÚ‹ ËÏÈΛ· ¤Ú¯ÔÓÙ·È Û Â·Ê‹ Ì ÙÔ˘˜ ËÏÂÎÙÚÔÓÈÎÔ‡˜ ˘ÔÏÔÁÈÛÙ¤˜ (∏À) ηÈ

Ì ÙÔ˘˜ ÎÈÓ‰‡ÓÔ˘˜ Ô˘ ·˘ÙÔ› ÂÁ΢ÌÔÓÔ‡Ó. ™ÎÔfi˜ Ù˘ ·ÚÔ‡Û·˜ ÌÂϤÙ˘ ‹Ù·Ó Ë Î·Ù·ÁÚ·Ê‹ Ù˘ ¯Ú‹Û˘

ÙÔ˘˜ ·fi Ù· ·È‰È¿ Ù˘ ∞ı‹Ó·˜ Î·È Ë ·Ó¿Ï˘ÛË ÙˆÓ ·ÈÙÈÔÏÔÁÈÎÒÓ ·Ú·ÁfiÓÙˆÓ.

ÀÏÈÎfi Î·È Ì¤ıÔ‰ÔÈ: 213 ·È‰È¿ (46% ·ÁfiÚÈ·, ̤ÛË ËÏÈΛ· 12,3 ÂÙÒÓ) ‰ËÌÔÙÈÎÔ‡ Î·È Á˘ÌÓ·Û›Ô˘ Ù˘ Â-

ÚÈÔ¯‹˜ Ù˘ ∞ı‹Ó·˜ Û˘ÌÏ‹ÚˆÛ·Ó ÂȉÈÎfi ·ÓÒÓ˘ÌÔ ÂÚˆÙËÌ·ÙÔÏfiÁÈÔ, ηٿ ÙË ¯ÚÔÓÈ΋ ÂÚ›Ô‰Ô ™ÂÙ¤Ì-

‚ÚÈÔ˜ - ¢ÂΤ̂ÚÈÔ˜ 2007.

∞ÔÙÂϤÛÌ·Ù·: ∞fi ÙÔ Û‡ÓÔÏÔ ÙˆÓ ·È‰ÈÒÓ, 90,1% ¯ÚËÛÈÌÔÔÈÔ‡Û·Ó ∏À Î·È 69,9% ‰È·‰›ÎÙ˘Ô, Ì ̤ÛË ËÏÈΛ· ¤Ó·Ú͢ ¯Ú‹Û˘ Ù· 8,5 ¤ÙË. ø˜ ·ÚÈÔÈ ÂÎ·È‰Â˘Ù¤˜ ·Ó·Ê¤ÚıËÎ·Ó ÔÈ ÁÔÓ›˜ Î·È Ù· ·‰¤ÏÊÈ· (44,6%), ÙÔ ÊÚÔÓÙÈÛÙ‹ÚÈÔ (22%) Î·È ÙÔ Û¯ÔÏÂ›Ô (14,5%). √ ·Ù¤Ú·˜ ›¯Â ÁÓÒÛÂȘ ∏À Û ÔÛÔÛÙfi 70%, ÂÓÒ Ë ÌËÙ¤Ú· Û ÔÛÔÛÙfi 55,3%, Û ¿ÌÂÛË Û˘Û¯¤ÙÈÛË Ì ÙÔ Â¿ÁÁÂÏÌ¿ ÙÔ˘˜ [OR (95% CI): 3,11 (1,556,26) Î·È 2,37 (1,31-4,28)]. 46,4% ÙˆÓ ·È‰ÈÒÓ Â›¯·Ó ∏À ÛÙÔ ‰ˆÌ¿ÙÈfi ÙÔ˘˜ Î·È Ë ¯Ú‹ÛË ‹Ù·Ó ηıËÌÂÚÈÓ‹ ÛÙÔ 52,6% Î·È 26,2% ÙˆÓ ·È‰ÈÒÓ ÁÈ· ÙÔÓ ∏À Î·È ÙÔ ‰È·‰›ÎÙ˘Ô, ·ÓÙ›ÛÙÔȯ·. √ ÛÎÔfi˜ Ù˘ ¯Ú‹Û˘ ‹Ù·Ó Ë ‰È·ÛΤ‰·ÛË Û ÔÛÔÛÙfi 70% Î·È Ë ÂÎ·›‰Â˘ÛË Û ÔÛÔÛÙfi 29%. ªfiÓÔ ÛÙÔ 51,6% ÙˆÓ ·È‰ÈÒÓ

ÔÈ ÁÔÓ›˜ Â¤‚ÏÂ·Ó ÙË ¯Ú‹ÛË. 32,3% ÙˆÓ ·È‰ÈÒÓ ÂÈÛΤÙÔÓÙ·Ó Û˘¯Ó¿ ›ÓÙÂÚÓÂ٠ηʤ (̤ÛË ËÏÈΛ· 13 ÂÙÒÓ) Î·È 37,8% ÔÚÓÔÁÚ·ÊÈÎÔ‡˜ ‰È·‰ÈÎÙ˘·ÎÔ‡˜ ÙfiÔ˘˜ (̤ÛË ËÏÈΛ· 12,5 ÂÙÒÓ). ∂ÈϤÔÓ, 43 ·È‰È¿ (22,3%) ·Ó¤ÊÂÚ·Ó ÚԂϋ̷ٷ ˘Á›·˜ ÌÂÙ¿ ·fi ÔχˆÚË ¯Ú‹ÛË. ™˘ÌÂÚ¿ÛÌ·Ù·: ∏ ¯Ú‹ÛË ÙˆÓ ∏À Î·È ÙÔ˘ ‰È·‰ÈÎÙ‡Ô˘ ·fi ÙËÓ

ËÏÈΛ· ÛÙËÓ ÂÚÈÔ¯‹ Ù˘

‹Ù·Ó Ô Î‡ÚÈÔ˜ ÂÎ·È‰Â˘Ù‹˜, ¯ˆÚ›˜ fï˜ Â·Ú΋ ÂÈÙ‹ÚËÛË, Î·È Ù· ·È‰È¿ ‹Ù·Ó ÂÎÙÂıÂÈ̤ӷ ÛÙÔ˘˜ ÎÈÓ‰‡ÓÔ˘˜ ÙÔ˘ ‰È·‰ÈÎÙ‡Ô˘. §¤ÍÂȘ

Computer and internet use by school age children in Athens

A. Papadopoulou, G. Michas, F. Michas, A. Zervoudakis, K. Tsoumakas, P. Georgiopoulou-Miha

Abstract

Background: Children are attracted to computer and internet early in life, which may make them vulnerable to adopting high risk behaviour. The aim of this study was to investigate the prevalence of internet use in school age children and to determine risk factors.

Methods: The population sample comprised 213 children (46% boys, mean age 12.3 years) from primary and secondary public schools in Athens, who answered an anonymous questionnaire.

Results: Among children in the study, 90.1% used a computer and 69.9% had access to internet, with a mean age of initiation 8.5 years. Children were instructed mainly by parents and siblings (44.6%), only 14.5% by school teachers, while 22% attended private tutorial centres. In their families, 70% of fathers and 55.3% of mothers used a computer, with significant relationship to their occupation [OR (95% CI): 3.11 (1.55-6.26) and 2.37 (1.31-4.28), respectively]. The computer was located in the child’s bedroom in 46.4% of the cases, and daily use was reported to be 52.6% for computer and 26.2% for internet. The main reasons given for the use were recreation (70%) and education (29%). Only 51.6% of parents regularly supervised their children’s use of internet. Among the study children, 32.3% reported visiting an internet café (mean age 13 years) and 37.8% pornographic sites (mean age 12.5 years). Health problems due to overuse were reported by 43 children (22.3%).

Conclusions: The majority of school age children in Athens use computer and internet, mainly for recreation. The family is reported to be the main educator; however, parental supervision is inadequate and many children have opportunities to visit “garbage sites”.

Key words: Computer, internet, children, risk factors

Adolescent Medicine Clinic, Paediatric Department, KAT General Hospital

Correspondence: Athina Papadopoulou athinapap@yahoo.com

Adolescent Medicine Clinic, Paediatric Department, KAT General Hospital

¢ËÌÔÙÈÎfi °˘ÌÓ¿ÛÈÔ

∞ÁfiÚÈ· ∫ÔÚ›ÙÛÈ· ™‡ÓÔÏÔ ∞ÁfiÚÈ· ∫ÔÚ›ÙÛÈ· ™‡ÓÔÏÔ ™‡ÓÔÏÔ p (%) (%) (%) (%) (%) (%)

N 68 (48,9)71 (51,01)139 (100)30 (40,5)44 (59,5)74 (100)213 (100)0,31

ª¤ÛË ËÏÈΛ· (¤ÙË)11,211,011,114,314,714,612,30,001

∆ÔÔıÂÛ›· Û¯ÔÏ›Ԣ

- ΤÓÙÚÔ17 (25)19 (27,8)36 (25,8)16 (53,3)19 (43,1)35 (47,3)71 (33,3)0,001

- ÚÔ¿ÛÙÈ·51 (75)52 (73,2)103 (74,2)14 (46,6)25 (56,8)39 (52,6)142 (66,6)

™ÂÈÚ¿ Á¤ÓÓËÛ˘

- ÌÔÓ·¯Ô·›‰È10 (14,7)15 (21,1)25 (18)4 (13,4)7 (15,9)11 (14,9)36 (16,9)

- ÚÒÙÔ31 (45,8)26 (36,9)57 (41)8 (26,6)16 (36,7)24 (32,4)81 (38)0,39

- ÌÂÛ·›Ô7 (10,3)4 (5,6)11 (7,9)2 (6,6)6 (13,6)8 (10,8)19 (8,9)

- ÙÂÏÂ˘Ù·›Ô20 (29,8)26 (36,6)46 (33)16 (53,3)15 (34,4)31 (41,9)77 (36,2)

°ÓÒÛÂȘ - ·ÁÁÏÈ΋˜ ÁÏÒÛÛ·˜62 (91,6)71 (100)134 (96,4)29 (96,7)43 (97,7)72 (97,3)204 (96,0)

- Á·ÏÏÈ΋˜ ÁÏÒÛÛ·˜11 (17,5)9 (12,6)16 (11,5)6 (23,2)5 (11,3)11 (14,8)31 (15)0,18

- ÁÂÚÌ·ÓÈ΋˜ ÁÏÒÛÛ·˜7 (10,3)7 (10)14 (10)3 (10,3)1 (2,5)4 (5,4)18 (8,5)

ª·ıËÛȷΤ˜ ‰˘ÛÎÔϛ˜3 (4,5)4 (5,6)7 (5,0)3 (10,3)6 (13,6)9 (12,1)16(7,5)0,10

∂¿ÁÁÂÏÌ· ÌËÙ¤Ú·˜ - ÔÈÎȷο20 (29,4)24 (33,8)44 (31,6)13 (43,3)17 (38,9)30 (40,5)74 (34,7) - ˘¿ÏÏËÏÔ˜23 (34,2)30 (42,7)53 (38,1)5 (16,7)18 (40,9)23 (31)76 (35,8)0,31 - ÂÈÛÙ‹ÌÔÓ·˜17 (25,5)14 (19,7)31 (22,3)10 (33,3)8 (18,1)18 (24,3)49 (23) - ÂȯÂÈÚËÌ·Ù›·˜8 (12,1)3 (4,5)11 (8)2 (6,6)1 (2,2)3 (4,1)14 (6,6)

∂¿ÁÁÂÏÌ· ·Ù¤Ú·

- ÂÚÁ¿Ù˘7 (10,3)12 (16,9)19 (13,6)4 (13,3)7 (15,9)11 (14,8)30 (14,2) - ˘¿ÏÏËÏÔ˜23 (33,9)29 (41)52 (37,4)12 (40,4)16 (36,7)28 (37,8)80 (37,5)

- ÂÈÛÙ‹ÌÔÓ·˜4 (5,8)14 (19,7)18 (12,9)8 (26,6)9 (20,4)17 (22,9)35 (16,4)0,30

- ÂȯÂÈÚËÌ·Ù›·˜27 (39,7)*13 (18,5)40 (28,7)7 (23,3)9 (20,4)16 (21,6)56 (26,3)

- Û˘ÓÙ·ÍÈÔ‡¯Ô˜7 (10,3)3 (4,4)10 (7,1)1 (3,3)1 (2,2)2 (2,7)12 (5,7)

* ¢ÂÓ ÛËÌÂÈÒıËΠÛÙ·ÙÈÛÙÈο ÛËÌ·ÓÙÈ΋ ‰È·ÊÔÚ¿ ·Ó¿ÌÂÛ· ÛÙ· ‰‡Ô ʇϷ, ÏËÓ Ù˘ ·ÚÔ˘Û›·˜ ÂÚÈÛÛfiÙÂÚˆÓ ·ÁÔÚÈÒÓ ÛÙÔ

‰ËÌÔÙÈÎfi Ì ·Ù¤Ú˜ ÂȯÂÈÚË̷ٛ˜

··ÓÙË̤ӷ ÂÚˆÙËÌ·ÙÔÏfiÁÈ· (46% ·ÁfiÚÈ·, ̤ÛË ËÏÈΛ· 12,3 ÂÙÒÓ), Ù· ÔÔ›· ηٷ¯ˆÚ‹ıËÎ·Ó Î·È ·Ó·Ï‡ıËÎ·Ó Ì ÙË ‚Ô‹ıÂÈ· ÙÔ˘ ÛÙ·ÙÈÛÙÈÎÔ‡ ÚÔÁÚ¿ÌÌ·ÙÔ˜ SPSS 12.0. ÃÚËÛÈÌÔÔÈ‹ıËΠÙÔ ÙÂÛÙ χ2 Î·È ÙÔ t ÙÂÛÙ ÁÈ· ÙË Û‡ÁÎÚÈÛË ÙˆÓ ÔÛÔÙÈÎÒÓ Î·È ÔÈÔÙÈÎÒÓ ÌÂÙ·‚ÏËÙÒÓ ·Ó¿ÌÂÛ· ÛÙÔ ‰ËÌÔÙÈÎfi Î·È ÙÔ Á˘ÌÓ¿ÛÈÔ Î·È ·Ó¿ÌÂÛ· ÛÙ· ·È‰È¿ Ô˘ ηÙÔÈÎÔ‡Û·Ó ÛÙÔ Î¤ÓÙÚÔ Î·È ÛÙ· ÚÔ¿ÛÙÈ· ÙˆÓ ∞ıËÓÒÓ. ∆· Odds Ratios Î·È 95% Confidence Intervals ˘ÔÏÔÁ›ÛÙËÎ·Ó Ì ÙË ‚Ô‹ıÂÈ· Ù˘ ÏÔÁÈÛÌÈ΋˜ ÔÏÏ·Ï‹˜ ·Ú·ÁÔÓÙÔÔ›ËÛ˘ (forward logistic regression) Î·È ·Ó·˙ËÙ‹ıËÎ·Ó ·Ú¿ÁÔÓÙ˜ ÎÈÓ‰‡ÓÔ˘ Î·È Û˘Û¯ÂÙ›ÛÂȘ ÌÂٷ͇ ÙˆÓ ‰Â‰Ô̤ӈÓ.

∞ÔÙÂϤÛÌ·Ù·

∆· ÎÔÈÓˆÓÈÎÔÔÈÎÔÓÔÌÈο ¯·Ú·ÎÙËÚÈÛÙÈο ÙˆÓ

·È‰ÈÒÓ ·ÚÔ˘ÛÈ¿˙ÔÓÙ·È ÛÙÔÓ ¶›Ó·Î· 1. ∆· ÂÚÈÛÛfiÙÂÚ· ·È‰È¿ ·Ú·ÎÔÏÔ˘ıÔ‡Û·Ó ÙÔ Û¯ÔÏÂ›Ô Ù˘

ÁÂÈÙÔÓÈ¿˜ ÙÔ˘˜ (33,3% ÛÙÔ Î¤ÓÙÚÔ Î·È 66,6% Û ÚÔ-

¿ÛÙÈ· ÙˆÓ ∞ıËÓÒÓ) Î·È Û¯Â‰fiÓ fiÏ· (96%) ·Ú·ÎÔ-

ÏÔ˘ıÔ‡Û·Ó ·ÁÁÏÈο ˆ˜ ͤÓË ÁÏÒÛÛ·. ¶·Ú·ÙËÚ‹ıË-

Π˘„ËÏfiÙÂÚÔ ÔÛÔÛÙfi Ì·ıËÛÈ·ÎÒÓ ‰˘ÛÎÔÏÈÒÓ ÛÙÔ

Á˘ÌÓ¿ÛÈÔ (12,1% ¤Ó·ÓÙÈ 5%), ¯ˆÚ›˜ fï˜ ÛÙ·ÙÈÛÙÈο

ÛËÌ·ÓÙÈ΋ ‰È·ÊÔÚ¿ [OR (95% CI): 2,44 (0,87-6,88)].

™Â ÔÛÔÛÙfi 16,9%, Ù· ·È‰È¿ ‰ÂÓ Â›¯·Ó ¿ÏÏ· ·‰¤ÏÊÈ·, ÂÓÒ 38% ‹Ù·Ó ÚÒÙ· Î·È 36,2% ÙÂÏÂ˘Ù·›· ÛÙË

ÛÂÈÚ¿ Á¤ÓÓËÛ˘. ∆Ô Â¿ÁÁÂÏÌ· ÙˆÓ ÁÔÓ¤ˆÓ, ˆ˜ ‰Â›ÎÙ˘ ÂÎ·›‰Â˘Û˘ Î·È ÎÔÈÓˆÓÈÎÔÔÈÎÔÓÔÌÈÎÔ‡ ÂÈ¤‰Ô˘ Ù˘ ÔÈÎÔÁ¤ÓÂÈ·˜, ¤‰ÂÈÍ fiÙÈ 42,7% ÙˆÓ ·Ù¤ÚˆÓ Î·È 29,6% ÙˆÓ ÌËÙ¤ÚˆÓ ·Ó‹Î·Ó Û ˘„ËÏ‹ ÎÔÈÓˆÓÈ΋ Ù¿ÍË, ÂÓÒ 1/3 ÙˆÓ ÌËÙ¤ÚˆÓ Â›¯·Ó ˆ˜ ··Û¯fiÏËÛË Ù· ÔÈÎȷο. ¢ÂÓ ·Ú·ÙËÚ‹ıËΠ‰È·ÊÔÚ¿

ÛÙ· ÎÔÈÓˆÓÈÎÔÔÈÎÔÓÔÌÈο ¯·Ú·ÎÙËÚÈÛÙÈο ÙˆÓ ·È‰ÈÒÓ ÙÔ˘ ‰ËÌÔÙÈÎÔ‡ Î·È ÙÔ˘ Á˘ÌÓ·Û›Ô˘. ™ÙË Û‡ÁÎÚÈÛË ÙˆÓ ·È‰ÈÒÓ ÙÔ˘ ΤÓÙÚÔ˘ Î·È ÙˆÓ ÚÔ·ÛÙ›ˆÓ (¶›Ó·Î·˜ 2), ‰È·ÈÛÙÒıËΠÛÙ·ÙÈÛÙÈο ÛËÌ·ÓÙÈ΋ ‰È·ÊÔÚ¿ ÛÙËÓ ÂÎÌ¿ıËÛË Ù˘ Á·ÏÏÈ΋˜ ÁÏÒÛÛ·˜ Î·È ÛÙÔ

ÔÛÔÛÙfi ÂȯÂÈÚËÌ·ÙÈÒÓ (p<0,05).

¶ÔÛÔÛÙfi 90,1% ÙˆÓ ·È‰ÈÒÓ (85,6% ÙÔ˘ ‰ËÌÔÙÈÎÔ‡ Î·È 98,6% ÙÔ˘ Á˘ÌÓ·Û›Ô˘ [OR (95% CI): 1,15 (1,07-1,24)] ‹ÍÂÚ ӷ ¯ÚËÛÈÌÔÔÈ› ∏À, Ì ̤ÛË ËÏÈΛ· ¤Ó·Ú͢ Ù˘ ÂÎÌ¿ıËÛ˘ Ù· 8,5 ¤ÙË (¶›Ó·Î·˜ 3). ™ËÌ·ÓÙÈο ÌÈÎÚfiÙÂÚË ËÏÈΛ· ¤Ó·Ú͢ ·Ú·ÙËÚ‹ıËÎÂ

ÛÙ· ·È‰È¿ ÙÔ˘ ‰ËÌÔÙÈÎÔ‡ [OR (95% CI): 1,55 (1,261,92)], ÛÙ· ·ÁfiÚÈ· [OR (95% CI): 1,20 (1,03-1,43)],

ÛÙ· ·È‰È¿ ÙˆÓ ÚÔ·ÛÙ›ˆÓ [OR (95% CI): 1,29 (1,061,56)] Î·È ÛÙ· ·È‰È¿ Ì ÁÔÓ›˜ (·Ù¤Ú·˜ ‹/Î·È ÌËÙ¤Ú·) ÁÓÒÛÙ˜ Ù˘ ¯Ú‹Û˘ ∏À [OR (95% CI): 0,77

∞ÁfiÚÈ· ∫ÔÚ›ÙÛÈ· ™‡ÓÔÏÔ ¡=35 (%) ¡=36 (%) ¡=71 (%) ¡=64 (%) ¡=78 (%) ¡=142 (%) p

ª¤ÛË ËÏÈΛ· (¤ÙË) 12,712,512,611,912,412,150,12

™ÂÈÚ¿ Á¤ÓÓËÛ˘

- ÌÔÓ·¯Ô·›‰È5 (14,2)8 (22,2)13 (18,3)9 (14,0)14 (17,9)23 (16,1)

- ÚÒÙÔ12 (34,2)14 (38,8)26 (36,8)27 (42,4)28 (36,1)55 (38,8)0,29

- ÌÂÛ·›Ô2 (5,7)1 (2,7)3 (4,7)7 (11,6)9 (12,0)16 (11,2)

- ÙÂÏÂ˘Ù·›Ô16 (45,7)13 (36,1)29 (40,9)21 (32,9)27 (34,7)48 (33,8)

°ÓÒÛÂȘ

- ·ÁÁÏÈ΋˜ ÁÏÒÛÛ·˜33 (95,5)35 (97,2)68 (95,7)58 (91,1)78 (100)136 (95,7)

- Á·ÏÏÈ΋˜ ÁÏÒÛÛ·˜1 (2,8)2 (5,5)3 (4,2)16 (26,4)12 (15,3)28 (19,7)0,04

- ÁÂÚÌ·ÓÈ΋˜ ÁÏÒÛÛ·˜3 (8,5)2 (5,5)5 (7,1)7 (11,3)6 (7,6)13 (9,1)

ª·ıËÛȷΤ˜ ‰˘ÛÎÔϛ˜2 (5,8)3 (8,3)5 (7,1)4 (6,4)7 (9,0)11 (7,8)0,9

∂¿ÁÁÂÏÌ· ÌËÙ¤Ú·˜

- ÔÈÎȷο15 (42,8)12 (33,3)27 (38,1)18 (28,2)29 (37,4)47 (33)

- ˘¿ÏÏËÏÔ˜8 (22,8)19 (52,7)*27 (38,1)20 (31,6)29 (37,4)49 (34,5)0,44

- ÂÈÛÙ‹ÌÔÓ·˜9 (25,7)*3 (8,3)12 (17,4)19 (29,6)18 (23,0)37 (26,0)

- ÂȯÂÈÚËÌ·Ù›·˜3 (8,5)2 (5,5)5 (7,1)7 (11,3)2 (2,5)9 (6,3) ∂¿ÁÁÂÏÌ· ·Ù¤Ú·

- ÂÚÁ¿Ù˘7 (2,0)9 (25,0)16 (22,6)6 (9,8)8 (10,2)14 (9,8)

- ˘¿ÏÏËÏÔ˜17 (48,2)13 (36,1)30 (42,5)18 (28,2)32 (41,1)50 (35,2)

- ÂÈÛÙ‹ÌÔÓ·˜4 (11,4)6 (16,6)10 (14,0)10 (16,0)15 (19,2)25 (17,6)0,05

- ÂȯÂÈÚËÌ·Ù›·˜6 (17,1)4 (11,1)10 (14,0)26 (40,8)20 (25,6)46 (32,3)

- Û˘ÓÙ·ÍÈÔ‡¯Ô˜1 (2,8)4 (11,1)5 (7,1)4 (6,8)3 (3,8)7 (4,9)

* ÛÙ·ÙÈÛÙÈο ÛËÌ·ÓÙÈ΋ ‰È·ÊÔÚ¿ ·Ó¿ÌÂÛ· ÛÙ· ‰‡Ô ʇϷ

(0,64-0,93)]. ¶ÔÛÔÛÙfi 70% ÙˆÓ ·Ù¤ÚˆÓ Î·È 55,4%

ÙˆÓ ÌËÙ¤ÚˆÓ ‹ÍÂÚ ӷ ¯ÚËÛÈÌÔÔÈ› ∏À Î·È Ë ¯Ú‹ÛË

›¯Â ¿ÌÂÛË Û˘Û¯¤ÙÈÛË Ì ÙÔ Â¿ÁÁÂÏÌ· [OR (95%

CI): 3,11 (1,55-6,26) Î·È 2,37(1,31-4,28), ·ÓÙ›ÛÙÔȯ·].

¶·ÚfiÏ· ·˘Ù¿, 62,7% ÙˆÓ ÌËÙ¤ÚˆÓ Ô˘ ‰‹ÏˆÛ·Ó ˆ˜

··Û¯fiÏËÛË Ù· ÔÈÎȷο ¯ÚËÛÈÌÔÔÈÔ‡Û·Ó ∏À.

∫‡ÚÈÔÈ ÂÎ·È‰Â˘Ù¤˜ (44,6%) ‹Ù·Ó ÔÈ ÁÔÓ›˜ Î·È Ù· ·‰¤ÚÊÈ· ηÈ, Û ÌÈÎÚfiÙÂÚÔ ÔÛÔÛÙfi, ÙÔ Û¯ÔÏÂ›Ô (14,5%). 22% ÙˆÓ ·È‰ÈÒÓ ‰‹ÏˆÛ·Ó fiÙÈ ·Ú·ÎÔÏÔ‡ıËÛ·Ó È‰ÈˆÙÈο Ì·ı‹Ì·Ù·. ™ÙÔ Î¤ÓÙÚÔ Ù˘ ∞ı‹Ó·˜, ÙÔ Û¯ÔÏÂ›Ô ÂÈÙÂÏÔ‡Û ÛËÌ·ÓÙÈÎfi ÚfiÏÔ ÛÙËÓ ÂÎ·›‰Â˘ÛË ÙˆÓ ·È‰ÈÒÓ ÙÔ˘ Á˘ÌÓ·Û›Ô˘ Î·È Ë ÔÈÎÔÁ¤ÓÂÈ·

¶›Ó·Î·˜ 3. ¶ÔÛÔÛÙ¿ Î·È OR (95% CI) ÁÈ· ÙË ¯Ú‹ÛË ÙˆÓ ∏À ÛÙ· ·È‰È¿ ÙÔ˘ ‰ËÌÔÙÈÎÔ‡ Î·È ÙÔ˘ Á˘ÌÓ·Û›Ô˘ Î·È ÛÙ· ‰‡Ô ʇϷ ™‡ÓÔÏÔ ¢ËÌÔÙÈÎfi °˘ÌÓ¿ÛÈÔ OR ∞ÁfiÚÈ· ∫ÔÚ›ÙÛÈ· OR ¡=213 (%) ¡=139 (%) ¡=74 (%) (95% CI) ¡=98 (%) ¡=115 (%) (95% CI)

ÃÚ‹ÛË ∏À192 (90,1)119 (85,6)73 (98,6)1,15 (1,07-1,24)*90 (91,8)102 (88,7)0,81 (0,46-1,43)

∏ÏÈΛ· ¤Ó·Ú͢ ¯Ú‹Û˘ (ÂÙÒÓ)8,57,79,61,55 (1,26-1,92)*8,08,91,28 (1,01-1,43)

∂Î·È‰Â˘Ù‹˜ - ÔÈÎÔÁ¤ÓÂÈ·95 (44,6)76 (54,6)19 (25,6)0,28 (0,15-0,53)*51 (52,0)44 (38,2) - Û¯ÔÏ›Ô31 (14,5)8 (5,7)23 (31,0)5,53 (2,50-12,2)*10 (10,2)21 (18,2)0,84 (0,5-1,42) - ÊÚÔÓÙÈÛÙ‹ÚÈÔ47 (22,0)24 (17,2)23 (31,0)2,21 (1,12-4,36)*20 (20,4)27 (23,4)

∫·ÙÔ¯‹ ∏À ÛÙÔ Û›ÙÈ185 (86,8)124 (89,2)62 (83,8)0,62 (0,27-1,41)89 (90,896 (83,4)0,69 (0,40-1,2)

£¤ÛË ∏À ÛÙÔ Û›ÙÈ - ˘ÓÔ‰ˆÌ¿ÙÈÔ ·È‰ÈÔ‡99 (46,4)59 (42,4)40 (54,0)2,04 (1,11-3,72)*48 (48,9)51 (44,3)0,98 (0,56-1,73) - Û·ÏfiÓÈ46 (21,6)33 (23,7)13 (17,5)2,56 (0,95-6,84)26 (26,5)20 (17,3)0,82 (0,38-1,78) - ÁÚ·Ê›Ô75 (35,2)45 (32,4)30 (40,5)3,42 (1,41-8,29)*39 (39,7)36 (31,3)0,94 (0,46-1,93)

∏ÏÈΛ· ÂÈÛfi‰Ô˘ ÙÔ˘ ∏À ÛÙÔ

˘ÓÔ‰ˆÌ¿ÙÈÔ ÙÔ˘ ·È‰ÈÔ‡ (¤ÙË)9,58,510,71,82 (1,30-2,53)*9,69,50,78 (0,48-1,28)

∫·ıËÌÂÚÈÓ‹ ¯Ú‹ÛË ∏À101 (52,6)55 (46,2)46 (63,0)2,51 (1,36-4,62)*51 (56,6)50 (49,0)1,16 (0,86-1,56)

ÃÚ‹ÛË ∏À ·fi ·Ù¤Ú·149 (70)106 (76,2)43 (58,1)0,40 (0,21-0,75)*68 (69,3)80 (69,5)0,48 (0.08-2,9)

ÃÚ‹ÛË ∏À ·fi ÌËÙ¤Ú·118 (55,3)80 (57,5)38 (51,4)0,77 (0,43-1,37)57 (58,1)61 (53,0)1,15 (0,20-6,48)

* p<0,05

¶›Ó·Î·˜ 4. ¶ÔÛÔÛÙ¿ Î·È OR (95% CI) ÁÈ· ÙË

™‡ÓÔÏÔ ∫¤ÓÙÚÔ ¶ÚÔ¿ÛÙÈ· OR (95% CI) ¡=213 (%) ¡=71 (%) ¡=142 (%)

ÃÚ‹ÛË ∏À192 (90,1)67 (94,3)125 (88,0)0,93 (0,85-1,01)

∏ÏÈΛ· ¤Ó·Ú͢ ¯Ú‹Û˘ (¤ÙË)8,59,18,21,07 (0,76-1,50)

∂Î·È‰Â˘Ù‹˜

- ÔÈÎÔÁ¤ÓÂÈ·95 (44,6)26 (36,6)69 (48,5)1,39 (1,01-1,90)*

- Û¯ÔÏ›Ô31 (14,5)18 (25,3)13 (9,1)0,48 (0,23-0,99)*

- ÊÚÔÓÙÈÛÙ‹ÚÈÔ47 (22,0)18 (25,3)29 (20,4)0,90 (0,53-1,52)

∫·ÙÔ¯‹ ∏À ÛÙÔ Û›ÙÈ185 (86,8)54 (76,0)131 (92,2)1,2 (1,06-1,39)*

£¤ÛË ∏À ÛÙÔ Û›ÙÈ

- ˘ÓÔ‰ˆÌ¿ÙÈÔ ·È‰ÈÔ‡99 (46,4)30 (42,2)69 (48,5)1,18 (0,85-1,65)

- Û·ÏfiÓÈ46 (21,6)18 (25,3)28 (19,7)0,70 (0,45-1,07)

- ÁÚ·Ê›Ô75 (35,2)33 (47,1)42 (29,5)1,38 (0,94-2,04)

∏ÏÈΛ· ÂÈÛfi‰Ô˘ ÙÔ˘ ∏À ÛÙÔ ˘ÓÔ‰ˆÌ¿ÙÈÔ ÙÔ˘ ·È‰ÈÔ‡ (¤ÙË)9,510,79,01,43 (1,02-2,00)*

∫·ıËÌÂÚÈÓ‹ ¯Ú‹ÛË ∏À101 (52,6)27 (40,0)74 (59,2)1,38 (0,97-1,97)

ÃÚ‹ÛË ∏À ·fi ·Ù¤Ú·149 (70)42 (59,1)107 (76,4)1,29 (1,04-1,61)*

ÃÚ‹ÛË ∏À ·fi ÌËÙ¤Ú·118 (55,3)35 (49,2)83 (58,4)1,16 (0,88-1,53)*

* p<0,05

ÏÈÁfiÙÂÚÔ [OR (95% CI): 0,48 (0,23-0,99)] Î·È ·˘Ùfi

Û˘Û¯ÂÙ›ÛÙËΠ̠ÙËÓ ·ÚÔ˘Û›· ·Ù¤ÚˆÓ ÌË ¯ÚË-

ÛÙÒÓ ÙˆÓ ∏À (¶›Ó·Î·˜ 4).

∫·ÙÔ¯‹ ∏À ÛÙÔ Û›ÙÈ ·Ú·ÙËÚ‹ıËΠ۠ÔÛÔÛÙfi

86,8% Î·È Û¯Â‰fiÓ Ù· ÌÈÛ¿ Û›ÙÈ· ›¯·Ó ÂÚÈÛÛfiÙÂ-

ÚÔ˘˜ ·fi 1 ∏À (44,7%). ¶·Ú·ÙËÚ‹ıËΠÛÙ·ÙÈÛÙÈο

ÛËÌ·ÓÙÈ΋ ‰È·ÊÔÚ¿ ÌÂٷ͇ ΤÓÙÚÔ˘ Î·È ÚÔ·ÛÙ›ˆÓ

[OR (95% CI): 1,2 (1,06-1,39)] (¶›Ó·Î˜ 3 Î·È 4). √

‹ ÔÈ ∏À ‹Ù·Ó ÙÔÔıÂÙË̤ÓÔÈ Û ÔÛÔÛÙfi 21,6% ÛÙÔ

Û·ÏfiÓÈ ÙÔ˘ ÛÈÙÈÔ‡, 35,2% ÛÙÔ ÁÚ·ÊÂ›Ô Î·È 46,4%

ÛÙÔ ˘ÓÔ‰ˆÌ¿ÙÈÔ ÙÔ˘ ·È‰ÈÔ‡. ∆· ·È‰È¿ ÙÔ˘ Á˘ÌÓ·Û›Ô˘ ›¯·Ó Û˘¯ÓfiÙÂÚ· ∏À ÛÙÔ ˘ÓÔ‰ˆÌ¿ÙÈfi

ÙÔ˘˜ [OR (95% CI): 2,04 (1,11-3,72)]. ŸÌˆ˜, Ë Ì¤ÛË

ËÏÈΛ· ÂÈÛfi‰Ô˘ ÙÔ˘ ∏À ÛÙÔ ‰ˆÌ¿ÙÈÔ ÙÔ˘ ·È‰ÈÔ‡ ÙÔ˘

‰ËÌÔÙÈÎÔ‡ ‹Ù·Ó ÛÙ·ÙÈÛÙÈο ÌÈÎÚfiÙÂÚË ÁÈ· Ù· ·È‰È¿

ÙÔ˘ ‰ËÌÔÙÈÎÔ‡ ·fi fi,ÙÈ ÁÈ· Ù· ·È‰È¿ ÙÔ˘ Á˘ÌÓ·Û›Ô˘ [OR (95% CI): 1,82 (1,30-2,53)] Î·È ÁÈ· Ù· ÚÔ¿ÛÙÈ· Û ۯ¤ÛË Ì ÙÔ Î¤ÓÙÚÔ [OR (95% CI): 1,43 (1,022,00)]. ∫·ıËÌÂÚÈÓ‹ ¯Ú‹ÛË ∏À ·Ó¤ÊÂÚ ÙÔ 62,1% ÙˆÓ ·È‰ÈÒÓ ÙÔ˘ Á˘ÌÓ·Û›Ô˘ Î·È ÙÔ 39,5% ÙÔ˘ ‰ËÌÔÙÈÎÔ‡ [OR (95% CI): 2,51 (1,36-4,62)]. ∏ ηıËÌÂÚÈÓ‹ ¯Ú‹ÛË Û˘Û¯ÂÙ›ÛÙËΠ̠ÙËÓ ·ÚÔ˘Û›· ∏À ÛÙÔ ‰ˆÌ¿ÙÈÔ ÙÔ˘ ·È‰ÈÔ‡ [OR (95% CI): 2,51 (1,364,62)] Î·È ‹Ù·Ó ·ÓÂÍ¿ÚÙËÙË ·fi ÙËÓ ÂÚÈÔ¯‹ ‰È·ÌÔÓ‹˜ (p=0,06) Î·È ÙÔ Â¿ÁÁÂÏÌ· ÙˆÓ ÁÔÓ¤ˆÓ (p=0,58).

∆Ô 69,9% ÙˆÓ ·È‰ÈÒÓ ‰‹ÏˆÛ ¯Ú‹ÛË ‰È·‰ÈÎÙ‡Ô˘, ÂÎ ÙˆÓ ÔÔ›ˆÓ 90,6% ÛÙÔ Û›ÙÈ (¶›Ó·Î˜ 5 Î·È 6). ∆Ô 20,1% Î·È ÙÔ 37,8% ÙˆÓ ·È‰ÈÒÓ ÙÔ˘ ‰ËÌÔÙÈÎÔ‡ Î·È ÙÔ˘ Á˘ÌÓ·Û›Ô˘, ·ÓÙ›ÛÙÔȯ·, ‰‹ÏˆÛ ηıËÌÂÚÈÓ‹

¶›Ó·Î·˜ 5. ¶ÔÛÔÛÙ¿ Î·È OR (95% CI) ÁÈ· ÙË ¯Ú‹ÛË ÙÔ˘ ›ÓÙÂÚÓÂÙ ·fi Ù· ·È‰È¿ ÙÔ˘ ‰ËÌÔÙÈÎÔ‡ Î·È ÙÔ˘ Á˘ÌÓ·Û›Ô˘ Î·È ÛÙ· ‰‡Ô ʇϷ

™‡ÓÔÏÔ ¢ËÌÔÙÈÎfi °˘ÌÓ¿ÛÈÔ OR ∞ÁfiÚÈ· ∫ÔÚ›ÙÛÈ· OR ¡=213 (%) ¡=139 (%) ¡=74 (%) (95% CI) ¡=98 (%) ¡=115 (%) (95% CI)

ÃÚ‹ÛË ‰È·‰ÈÎÙ‡Ô˘149 (69,9)94 (67,6)55 (74,3)1,13 (0,92-1,39)73 (74,4)76 (66,0)1,12 (0,94-1,33)

ÃÚ‹ÛË ‰È·‰ÈÎÙ‡Ô˘ ÛÙÔ Û›ÙÈ135 (63,3)90 (64,7)45 (60,8)0,85 (0,47-1,53)65 (66,3)70 (60,8)1,12 (0,91-1,37)

ÃÚ‹ÛË ‰È·‰ÈÎÙ‡Ô˘ ηıËÌÂÚÈÓ¿56 (26,2)28 (20,1)28 (37,8)1,21 (1,07-1,43)*30 (30,6)26 (22,6)1,08 (0,87-1,43)

∂›ÛÎÂ„Ë Û ›ÓÙÂÚÓÂ٠ηʤ48 (32,3)28 (29,7)20 (36,3)1,20 (0,72-2,01)25(34,2)23 (30,2)1,24 (0,80-1,92)

ª¤ÛË ËÏÈΛ· ·È‰ÈÒÓ

ÛÙ· ›ÓÙÂÚÓÂ٠ηʤ (¤ÙË)1311,614,96,99 (2,8-17,2)*13,213,10,89 (0,42-1,21)

™˘¯ÓfiÙËÙ· Â›Û΄˘27 (56,3)16 (56,2)11 (55,0)1,10 (0,70-1,35)19 (76)8 (34,7)2,46 (1,24-4,86)*

(1-2 ÊÔÚ¤˜/‚‰ÔÌ¿‰·)

∂›ÛÎÂ„Ë Û sites ÌÂ

ÔÚÓÔÁÚ·ÊÈÎfi ÂÚȯfiÌÂÓÔ56 (37,8)25 (26,6)21 (38,1)1,02 (0,53-1,57)30 (41,0)26 (34,2)1,45 (0,89-2,35)

ª¤ÛË ËÏÈΛ· ·È‰ÈÒÓ

ÛÙ· ÈÔ ¿Óˆ sites (¤ÙË)12,511,2814,66,81 (3,8-18,4)*12,712,21,04 (0,66-1,78)

¶·Ú·ÎÔÏÔ‡ıËÛË ·fi ÁÔÓ›˜77 (51,6)50 (53,1)27 (49,0)0,60 (0,32-1,13)21 (43,8)56 (48,6)0,88 (0,63-1,21)

* p<0,05

¶›Ó·Î·˜ 6. ¶ÔÛÔÛÙ¿ Î·È OR (95% CI) ÁÈ· ÙË ¯Ú‹ÛË

Ù˘ ∞ı‹Ó·˜ ™‡ÓÔÏÔ ∫¤ÓÙÚÔ ¶ÚÔ¿ÛÙÈ· OR ¡=213 (%) ¡=71 (%) ¡=142 (%) (95% CI)

ÃÚ‹ÛË ‰È·‰ÈÎÙ‡Ô˘149 (69,9)41 (57,7)108 (76,0)1,32 (1,07-1,64)

ÃÚ‹ÛË ‰È·‰ÈÎÙ‡Ô˘ ÛÙÔ Û›ÙÈ135 (63,3)31 (43,6)104 (73,2)1,64 (1,24-2,16)

ÃÚ‹ÛË ‰È·‰ÈÎÙ‡Ô˘ ηıËÌÂÚÈÓ¿39 (26,2)18 (25,3)21 (19,4)

∂›ÛÎÂ„Ë Û ›ÓÙÂÚÓÂ٠ηʤ48 (32,3)14 (34,1)34 (31,4)0,98 (0,63-1,59)

ª¤ÛË ËÏÈΛ· ·È‰ÈÒÓ ÛÙ· ›ÓÙÂÚÓÂ٠ηʤ (¤ÙË)1314,612,43,25 (1,49-7,06)*

™˘¯ÓfiÙËÙ· Â›Û΄˘ (1-2 ÊÔÚ¤˜/‚‰ÔÌ¿‰·)27 (56,3)11 (78,5)16 (47,0)0,61 (0,39-0,94)*

∂›ÛÎÂ„Ë Û sites Ì ÔÚÓÔÁÚ·ÊÈÎfi ÂÚȯfiÌÂÓÔ56 (37,8)17 (41,4)40 (36,0)0,89 (0,56-1,41)

ª¤ÛË ËÏÈΛ· ·È‰ÈÒÓ ÛÙ· ÈÔ ¿Óˆ sites (¤ÙË)12,513,5120,29 (0,10-0,84)

¶·Ú·ÎÔÏÔ‡ıËÛË ·fi ÁÔÓ›˜77 (51,6)19 (46)58 (53,7)0,81 (0,54-1,32)

* p<0,05

¯Ú‹ÛË [OR (95% CI): 1,21 (1,07-1,43)]. ∆Ô 32,3%

ÙˆÓ ·È‰ÈÒÓ Ô˘ ‰‹ÏˆÛ·Ó ¯Ú‹ÛË ÂÈÛΤÙÂÙ·È Ù·

›ÓÙÂÚÓÂ٠ηʤ (̤ÛË ËÏÈΛ· 13 ÂÙÒÓ), ÂÎ ÙˆÓ ÔÔ›ˆÓ

Ù· ÌÈÛ¿ (56,3%) ÙÔ˘Ï¿¯ÈÛÙÔÓ 1-2 ÊÔÚ¤˜/ ‚‰ÔÌ¿‰·.

¢ÂÓ ·Ú·ÙËÚ‹ıËΠ‰È·ÊÔÚ¿ ÛÙË Û˘¯ÓfiÙËÙ· ÂÈÛΤ-

„ÂˆÓ ·Ó¿ÌÂÛ· ÛÙ· ·È‰È¿ ÙÔ˘ Á˘ÌÓ·Û›Ô˘ Î·È ÙÔ˘

‰ËÌÔÙÈÎÔ‡. ™ËÌÂÈÒıËÎÂ, fï˜, ÌÂÁ·Ï‡ÙÂÚË ÚÔÛ¤-

Ï¢ÛË ÛÙ· ›ÓÙÂÚÓÂ٠ηʤ ·fi Ù· ·È‰È¿ ÙÔ˘ ΤÓÙÚÔ˘

Ù˘ ∞ı‹Ó·˜ [OR (95% CI): 0,61 (0,39-0,94)] Î·È ·fi

Ù· ·ÁfiÚÈ· [OR (95% CI): 2,46 (1,24-4,86)]. ∆Ô 87%

ÙˆÓ ·È‰ÈÒÓ ÁÓÒÚÈ˙ ÁÈ· Ù· “ÛÎÔ˘›‰È·” ÙÔ˘ ‰È·‰È-

ÎÙ‡Ô˘ Î·È ÙÔ 37,8% Ù· ¤¯ÂÈ ¯ÚËÛÈÌÔÔÈ‹ÛÂÈ ¤ÛÙˆ ÁÈ·

Ì›· ÊÔÚ¿, ÂÓÒ ‰ÂÓ ‰È·ÈÛÙÒıËΠ‰È·ÊÔÚ¿ ·Ó¿ÌÂÛ·

ÛÙ· ·È‰È¿ ÙÔ˘ Á˘ÌÓ·Û›Ô˘ Î·È ÙÔ˘ ‰ËÌÔÙÈÎÔ‡, ÛÙ·

Ù̷̋ٷ Ù˘ ∞ı‹Ó·˜ Î·È ÛÙ· ‰‡Ô ʇϷ. ∏ ›ÛÔ‰Ô˜

ÙˆÓ ·È‰ÈÒÓ Û ‰È·‰ÈÎÙ˘·ÎÔ‡˜ ÙfiÔ˘˜ Ì ÔÚÓÔ-

ÁÚ·ÊÈÎfi ˘ÏÈÎfi Û˘Û¯ÂÙ›ÛÙËΠÛËÌ·ÓÙÈο Ì ÙËÓ Â›-

ÛÎÂ„Ë Û ›ÓÙÂÚÓÂ٠ηʤ [OR (95% CI): 3,29 (1,358,01)] (¶›Ó·Î·˜ 6).

™·Ú¿ÓÙ· ÙÚ›· ·È‰È¿ (22,3%) ·Ó¤ÊÂÚ·Ó ÚÔ‚Ï‹-

Ì·Ù· ˘Á›·˜ ÌÂÙ¿ ·fi ÔχˆÚË ¯Ú‹ÛË (>3 ÒÚ·/Ë̤ڷ): ÎÂÊ·Ï·ÏÁ›· 7%, ˙¿ÏË 10,9%, Ì˘˚Îfi ¿ÏÁÔ˜ 7,8%. √È ·Èٛ˜ ¯Ú‹Û˘ ÙÔ˘ ∏À Î·È ÙÔ˘ ‰È·‰ÈÎÙ‡-

Ô˘ ‹Ù·Ó ΢ڛˆ˜ Ë ‰È·ÛΤ‰·ÛË Î·È Ôχ ÏÈÁfiÙÂÚÔ Ë

ÂÎ·›‰Â˘ÛË (∂ÈÎfiÓ· 1). ŸÌˆ˜, ÙÔ 79% ÙˆÓ ·È‰ÈÒÓ ı· ÚÔÙÈÌÔ‡Û ̛· ÒÚ· ‰È·ÛΤ‰·Û˘ Ì ¤Ó·Ó ηÏfi

Ê›ÏÔ ·Ú¿ Ì ¤Ó·Ó ∏À.

∏À ·fi

Center of Education Statistics)

ÂÚÈÂϿ̂·ÓÂ

ÌÈÎÚfiÙÂÚ· ÙˆÓ 9 ÂÙÒÓ, ·ÍÈÔÏÔÁÒÓÙ·˜ fï˜ ÙËÓ ËÏÈΛ· ¤Ó·Ú͢ ¯Ú‹Û˘, Ô˘ ÛÙËÓ Ú·ÁÌ·ÙÈÎfiÙËÙ· ÂÚÈÁÚ¿ÊÂÈ ÙË ¯Ú‹ÛË ÚÈÓ ·fi ÙÔ˘Ï¿¯ÈÛÙÔÓ 5 ¤ÙË (2002-3), ‰È·ÈÛÙÒıËΠÔχ ÌÈÎÚfiÙÂÚÔ ÔÛÔÛÙfi (1/5), Û ۇÁÎÚÈÛË Ì ÙÔ ÔÛÔÛÙfi ¯Ú‹Û˘ ÛÙȘ ∏¶∞, ÂÓ‰ÂÈÎÙÈÎfi Ù˘ ηı˘ÛÙÂÚË̤Ó˘ ÂÁηٿÛÙ·Û˘ ÙˆÓ ∏À ÛÙËÓ Î·ıËÌÂÚÈÓfiÙËÙ· Ù˘ ÂÏÏËÓÈ΋˜ ÎÔÈÓˆÓ›·˜. ∂ÈϤÔÓ, ‚¿ÛÂÈ Ù˘ ‰È·ÊÔÚ¿˜ Ô˘ ·Ú·ÙËÚ‹ıËΠÛÙË Ì¤ÛË ËÏÈΛ· ¤Ó·Ú͢ ¯Ú‹Û˘ ÛÙ· ·È‰È¿ ÙÔ˘ ‰ËÌÔÙÈÎÔ‡ Î·È ÙÔ˘ Á˘ÌÓ·Û›Ô˘ (7,7 ÂÙÒÓ ¤Ó·ÓÙÈ 9,6 ÂÙÒÓ), ‰È·ÎÚ›ÓÂÙ·È ÌÈ· ·˘ÍËÙÈ΋ Ù¿ÛË ¤ÎıÂÛ˘ ÙˆÓ ·È‰ÈÒÓ ÛÙÔ˘˜ ∏À Û Ó·ÚfiÙÂÚË ËÏÈΛ·. ∆· ÌÈÛ¿ ۯ‰fiÓ ·ıËÓ·˚ο Û›ÙÈ· ›¯·Ó ÂÚÈÛÛfiÙÂÚÔ˘˜ ·fi ¤Ó·Ó ∏À, fï˜ Ë Î·ÙÔ¯‹ ∏À ÛÙÔ Û›ÙÈ ‰È¤ÊÂÚ ÌÂٷ͇ ÙÔ˘ ΤÓÙÚÔ˘ Î·È ÙˆÓ ÚÔ·ÛÙ›ˆÓ Ù˘ ∞ı‹Ó·˜, ÁÂÁÔÓfi˜ Ô˘

¯ÒÚÔ ÙÔ˘ Û¯ÔÏ›Ԣ. ∂ÓÒ ÙÔ ›ÓÙÂÚÓÂÙ ·ÔÙÂÏ› ·-

Ú¿ı˘ÚÔ ÛÙË ÁÓÒÛË Î·È ÛÙËÓ ÂÎ·›‰Â˘ÛË Î·È ¤¯ÂÈ ÙË

‰˘Ó·ÌÈ΋ Ó· ÙÂÏÂÈÔÔÈ‹ÛÂÈ fiϘ ÙȘ ‰ÂÍÈfiÙËÙ˜

ÂÓfi˜ ·È‰ÈÔ‡, ηٷÓÙ¿ ÙÂÏÈο ̤ÛÔ ÂÊ·ÚÌÔÁ‹˜ ‚›·È-

ˆÓ ·È¯ÓȉÈÒÓ ÛÙÚ·ÙËÁÈ΋˜, ¿Ï˘ ͈ÙÈÎÒÓ Î·È ÙÂ-

Ú¿ÙˆÓ ‹ ηٷÛ΢‹˜ ·ÛÙÂÚÈÒÓ-ÌÔÓÙ¤ÏˆÓ (10). ∆Ô

48% ÙˆÓ ·È‰ÈÒÓ Ù˘ µÔÛÙfiÓ˘ ·›˙ÂÈ Û˘¯Ó¿ ÙÔ˘-

Ï¿¯ÈÛÙÔÓ ¤Ó· ‚›·ÈÔ ·È¯Ó›‰È (ÙÔ 30% ÙˆÓ ·ÁÔÚÈÒÓ

ηıËÌÂÚÈÓ¿ ηÈ, fi¯È Û¿ÓÈ·, Ì ·ÁÓÒÛÙÔ˘˜, ̤ۈ

›ÓÙÂÚÓÂÙ) Î·È ¯ÚËÛÈÌÔÔÈ› Ù· ·È¯Ó›‰È· ÁÈ· Ó· ·ÓÙÈ-

ÌÂÙˆ›ÛÂÈ ÙÔ ı˘Ìfi ÙÔ˘ (1). √È Subrahmanyam K. et al. ‰È·›ÛÙˆÛ·Ó fiÙÈ Ù· ·È¯Ó›‰È· ·˘Ù¿ ·˘Í¿ÓÔ˘Ó ÙËÓ

ÂÈıÂÙÈÎfiÙËÙ·, ·¢·ÈÛıËÙÔÔÈÔ‡Ó Ù· ·È‰È¿ ÛÙÔÓ

fiÓÔ Î·È ÚÔηÏÔ‡Ó Û‡Á¯˘ÛË Ù˘ Ú·ÁÌ·ÙÈÎfiÙË-

Ù·˜ Ì ÙË Ê·ÓÙ·Û›· (11). ™‡Ìʈӷ Ì ÙȘ ÙÂÏÂ˘Ù·›-

˜ ıˆڛ˜, ˘¿Ú¯ÂÈ Ë ¿ÌÂÛË Î·È Ë fi„ÈÌË ·ÚÓËÙÈ΋

Â›‰Ú·ÛË. ÕÌÂÛË Â›Ó·È Ë ÂÈıÂÙÈ΋ Û˘ÌÂÚÈÊÔÚ¿

Ô˘ ÂΉËÏÒÓÂÙ·È Û ¿ÌÂÛË ¯ÚÔÓÈ΋ Û¯¤ÛË Ì ÙÔ

ÓÈÌ· Û ¤Ó· ·È‰› Ô˘ Û˘ÛÙËÌ·ÙÈο ·Ú·ÎÔÏÔ˘ı›

Î·È ·ÓÙÈÁÚ¿ÊÂÈ ‚›·È˜ ÂΉËÏÒÛÂȘ. ∆· ·È‰È¿ ‰È·ı¤ÙÔ˘Ó “Ó¢ÚÒÓ˜ ηıÚ¤Ù˜” Ô˘ ÏÂÈÙÔ˘ÚÁÔ‡Ó

ÙÈο, ¯ˆÚ›˜ ‰˘Ó·ÙfiÙËÙ· ÊÈÏÙÚ·Ú›ÛÌ·ÙÔ˜ Î·È Â›Ó·È

ÈÔ ÂÈÚÚÂ‹ ÛÙÔ Ó· ·ÓÙÈÁÚ¿„Ô˘Ó Û˘ÌÂÚÈÊÔÚ¤˜ (12,13).

∏ ÔχˆÚË ¯Ú‹ÛË (ÂÚÈÛÛfiÙÂÚ˜ ·fi 3 ÒÚ˜/Ë̤ڷ) ÂÁ΢ÌÔÓ› ÙÔÓ Î›Ó‰˘ÓÔ ·Ó¿Ù˘Í˘

‰È·‰ÈÎÙ˘·ÎÔ‡ ÂıÈÛÌÔ‡, Ë ÛÔ‚·ÚfiÙËÙ· ÙÔ˘ ÔÔ›Ô˘

¤¯ÂÈ ·Ó·ÁÓˆÚÈÛÙ› Î·È ·ÓËÛ˘¯‹ÛÂÈ ÔÏϤ˜ ¯ÒÚ˜.

¶Úfi‰ÚÔÌ· Û˘ÌÙÒÌ·Ù· ·ÔÙÂÏÔ‡Ó Ô ˘ÂÚ‚ÔÏÈÎfi˜

¯ÚfiÓÔ˜ ÂÓ·Û¯fiÏËÛ˘, Ë ·Ú·Ì¤ÏËÛË ˘Ô¯ÚÂÒÛÂ-

ˆÓ, Ë ·fiÙÔÌË ÙÒÛË Ù˘ Û¯ÔÏÈ΋˜ Â›‰ÔÛ˘, Ë

·ÔÌfiÓˆÛË Î·È Ë ¿ÚÓËÛË Û˘Ó¿ÓÙËÛ˘ Ì ʛÏÔ˘˜, Ë

ÂÈıÂÙÈÎfiÙËÙ·, Ë ·ÏÏ·Á‹ ÛÙË Û˘ÌÂÚÈÊÔÚ¿, ÔÈ Ô-

ÓÔΤʷÏÔÈ Î·È Ë ÍËÚÔÊı·ÏÌ›· (14-16). ªÂÙ¿ ·fi

ÔχˆÚË ¯Ú‹ÛË, 22% ÙˆÓ ·È‰ÈÒÓ Ù˘ ÌÂϤÙ˘

·Ó¤ÊÂÚ·Ó ÚԂϋ̷ٷ ˘Á›·˜, ΢ڛˆ˜ ÎÂÊ·Ï·ÏÁ›·, Ì˘˚Îfi fiÓÔ Î·È ˙¿ÏË, Û˘ÌÙÒÌ·Ù· ˘„ËÏÔ‡ ÎÈÓ‰‡-

ÓÔ˘ Ô˘ ¯·Ú·ÎÙËÚ›˙Ô˘Ó Î·Ù¿ÛÙ·ÛË ÚÔ-ÂıÈÛÌÔ‡.

∞ÓÙ›ÛÙÔÈ¯Ô ÔÛÔÛÙfi (18%) ¤¯ÂÈ ‰È·ÈÛÙˆı› ηÈ

ÛÙË ªÔÓ¿‰· ∂ÊË‚È΋˜ ÀÁ›·˜ Ù˘ ¶·ÓÂÈÛÙËÌȷ΋˜ ¶·È‰È·ÙÚÈ΋˜ ∫ÏÈÓÈ΋˜ ÙÔ˘ ¡ÔÛÔÎÔÌ›Ԣ

“∞ÁÏ·˝· ∫˘ÚÈ·ÎÔ‡” (17). ∆Ô Ê·ÈÓfiÌÂÓÔ Â›Ó·È Û˘¯ÓfiÙÂÚÔ ÛÙ· ·ÁfiÚÈ·, Û ÌÔÓÔÁÔÓÂ˚Τ˜ ‹ ‰˘ÛÏÂÈÙÔ˘ÚÁÈΤ˜ ÔÈÎÔÁ¤ÓÂȘ, Û ˘ÂÚÎÈÓËÙÈο ‹ ηٷıÏÈ-

ÙÈο ·È‰È¿, Û ÂÚ›ÙˆÛË ÂÏÏÈÔ‡˜ Â›‚Ï„˘

·ÚÔ˘ÛÈ¿˙ÂÈ È‰È·›ÙÂÚ˜ ‰˘ÛÎÔϛ˜, ÁÈ·Ù› Û˘Ó‹-

ηٿÛÙ·Û˘ Î·È ··ÈÙÔ‡ÓÙ·È ÂȉÈο ıÂÚ·Â˘Ù‹ÚÈ·

Ô˘ Ï›Á˜ ¯ÒÚ˜ ‰È·ı¤ÙÔ˘Ó.

∂›Ó·È ·Ó·ÌÊÈÛ‚‹ÙËÙÔ ÙÔ ÁÂÁÔÓfi˜ fiÙÈ ÔÈ ∏À ‚ÂÏ-

ÙÈÒÓÔ˘Ó ÙËÓ ·ÓÙÈÏËÙÈ΋ ÈηÓfiÙËÙ· ÙˆÓ ·È‰ÈÒÓ, ÙÔÓ Û˘ÓÙÔÓÈÛÌfi ÙˆÓ ÎÈÓ‹ÛÂˆÓ Î·È ÙÔÓ Ù·˘Ùfi¯ÚÔÓÔ

¯ÂÈÚÈÛÌfi ÔÏÏÒÓ ÂÈÎfiÓˆÓ, fï˜ ÂÈÚfiÛıÂÙ· ÚÔηÏÔ‡Ó ·›ÛıËÌ· ÌÔÓ·ÍÈ¿˜ Î·È ÌÂÏ·Á¯ÔÏ›·˜ (11,25).

∂›Ó·È ¤Ó· ÌÔÓ·¯ÈÎfi “¿ıÏËÌ·”. ∞ÎfiÌ· Î·È Ë ÂÈÎÔÈ-

ÓˆÓ›· Ì ʛÏÔ˘˜ ̤ۈ ›ÓÙÂÚÓÂÙ ·Ó·ÈÚ› ÙËÓ ÚÔÛˆ-

È΋ Î·È ÔÙÈ΋ Â·Ê‹, ÙË ÛˆÌ·ÙÈ΋ Î·È ·ÈÛıËÙÈ΋

Û˘Û¯¤ÙÈÛË, ÂÓÒ Û˘¯Ó¿ ‰ËÌÈÔ˘ÚÁ› „‡ÙÈÎË ÂÈÎfiÓ· ÙÔ˘ ÂÈÎÔÈÓˆÓÔ‡ÓÙÔ˜. º·›ÓÂÙ·È fiÙÈ

Î·È ÂÈÚÚÂ‹ Û ÎÈÓ‰‡ÓÔ˘˜, fiˆ˜ Ë ·Ó¿Ù˘ÍË ÂÈıÂÙÈ΋˜ Û˘ÌÂÚÈÊÔÚ¿˜, Ë ÛÂÍÔ˘·ÏÈ΋ ·ÚÂÓfi¯ÏËÛË Î·È Ô ‰È·‰ÈÎÙ˘·Îfi˜ ÂıÈÛÌfi˜. ∆· ‰Â‰Ô̤ӷ Â›Ó·È ·ÓËÛ˘¯ËÙÈο Î·È ··ÈÙÂ›Ù·È ¿ÌÂÛË ÂÓË̤ڈÛË ÙˆÓ ÁÔÓ¤ˆÓ, ÙˆÓ ÂÎ·È‰Â˘ÙÈÎÒÓ Î·È ÙˆÓ

·È‰È¿ÙÚˆÓ Î·È ‰ËÌÈÔ˘ÚÁ›· Û˘Ì‚Ô˘Ï¢ÙÈÎÒÓ ˘ËÚÂÛÈÒÓ Î·È ÊÔÚ¤ˆÓ ηıÔÚÈÛÌÔ‡ ÔÌ¿‰ˆÓ ˘„ËÏÔ‡

ÎÈÓ‰‡ÓÔ˘ Î·È ¤ÁηÈÚ˘ ·ÓÙÈÌÂÙÒÈÛ˘.

µÈ‚ÏÈÔÁÚ·Ê›·

1. Olson CK, Kutner LA, Warner DE, Almerigi JB, Baer L, Nicholi AM 2nd, et al. Factors correlated with violent video game use by adolescent boys and girls. J Adolesc Health 2007;41:77-83.

2. Bushman BJ, Huesmann LR. Short-term and long-term effects of violent media on aggression in children and adults. Arch Pediatr Adolesc Med 2006;160:348-352.

3. Wood W, Wong FY, Chachere JG. Effects of media violence on viewers’ aggression in unconstrained social interaction. Psychol Bull 1991;109:371-383.

4. Mitchell KJ, Finkelhor D, Wolak J. Risk factors for and impact of online sexual solicitation of youth. JAMA 2001;285:3011-3014.

5. Young KS. Psychology of computer use: XL. Addictive use of the Internet: a case that breaks the stereotype. Psychol Rep 1996;79:899-902.

6. Young KS. Cognitive behavior therapy with Internet addicts: treatment outcomes and implications. Cyberpsychol Behav 2007;10:671-679.

7. Ng BD, Wiemer-Hastings P. Addiction to the internet and online gaming. Cyberpsychol Behav 2005;8:110-113.

ÙˆÓ ÁÔÓ¤ˆÓ ‹ ÌÂÙ¿ ·fi ÔχˆÚË ¯Ú‹ÛË ÙˆÓ chat rooms (18-20). ¶ÔÛÔÛÙ¿ 20-37% ‹ÈÔ˘ ‹ ̤ÙÚÈÔ˘ ÂıÈÛÌÔ‡ ¤¯Ô˘Ó ·Ó·ÎÔÈÓˆı› ·fi ·ÚÎÂÙ¤˜ ¯ÒÚ˜, ÂÓÒ Ù· ÔÛÔÛÙ¿ ‚·Ú¤Ô˜ ÂıÈÛÌÔ‡ ·Ó¤Ú¯ÔÓÙ·È Û 9,3% ÛÙÔ µÂÚÔÏ›ÓÔ, 5,5% ÛÙËÓ ∫›Ó·, 2-4% ÛÙËÓ ∫ÔÚ¤·, 2% ÛÙË ¡ÔÚ‚ËÁ›·, 1,4% ÛÙË ƒÔ˘Ì·Ó›· Î·È 1% ÛÙËÓ ∂ÏÏ¿‰· (17,21-27). ∏ ·ÂÍ¿ÚÙËÛË ·fi ÙÔ˘˜

8. US Department of Education, National Centre for Education Statistics. Rates of computer and internet use by children in nursery school and students in kindergarten through twelfth grade: 2003. [Internet]. 2005 Oct: Webpage: http://nces.ed.gov/pubs2005/2005111rev.pdf

9. Becker HJ. Who’s wired and who’s not: children’s access to and use of computer technology. The Future of Children 2000;10:44-75.

10. ∂ÏÏËÓÈ΋ ∫·Ù·Ó·ÏˆÙÈ΋ √ÚÁ¿ÓˆÛË (E.KAT.O.). ŒÚ¢ӷ Ù˘ ∂.∫∞∆.√. ÁÈ· ÙȘ Û˘Ó‹ıÂȘ Î·È ÙË ¯Ú‹ÛË ÙÔ˘ ‰È·‰ÈÎÙ‡Ô˘ ·fi ÙÔ˘˜ Ó¤Ô˘˜. [Internet]. 2006: Webpage: http:// www.ekato.org/gr/research/2006/Internet_Use_survey.pdf

11. Subrahmanyam K, Kraut RE, Greenfield PM, Gross EF. The impact of home computer use on children’s activities and development. Future Child 2000;10:123-144.

12. Rizzolatti G, Fadiga L, Gallese V, Fogassi L. Premotor cortex and the recognition of motor actions. Brain Res Cogn Brain Res 1996;3:131-141.

13. Meltzoff AN, Moore MK. Imitation of facial and manual gestures by human neonates: resolving the debate about early imitation. In: Muir D, Slater A, editors. Infant Development: The Essential Readings. Malden, MA: Blackwell Publishers; 2000. p. 167-181.

14. Ko CH, Yen JY, Chen CC, Chen SH, Yen CF. Proposed diagnostic criteria of Internet addiction for adolescents. J Nerv Ment Dis 2005;193:728-733.

15. Dannon PN, Iancu I. Internet addiction. Harefuah 2007; 146:549-553.

16. Nichols LA, Nicki R. Development of a psychometrically sound internet addiction scale: a preliminary step. Psychol Addict Behav 2004;18:381-384.

17. ªÔÓ¿‰· ∂ÊË‚È΋˜ ÀÁ›·˜ (ª.∂.À.), ¡ÔÛÔÎÔÌÂ›Ô ¶·›‰ˆÓ “¶. & ∞. ∫˘ÚÈ·ÎÔ‡”. SOS: ¢È·‰ÈÎÙ˘·Îfi˜ ∂ıÈÛÌfi˜, ¢È¿ÁÓˆÛË ˘ÂÚ‚ÔÏÈ΋˜ ¯Ú‹Û˘, ™˘Ì‚Ô˘Ï¤˜ ÚfiÏ˄˘, ¶Úfi‰ÚÔÌ· Û˘ÌÙÒÌ·Ù·. ∂ÊËÌÂÚ›‰· “∂Ï¢ıÂÚÔÙ˘›·”, ʇÏÏÔ 18/1/2008.

18. Hur MH. Demographic, habitual, and socioeconomic determinants of Internet addiction disorder: an empirical study of Korean teenagers. Cyberpsychol Behav 2006;9: 514-525.

19. Ferraro G, Caci B, D’Amico A, Di Blasi M. Internet addiction disorder: an Italian study. Cyberpsychol Behav 2007;10:170-175.

20. Yen JY, Yen CF, Chen CC, Chen SH, Ko CH. Family factors of internet addiction and substance use experience in Taiwanese adolescents. Cyberpsychol Behav 2007;10: 323-329.

21. Deng YX, Hu M, Hu GQ, Wang LS, Sun ZQ. An investigation on the prevalence of internet addiction disorder in middle school students of Hunan province. Zhonghua Liu Xing Bing Xue Za Zhi 2007;28:445-448.

22. June KJ, Sohn SY, So AY, Yi GM, Park SH. A study of factors that influence Internet addiction, smoking, and drinking in high school students. Taehan Kanho Hakhoe Chi 2007;37:872-882.

23. Stefa nescu C, Chele G, Chirit , a V, Chirit , a R, Mavros M, Macarie G, Ilinca M. The effects of computer-use on adolescents. Rev Med Chir Soc Med Nat Iasi 2005;109: 871-877.

24. Grüsser SM, Thalemann R, Albrecht U, Thalemann CN. Excessive computer usage in adolescents-results of a psychometric evaluation. Wien Klin Wochenschr 2005;117: 188-195.

25. Jang KS, Hwang SY, Choi JY. Internet addiction and psychiatric symptoms among Korean adolescents. J Sch Health 2008;78:165-171.

26. Cao F, Su L. Internet addiction among Chinese adolescents: prevalence and psychological features. Child Care Health Dev 2007;33:275-281.

27. Johansson A, Götestam KG. Internet addiction: characteristics of a questionnaire and prevalence in Norwegian youth (12-18 years). Scand J Psychol 2004;45: 223-229.

π·ÙÚÂ›Ô ∞Ó·Ù˘Íȷ΋˜

¶·È‰È·ÙÚÈ΋˜, ¡ÔÛÔÎÔÌ›Ô

¶·›‰ˆÓ “¶. & ∞. ∫˘ÚÈ·ÎÔ‡”,

∞ı‹Ó·

AÏÏËÏÔÁÚ·Ê›·:

§ˆÚ¤ÙÙ· £ˆÌ·˝‰Ô˘ developmental-health@ yahoo.gr

π·ÙÚÂ›Ô ∞Ó·Ù˘Íȷ΋˜

¶·È‰È·ÙÚÈ΋˜, ¡ÔÛÔÎÔÌ›Ô

¶·›‰ˆÓ “¶. & ∞. ∫˘ÚÈ·ÎÔ‡”, ∞ı‹Ó·

∞ÓȯÓ¢ÙÈ΋ ‰ÔÎÈÌ·Û›· Û¯ÔÏÈ΋˜ ÂÙÔÈÌfiÙËÙ·˜:

™. ª·ÓÙÔ‡‰Ë˜, §. £ˆÌ·˝‰Ô˘

¶ÂÚ›ÏË„Ë

™ÎÔfi˜: ∏ ‰ËÌÈÔ˘ÚÁ›· ÂÓfi˜ Û‡ÓÙÔÌÔ˘, ¢¤ÏÈÎÙÔ˘ Î·È ·ÍÈfiÈÛÙÔ˘ ÂÚÁ·Ï›Ԣ ÁÈ· ÙÔÓ ÂÓÙÔÈÛÌfi ÚÒÈÌˆÓ ‰ÂÈÎÙÒÓ Ì·ıËÛÈ·ÎÒÓ ‰˘ÛÎÔÏÈÒÓ.

ÀÏÈÎfi Î·È Ì¤ıÔ‰ÔÈ: ªÂÏÂÙ‹ıËÎ·Ó ‰‡Ô ·ÓÙÈÚÔÛˆ¢ÙÈο ‰Â›ÁÌ·Ù· ·È‰ÈÒÓ: ÙÔ ‰Â›ÁÌ· ÈÏÔÙÈ΋˜ ¤Ú¢ӷ˜ (¡=322), ËÏÈΛ·˜ 4-7 ÂÙÒÓ, Î·È ÙÔ ‰Â›ÁÌ· ÙÂÏÈ΋˜ ÛÙ¿ıÌÈÛ˘ (¡=2002), Ì ̤ÛË ËÏÈΛ· 5 ¯ÚfiÓÈ· Î·È 8 ̋Ә. °È· ÙËÓ ÂÈÏÔÁ‹ ÙˆÓ ÂÈ̤ÚÔ˘˜ ÎÏÈÌ¿ÎˆÓ Ù˘ ‰ÔÎÈÌ·Û›·˜ ÌÂÏÂÙ‹ıËÎ·Ó Î·È ‰ÔÎÈÌ¿ÛıËÎ·Ó ÔÏÏ¿ ‰È·ÁÓˆÛÙÈο ÂÚÁ·Ï›· ·Ó·Ù˘Íȷ΋˜ ÂÎÙ›ÌËÛ˘, fiˆ˜ ‰ÔÎÈ̷ۛ˜ ÔÙÈÎÔÎÈÓËÙÈÎÔ‡ Û˘ÓÙÔÓÈÛÌÔ‡, ÔÙÈ΋˜ ·ÓÙ›Ï˄˘, ÁψÛÛÈ΋˜ ÂͤÏÈ͢, ÓÔËÌÔÛ‡Ó˘ Î·È Ì·ıËÛÈ·ÎÒÓ ‰˘ÛÎÔÏÈÒÓ. ∂ÂϤÁËÛ·Ó ÔÈ ÙÔÌ›˜ ÂΛÓÔÈ Ô˘ ÂÌÊ·Ó›˙Ô˘Ó ·fiÎÏÈÛË ÌÂÁ·Ï‡ÙÂÚË ‹ ›ÛË ÙˆÓ 2 ÛÙ·ıÂÚÒÓ ·ÔÎϛۈÓ. ªÂÙ¿ ÙË ÛÙ·ÙÈÛÙÈ΋ ·Ó¿Ï˘ÛË, Ë ÙÂÏÈ΋ Û‡ÓıÂÛË ÙˆÓ ÂÚˆÙ‹ÛÂˆÓ Ô˘ ÂÂϤÁËÛ·Ó Ô‰‹ÁËÛ ÛÙË ‰ËÌÈÔ˘ÚÁ›· ÙˆÓ 7 ‚·ÛÈÎÒÓ ÎÏÈ̿ΈÓ

ÈηÓÔÙ‹ÙˆÓ ÙˆÓ ·È‰ÈÒÓ (∂Í·ÈÚÂÙÈ΋

Department of Developmental Paediatrics, “P. & A. Kyriakou” Children’s Hospital, Athens, Greece

Correspondence: Loretta Thomaidis developmental-health@ yahoo.gr Department of Developmental Paediatrics, “P. & A. Kyriakou” Children’s Hospital, Athens, Greece

Ì ÙËÓ Îϛ̷η TVƒS (r=0,895, p=0,000) Ô˘ ÌÂÙÚ¿

TVªS (r=0,599, p=0,000) Ô˘ ÌÂÙÚ¿ ·ÔÎÏÂÈ-

The A TEST; assessment of school readiness

Abstract

Objectives: The development of a reliable, flexible, short instrument for the detection of early learning disabilities.

Methods: Two representative samples of children were studied: a sample aged 4-7 years for a pilot study (N=322), and a sample with an average age of 5 years and 8 months, that of the final study (¡=2002). In order to decide on the final scales to be included in the test, many developmental assessment instruments were used, such as: hand-eye coordination, visual perception, linguistic development tasks, intelligence scales and learning ability tests. The sectors that showed a deviation of equal to or more than two standard deviations were selected. The final composition of the 7 scales which comprise the test was based on the statistical analysis.

Results: The assessment standards of children’s abilities were determined according to the first administration of the A TEST (Excellent, Normal, Borderline and Low performance). The A TEST was found to be positively correlated with the TVPS scale (r=0.895, p=0.000), which is used exclusively for the assessment of Visual Perception, and with the TVMS scale (r=0.599, p=0.000), which is used exclusively for the assessment of hand-eye coordination.

Conclusions: The reliability and validity of the ∞ TEST were found to be 99.8% and 97%, respectively; the A TEST thus detects effectively both those children who have all the essential skills to start primary school and those who do not.

Key words: A ∆∂S∆, school readiness.

™¯ÔÏÂ›Ô 1996 1997 1998 1999 2000 2001 2002

™‡ÓÔÏÔ

µ‡ÚˆÓ·˜1982441778167108150901 æ˘¯ÈÎfi16792860 ºÈÏÔı¤Ë121621352 ¡. ∏Ú¿ÎÏÂÈÔ224632

∑ˆÁÚ¿ÊÔ˘ 243357 ∞ı‹Ó·47478728209 ∞ÌÂÏfiÎËÔÈ10171138

∞Á. ¶·Ú·Û΢‹1515 °Ï˘Î¿ ¡ÂÚ¿19611696 ªÂÙ·ÌfiÚʈÛË243155 °¤Ú·Î·˜2323 ∏ÏÈÔ‡ÔÏË4747 ¶ÂÚÈÛÙ¤ÚÈ242448 ∫·Ì›ÓÈ·2424 ÕÓ‰ÚÔ˜2424

¶ÂÚÈʤÚÂÈ· ∞ÙÙÈ΋˜2424246072464724321 ™‡ÓÔÏÔ155210641821441412322842903002002

ÌËÓÒÓ (̤ÛË ËÏÈΛ·: 5 ¯ÚfiÓÈ· Î·È 8 ̋Ә). ∆· ·È‰È¿ ÊÔÈÙÔ‡Û·Ó Û ÓËÈ·ÁˆÁ›· ÙÔ˘ ÓÔÌÔ‡ ∞ÙÙÈ΋˜ (¶›Ó·Î·˜ 1).

∞ÔÙÂϤÛÌ·Ù· ∆ÂÏÈ΋˜ ™Ù¿ıÌÈÛ˘ ∆· ·ÔÙÂϤÛÌ·Ù· ÙÔ˘ ∞ã ∆∂™∆ ·ÚÔ˘ÛÈ¿˙ÔÓÙ·È ·Ó·Ï˘ÙÈο ÛÙÔÓ ¶›Ó·Î· 2 Î·È ÛÙËÓ ∂ÈÎfiÓ· 1. Ÿˆ˜ ÚÔ·ÙÂÈ ·fi ÙÔÓ ¶›Ó·Î· 2 Î·È ÙËÓ ∂ÈÎfiÓ· 1, ÛÙÔÓ ÙÔ̤· ÙˆÓ ∞ÎÔÏÔ˘ıÈÒÓ, 73,8% ÙˆÓ ·È-

‰ÈÒÓ Ô˘ Û˘ÌÌÂÙ›¯·Ó ·ÚÔ˘ÛÈ¿˙Ô˘Ó Ù˘È΋ ·Ó¿-

Ù˘ÍË ÁÈ· ÙËÓ ËÏÈΛ· ÙÔ˘˜, 8,2% ÙˆÓ ·È‰ÈÒÓ ·ÚÔ˘ÛÈ¿˙Ô˘Ó Î¿ÔÈÔ Èı·Ófi Úfi‚ÏËÌ· ÛÙËÓ ·Ó¿Ù˘ÍË Î·È 17,9% ÙˆÓ ·È‰ÈÒÓ ·ÚÔ˘ÛÈ¿˙Ô˘Ó ÚÔ¯ˆÚË-

̤ÓË ·Ó¿Ù˘ÍË ÁÈ· ÙËÓ ËÏÈΛ· ÙÔ˘˜. ™ÙÔÓ ÙÔ̤· Ù˘ √ÙÈ΋˜ ∞ÓÙ›Ï˄˘, 75,2% ÙÔ˘ Û˘ÓfiÏÔ˘ ÙˆÓ ·È‰ÈÒÓ ·ÚÔ˘ÛÈ¿˙Ô˘Ó Ù˘È΋ ·Ó¿-

Ù˘ÍË ÁÈ· ÙËÓ ËÏÈΛ· ÙÔ˘˜. ∫¿ÔȘ ‰˘ÛÎÔϛ˜ ÛÙËÓ

·Ó¿Ù˘ÍË ÛÙÔÓ Û˘ÁÎÂÎÚÈ̤ÓÔ ÙÔ̤· ·ÚÔ˘ÛÈ¿˙Ô˘Ó

16,7% ÙˆÓ ·È‰ÈÒÓ. ™˘ÁÎÂÎÚÈ̤ӷ, 8,3% ·ÚÔ˘ÛÈ¿-

˙Ô˘Ó Èı·Ófi Úfi‚ÏËÌ·, 6,5% ‹È· ‰˘ÛÎÔÏ›· Î·È ÈÔ

·ÚÁ‹ ·Ó¿Ù˘ÍË Î·È, Ù¤ÏÔ˜, 1,9% ÛÔ‚·Úfi Úfi‚ÏËÌ·

Î·È ·Ó·Ù˘Íȷ΋ ηı˘ÛÙ¤ÚËÛË. ¶ÚÔ¯ˆÚË̤ÓË ·Ó¿-

Ù˘ÍË ÁÈ· ÙËÓ ËÏÈΛ· ÙÔ˘˜ ÂÌÊ·Ó›˙Ô˘Ó 8,2% ÙˆÓ ·È‰ÈÒÓ.

ÙÔ̤· ÙÔ˘ √ÙÈÎÔÎÈÓËÙÈÎÔ‡ ™˘ÓÙÔÓÈÛÌÔ‡, ¤Ó· Ôχ ÌÈÎÚfiÙÂÚÔ ÔÛÔÛÙfi ·È‰ÈÒÓ, Û ۇÁÎÚÈÛË

ÙÔÌ›˜ Ù˘ ·Ó¿Ù˘Í˘, ·ÚÔ˘ÛÈ¿˙ÂÈ Ù˘È΋ ·Ó¿Ù˘ÍË ÁÈ· ÙËÓ ËÏÈΛ· ÙÔ˘˜ (58,6%) Î·È 9,6% ÙˆÓ ·È‰ÈÒÓ ·ÚÔ˘ÛÈ¿˙Ô˘Ó Î¿ÔÈ· ‰˘ÛÎÔÏ›· ÛÙËÓ ·Ó¿Ù˘ÍË. ∂ȉÈÎfiÙÂÚ·, 3,5% ·ÚÔ˘ÛÈ¿˙Ô˘Ó Èı·Ófi Úfi‚ÏËÌ·, 5,5% ‹Ș ‰˘ÛÎÔϛ˜ Î·È ÈÔ ·ÚÁ‹ ·Ó¿Ù˘ÍË Î·È 0,6% ÛÔ‚·Úfi

Úfi‚ÏËÌ· Î·È ·Ó·Ù˘Íȷ΋ ηı˘ÛÙ¤ÚËÛË. ∆¤ÏÔ˜, ·Í›˙ÂÈ Ó· ÛËÌÂȈı› fiÙÈ ÛÙÔÓ ÙÔ̤· ·˘Ùfi ¤Ó· Û˘ÁÎÚÈÙÈο ÌÂÁ¿ÏÔ ÔÛÔÛÙfi ·È‰ÈÒÓ (31,9%) ·ÚÔ˘ÛÈ¿˙ÂÈ ÚÔ¯ˆÚË̤ÓË ·Ó¿Ù˘ÍË ÁÈ· ÙËÓ ËÏÈΛ· ÙÔ˘˜.

™ÙÔÓ ÙÔ̤· Ù˘ ∞Ê·ÈÚÂÙÈ΋˜ ™Î¤„˘, ·Ú·ÙËÚԇ̠fiÙÈ 71,7% ÙˆÓ ·È‰ÈÒÓ ·ÚÔ˘ÛÈ¿˙Ô˘Ó ÈηÓfiÙËÙ˜ Ù˘ÈΤ˜ ÁÈ· ÙËÓ ËÏÈΛ· ÙÔ˘˜, 15,5% ÈηÓfiÙËÙ˜ ÚÔ¯ˆÚË̤Ó˜ ÁÈ· ÙËÓ ËÏÈΛ· ÙÔ˘˜ Î·È 12,9% ÈηÓfiÙËÙ˜ ¯·ÌËÏfiÙÂÚ˜ ÁÈ· ÙËÓ ËÏÈΛ· ÙÔ˘˜. ∂ȉÈÎfiÙÂÚ·, 6,5% ·ÚÔ˘ÛÈ¿˙Ô˘Ó Èı·Ófi Úfi‚ÏËÌ· ÛÙÔÓ

ÙÔ̤· ·˘Ùfi Ù˘ ·Ó¿Ù˘Í˘, 3% ‹Ș ‰˘ÛÎÔϛ˜ Î·È 3,4% ÛÔ‚·Úfi Úfi‚ÏËÌ·.

™ÙÔÓ ÙÔ̤· ÙˆÓ °ÏˆÛÛÈÎÒÓ ∞Ó·ÏÔÁÈÒÓ, ·Ú·ÙËÚԇ̠fiÙÈ ÌÂÁ¿ÏÔ ÔÛÔÛÙfi ÙˆÓ ·È‰ÈÒÓ, Û ۇÁÎÚÈÛË Ì ÙÔ˘˜ ÚÔËÁÔ‡ÌÂÓÔ˘˜ ÙÔÌ›˜ Ù˘ ·Ó¿Ù˘Í˘,

¶›Ó·Î·˜ 2. µ·ıÌÔÏfiÁËÛË (%) ÛÙÔ˘˜ ‰È¿ÊÔÚÔ˘˜ ÙÔÌ›˜ Ù˘ ·Ó¿Ù˘Í˘ (¡=2002)

∂›‰ÔÛË ∫ÚÈÙÈ΋ °ÏˆÛÛÈΤ˜ ∞Ê·ÈÚÂÙÈ΋ OÙÈÎÔÎÈÓËÙÈÎfi˜ √ÙÈ΋ ∞ÎÔÏÔ˘ı›Â˜ ÈηÓfiÙËÙ· ·Ó·ÏÔÁ›Â˜ ÛΤ„Ë Û˘ÓÙÔÓÈÛÌfi˜ ·ÓÙ›ÏË„Ë

1. ÷ÌËÏ‹1,91,53,40,61,9

2. ◊È· ‰˘ÛÎÔÏ›·5,06,03,05,56,5

3. ¶Èı·Ófi Úfi‚ÏËÌ·2,72,46,53,58,38,2

4. º˘ÛÈÔÏÔÁÈ΋78,279,571,758,675,273,8

5. ∂Í·ÈÚÂÙÈ΋12,110,815,531,98,217,9

∆ÔÌ›˜

∞ÎÔÏÔ˘ı›Â˜

√ÙÈ΋ ∞ÓÙ›ÏË„Ë

√ÙÈÎÔÎÈÓËÙÈÎfi˜ Û˘ÓÙÔÓÈÛÌfi˜

∞Ê·ÈÚÂÙÈ΋ ÛΤ„Ë

°ÏˆÛÛÈΤ˜ ·Ó·ÏÔÁ›Â˜

∫ÚÈÙÈ΋ ÈηÓfiÙËÙ·

∂ÈÎfiÓ· 1. ∞ÓȯÓ¢ÙÈ΋ ‰ÔÎÈÌ·Û›· Û¯ÔÏÈ΋˜ ÂÙÔÈÌfiÙËÙ·˜ (∞ã

1. ™Ô‚·Úfi Úfi‚ÏËÌ·

2. ◊È· ‰˘ÛÎÔÏ›·

3. ¶Èı·Ófi Úfi‚ÏËÌ·

4. ∆˘ÈÎfi

5. ¶ÚÔ¯ˆÚË̤ÓÔ

µ·ıÌÔÏfiÁËÛË ÛÙÔ˘˜ ÙÔÌ›˜ ·Ó¿Ù˘Í˘. µ¿ÛË: Û‡ÓÔÏÔ Ì·ıËÙÒÓ (¡=2000).

· ÚÔ˘ÛÈ¿˙ÂÈ Ù˘È΋ ·Ó¿Ù˘ÍË ÁÈ· ÙËÓ ËÏÈΛ· ÙÔ˘˜

(79,5%), ÂÓÒ 10,8% ÙˆÓ ·È‰ÈÒÓ ·ÚÔ˘ÛÈ¿˙Ô˘Ó ÚÔ-

¯ˆÚË̤Ó˜ ÈηÓfiÙËÙ˜ Î·È 9,9% ·ÚÔ˘ÛÈ¿˙Ô˘Ó ¯·ÌË-

ÏfiÙÂÚ˜ ÈηÓfiÙËÙ˜ ·fi ÙȘ ·Ó·ÌÂÓfiÌÂÓ˜ ÁÈ· ÙËÓ

ËÏÈΛ· ÙÔ˘˜. ∂ȉÈÎfiÙÂÚ·, 2,4% ÙˆÓ ·È‰ÈÒÓ ·ÚÔ˘ÛÈ¿-

˙Ô˘Ó Èı·Ófi Úfi‚ÏËÌ·, 6% ¤¯Ô˘Ó ‹Ș ‰˘ÛÎÔϛ˜

Î·È ÈÔ ·ÚÁfi Ú˘ıÌfi ·Ó¿Ù˘Í˘ Î·È 1,5% ¤¯Ô˘Ó ÛÔ‚·-

Ú‹ ·Ó·Ù˘Íȷ΋ ηı˘ÛÙ¤ÚËÛË.

∆¤ÏÔ˜, ÛÙÔÓ ÙÔ̤· Ù˘ ∫ÚÈÙÈ΋˜ πηÓfiÙËÙ·˜, 78,2% ÙˆÓ ·È‰ÈÒÓ ·ÚÔ˘ÛÈ¿˙Ô˘Ó ÈηÓfiÙËÙ˜ Ù˘È-

Τ˜ ÁÈ· ÙËÓ ËÏÈΛ· ÙÔ˘˜, 12,1% ÈηÓfiÙËÙ˜ ÚÔ¯ˆÚË̤Ó˜ ÁÈ· ÙËÓ ËÏÈΛ· ÙÔ˘˜ Î·È 9,6% ÈηÓfiÙËÙ˜

¯·ÌËÏfiÙÂÚ˜ ·fi ÙȘ ·Ó·ÌÂÓfiÌÂÓ˜ ÁÈ· ÙËÓ ËÏÈΛ·

ÙÔ˘˜. ∞Ó·Ï˘ÙÈÎfiÙÂÚ·, 2,7% ·ÚÔ˘ÛÈ¿˙Ô˘Ó Èı·Ófi

Úfi‚ÏËÌ· ÛÙÔÓ ÙÔ̤· ·˘Ùfi Ù˘ ·Ó¿Ù˘Í˘, 5%

‹Ș ‰˘ÛÎÔϛ˜ Î·È 1,9% ÛÔ‚·Úfi Úfi‚ÏËÌ·.

¶›Ó·Î·˜ 3. ™˘ÁÎÚÈÙÈο ∞ÔÙÂϤÛÌ·Ù· ÌÂٷ͇

ÛÙ· ·È‰È¿ Î·È ‰‡Ô ÂÈÚfiÛıÂÙ˜ Îϛ̷Θ, Ë ∫ϛ̷η TVPS Ô˘ ÌÂÙÚ¿ ·ÔÎÏÂÈÛÙÈο √ÙÈ΋ ∞ÓÙ›ÏË„Ë

Î·È Ë ∫ϛ̷η TVMS Ô˘ ÌÂÙÚ¿ ·ÔÎÏÂÈÛÙÈο ÙÔÓ √ÙÈÎÔÎÈÓËÙÈÎfi ™˘ÓÙÔÓÈÛÌfi (13,14).

√È ÙÈ̤˜ Ù˘ Îϛ̷η˜ TVPS Î˘Ì·›ÓÔÓÙ·È ·fi 010 (1: ÛÔ‚·Ú‹ ‰˘ÛÎÔÏ›·, ¯ÚÔÓÔÏÔÁÈ΋ ËÏÈΛ· 4 ÂÙÒÓ, 2: ÛÔ‚·Ú‹ ‰˘ÛÎÔÏ›·, ¯ÚÔÓÔÏÔÁÈ΋ ËÏÈΛ· 4 ÂÙÒÓ Î·È 3 ÌËÓÒÓ, 3: ‹È· ‰˘ÛÎÔÏ›·, ¯ÚÔÓÔÏÔÁÈ΋ ËÏÈΛ· 4

Ù· ·Ú·¿Óˆ ÚÔ·ÙÂÈ fiÙÈ ÔÈ ÙÔÌ›˜ ÙˆÓ ∞ÎÔÏÔ˘ıÈÒÓ, ÙÔ˘ √ÙÈÎÔÎÈÓËÙÈÎÔ‡ ™˘ÓÙÔÓÈÛÌÔ‡, ÙˆÓ °ÏˆÛÛÈÎÒÓ ∞Ó·ÏÔÁÈÒÓ Î·È Ù˘ ∫ÚÈÙÈ΋˜ πηÓfiÙËÙ·˜ Â›Ó·È ÔÈ ÙÔÌ›˜ Ô˘ ÂÌÊ·Ó›˙Ô˘Ó ÌÈÎÚfiÙÂÚÔ ÔÛÔÛÙfi ·È‰ÈÒÓ Ì ¯·ÌËÏfiÙÂÚ˜ ÂȉfiÛÂȘ ·fi ÙȘ ·Ó·ÌÂÓfiÌÂÓ˜ ÁÈ· ÙËÓ ËÏÈΛ· ÙÔ˘˜. ∞ÓÙ›ıÂÙ·, ÔÈ ÙÔÌ›˜ √ÙÈ΋ ∞ÓÙ›ÏË„Ë Î·È ∞Ê·ÈÚÂÙÈ΋ ™Î¤„Ë Ê·›ÓÂÙ·È ˆ˜ Â›Ó·È ÔÈ ÙÔÌ›˜ Ô˘ ÂÌÊ·Ó›˙Ô˘Ó ÌÂÁ·Ï‡ÙÂÚÔ ÔÛÔÛÙfi ·È‰ÈÒÓ Ì ¯·ÌËÏfiÙÂÚ˜ ÂȉfiÛÂȘ ·fi ÙȘ ·Ó·ÌÂÓfiÌÂÓ˜ ÁÈ· ÙËÓ ËÏÈΛ· ÙÔ˘˜. ªÂ ÛÎÔfi ÙË Û‡ÁÎÚÈÛË ÙˆÓ ·ÔÙÂÏÂÛ̿وÓ, ·Ú¿ÏÏËÏ· Ì ÙË ¯ÔÚ‹ÁËÛË ÙÔ˘ ∞ã ∆∂™∆ ¯ÔÚËÁ‹ıËηÓ

∆·ÍÈÓfiÌËÛË TVPS Aã TEST Frequency Valid percent Frequency Valid percent

™Ô‚·Ú‹ ‰˘ÛÎÔÏ›·854,31004,9 ◊È· ‰˘ÛÎÔÏ›·984,9824,2

¶Èı·Ó‹ ‰˘ÛÎÔÏ›·48524,374737,2 ª¤ÛË Â›‰ÔÛË110255,281240,7

¶ÚÔ¯ˆÚË̤ÓË Â›‰ÔÛË22811,526113,0 ™‡ÓÔÏÔ19981002002100 1,95,02,778,212,1 1,5 6,0

T-test

TVPS6,646,85t(1996) = -2,576, p=0,010

Aã TEST12,6513,09t(2000) = -2,909, p=0,004

ÂÙÒÓ Î·È 6 ÌËÓÒÓ, 4: ‹È· ‰˘ÛÎÔÏ›·, ¯ÚÔÓÔÏÔÁÈ΋

ËÏÈΛ· 4 ÂÙÒÓ Î·È 9 ÌËÓÒÓ, 5: Èı·Ó‹ ‰˘ÛÎÔÏ›·, ¯ÚÔÓÔÏÔÁÈ΋ ËÏÈΛ· 5 ÂÙÒÓ, 6: Èı·Ó‹ ‰˘ÛÎÔÏ›·, ¯ÚÔÓÔÏÔÁÈ΋ ËÏÈΛ· 5 ÂÙÒÓ Î·È 3 ÌËÓÒÓ, 7: Ù˘ÈÎfi, ¯ÚÔÓÔÏÔÁÈ΋ ËÏÈΛ· 5 ÂÙÒÓ Î·È 6 ÌËÓÒÓ, 8: Ù˘ÈÎfi, ¯ÚÔÓÔÏÔÁÈ΋ ËÏÈΛ· 5 ÂÙÒÓ Î·È 9 ÌËÓÒÓ, 9: ÚÔ¯ˆÚË̤ÓÔ, ¯ÚÔÓÔÏÔÁÈ΋ ËÏÈΛ· 6 ÂÙÒÓ, 10: ÚÔ¯ˆÚË̤ÓÔ, ¯ÚÔÓÔÏÔÁÈ΋ ËÏÈΛ· 6 ÂÙÒÓ Î·È 3 ÌËÓÒÓ). ¶ÚÔÎÂÈ̤ÓÔ˘

Ó· Û˘ÁÎÚ›ÓÔ˘Ì ٷ ·ÔÙÂϤÛÌ·Ù· Ù˘ Îϛ̷η˜

∆VPS Ì ÙËÓ ˘ÔÎϛ̷η Ù˘ √ÙÈ΋˜ ∞ÓÙ›Ï˄˘

ÙÔ˘ ∞ã ∆∂™∆, ηÙËÁÔÚÈÔÔȋ۷Ì ÙȘ ÙÈ̤˜ ˆ˜ ÂÍ‹˜:

0-2: ÛÔ‚·Ú‹ ‰˘ÛÎÔÏ›·, 3-4: ‹È· ‰˘ÛÎÔÏ›·, 5-6 Èı·Ó‹ ‰˘ÛÎÔÏ›·, 7-8: Ù˘ÈÎfi, 9-10: ÚÔ¯ˆÚË̤ÓÔ. ™Â

Ï‹ÚË ·ÓÙÈÛÙÔȯ›·, ÔÈ ÙÈ̤˜ Ù˘ ˘ÔÎϛ̷η˜ √ÙÈ΋ ∞ÓÙ›ÏË„Ë ÙÔ˘ ∞ã ∆∂™∆, Ô˘ Â›Ó·È 0-20 ηÙËÁÔÚÈÔÔÈ‹ıËÎ·Ó Û ¤ÓÙ ηÙËÁÔڛ˜ ˆ˜ ÂÍ‹˜ 0-4: ÛÔ‚·Ú‹ ‰˘ÛÎÔÏ›·, 5-8: ‹È· ‰˘ÛÎÔÏ›·, 9-12: Èı·Ó‹

‰˘ÛÎÔÏ›·, 13-16: Ù˘ÈÎfi, 17-20: ÚÔ¯ˆÚË̤ÓÔ. ªÂ

‚¿ÛË ÙËÓ ·Ú·¿Óˆ ηÙËÁÔÚÈÔÔ›ËÛË ÙˆÓ ÙÈÌÒÓ

ÚԤ΢„·Ó Ù· ·ÔÙÂϤÛÌ·Ù· Ô˘ ·ÂÈÎÔÓ›˙ÔÓÙ·È

ÛÙÔÓ ¶›Ó·Î· 3.

£¤ÏÔÓÙ·˜ Ó· ‰ÈÂÚ¢ӋÛÔ˘Ì Èı·Ó¤˜ ‰È·ÊÔÚ¤˜

ÛÙȘ ÂȉfiÛÂȘ ÌÂٷ͇ ·ÁÔÚÈÒÓ/ÎÔÚÈÙÛÈÒÓ ÛÙËÓ

√ÙÈ΋ ∞ÓÙ›ÏË„Ë, ¯ÚËÛÈÌÔÔȋ۷Ì ÙË ÛÙ·ÙÈÛÙÈ΋

̤ıÔ‰Ô ÙÔ˘ t-test. ™ÙÔÓ ¶›Ó·Î· 4 ·Ó·Ê¤ÚÔÓÙ·È ÔÈ Ì¤-

Û˜ ÙÈ̤˜ Ô˘ ÛËÌ›ˆÛ·Ó Ù· ·ÁfiÚÈ· Î·È Ù· ÎÔÚ›ÙÛÈ·

ÛÙÔ TVPS Î·È ÛÙËÓ √ÙÈ΋ ∞ÓÙ›ÏË„Ë ÙÔ˘ ∞ã ∆∂™∆.

Ÿˆ˜ Ê·›ÓÂÙ·È ·fi ÙÔÓ ¶›Ó·Î· 4, Ù· ÎÔÚ›ÙÛÈ·

ÂÌÊ·Ó›˙Ô˘Ó ÛÙ·ÙÈÛÙÈο ÛËÌ·ÓÙÈ΋ ‰È·ÊÔÚ¿ ¤Ó·ÓÙÈ

ÙˆÓ ·ÁÔÚÈÒÓ ÛÙË ‚·ıÌÔÏÔÁ›· Ô˘ ÛËÌÂÈÒÓÔ˘Ó ÙfiÛÔ

ÛÙÔ TVPS fiÛÔ Î·È ÛÙËÓ ˘ÔÎϛ̷η ÙÔ˘ ∞ã ∆∂™∆.

™˘ÁÎÂÎÚÈ̤ӷ, Ù· ÎÔÚ›ÙÛÈ· ÛËÌÂÈÒÓÔ˘Ó Î·Ï‡ÙÂÚË

Â›‰ÔÛË Î·È ˘„ËÏfiÙÂÚË Ì¤ÛË ‚·ıÌÔÏÔÁ›· ·fi Ù· ·ÁfiÚÈ·.

∂›Û˘, Ë Îϛ̷η ∆VPS Î·È Ë ˘ÔÎϛ̷η √ÙÈ΋ ∞ÓÙ›ÏË„Ë ÙÔ˘ ∞ã ∆∂™∆ ÂÌÊ·Ó›˙Ô˘Ó ÛÙ·ÙÈÛÙÈο

¶›Ó·Î·˜ 5. ™˘ÁÎÚÈÙÈο ∞ÔÙÂϤÛÌ·Ù·

ÛËÌ·ÓÙÈ΋ ıÂÙÈ΋ Û˘Û¯¤ÙÈÛË (r=0,895, p=0,000).

ŸÛÔÓ ·ÊÔÚ¿ ÙËÓ Îϛ̷η TVªS, ηÙËÁÔÚÈÔÔȋ۷Ì ÙȘ ÙÈ̤˜ Ù˘, fiˆ˜ Î·È ÚÈÓ, ÒÛÙ ӷ ÌÔÚ¤ÛÔ˘Ì ӷ Û˘ÁÎÚ›ÓÔ˘Ì ٷ ·ÔÙÂϤÛÌ·Ù· Ì ·˘Ù¿

Ù˘ ˘ÔÎϛ̷η˜ √ÙÈÎÔÎÈÓËÙÈÎfi˜ ™˘ÓÙÔÓÈÛÌfi˜

ÙÔ˘ ∞ã ∆∂™∆. √È ÙÈ̤˜ Ù˘ Îϛ̷η˜ TVªS Â›Ó·È 022, (0-7: ÛÔ‚·Ú‹ ‰˘ÛÎÔÏ›·, ¯ÚÔÓÔÏÔÁÈ΋ ËÏÈΛ· 4 ÂÙÒÓ Î·È 3 ÌËÓÒÓ, 8-13: ‹È· ‰˘ÛÎÔÏ›·, ¯ÚÔÓÔÏÔÁÈ΋

ËÏÈΛ· 4 ÂÙÒÓ Î·È 9 ÌËÓÒÓ, 14-16: Èı·Ó‹ ‰˘ÛÎÔÏ›·, ¯ÚÔÓÔÏÔÁÈ΋ ËÏÈΛ· 5 ÂÙÒÓ Î·È 3 ÌËÓÒÓ, 17-19: Ù˘ÈÎfi, ¯ÚÔÓÔÏÔÁÈ΋ ËÏÈΛ· 5 ÂÙÒÓ Î·È 9 ÌËÓÒÓ, 20-22:

ÚÔ¯ˆÚË̤ÓÔ, ¯ÚÔÓÔÏÔÁÈ΋ ËÏÈΛ· 6 ÂÙÒÓ Î·È 3 ÌËÓÒÓ). ™Â ·ÓÙÈÛÙÔȯ›·, ÔÈ ÙÈ̤˜ Ù˘ ˘ÔÎϛ̷η˜ √ÙÈÎÔÎÈÓËÙÈÎfi˜ ™˘ÓÙÔÓÈÛÌfi˜ ÙÔ˘ ∞ã ∆∂™∆ Â›Ó·È 012 (0-2: ÛÔ‚·Ú‹ ‰˘ÛÎÔÏ›·, 3-4: ‹È· ‰˘ÛÎÔÏ›·, 5-6: Èı·Ó‹ ‰˘ÛÎÔÏ›·, 7-9: Ù˘ÈÎfi, 10-12: ÚÔ¯ˆÚË̤ÓÔ). ªÂ ‚¿ÛË ÙËÓ ·Ú·¿Óˆ Ù·ÍÈÓfiÌËÛË, ÚԤ΢„·Ó Ù· ·ÔÙÂϤÛÌ·Ù· Ô˘ ·ÂÈÎÔÓ›˙ÔÓÙ·È ÛÙÔÓ ¶›Ó·Î· 5.

£¤ÏÔÓÙ·˜ Ó· ‰ÈÂÚ¢ӋÛÔ˘Ì ÙȘ ‰È·ÊÔÚ¤˜ ÙÔ˘ ʇÏÔ˘ ÛÙËÓ ÔÙÈ΋ ·ÓÙ›ÏË„Ë, ¯ÚËÛÈÌÔÔȋ۷Ì ÙË

ÛÙ·ÙÈÛÙÈ΋ ̤ıÔ‰Ô ÙÔ˘ t-test. ™ÙÔÓ ¶›Ó·Î· 6 ·Ó·Ê¤ÚÔÓÙ·È ÔÈ Ì¤Û˜ ÙÈ̤˜ Ô˘ ÛËÌ›ˆÛ·Ó Ù· ·ÁfiÚÈ· ηÈ

Ù· ÎÔÚ›ÙÛÈ· ÛÙÔ TVªS Î·È ÛÙËÓ ˘ÔÎϛ̷η √ÙÈÎÔÎÈÓËÙÈÎfi˜ ™˘ÓÙÔÓÈÛÌfi˜ ÙÔ˘ ∞ã ∆∂™∆.

Ÿˆ˜ ·Ú·ÙËÚԇ̠ÛÙÔÓ ·Ú·¿Óˆ ›Ó·Î·, Ù·

ÎÔÚ›ÙÛÈ· ÂÌÊ·Ó›˙Ô˘Ó ÛÙ·ÙÈÛÙÈο ÛËÌ·ÓÙÈ΋ ‰È·ÊÔÚ¿ ¤Ó·ÓÙÈ ÙˆÓ ·ÁÔÚÈÒÓ ÛÙË ‚·ıÌÔÏÔÁ›· Ô˘ ÛËÌÂÈÒ-

ÓÔ˘Ó ÙfiÛÔ ÛÙÔ TVªS fiÛÔ Î·È ÛÙËÓ ˘ÔÎϛ̷η ÙÔ˘

∞ã ∆∂™∆. ™˘ÌÂÚ·ÛÌ·ÙÈο, Ù· ÎÔÚ›ÙÛÈ· ÛËÌÂÈÒÓÔ˘Ó

ηχÙÂÚË Â›‰ÔÛË Î·È ˘„ËÏfiÙÂÚË Ì¤ÛË ‚·ıÌÔÏÔÁ›·

·fi Ù· ·ÁfiÚÈ·.

∂›Û˘, Ë Îϛ̷η ∆VªS Î·È Ë ˘ÔÎϛ̷η

√ÙÈÎÔÎÈÓËÙÈÎfi˜ ™˘ÓÙÔÓÈÛÌfi˜ ÙÔ˘ ∞ã ∆∂™∆ ÂÌÊ·Ó›-

ÛÙ·ÙÈÛÙÈο ÛËÌ·ÓÙÈ΋ ıÂÙÈ΋ Û˘Û¯¤ÙÈÛË (r=0,599, p=0,000).

∆·ÍÈÓfiÌËÛË TVMS A TEST Frequency Valid percent Frequency Valid percent

™Ô‚·Ú‹ ‰˘ÛÎÔÏ›·371,9130,6

◊È· ‰˘ÛÎÔÏ›·954,81105,5

¶Èı·Ó‹ ‰˘ÛÎÔÏ›·472,3482,4

ª¤ÛË Â›‰ÔÛË52626,344022,0

¶ÚÔ¯ˆÚË̤ÓË Â›‰ÔÛË129564,7139169,5

™‡ÓÔÏÔ 20001002002100

¶›Ó·Î·˜ 6. √È ‰È·ÊÔÚ¤˜ ÙÔ˘ ʇÏÔ˘ ÛÙȘ

T-test

TVªS19,0519,52t(1998) = -3,210, p=0,001

Aã TEST9,5510,03t(2000) = -3,545, p=0,000

∏ Û‡ÁÎÚÈÛË ÙˆÓ ·ÔÙÂÏÂÛÌ¿ÙˆÓ ÙˆÓ ÎÏÈ̿ΈÓ

∆VPS Î·È TVMS Ì ٷ ·ÔÙÂϤÛÌ·Ù· ÙˆÓ ·ÓÙ›ÛÙÔÈ-

¯ˆÓ ˘ÔÎÏÈÌ¿ÎˆÓ ÙÔ˘ ∞ã ∆∂™∆ ¤‰ÂÈÍ fiÙÈ ÙÔ ∞ã

∆∂™∆ ‚Ú›ÛÎÂÙ·È ÛÂ Û˘Ìʈӛ· Ì ÙȘ ÁÓˆÛÙ¤˜ Îϛ̷-

Θ, ·ÊÔ‡ ÔÈ ‰È·ÊÔÚ¤˜ Ô˘ ·ÚÔ˘ÛÈ¿ÛÙËÎ·Ó ‰ÂÓ Â›-

Ó·È ÛËÌ·ÓÙÈΤ˜.

™ÙÔÓ ¶›Ó·Î· 7, ·Ó·Ê¤ÚÂÙ·È Ô ·ÚÈıÌfi˜ ÙˆÓ ·È-

‰ÈÒÓ Ô˘, Ì ‚¿ÛË ÙËÓ ÎÏÈÓÈ΋ ÂÎÙ›ÌËÛË ·ÏÏ¿ Î·È ÙË

‚·ıÌÔÏÔÁ›· ÛÙÔ ∞ã ∆∂™∆, ›¯·Ó Ê˘ÛÈÔÏÔÁÈΤ˜ ÈηÓfi-

ÙËÙ˜, ÔÚȷΤ˜ ÈηÓfiÙËÙ˜ Î·È ÛÔ‚·Ú‹ ·Ó·Ù˘Íȷ΋

ηı˘ÛÙ¤ÚËÛË. ∆· ·È‰È¿ ηÙËÁÔÚÈÔÔÈ‹ıËÎ·Ó ÛÙȘ

ÙÚÂȘ ηÙËÁÔڛ˜ Ì ÎÚÈÙ‹ÚÈÔ ÙË Û˘ÓÔÏÈ΋ ÙÔ˘˜ ‚·ı-

ÌÔÏÔÁ›· ÛÙÔ ∞ã ∆∂™∆. ™˘ÁÎÂÎÚÈ̤ӷ, ÛÙËÓ Î·ÙËÁÔÚ›· ÙˆÓ Ê˘ÛÈÔÏÔÁÈÎÒÓ ˘¿ÁÔÓÙ·Ó fiÏ· Ù· ·È‰È¿ ÌÂ

Û˘ÓÔÏÈ΋ ‚·ıÌÔÏÔÁ›· ÌÂÁ·Ï‡ÙÂÚË ‹ ›ÛË ÙÔ˘ 33, ÛÙËÓ Î·ÙËÁÔÚ›· ÙˆÓ ÔÚÈ·ÎÒÓ ÈηÓÔÙ‹ÙˆÓ ˘¿ÁÔ-

ÓÙ·Ó Ù· ·È‰È¿ ÌÂ Û˘ÓÔÏÈ΋ ‚·ıÌÔÏÔÁ›· ÌÂÁ·Ï‡ÙÂÚË

‹ ›ÛË ÙÔ˘ 26 Î·È ÌÈÎÚfiÙÂÚË ‹ ›ÛË ÙÔ˘ 32, ÂÓÒ ÛÙËÓ

ηÙËÁÔÚ›· Ù˘ ÛÔ‚·Ú‹˜ ·Ó·Ù˘Íȷ΋˜ ηı˘ÛÙ¤ÚË-

Û˘ ˘¿ÁÔÓÙ·Ó fiÏ· Ù· ·È‰È¿ ÌÂ Û˘ÓÔÏÈ΋ ‚·ıÌÔÏÔ-

Á›· ÌÈÎÚfiÙÂÚË ‹ ›ÛË ÙÔ˘ 25. ∂ÈϤÔÓ, ·fi ÙË Û˘ÓÔÏÈ΋ ‚·ıÌÔÏÔÁ›· Ô˘ ÛË-

Ì›ˆÛ·Ó Ù· ·È‰È¿ ÛÙÔ ∞ã ∆∂™∆ Î·È ·fi ÙËÓ ·Ú¯È΋

ÎÏÈÓÈ΋ ÂÎÙ›ÌËÛË Ô˘ ¤ÁÈÓ ÛÙÔ Û‡ÓÔÏÔ ÙˆÓ ·È‰ÈÒÓ

ÚԤ΢„·Ó Ù· ÔÛÔÛÙ¿ Ô˘ ·Ó·Ê¤ÚÔÓÙ·È ÛÙÔÓ ¶›Ó·Î· 8.

∞fi ÙÔ˘˜ ¶›Ó·Î˜ 7 Î·È 8 ÌÔÚԇ̠ӷ ·Ú·ÙËÚ‹ÛÔ˘Ì fiÙÈ ˘¿Ú¯ÂÈ Ù·‡ÙÈÛË ·Ó¿ÌÂÛ· ÛÙËÓ ÎÏÈÓÈ΋

ÂÎÙ›ÌËÛË Î·È ÛÙË Û˘ÓÔÏÈ΋ ‚·ıÌÔÏÔÁ›· Ô˘ ÛËÌ›ˆÛ·Ó Ù· ·È‰È¿ ÛÙÔ ∞ã ∆∂™∆.

∞ÍÈÔÈÛÙ›· Î·È ÂÁ΢ÚfiÙËÙ· Ù˘ ‰ÔÎÈÌ·Û›·˜

∞’ ∆∂™∆

¢‡Ô ¯ÚfiÓÈ· ÌÂÙ¿ ÙËÓ ·Ú¯È΋ ÛÙ¿ıÌÈÛË Ù˘ ‰ÔÎÈÌ·Û›·˜ ∞ã ∆∂™∆, ·fi ÙÔ ·Ú·¿Óˆ ‰Â›ÁÌ· ÙˆÓ 2002

·È‰ÈÒÓ Â·ÓÂÍÂÙ¿Û·Ì 240 ·È‰È¿ (120 ·È‰È¿ Ù˘

ηÙËÁÔÚ›·˜ Ê˘ÛÈÔÏÔÁÈο, 30 ·È‰È¿ Ù˘ ηÙËÁÔÚ›·˜

ÔÚȷΤ˜ ÈηÓfiÙËÙ˜ Î·È 90 ·È‰È¿ Ù˘ ηÙËÁÔÚ›·˜ ÛÔ‚·Ú‹ ·Ó·Ù˘Íȷ΋ ηı˘ÛÙ¤ÚËÛË). ∆· ·È‰È¿ Ô˘ ›¯·Ó ÂÏÂÁ¯ı› Ì ÙË ‰ÔÎÈÌ·Û›· ∞ã ∆∂™∆ ÛÙËÓ ËÏÈΛ· 5-6 ¯ÚfiÓˆÓ ÊÔÈÙÔ‡Û·Ó ϤÔÓ ÛÙË µã ‰ËÌÔÙÈÎÔ‡. ∞fi ·˘Ù¿ ÌÔÚ¤Û·Ì ӷ ¤ÚıÔ˘Ì ÙÂÏÈο Û Â·Ê‹ Ì 201 ·È‰È¿ (100 ·È‰È¿ ÌÂ Ê˘ÛÈÔÏÔÁÈΤ˜ ÈηÓfiÙËÙ˜, 20 ·È‰È¿ Ì ÔÚȷΤ˜ ÈηÓfiÙËÙ˜ Î·È 81 ·È‰È¿ Ì ÛÔ‚·Ú‹ ·Ó·Ù˘Íȷ΋ ηı˘ÛÙ¤ÚËÛË). ∞fi Ù· 201 ·È‰È¿, Ù· 123 Â›Ó·È ·ÁfiÚÈ· (61,2%) Î·È Ù· 78 ÎÔÚ›ÙÛÈ· (38,8%). ∆· ·ÔÙÂϤÛÌ·Ù· ÙÔ˘ ∞ã ∆∂™∆ ÙˆÓ 201 ·È‰ÈÒÓ ·ÚÔ˘ÛÈ¿˙ÔÓÙ·È ·Ó·Ï˘ÙÈο ÛÙËÓ ∂ÈÎfiÓ· 2 Î·È ÛÙÔÓ ¶›Ó·Î· 9. Ÿˆ˜ ·Ú·ÙËÚԇ̠ÛÙËÓ ∂ÈÎfiÓ· 2 Î·È ÛÙÔÓ

ÛÙÔ˘˜ ÂÈ̤ÚÔ˘˜ ÙÔÌ›˜

·Ó¿Ù˘Í˘ Â›Ó·È ÌÂÁ·Ï‡ÙÂÚÔ ·fi fi,ÙÈ ÛÙÔ Û˘ÓÔÏÈÎfi ‰Â›ÁÌ·, ÏfiÁˆ ÙÔ˘ fiÙÈ ÙÔ ÌÈÛfi ‰Â›ÁÌ· ·ÔÙÂÏÂ›Ù·È ·fi ¿ÙÔÌ· Ì ¯·ÌËÏfiÙÂÚ˜ ÈηÓfiÙËÙ˜ ·fi ÙȘ ·Ó·ÌÂÓfiÌÂÓ˜ ÁÈ· ÙËÓ ËÏÈΛ· ÙÔ˘˜. ∂›Û˘, ·Ó Û˘ÁÎÚ›ÓÔ˘Ì ÙÔÓ ¶›Ó·Î· 8 Ì ÙÔÓ ¶›Ó·Î· 1 Î·È ÙËÓ ∂ÈÎfiÓ· 2 Ì ÙËÓ ∂ÈÎfiÓ· 1, ηٷϋÁÔ˘Ì ÛÙÔ Û˘Ì¤Ú·ÛÌ· fiÙÈ ÔÈ ÙÔÌ›˜ √ÙÈ΋ ∞ÓÙ›ÏË„Ë Î·È ∞Ê·ÈÚÂÙÈ΋

™Î¤„Ë Ê·›ÓÂÙ·È ˆ˜ ÂÌÊ·Ó›˙Ô˘Ó ÌÂÁ·Ï‡ÙÂÚÔ ÔÛÔÛÙfi ·È‰ÈÒÓ Ì ÈηÓfiÙËÙ˜ ¯·ÌËÏfiÙÂÚ˜ ·fi ÙȘ ·Ó·ÌÂÓfiÌÂÓ˜ ÁÈ· ÙËÓ ËÏÈΛ· ÙÔ˘˜.

◊Úı·Ì Û Â·Ê‹ Ì ÙÔÓ ‰¿ÛηÏÔ ÙˆÓ ·È‰ÈÒÓ ÙÔ˘ ‰Â›ÁÌ·ÙÔ˜ (¡=201) Î·È ÙÔ˘ ˙ËÙ‹Û·Ì ӷ Û˘ÌÏËÚÒÛÂÈ ÂȉÈÎfi ÂÚˆÙËÌ·ÙÔÏfiÁÈÔ ÚÔÎÂÈ̤ÓÔ˘ Ó· ÂϤÁÍÔ˘Ì ηٿ fiÛÔ Ù· ·È‰È¿ Ô˘ ηٿ ÙËÓ ÎÏÈÓÈ΋ ÂÎÙ›ÌËÛË Î·È ÙË ‚·ıÌÔÏÔÁ›· ÛÙÔ ∞ã ∆∂™∆ ›¯·Ó ¯·ÌËÏfiÙÂÚ˜ ÈηÓfiÙËÙ˜ ¯ÚÂÈ¿˙ÔÓÙ·Ó, Û‡Ìʈӷ Ì ÙËÓ ÂÎÙ›ÌËÛË ÙÔ˘ ‰·ÛοÏÔ˘, ÙËÓ ·Ú¤Ì‚·ÛË ÂȉÈÎÔ‡ ‹ ÙËÓ ¤ÓÙ·ÍË Û Ù̷̋ ÂÓÈÛ¯˘ÙÈ΋˜ ‰È‰·Ûηϛ·˜.

πηÓfiÙËÙ˜ º˘ÛÈÔÏÔÁÈÎfi1817--1817 ™Ô‚·Ú‹ ·Ó·Ù˘Íȷ΋ ηı˘ÛÙ¤ÚËÛË312927159

√ÚȷΤ˜ πηÓfiÙËÙ˜5-1924 ™‡ÓÔÏÔ1825129462000

∞ÓȯÓ¢ÙÈ΋ ‰ÔÎÈÌ·Û›· Û¯ÔÏÈ΋˜ ÂÙÔÈÌfiÙËÙ·˜

¶›Ó·Î·˜ 8. ¶ÔÛÔÛÙfi ·È‰ÈÒÓ (%) Ô˘ ˘¿ÁÔÓÙ·Ó ÛÙËÓ Î¿ı ηÙË-

ÁÔÚ›·, Ì ‚¿ÛË ÙËÓ ÎÏÈÓÈ΋ ÂÎÙ›ÌËÛË Î·È ÙË Û˘ÓÔÏÈ΋ ‚·ıÌÔÏÔÁ›·

¢Â›ÎÙ˘ Û¯ÔÏÈ΋˜ ¶ÔÛÔÛÙfi (%) ¶ÔÛÔÛÙfi (%)

ÂÙÔÈÌfiÙËÙ·˜

∫ÏÈÓÈ΋ ™˘ÓÔÏÈ΋

ÂÎÙ›ÌËÛË µ·ıÌÔÏÔÁ›·

º˘ÛÈÔÏÔÁÈÎfi91,390,9 ™Ô‚·Ú‹ ·Ó·Ù˘Íȷ΋

ηı˘ÛÙ¤ÚËÛË6,58,0

√ÚȷΤ˜ ÈηÓfiÙËÙ˜2,31,2

ÚԤ΢„ fiÙÈ: 95 ·È‰È¿ (47,3% ÙÔ˘ ‰Â›ÁÌ·ÙÔ˜)

·ÍÈÔÏÔÁ‹ıËÎ·Ó fiÙÈ ¯ÚÂÈ¿˙ÔÓÙ·È Î·È 106 ·È‰È¿ (52,7% ÙÔ˘ ‰Â›ÁÌ·ÙÔ˜) fiÙÈ ‰ÂÓ ¯ÚÂÈ¿˙ÔÓÙ·È ÙËÓ ·-

ڤ̂·ÛË ÂÓfi˜ ÂȉÈÎÔ‡ ‹ ÙËÓ ¤ÓÙ·ÍË Û Ù̷̋ ÂÓÈÛ¯˘ÙÈ΋˜ ‰È‰·Ûηϛ·˜. ™ÙÔÓ ¶›Ó·Î· 10 ·Ó·Ê¤ÚÂÙ·È

Ë ‰È·ÛÙ·‡ÚˆÛË ÙˆÓ ·ÔÙÂÏÂÛÌ¿ÙˆÓ Ù˘ ·ÍÈÔÏfiÁËÛ˘ ÙˆÓ ‰·ÛÎ¿ÏˆÓ ÁÈ· ÙËÓ ÙˆÚÈÓ‹ Û¯ÔÏÈ΋ Â›‰ÔÛË

·È‰ÈÒÓ Ì ÙËÓ ÎÏÈÓÈ΋ ÂÎÙ›ÌËÛË Ô˘ ‰ÈÂÍ‹¯ıË ÛÙÔ ·ÚÂÏıfiÓ ÛÙ·

ÙÔ˘ ˘fi ÌÂϤÙË ‰Â›ÁÌ·ÙÔ˜ Ì ÙË ‰ÔÎÈÌ·Û›· ∞ã ∆∂™∆, fiÙ·Ó ·˘Ù¿ ›¯·Ó ̤ÛË ËÏÈ-

Λ· 5 ÂÙÒÓ Î·È 8 ÌËÓÒÓ. º˘ÛÈÔÏÔÁÈο Â›Ó·È Ù· ·È‰È¿ Ô˘ Ë ·Ó¿Ù˘ÍË

ÙÔ˘˜ ÛÙÔ˘˜ ‰È¿ÊÔÚÔ˘˜ ÙÔÌ›˜ Ù˘ ·Ó¿Ù˘Í˘ ›ӷÈ

Ê˘ÛÈÔÏÔÁÈ΋ Î·È ÔÈ ÈηÓfiÙËÙ˜ ÙÔ˘˜ Ù˘ÈΤ˜ ÁÈ· ÙËÓ

ËÏÈΛ· ÙÔ˘˜. ¶·ıÔÏÔÁÈο Â›Ó·È Ù· ·È‰È¿ Ô˘ ¤¯Ô˘Ó

ÈÔ ·ÚÁfi Ú˘ıÌfi ·Ó¿Ù˘Í˘ Î·È ÔÚȷΤ˜ ÈηÓfiÙËÙ˜

‹ ÛÔ‚·Ú‹ ηı˘ÛÙ¤ÚËÛË ÛÙËÓ ·Ó¿Ù˘ÍË Î·È ÈηÓfiÙË-

Ù˜ ¯·ÌËÏfiÙÂÚ˜ ·fi ·˘Ù¤˜ Ô˘ ı· ¤ÚÂ ӷ ¤¯Ô˘Ó

·Ó·Ù‡ÍÂÈ Û‡Ìʈӷ Ì ÙËÓ ËÏÈΛ· ÙÔ˘˜.

™ÙÔÓ ›Ó·Î· 10 ·Ú·ÙËÚԇ̠ˆ˜ Ë ÎÏÈÓÈ΋

ÂÎÙ›ÌËÛË Ì ÙÔ ∞ã ∆∂™∆ Ù·˘Ù›˙ÂÙ·È Ì ÙËÓ ÂÎÙ›ÌËÛË

ÙˆÓ ‰·ÛÎ¿ÏˆÓ ÁÈ· ÙË ÌÂÙ¤ÂÈÙ· ÔÚ›· ÙˆÓ ·È‰ÈÒÓ

ÛÙÔ Û¯ÔÏ›Ô.

™˘ÁÎÂÎÚÈ̤ӷ, 98,9% ÙˆÓ ·È‰ÈÒÓ Ô˘ ÂÎÙÈÌ‹ıËΠ·fi ÙÔ˘˜ ‰·ÛοÏÔ˘˜ fiÙÈ ¯ÚÂÈ¿˙ÔÓÙ·È ÙËÓ ·-

ڤ̂·ÛË ÂȉÈÎÔ‡ ıÂÚ·Â˘Ù‹ ‹ ¤ÓÙ·ÍË Û Ù̷̋ ÂÓÈÛ¯˘ÙÈ΋˜ ‰È‰·Ûηϛ·˜ ›¯·Ó ·ÍÈÔÏÔÁËı› ·fi ÙÔ ∞ã

∆∂™∆ ˆ˜ ·ıÔÏÔÁÈο Î·È 93,4% ÙˆÓ ·È‰ÈÒÓ Ô˘

ÂÎÙÈÌ‹ıËΠ·fi ÙÔ˘˜ ‰·ÛοÏÔ˘˜ fiÙÈ ‰ÂÓ ¯Ú‹˙Ô˘Ó Î¿ÔÈ·˜ ÂȉÈ΋˜ ·Ú¤Ì‚·Û˘ ›¯·Ó ·ÍÈÔÏÔÁËı› ·fi ÙÔ

·Ó¿Ù˘ÍË,

‰¿ÛηÏfi ÙÔ˘ fiÙÈ ¯ÚÂÈ¿˙ÂÙ·È Î¿-

ÂȉÈ΋ ·Ú¤Ì‚·ÛË. ∫·È ÌfiÓÔ ÂÊÙ¿ ·È‰È¿ Ô˘ ›¯·Ó οÔȘ ‰˘ÛÎÔϛ˜ ÛÙËÓ ·Ó¿Ù˘Í‹ ÙÔ˘˜, Û‡Ìʈӷ Ì ÙËÓ ÎÏÈÓÈ΋ ÂÎÙ›ÌËÛË, ·ÍÈÔÏÔÁ‹ıËÎ·Ó ·fi

ÙÔ˘˜ ‰·ÛοÏÔ˘˜ fiÙÈ ‰ÂÓ ¯ÚÂÈ¿˙ÔÓÙ·Ó Î¿ÔÈ· ·Ú¤Ì-

‚·ÛË. ™˘ÓÂÒ˜, ÚÔ·ÙÂÈ ÙÔ Û˘Ì¤Ú·ÛÌ· fiÙÈ Ë

ÎÏÈÓÈ΋ ÂÎÙ›ÌËÛË, Ë ÔÔ›·, fiˆ˜ ¤¯Ô˘Ì ‹‰Ë ·Ó·Ê¤-

ÚÂÈ, Ù·˘Ù›˙ÂÙ·È ıÂÙÈο Ì ÙË ‚·ıÌÔÏÔÁ›· ÙˆÓ ·È-

‰ÈÒÓ ÛÙÔ ∞ã ∆∂™∆ (‚Ï. ¶›Ó·Î· 4), ‚Ú›ÛÎÂÙ·È ÛÂ Û˘Ì-

ʈӛ· Î·È Ì ÙËÓ ÂÎÙ›ÌËÛË ÙˆÓ ‰·ÛÎ¿ÏˆÓ ÁÈ· ÙË

Û¯ÔÏÈ΋ Â›‰ÔÛË ÙˆÓ ·È‰ÈÒÓ. ™˘˙‹ÙËÛË

ÙÔ˘

ÛÙÔ Û¯ÔÏÂ›Ô ·ÔÙÂÏ›

Ì›˙ÔÓ· ·ÏÏ·Á‹ ÛÙË ˙ˆ‹ ÙÔ˘. ¶Ú¤ÂÈ ÏÔÈfiÓ Ó· ›-

fï˜ Ï·›ÛÈÔ Î·È Ì ηıÔÚÈṲ̂ÓÔ

∞ÔÙÂÏ› Û‡ÓıÂÙË ÏÂÈÙÔ˘ÚÁ›· Ô˘ ÚÔ¸Ô-

ÂÙÔÈÌfiÙËÙ˜ fiˆ˜: °ÓˆÛÙÈ΋, °ÏˆÛÛÈ΋, ∫ÈÓËÙÈ΋, ™˘Ó·ÈÛıËÌ·ÙÈ΋ Î·È °Ú·ÊÈ΋. ∂ÈϤÔÓ, Ô fiÚÔ˜ ™¯ÔÏÈ΋ ∂ÙÔÈÌfiÙËÙ· ‰ÂÓ ÂÚÈÔÚ›˙ÂÙ·È ÌfiÓÔ ÛÙËÓ ÂÙÔÈÌfiÙËÙ· ÙÔ˘ ·È‰ÈÔ‡. ∂ÂÎÙ›ÓÂÙ·È Î·È ·ÊÔÚ¿ ÂÍ›ÛÔ˘ Î·È ÙÔ Û¯ÔÏÂ›Ô Î·È ÙËÓ ÔÈÎÔ-

Á¤ÓÂÈ· Î·È ÙËÓ ÔÏÈÙ›·. Œ¯ÂÈ ϤÔÓ ·Ô‰Âȯı› fiÙÈ Ë

‰È·‰Èηۛ· ÂÎÌ¿ıËÛ˘ ÙÔ˘ ÁÚ·ÙÔ‡ ÏfiÁÔ˘ Î·È Î·Ù¿

Û˘Ó¤ÂÈ· Ë Û¯ÔÏÈ΋ ÂÙÔÈÌfiÙËÙ· ·Ú¯›˙ÂÈ ·fi Ôχ

ÓˆÚ›˜. ∆· ·È‰È¿ ˙Ô˘Ó Î·È ÌÂÁ·ÏÒÓÔ˘Ó Û ÂÁÁÚ¿ÌÌ·Ù˜ ÎÔÈӈӛ˜, fiÔ˘ ΢Úȷگ› Ô ¤ÓÙ˘Ô˜ ÏfiÁÔ˜, ÌÂ

ÙÔÓ ÔÔ›Ô ÂÍÔÈÎÂÈÒÓÔÓÙ·È ·fi ÌÈÎÚ‹ ËÏÈΛ· Î·È ÙÔÓ

ÔÔ›Ô ÛÙ·‰È·Î¿ ÚÔÛ·ıÔ‡Ó Ó· ·ÔΈ‰ÈÎÔÔÈ‹-

ÛÔ˘Ó. ™¯ÔÏÈ΋ ÂÙÔÈÌfiÙËÙ· ÏÔÈfiÓ ÛËÌ·›ÓÂÈ: ∂›Ó·È ÙÔ

·È‰› ¤ÙÔÈÌÔ Ó· ·Ú¯›ÛÂÈ ÙÔ Û¯ÔÏ›Ô; ∂›Ó·È fï˜ Î·È ÙÔ

Û¯ÔÏÂ›Ô ¤ÙÔÈÌÔ Ó· ‰Â¯ı›, Ó· ÂÎ·È‰Â‡ÛÂÈ Î·È Ó· η-

χ„ÂÈ ÙȘ ·Ó¿ÁΘ ÙÔ˘ ·È‰ÈÔ‡; ∫·È ·ÎfiÌË, Â›Ó·È Ë ÔÈ-

ÎÔÁ¤ÓÂÈ· ¤ÙÔÈÌË Ó· ‰È¢ÎÔχÓÂÈ Î·È Ó· ÛÙËÚ›ÍÂÈ ÙË

ÌÂÙ¿‚·ÛË ÙÔ˘ ·È‰ÈÔ‡ Û ¤Ó· ‰ÔÌË̤ÓÔ ÂÎ·È‰Â˘ÙÈÎfi Ï·›ÛÈÔ; ∫·È Ù¤ÏÔ˜, Â›Ó·È Ë ÔÏÈÙ›· Â·ÚÎÒ˜ ÔÚ-

Á·ÓˆÌ¤ÓË ÒÛÙ ӷ ÛÙËÚ›ÍÂÈ fiÏÔ ·˘Ùfi ÙÔ Û‡ÛÙËÌ·; √È Î·Ï¿ ÔÚÁ·ÓˆÌ¤Ó˜ ÎÔÈӈӛ˜ ÌÂÚÈÌÓÔ‡Ó Î·È

¶›Ó·Î·˜ 9. µ·ıÌÔÏfiÁËÛË (%) ÛÙÔ˘˜ ÂÈ̤ÚÔ˘˜ ÙÔÌ›˜ ·Ó¿Ù˘Í˘ (¡=201)

∫ÏÈÓÈ΋ ∂ÎÙ›ÌËÛË ∫ÚÈÙÈ΋ °ÏˆÛÛÈΤ˜ ∞Ê·ÈÚÂÙÈ΋ OÙÈÎÔÎÈÓËÙÈÎfi˜ √ÙÈ΋ ∞ÎÔÏÔ˘ı›Â˜ ÈηÓfiÙËÙ· ·Ó·ÏÔÁ›Â˜ ÛΤ„Ë Û˘ÓÙÔÓÈÛÌfi˜ ·ÓÙ›ÏË„Ë

1. ™Ô‚·Úfi Úfi‚ÏËÌ·9,010,912,44,59,5

2. ◊È· ‰˘ÛÎÔÏ›·30,327,421,426,935,3

3. ¶Èı·Ófi Úfi‚ÏËÌ·6,07,515,415,48,544,8

4. ∆˘ÈÎfi49,347,340,838,342,842,8

5. ¶ÚÔ¯ˆÚË̤ÓÔ5,57,010,014,94,012,4

∞ÓÙ›ÏË„Ë √ÙÈÎÔÎÈÓËÙÈÎfi˜ Û˘ÓÙÔÓÈÛÌfi˜

∆ÔÌ›˜ 1. ™Ô‚·Úfi Úfi‚ÏËÌ·

∞Ê·ÈÚÂÙÈ΋ ÛΤ„Ë °ÏˆÛÛÈΤ˜ ·Ó·ÏÔÁ›Â˜

∫ÚÈÙÈ΋ ÈηÓfiÙËÙ·

∂ÈÎfiÓ· 2. µ·ıÌÔÏfiÁËÛË ÛÙÔ˘˜ ÙÔÌ›˜ ·Ó¿Ù˘Í˘. µ¿ÛË: fiÏÔ ÙÔ ‰Â›ÁÌ· (¡=201).

ÂϤÁ¯Ô˘Ó ÙË Û¯ÔÏÈ΋ ÂÙÔÈÌfiÙËÙ· Î·È Â¿ÚÎÂÈ· ÙˆÓ

·È‰ÈÒÓ, ηıÒ˜ ¤¯ÂÈ ·Ô‰Âȯı› fiÙÈ Ë Û¯ÔÏÈ΋ ·ÔÙ˘¯›· ‰ËÌÈÔ˘ÚÁ› ÛÙ· ·È‰È¿ η΋ ÂÈÎfiÓ· ÁÈ· ÙÔÓ

·˘Ùfi ÙÔ˘˜, Ô˘ Ù· Ô‰ËÁ› Û ¯·ÌËÏ‹ ·˘ÙÔÂÎÙ›ÌËÛË

Î·È ·ÚÓËÙÈ΋ ı¤ÛË, fi¯È ÌfiÓÔ ÁÈ· ÙÔ Û¯ÔÏ›Ô, ·ÏÏ¿ ÁÈ·

ÙË Ì¿ıËÛË ÁÂÓÈÎfiÙÂÚ·, ηıÒ˜ Î·È Û ‰È·Ù·Ú·¯¤˜ Û˘ÌÂÚÈÊÔÚ¿˜. ∂¿Ó ·˘Ù¿ Ù· Û˘ÌÙÒÌ·Ù· ‰ÂÓ ·ÓÙÈÌÂ-

ÙˆÈÛıÔ‡Ó ¤ÁηÈÚ·, Ù· ·È‰È¿ ¤¯Ô˘Ó ˘„ËÏfi ΛӉ˘ÓÔ

Ó· ÂÁηٷÏ›„Ô˘Ó ÚfiˆÚ· ÙÔ Û¯ÔÏÂ›Ô Î·È ÙË Ì¿ıËÛË, Ó· ÂÌÊ·Ó›ÛÔ˘Ó ·Ú·‚·ÙÈΤ˜ Û˘ÌÂÚÈÊÔÚ¤˜, Ó·

Ô‰ËÁËıÔ‡Ó Û ¯Ú‹ÛË ÂıÈÛÙÈÎÒÓ Ô˘ÛÈÒÓ Î·È Û ÂÊË-

‚È΋ ÂÁ΢ÌÔÛ‡ÓË (15,7,16).

∏ Û¯ÔÏÈ΋ ÂÙÔÈÌfiÙËÙ·, fiˆ˜ Î·È fiÏ· Ù· ·Ó·Ù˘-

Íȷο ÌÂÁ¤ıË, ÌÂÙÚÒÓÙ·È Ì ÚfiÙ˘˜ Î·È ÛÙ·ıÌÈ-

Ṳ̂Ó˜ ·Ó·Ù˘ÍȷΤ˜ ‰ÔÎÈ̷ۛ˜. √È ‰ÔÎÈ̷ۛ˜

Ô˘ ÂϤÁ¯Ô˘Ó ÙË Û¯ÔÏÈ΋ ÂÙÔÈÌfiÙËÙ· ‰È·ÎÚ›ÓÔÓÙ·È

Û ·ÓȯÓ¢ÙÈΤ˜ Î·È Û ‰È·ÁÓˆÛÙÈΤ˜. √È ·ÓȯÓ¢ÙÈΤ˜ Â›Ó·È Û‡ÓÙÔ̘ Î·È ·Ϥ˜ ‰È·‰Èηۛ˜ Ì ۷ʋ ÎÚÈÙ‹ÚÈ·

‹

2. ◊È· ‰˘ÛÎÔÏ›·

3. ¶Èı·Ófi Úfi‚ÏËÌ·

4. ∆˘ÈÎfi

5. ¶ÚÔ¯ˆÚË̤ÓÔ

Î·È Û¯ÔÏÈ΋ ·ÔÙ˘¯›·. ÃÚËÛÈÌÔÔÈÔ‡ÓÙ·È ÁÈ· ÚÔÏËÙÈÎfi ÏËı˘ÛÌÈ·Îfi ¤ÏÂÁ¯Ô fiÏˆÓ ÙˆÓ ·È‰ÈÒÓ ÚÔÛ¯ÔÏÈ΋˜ ËÏÈΛ·˜ Ô˘ ·Ú·ÎÔÏÔ˘ıÔ‡Ó ÓËÈ·ÁˆÁ›·, ÒÛÙ ¤ÁηÈÚ· Ó· ·ÓȯÓ‡ÔÓÙ·È fiÛ· ·fi ·˘Ù¿ ‰ÂÓ Â›Ó·È ¤ÙÔÈÌ· Ó· ·Ú¯›ÛÔ˘Ó ÙÔ Û¯ÔÏ›Ô. √È ‰È·ÁÓˆÛÙÈΤ˜ ‰ÔÎÈ̷ۛ˜ Â›Ó·È ¯ÚÔÓÔ‚fiÚ˜ ‰È·‰Èηۛ˜. ∂ϤÁ¯Ô˘Ó ÔÏÏÔ‡˜ Ì·ıËÛÈ·ÎÔ‡˜ Î·È ÁÓˆÛÙÈÎÔ‡˜ ÙÔÌ›˜ Î·È ¯ÚËÛÈÌÔÔÈÔ‡ÓÙ·È Û ÂÈÏÂÁ̤Ó˜ ÂÚÈÙÒÛÂȘ fiÙ·Ó ˘¿Ú¯ÂÈ ·ÓËÛ˘¯›· ·fi ÙÔ˘˜ ÁÔÓ›˜ ‹ ÙÔ˘˜

‰·ÛοÏÔ˘˜ ‹ Û ·È‰È¿ Ô˘ ¤¯Ô˘Ó ·ÔÙ‡¯ÂÈ ÛÙȘ ·ÓȯÓ¢ÙÈΤ˜ ‰ÔÎÈ̷ۛ˜ (4,6).

™ÙË ¯ÒÚ· Ì·˜, ‰ÂÓ Á›ÓÂÙ·È Û˘ÛÙËÌ·ÙÈο ÚÔÏËÙÈÎfi˜ ¤ÏÂÁ¯Ô˜ Û¯ÔÏÈ΋˜ ÂÙÔÈÌfiÙËÙ·˜. ŒÓ·˜ ÏfiÁÔ˜

Ô˘ Û˘Ó‹ıˆ˜ ÚÔ‚¿ÏÏÂÙ·È Â›Ó·È fiÙÈ ·˘Ùfi Á›ÓÂÙ·È ÁÈ· Ó· ÌËÓ ÂÊ·ÚÌfi˙ÔÓÙ·È ‰È·ÎÚ›ÛÂȘ ÛÙ·

Û¯ÔÏÂ›Ô ‹ ¢ÂÓ ∂›Ó·È ŒÙÔÈÌÔ ÁÈ· ÙÔ Û¯ÔÏ›Ô). ∂›Ó·È ۯ‰ȷṲ̂Ó˜ ¤ÙÛÈ ÒÛÙ ӷ ÂÓÙÔ›˙Ô˘Ó ÁÚ‹ÁÔÚ· Î·È ¤ÁηÈÚ· Ù· ·È‰È¿ ˘„ËÏÔ‡ ÎÈÓ‰‡ÓÔ˘ ÁÈ· Ì·ıËÛȷΤ˜ ‰˘ÛÎÔϛ˜

Á›ÓÂÙ·È ÚÔÏËÙÈÎfi˜ ¤ÏÂÁ¯Ô˜ Û¯ÔÏÈ΋˜ ÂÙÔÈÌfiÙËÙ·˜

Û ϛÁ· ÌÂÁ¿Ï· ȉȈÙÈο Û¯ÔÏ›· Ô˘ ‰È·ı¤ÙÔ˘Ó ÔÚÁ·ÓˆÌ¤Ó˜ ˘ËÚÂۛ˜ ÂȉÈ΋˜ ·ÁˆÁ‹˜. ŒÙÛÈ ÛÙË ¯ÒÚ· Ì·˜, Ô ÚÔÏËÙÈÎfi˜ ¤ÏÂÁ¯Ô˜ Á›ÓÂÙ·È fi¯È ÛÙȘ ÔÈ-

ÎÔÓÔÌÈο ·‰‡Ó·Ì˜ ÎÔÈÓˆÓÈΤ˜ ÔÌ¿‰Â˜ Ô˘ ¤¯Ô˘Ó

Î·È ˘„ËÏfiÙÂÚÔ Î›Ó‰˘ÓÔ ÁÈ· Û¯ÔÏÈ΋ ·ÔÙ˘¯›·, ·ÏÏ¿

Ì¿ÏÏÔÓ Û ‡ڈÛÙ˜ ÔÈÎÔÓÔÌÈο ÎÔÈÓˆÓÈΤ˜ ÔÌ¿‰Â˜

Ô˘ ÂÈϤÁÔ˘Ó Ù· ȉȈÙÈο ÓËÈ·ÁˆÁ›·. ∆· ·ÓÈ-

¯Ó¢ÙÈο ÙÂÛÙ Ô˘ ¯ÚËÛÈÌÔÔÈÔ‡ÓÙ·È Û ·˘Ù¤˜ ÙȘ

ÂÚÈÙÒÛÂȘ, ·ÚfiÙÈ ‰ÂÓ Â›Ó·È ÛÙ·ıÌÈṲ̂ӷ, ›ӷÈ

¯Ú‹ÛÈÌ· ˘fi ÙËÓ ¤ÓÓÔÈ· fiÙÈ ÌÔÚ› οÔȘ ÊÔÚ¤˜

Ó· ÂÓÙÔ›ÛÔ˘Ó ÁÓˆÛÙÈΤ˜ ÌÂÈÔÓÂ͛˜ Î·È Ó· ‰ÒÛÔ˘Ó

ÙËÓ Â˘Î·ÈÚ›· ÛÙÔ˘˜ ÁÔÓ›˜ Ó· ÙȘ ‰ÈÔÚıÒÛÔ˘Ó Ì ÂÈ-

‰È΋ ·ÁˆÁ‹, ÚÈÓ Ù· ·È‰È¿ ·Ú¯›ÛÔ˘Ó ÙË ÊÔ›ÙËÛË.

∂ÓÒ fï˜ ÛÙË ¯ÒÚ· Ì·˜ ‰ÂÓ ‰È·ı¤ÙÔ˘Ì ·ÓȯÓ¢-

ÙÈο ÙÂÛÙ Û¯ÔÏÈ΋˜ ÂÙÔÈÌfiÙËÙ·˜, ‰È·ı¤ÙÔ˘Ì ‰È·-

ÁÓˆÛÙÈο ÙÂÛÙ Ì·ıËÛÈ·ÎÒÓ ‰˘ÛÎÔÏÈÒÓ. ∞fi ÙË ºÈ-

ÏÔÛÔÊÈ΋ ™¯ÔÏ‹ ÙÔ˘ ¶·Ó/Ì›Ô˘ ∞ıËÓÒÓ ¤¯ÂÈ ÛÙ·ıÌÈÛÙ› Û ÂÏÏËÓÈÎfi ÏËı˘ÛÌfi ÙÔ ÙÂÛÙ «∞ıËÓ¿», Ô˘

ۯ‰ȿÛÙËΠÁÈ· ÙË ‰È¿ÁÓˆÛË ÙˆÓ ‰˘ÛÎÔÏÈÒÓ Ì¿ıË-

Û˘ Î·È ÌÔÚ› Ó· ¯ÚËÛÈÌÔÔÈËı› Î·È ÁÈ· ÙÔÓ ‰È·-

ÁÓˆÛÙÈÎfi ¤ÏÂÁ¯Ô Ù˘ Û¯ÔÏÈ΋˜ ÂÙÔÈÌfiÙËÙ·˜ (17).

∆Ô ∞ã ∆∂™∆ ¤¯ÂÈ ÛÙ·ıÌÈÛÙ› ·ÔÎÏÂÈÛÙÈο Û ÂÏ-

ÏËÓÈÎfi ÏËı˘ÛÌfi (¡=2000 ·È‰È¿ Ô˘ ·Ú·ÎÔÏÔ˘ıÔ‡Û·Ó 50 ÓËÈ·ÁˆÁ›·, ΢ڛˆ˜ Ù˘ ∞ÙÙÈ΋˜). ™Ùfi-

¯Ô˜ Ì·˜ Â›Ó·È Ó· ÂÂÎÙ›ÓÔ˘Ì ÙË ‰ÔÎÈÌ·Û›· Î·È Ó·

ÌÂÏÂÙ‹ÛÔ˘ÌÂ Î·È ÏËı˘ÛÌÔ‡˜ ·fi ËÌÈ·ÛÙÈΤ˜ ηÈ

·ÁÚÔÙÈΤ˜ ÂÚÈÔ¯¤˜ Ù˘ ∂ÏÏ¿‰·˜, ÒÛÙ ٷ ·ÔÙÂϤ-

ÛÌ·Ù· Ó· Â›Ó·È ÂÚÈÛÛfiÙÂÚÔ ·ÓÙÈÚÔÛˆ¢ÙÈο.

∆Ô ∞ã ∆∂™∆ Â›Ó·È ¤Ó· ·Ïfi, Û‡ÓÙÔÌÔ Î·È Â‡ÎÔÏÔ

ÛÙË ¯ÔÚ‹ÁËÛË ÙÂÛÙ ·Ó›¯Ó¢Û˘ Ù˘ Û¯ÔÏÈ΋˜ ÂÙÔÈ-

ÌfiÙËÙ·˜, Ô˘ ··ÓÙ¿ Ì ·ÓÙÈÎÂÈÌÂÓÈÎfi ÙÚfiÔ ÛÙÔ

ÂÚÒÙËÌ· “∂›Ó·È ÙÔ ·È‰› ¤ÙÔÈÌÔ Ó· ÊÔÈÙ‹ÛÂÈ ÛÙÔ

™¯ÔÏ›Ô;”, “¡∞π ‹ √Ãπ”.

∆Ô È‰È·›ÙÂÚÔ ¯·Ú·ÎÙËÚÈÛÙÈÎfi ÙÔ˘, ÙÔ ÔÔ›Ô ÂÈ‚¿ÏÏÂÙ·È Ó· ÛËÌÂȈı›, Â›Ó·È Ë ÈηÓfiÙËÙ¿ ÙÔ˘ Ó·

ÂϤÁ¯ÂÈ ÔÏ˘Â›‰· ÙË Ì·ıËÛȷ΋ ÈηÓfiÙËÙ·. ¶Â-

ÚÈÏ·Ì‚¿ÓÂÈ 4 Ú·ÎÙÈΤ˜ Î·È 4 ÏÂÎÙÈΤ˜ ÈηÓfiÙËÙ˜. ŒÙÛÈ, ÂϤÁ¯ÔÓÙ·È Ë ÔÙÈ΋ ·ÓÙ›ÏË„Ë Î·È Ô ÔÙÈÎÔÎÈÓËÙÈÎfi˜ Û˘ÓÙÔÓÈÛÌfi˜, Ë ÌÓ‹ÌË Î·È Ë ·‰Ú‹ ÎÈÓËÙÈÎfiÙËÙ·, ηıÒ˜ Â›Û˘ ÔÈ ÁψÛÛÈΤ˜ ÈηÓfiÙËÙ˜, Ë

ÚÒÈÌË ·Ê·ÈÚÂÙÈ΋ Ì·ıËÌ·ÙÈ΋ ÛΤ„Ë, Ë ÎÚ›ÛË Î·È Ô Û˘ÏÏÔÁÈÛÌfi˜. ¶·Ú¿ÏÏËÏ· ‰È·ı¤ÙÂÈ 2 Û˘ÌÏËڈ̷ÙÈΤ˜ Îϛ̷Θ. ∏ ÚÒÙË ·ÊÔÚ¿ ÛÙ· ‰È·ÁÓˆÛÙÈο

Ù˘ ˘ÂÚÎÈÓËÙÈÎfiÙËÙ·˜

ÁÂÁÔÓfi˜ Ô˘ ÂÍ·ÛÊ·Ï›˙ÂÈ ÙËÓ ·ÓÙÈÎÂÈ-

ÌÂÓÈÎfiÙËÙ· ÙÔ˘ ·ÔÙÂϤÛÌ·ÙÔ˜. ¢È·ı¤ÙÂÈ ˘„ËÏ‹ ¢·ÈÛıËÛ›· Î·È ÂÍÂȉ›Î¢ÛË, ÒÛÙ ӷ ÌË ‰›ÓÂÈ „¢‰Ò˜ ıÂÙÈο ‹ ·ÚÓËÙÈο ·ÔÙÂϤÛÌ·Ù·. ∂ÓÙÔ›˙ÂÈ

ÛˆÛÙ¿ Ù· ·È‰È¿ ÂΛӷ Ô˘ ‰ÂÓ Â›Ó·È ¤ÙÔÈÌ· Ó· ·Ú-

¯›ÛÔ˘Ó ÙÔ Û¯ÔÏ›Ô, ¯ˆÚ›˜ Ó· ·ÓËÛ˘¯Â› ·Ó·›ÙÈ· ÙÔ˘˜

ÁÔÓ›˜. ¶Ú¤ÂÈ Ó· ÙÔÓÈÛı› fiÙÈ ÙÔ ∞ã ∆∂™∆ ‰ÂÓ ÌÂÙÚ¿ÂÈ ÙÔ IQ, Ô‡Ù ÙËÓ Â˘Ê˘˝· ÁÂÓÈο, Ô‡Ù ·ÛÊ·ÏÒ˜

‚¿˙ÂÈ Î¿ÔÈ· ‰È¿ÁÓˆÛË. ∞Ï¿ ÂϤÁ¯ÂÈ Ì ·ÓÙÈÎÂÈÌÂ-

ÓÈÎfi ÙÚfiÔ ÙË Û¯ÔÏÈ΋ ÂÙÔÈÌfiÙËÙ· ÛÙȘ ·Ú·Ì¤-

ÙÚÔ˘˜ Ô˘ ·Ó·Ê¤ÚıËηÓ.

¶ÚÔÏËÙÈÎfi˜ ¤ÏÂÁ¯Ô˜ Ù˘ Û¯ÔÏÈ΋˜ ÂÙÔÈÌfiÙËÙ·˜

ÛÙȘ ÂÚÈÛÛfiÙÂÚ˜ ·ÓÂÙ˘Á̤Ó˜ ¯ÒÚ˜ ÙÔ˘ Â͈ÙÂÚÈÎÔ‡. ∏ ηıȤڈۋ ÙÔ˘ Î·È ÛÙË ¯ÒÚ·

µÈ‚ÏÈÔÁÚ·Ê›·

1. Crnic K, Lamberty G. Reconsidering school readiness: conceptual and applied perspectives. Early education and development 1994;5:91-105.

2. De Lemos MM, Mellor EJ. A longitudinal study of developmental maturity, school entry age and school progress. Journal of Australian Research in Early Childhood Education 1994;1:42-50.

3. Routley V, De Lemos MM. Changing trends in school entry age in Victoria. Australian Journal of Early Education 199; 18:30-38.

4. Janus M, Offord DR. Reporting on readiness to learn at school in Canada. Canadian Journal of Policy Research 2000;1:71-75.

5. Erikson E. ∏ ·È‰È΋ ËÏÈΛ· Î·È Ë ÎÔÈÓˆÓ›·, ∞ı‹Ó·: ∂ΉfiÛÂȘ ∫·ÛÙ·ÓÈÒÙ˘; 1990.

6. Meisels SJ. Assessing Readiness. In: Pianta RC and Cox M, editors. The transition to Kindergarten. Baltimore: Paul Brookers Press; 1999. p. 39-66.

7. Moffit TE. Adolescence-limited and life-course-persistent antisocial behaviour: a developmental taxonomy. Psychological Review 1993;100:674-701.

8. Barnett S. Economics of early childhood intervention. In: Meisels SJ, editor. Handbook of early childhood intervention. 2nd ed. New York, NY: Cambridge University Press; 2000. p. 589-610.

9. Kolb B, Fantie B. Development of the child’s brain and behaviour. In: Reynolds CE, Fletcher-Janzen E, editors. Handbook of clinical child neuropsychology. New York: Plenum Press; 1997. p. 17-41.

10. Ayres AJ. Sensory Integration and Praxis Tests. Los Angeles: Western Psychological Services; 1989. p 52-78.

11. Kamphaus RW, Kaufman AS. The assessment of preschool children with the Kaufman Assessment Battery for Children. In: Bracken BA, editor. The Psychoeducational Assessment

of Preschool Children. 2nd ed. Needham Heights, MA: Allyn & Bacon; 1991.

12. Hresko W, Reid DK, Hammill DD. Test of Early Language Development. 2nd ed. Austin, TX: PRO-ED; 1991.

13. Gardner MF. Test of visual-perceptual skills TVPS (nonmotor) (upper level). Burlingame, CA: Psychological and Educational Publications; 1992.

14. Gardner MF. Test of visual-motor skills TVMS - revised. Burlingame, CA: Psychological and Educational Publications; 1996.

15. Shaw DS, Gilliom M, Giovanelli J. Aggressive behaviour disorders. In: Zeanah CH, editor. Handbook of infant mental health. 2nd ed. New York: Guilford; 2000. p. 397-411.

16. Moffit TE. Adolescent limited and life course persistent anti-social behaviour. A developmental taxonomy. Psychological Review 1993;100:674-701.

17. Richman N, Stevenson J, Graham P. Preschool to school: a behavioural study. Academic Press; 1982. p. 12-56.

18. ¶·Ú·Û΢fiÔ˘ÏÔ˜ π¡, ∫·Ï·ÓÙ˙‹-∞˙›˙È ∞, °È·ÓÓ›ÙÛ·˜ ¡¢. ∞ıËÓ¿ ∆ÂÛÙ ¢È¿ÁÓˆÛ˘ ¢˘ÛÎÔÏÈÒÓ ª¿ıËÛ˘. ∞ı‹Ó·: ∂ÏÏËÓÈο °Ú¿ÌÌ·Ù·; 1999.

¶ÚfiÙ˘Ô ÚfiÁÚ·ÌÌ·

ÎÔÈÓfiÙËÙ· ·fi ÊÔÚ¤·

∞. •ÂηϿÎË1, ¢. ª¤ÓÂÁ·˜1, ∞ÈÎ. ∑ÔÏÒÙ·1, ∑. ∏ÏÈÔ‰ÚÔÌ›ÙË1, ∞. ¶Ú·ÛÔ‡ÏË1, ∂. ∆˙›ÓË1, ¶. ª·˘Ú›Î·1,

∞ÈÎ. ¢ËÌÔÔ‡ÏÔ˘1, ∞. ª¿ÚÁ·ÚË2, π. ∞ÓÙˆÓÈ¿‰Ô˘-∫Ô˘Ì¿ÙÔ˘1

¶ÂÚ›ÏË„Ë

∂ÈÛ·ÁˆÁ‹: √ ÚfiÏÔ˜ Ù˘ ÚˆÙÔ‚¿ıÌÈ·˜ ÊÚÔÓÙ›‰·˜ ˘Á›·˜ Û Â›Â‰Ô ÎÔÈÓfiÙËÙ·˜ ¤¯ÂÈ ·Ó·ÁÓˆÚÈÛı› ˆ˜

ȉȷ›ÙÂÚ· ÛËÌ·ÓÙÈÎfi˜ ÁÈ· ÙË ‚ÂÏÙ›ˆÛË Ù˘ ˘Á›·˜ ÙÔ˘ ÏËı˘ÛÌÔ‡. ∏ ÂÓÂÚÁÔÔ›ËÛË Ù˘ ÎÔÈÓfiÙËÙ·˜ ·ÔÙÂÏ› ÚÔ¸fiıÂÛË ÛÙ· Û‡Á¯ÚÔÓ· ÌÔÓ٤Ϸ ÚÔ·ÁˆÁ‹˜ Ù˘ ˘Á›·˜.

∆Ô ∫¤ÓÙÚÔ ÀÁ›·˜ ÙÔ˘ ¶·È‰ÈÔ‡ ∫·ÈÛ·ÚÈ·Ó‹˜ (∫.À.¶.∫.), Ô˘ ÂÔÙ‡ÂÙ·È ÂÈÛÙËÌÔÓÈο ·fi ÙÔ πÓÛÙÈÙÔ‡-

ÙÔ ÀÁ›·˜ ÙÔ˘ ¶·È‰ÈÔ‡, ۯ‰›·ÛÂ Î·È ÂÊ¿ÚÌÔÛ ¤Ó· ÚfiÁÚ·ÌÌ· ·ÁˆÁ‹˜-ÚÔ·ÁˆÁ‹˜ Ù˘ ˘Á›·˜ Ì ı¤Ì·

“¶ÂÚÈ‚¿ÏÏÔÓ Î·È ÀÁ›·”.

™Ùfi¯Ô˜ ÙÔ˘ ÚÔÁÚ¿ÌÌ·ÙÔ˜ ‹Ù·Ó: ·) Ë ·ÚÔ¯‹ ¤ÁÎ˘ÚˆÓ ÁÓÒÛÂˆÓ Û ̷ıËÙ¤˜ ÁÈ· ÙËÓ Â›‰Ú·ÛË Ù˘ Ú‡-

·ÓÛ˘ ÙÔ˘ ÂÚÈ‚¿ÏÏÔÓÙÔ˜ ÛÙËÓ ˘Á›·, ÒÛÙ ӷ Û˘ÓÂȉËÙÔÔÈ‹ÛÔ˘Ó fiÙÈ Ë ÊÚÔÓÙ›‰· ÙÔ˘ ÂÚÈ‚¿ÏÏÔÓÙÔ˜

¤¯ÂÈ ˆ˜ ¿ÌÂÛÔ Î·È Ì·ÎÚÔÚfiıÂÛÌÔ ·ÔÙ¤ÏÂÛÌ· ÙËÓ ÚÔÛÙ·Û›· Ù˘ ˘Á›·˜, Î·È ‚) Ë ÚÔÙ˘ÔÔ›ËÛË ÙÔ˘

ۯ‰ȷÛÌÔ‡ Î·È Ë ·Ú·ÁˆÁ‹ ÂÔÙÈÎÔ‡ ˘ÏÈÎÔ‡, ÒÛÙ ÙÔ ÚfiÁÚ·ÌÌ· Ó· ÌÔÚ› Ó· ·Ó··Ú·¯ı› Î·È ·fi

¿ÏÏÔ˘˜ ÊÔÚ›˜.

ÀÏÈÎfi Î·È Ì¤ıÔ‰ÔÈ: ¶ÏËı˘ÛÌfi˜ ÛÙfi¯Ô˜ ‹Ù·Ó ÔÈ Ì·ıËÙ¤˜ ÙˆÓ ÓËÈ·ÁˆÁ›ˆÓ, ‰ËÌÔÙÈÎÒÓ Î·È Á˘ÌÓ·Û›ˆÓ

Ù˘ ÂÚÈÔ¯‹˜. √ ۯ‰ȷÛÌfi˜ ÂÚÈÂϿ̂·ÓÂ: ·) ÎÔÈÓÔÙÈ΋ Û˘ÌÌÂÙÔ¯‹, ‚) ‰Ú¿ÛÂȘ ¢·ÈÛıËÙÔÔ›ËÛ˘-ÂÎ·›‰Â˘Û˘ Â·ÁÁÂÏÌ·ÙÈÒÓ Î·È ÂÎ·È‰Â˘ÙÒÓ, Á) ·ÁˆÁ‹ ˘Á›·˜ ÛÙ· Û¯ÔÏ›·, ‰) ·ÁˆÁ‹ ˘Á›·˜ ÛÙËÓ ÎÔÈÓfi-

ÙËÙ·, Â) ·ÍÈÔÏfiÁËÛË ÙÔ˘ ÚÔÁÚ¿ÌÌ·ÙÔ˜ Ì ÂÚˆÙËÌ·ÙÔÏfiÁÈ· Û ̷ıËÙ¤˜ Î·È Û ÂÎ·È‰Â˘ÙÈÎÔ‡˜.

∞ÔÙÂϤÛÌ·Ù·: ∫·Ù·ÁÚ¿ÊËÎÂ

ÙËÓ

ÙˆÓ

·ÚÔ˘ÛÈ¿ÛÂˆÓ ·ÍÈÔÏÔÁ‹ıËΠ·fi ÂÍ·ÈÚÂÙÈÎfi ¤ˆ˜ Ôχ ηٿÏÏËÏÔ, ·Ó¿ ËÏÈÎȷ΋ ÔÌ¿‰·, ·fi 89,6% ÙˆÓ

ÂÎ·È‰Â˘ÙÈÎÒÓ ÛÙ· ‰ËÌÔÙÈο Î·È 84,2% ÛÙ· Á˘ÌÓ¿ÛÈ·. √ ÙÚfiÔ˜ ·ÚÔ˘Û›·Û˘ ·fi ÙÔ˘˜ ÔÌÈÏËÙ¤˜ ÂÎÙÈÌ‹ıËΠ·fi ÙÔ˘˜ ÂÎ·È‰Â˘ÙÈÎÔ‡˜ ·fi Ôχ ˆ˜ ÂÍ·ÈÚÂÙÈο Û·Ê‹˜, ˙ˆÓÙ·Ófi˜ Î·È Â˘¤ÏÈÎÙÔ˜.

™˘ÌÂÚ¿ÛÌ·Ù·: ∏ ÂÓÂÚÁÔÔ›ËÛË Ù˘ ÎÔÈÓfiÙËÙ·˜ ·fi ¤Ó·Ó ÊÔÚ¤· ÚˆÙÔ‚¿ıÌÈ·˜ ÊÚÔÓÙ›‰·˜ ˘Á›·˜

·ÔÙÂÏ› ηÈÓÔÙfiÌÔ ÚÔÛ¤ÁÁÈÛË ÁÈ· Ù· ÂÏÏËÓÈο ‰Â‰Ô̤ӷ.

§¤ÍÂȘ ÎÏÂȉȿ: ∞ÁˆÁ‹ ˘Á›·˜, ÂÚÈ‚¿ÏÏÔÓ, ÎÔÈÓfiÙËÙ·.

Model health promotion program in an urban community by a primary health care setting

A. Xekalaki1, D. Menegas1, K. Zolota1, Z. Iliodromiti1, A. Prasouli1, E. Tzini1, P. Mavrika1, K. Dimopoulou1, A. Margari2, I. Antoniadou-Koumatou1

Abstract Background: The role of primary health care has been identified as very important for improving the health of the population. Community participation is a prerequisite in contemporary health promotion models.

The Child Health Centre of Kessariani, an urban primary health care centre scientifically supervised by the Institute of Child Health, designed and implemented a health education-promotion programme in the community, on the issue of “Health and the Environment”. The aims of the programme were: a) to enable the children to understand how the pollution of the environment affects health, and that health is protected when environment is protected, and b) to create a model programme which can be implemented by various settings.

Methods: The target population comprised the pupils of the kindergartens and the elementary and secondary schools of the area. The action plan included: 1) community participation, 2) education of professionals and educators, 3) health education sessions in schools, 4) community health education, and 5) evaluation of the programme using questionnaires completed by pupils and teachers.

Results: Data from the analysis of the questionnaires showed a statistically significant difference (p<0.01) in the level of relevant knowledge after the interventions, which was demonstrated to be excellent. The content of the electronic presentations was evaluated as from exceptional to very appropriate for each age

1 Institute of Child Health, Health Care Centre of Kessariani, Athens, Greece

2 Ecological Workshop of Municipality of Kessariani, Athens, Greece

Correspondence: Ioanna AntoniadouKoumatou inchildh@otenet.gr Institute of Child Health “Aghia Sophia” Children’s Hospital Thivon and Levadias St. 11527, Athens, Greece

group by 89.6% of the elementary school teachers and 84.2% of the secondary school teachers. The mode of presentation was evaluated by the teachers as very accurate, vivid and flexible.

Conclusions: Promoting community participation in health education-promotion by a primary health care team is an innovative approach in Greece, since it requires a health care system based on primary care. It is suitable for standard work practice in the primary care setting.

Key words: Health education, environment, community.

Á›ÓÔÓÙ·È ÁÈ· ÙËÓ Î·Ï˘Ù¤Ú¢ÛË Ù˘ ˘Á›·˜ (2). Œ¯ÂÈ ‰È·ÈÛÙˆı› fiÙÈ ÔÏÏ¿ ·fi Ù· ÓÔÛ‹-

Ì·Ù· Ô˘ ·ÔÙÂÏÔ‡Ó ÙȘ ‚·ÛÈÎfiÙÂÚ˜ ·Èٛ˜

ıÓËÛÈÌfiÙËÙ·˜ Î·È ÓÔÛËÚfiÙËÙ·˜ Ù˘ ÂÔ¯‹˜

Ì·˜ ¤¯Ô˘Ó ÔÏ˘·Ú·ÁÔÓÙÈ΋ ·ÈÙÈÔÏÔÁ›· (3). √

ÎÏ·ÛÈÎfi˜ ÔÚÈÛÌfi˜ Ù˘ ˘Á›·˜ ·fi ÙÔÓ ¶·ÁÎfi-

ÛÌÈÔ √ÚÁ·ÓÈÛÌfi ÀÁ›·˜ (¶.√.À.) ·Ó·Ê¤ÚÂÙ·È

ÛÙËÓ Î·Ù¿ÛÙ·ÛË Ù˘ Ï‹ÚÔ˘˜ ۈ̷ÙÈ΋˜, „˘¯È΋˜, Î·È ÎÔÈÓˆÓÈ΋˜ ¢ÂÍ›·˜ Î·È fi¯È ÌfiÓÔ

ÛÙËÓ ·Ô˘Û›· ·Ûı¤ÓÂÈ·˜ ‹ ·Ó·ËÚ›·˜ (4). ∏

ÚÔÛˆÈ΋ ‰È¿ÛÙ·ÛË Ù˘ ˘Á›·˜ Â›Ó·È ÔÚ·Ù‹

Û ·˘ÙfiÓ ÙÔÓ ÔÚÈÛÌfi Î·È Â›Ó·È ‚È‚ÏÈÔÁÚ·ÊÈο

‰È·ÈÛو̤ÓÔ fiÙÈ ˘Á›· ÛËÌ·›ÓÂÈ ‰È·ÊÔÚÂÙÈο

Ú¿ÁÌ·Ù· Û ‰È·ÊÔÚÂÙÈÎÔ‡˜ ·ÓıÚÒÔ˘˜ ‹

ÔÌ¿‰Â˜ Î·È ÔˆÛ‰‹ÔÙ ÛËÌ·ÙÔ‰ÔÙ› ÌÈ· ‰˘-

Ó·ÌÈ΋ ·ÏÏËÏÂ›‰Ú·ÛË ÙÔ˘ ·ÙfiÌÔ˘ Ì ÙÔ Â˘-

Ú‡ÙÂÚÔ ÂÚÈ‚¿ÏÏÔÓ ÙÔ˘. √ ¶.√.À., ÛÙË ‰È·Î‹Ú˘ÍË "ÀÁ›· ÁÈ· fiÏÔ˘˜ ̤¯ÚÈ ÙÔ ¤ÙÔ˜ 2000" (5), ·Ó¤‰ÂÈÍ ·˘Ù‹Ó ÙË ‰˘Ó·ÌÈ΋ Û¯¤ÛË. ∏ ÚÔ·ÁˆÁ‹ Ù˘ ˘Á›·˜ Û˘ÌÂÚȤϷ‚ ηÈ

ÚÈ·Ó‹ (∫.À.¶.K.), ÙÔ ÔÔ›Ô È‰Ú‡ıËÎÂ Î·È ÂÔÙ‡ÂÙ·È ÂÈÛÙËÌÔÓÈο ·fi ÙË ¢È‡ı˘ÓÛË ∫ÔÈÓˆÓÈ΋˜ ¶·È‰È·ÙÚÈ΋˜ ÙÔ˘ πÓÛÙÈÙÔ‡ÙÔ˘ ÀÁ›·˜ ÙÔ˘ ¶·È‰ÈÔ‡, ¤¯ÂÈ Ì·ÎÚ¿ ÂÌÂÈÚ›· ÛÙËÓ ÂÊ·ÚÌÔÁ‹ ÚÔÁÚ·ÌÌ¿ÙˆÓ ·ÁˆÁ‹˜ Î·È ÚÔ·ÁˆÁ‹˜ Ù˘ ˘Á›·˜ ÛÙËÓ ÎÔÈÓfiÙËÙ· Ù˘ ∫·ÈÛ·ÚÈ·Ó‹˜. ™ÙÔÓ Û¯Â‰È·ÛÌfi ÙˆÓ ÎÔÈÓÔÙÈÎÒÓ ÚÔÁÚ·ÌÌ¿ÙˆÓ Á›ÓÂÙ·È ÂÊ·ÚÌÔÁ‹ ÙˆÓ Û‡Á¯ÚÔÓˆÓ Ù¿ÛÂˆÓ ÛÙËÓ ÚÔ·ÁˆÁ‹ Ù˘ ˘Á›·˜, Ô˘ ÚÔ¸Ôı¤ÙÔ˘Ó ÙËÓ ÂÓÂÚÁÔÔ›ËÛË Î·È ÙË Û˘ÌÌÂÙÔ¯‹ Ù˘ ÎÔÈÓfiÙËÙ·˜ ÛÙÔÓ Î·ıÔÚÈÛÌfi ÙˆÓ ÚÔÙÂÚ·ÈÔًوÓ, ÙÔÓ Û¯Â‰È·ÛÌfi Î·È ÙËÓ ÂÊ·ÚÌÔÁ‹ ÙÔ˘˜. (∫·Ù·ÛÙ·ÙÈÎfi˜ ¯¿ÚÙ˘ Ù˘ √Ù¿‚·, ¶.√.À, 1986) (6). ™Ùfi¯Ô˜ Â›Ó·È Ë ÚÔÙ˘ÔÔ›ËÛË ÙˆÓ ÚÔÁÚ·Ì̿وÓ, ÒÛÙ ӷ ÌÔÚÔ‡Ó Ó· ·Ó··Ú·¯ıÔ‡Ó.

√ ÛÎÔfi˜ ÙÔ˘ ÚÔÁÚ¿ÌÌ·ÙÔ˜ ·ÁˆÁ‹˜ Î·È ÚÔ·ÁˆÁ‹˜ Ù˘ ˘Á›·˜ ÁÈ· ÙÔ 2007 ‹Ù·Ó “¶ÂÚÈ‚¿ÏÏÔÓ Î·È ÀÁ›·”.

ÙÔ˘ ¢ڇÙÂÚÔ˘ ÎÔÈÓˆÓÈÎÔÔÈÎÔÓÔÌÈÎÔ‡ ÂÚÈ‚¿ÏÏÔÓÙÔ˜. ∂ÓÒ, ·fi ÙËÓ

ÙÔ˘ ·ÙfiÌÔ˘ Ó· ÂÈϤÍÂÈ ÙËÓ ÂÚÈÛÛfiÙÂÚÔ "˘ÁÈ‹" Û˘ÌÂÚÈÊÔÚ¿ ("healthier choices, easier choices") (6) ÂÓÈÛ¯‡ÂÙ·È fiÙ·Ó ÙÔ ÂÚÈ‚¿ÏÏÔÓ Â›Ó·È Â˘ÓÔ˚ÎfiÙÂÚÔ.

∫·ÈÛ·-

∆Ô Ê˘ÛÈÎfi ÂÚÈ‚¿ÏÏÔÓ ÙˆÓ ·È‰ÈÒÓ, ÂΛ ‰ËÏ·‰‹ Ô˘ Ù· ·È‰È¿ ˙Ô˘Ó, ·›˙Ô˘Ó Î·È Ì·ı·›ÓÔ˘Ó, ·ÔÙÂÏ› ηıÔÚÈÛÙÈÎfi ·Ú¿ÁÔÓÙ· ÁÈ· ÙËÓ ˘Á›· ÙÔ˘˜ Î·È ÙËÓ ÔÈfiÙËÙ· Ù˘ ˙ˆ‹˜ ÙÔ˘˜. ∏ Ú‡·ÓÛË fï˜ ÙÔ˘ ÂÚÈ‚¿ÏÏÔÓÙÔ˜ ÌÔÚ› Ó· ¤¯ÂÈ ÛËÌ·ÓÙÈΤ˜ Û˘Ó¤ÂȘ ÛÙËÓ ˘Á›· ÙˆÓ ·È‰ÈÒÓ Û fiÏÔ ÙÔÓ Ï·Ó‹ÙË (7,8,9,10,11). ∆· ·È‰È¿ ÛÙËÓ ∂ÏÏ¿‰· ‰ÂÓ ·ÔÙÂÏÔ‡Ó ÂÍ·›ÚÂÛË. ∏ ÚÔÛÙ·Û›· ÙˆÓ ·È‰ÈÒÓ ·fi ÙÔ˘˜ ‚Ï·ÙÈÎÔ‡˜ ÂÚÈ‚·ÏÏÔÓÙÈÎÔ‡˜ ·Ú¿ÁÔÓÙ˜ ··ÈÙ› ¤Ú¢ӷ, ηٿÏÏËÏË Û¯ÂÙÈ΋ ÓÔÌÔıÂÛ›· Î·È ·ÚÂÌ‚¿ÛÂȘ, ·ÏÏ¿ Î·È Û˘ÛÙËÌ·ÙÈ΋ ÂÓË̤ڈÛË ÙˆÓ ÁÔÓÈÒÓ Î·È ÙˆÓ ·È‰ÈÒÓ. ªÂ ÙÂÏÈÎfi ÛÙfi¯Ô ÙËÓ ÚÔÛÙ·Û›· Ù˘ ˘Á›·˜ ÙÔ˘, ÙÔ ¿ÙÔÌÔ Ì·ı·›ÓÂÈ, fi¯È ÌfiÓÔ Ó· ·Ó·ÁÓˆÚ›˙ÂÈ Î·È Ó· ·ÔʇÁÂÈ ÙÔ˘˜ ‚Ï·ÙÈÎÔ‡˜ ÂÚÈ‚·ÏÏÔÓÙÈÎÔ‡˜ ·Ú¿ÁÔÓÙ˜, ·ÏÏ¿ Î·È Ó· ÚÔÛٷهÂÈ ÂÓÂÚÁËÙÈο ÙÔ ÂÚÈ‚¿ÏÏÔÓ ·fi ÂÚ·ÈÙ¤Úˆ ÌfiÏ˘ÓÛË. ∆· ·È‰È¿ ‰ÂÓ Â›Ó·È “ÌÈÎÚÔ› ÂÓ‹ÏÈΘ”. ∂ÎÙ›ıÂÓÙ·È, fiˆ˜ Î·È ÔÈ ÂÓ‹ÏÈΘ, Û ڇÔ˘˜ Ô˘ ‚Ú›ÛÎÔÓÙ·È ÛÙÔÓ ·¤Ú·, ÙÔ ¤‰·ÊÔ˜ ‹ ÙÔ ÓÂÚfi, Ô˘ ÙÔ˘˜ ¤ÙÔ˘Ó, ÙÔ˘˜ ÂÈÛÓ¤Ô˘Ó ‹ ÙÔ˘˜ ·ÔÚÚÔÊÔ‡Ó ·fi ÙÔ ‰¤ÚÌ· ÙÔ˘˜. √È ·Ó·Ù˘ÛÛfiÌÂÓÔÈ,

οو ÙÔ˘ ̤ÛÔ˘ ̤ÙÚÈÔÈηÓÔÔÈËÙÈÎfi¿ÚÈÛÙÔ

∂ÈÎfiÓ· 1. ∫·Ù·ÓÔÌ‹ ÁÓˆÛÙÈÎÔ‡ ÂÈ¤‰Ô˘ ·È‰ÈÒÓ ∂ã Î·È ™∆ã ‰Ë-

√È ÔÌÈϛ˜ ÛÙÔ ‰ËÌÔÙÈÎfi Û¯ÔÏÂ›Ô ¤ÁÈÓ·Ó ·fi Ù· ̤ÏË ÙÔ˘ √È-

ÎÔÏÔÁÈÎÔ‡ ∂ÚÁ·ÛÙËÚ›Ô˘, ÛÂ Û˘ÓÂÚÁ·Û›· Ì ÙÔ˘˜ ·È‰›·-

ÙÚÔ˘˜ ÙÔ˘ ∫.À.¶.∫., ÂÓÒ ÔÈ ÔÌÈϛ˜ ÛÙÔ Á˘ÌÓ¿ÛÈÔ ¤ÁÈÓ·Ó ·fi

ÙÔ˘˜ ·È‰›·ÙÚÔ˘˜ ÙÔ˘ ∫.À.¶.∫. ªÂÙ¿ ÙËÓ ÔÏÔÎϋڈÛË ÙÔ˘

ÚÔÁÚ¿ÌÌ·ÙÔ˜, ÙÔ ÂÔÙÈÎfi ˘ÏÈÎfi ‰fiıËΠ۠ËÏÂÎÙÚÔÓÈ΋ ÌÔÚÊ‹ ÛÙÔ˘˜ ÂÎ·È‰Â˘ÙÈÎÔ‡˜ fiÏˆÓ ÙˆÓ Û¯ÔÏ›ˆÓ.

¶·È‰ÈÎÔ› ÛÙ·ıÌÔ› Î·È ÓËÈ·ÁˆÁ›·:

·È‰ÈÎÒÓ ÛÙ·ıÌÒÓ Î·È ÙˆÓ ÓËÈ·ÁˆÁ›ˆÓ

Ù· ›‰È· ı¤Ì·Ù· -ÚÔÛ·ÚÌÔṲ̂ӷ ÛÙËÓ ËÏÈΛ· ÙÔ˘˜- Ì ÙË

ÌÔÚÊ‹ ÎÔ˘ÎÏÔı¤·ÙÚÔ˘. ∆· ΛÌÂÓ· Î·È ÙËÓ

Ú·ÁÌ·ÙÔÔ›ËÛ·Ó Ì¤ÏË ÙÔ˘ √ÈÎÔÏÔÁÈÎÔ‡ ∂ÚÁ·ÛÙËÚ›Ô˘, ÌÂ

ÙËÓ ˘ÔÛÙ‹ÚÈÍË Î·È ÙËÓ ÂÔÙ›· ÙˆÓ ÂÈÛÙËÌfiÓˆÓ ÙÔ˘

∫.À.¶.∫. √È ·È‰·ÁˆÁÔ› Û˘ÌÌÂÙ›¯·Ó Ì ۯÂÙÈΤ˜ Û˘˙ËÙ‹-

ÛÂȘ Î·È ÂÚÁ·Û›Â˜ ÛÙËÓ Ù¿ÍË.

4. ∞ÁˆÁ‹ ˘Á›·˜ ÛÙËÓ ÎÔÈÓfiÙËÙ·

∂ΉfiıËÎ·Ó 4 Ê˘ÏÏ¿‰È· ÁÈ· ÙËÓ ÂÓË̤ڈÛË Î·È ÙËÓ Â˘·È-

ÛıËÙÔÔ›ËÛË ÙÔ˘ ¢ڇÙÂÚÔ˘ ÔÈÎÔÁÂÓÂÈ·ÎÔ‡/ÎÔÈÓˆÓÈÎÔ‡ Â-

ÚÈ‚¿ÏÏÔÓÙÔ˜, Ô˘ ÌÔÈÚ¿ÛÙËÎ·Ó Û fiÏ· Ù· ·È‰È¿ Î·È ÙÔ˘˜

ÂÎ·È‰Â˘ÙÈÎÔ‡˜ Ù˘ ÂÚÈÔ¯‹˜. ∏ ıÂÌ·ÙÔÏÔÁ›· ÙÔ˘˜ ÂÚÈÂ-

Ͽ̂·Ó ˙ËÙ‹Ì·Ù· ‰È·ÙÚÔÊ‹˜, ÔÈfiÙËÙ·˜ Î·È Â¿ÚÎÂÈ·˜ ÙÔ˘

fiÛÈÌÔ˘ ÓÂÚÔ‡, ÙÔ˘ ÙÈ ·ÁÁ›˙Ô˘ÌÂ Î·È ÙÈ ·Ó·Ó¤Ô˘Ì ηÈ, Ù¤ÏÔ˜, ¯Ú‹ÛÈ̘ ÏËÚÔÊÔڛ˜ ÁÈ· ÙË ÊÚÔÓÙ›‰· Ù˘ ˘Á›·˜ Ì·˜

Î·È ÙÔ˘ ÂÚÈ‚¿ÏÏÔÓÙÔ˜. ∂›Û˘, ‰ËÌÈÔ˘ÚÁ‹ıËΠÌÈ· ÌÈÎÚ‹ ÔÈÎÔÏÔÁÈ΋ ‚È‚ÏÈÔı‹ÎË Ì ÂχıÂÚË ÚfiÛ‚·ÛË, ÁÈ· ÂÚÈÛÛfiÙÂÚ˜ ÏËÚÔÊÔڛ˜.

5. ∞ÍÈÔÏfiÁËÛË ÙÔ˘ ÚÔÁÚ¿ÌÌ·ÙÔ˜ ŒÁÈÓ ÚÔÛ¿ıÂÈ· ·ÍÈÔÏfiÁËÛ˘ ÙÔ˘ ÚÔÁÚ¿ÌÌ·ÙÔ˜ ÌÂ

ÙÚÂȘ ÙÚfiÔ˘˜: ·) ∫·Ù·Û΢¿ÛıËΠÂÚˆÙËÌ·ÙÔÏfiÁÈÔ ÁÓÒÛˆÓ, ÙÔ ÔÔ›Ô

‰fiıËΠ۠fiÏÔ˘˜ ÙÔ˘˜ Ì·ıËÙ¤˜ Ù˘ ∂ã Î·È ™Tã ‰ËÌÔÙÈÎÔ‡ ÌÂ-

0-910-1213-1516-17 ∞ÚÈıÌfi˜ ÛˆÛÙÒÓ ··ÓÙ‹ÛˆÓ

ηٿ ÙË ‰È¿ÚÎÂÈ· ÙˆÓ ·ÚÔ˘ÛȿۈÓ, Ì ÛÙfi¯Ô Ó· ·ÍÈÔÏÔÁËı› ÙÔ ÂÚȯfiÌÂÓÔ Ù˘ ÔÌÈÏ›·˜, Ô ÙÚfiÔ˜ Ù˘ ·ÚÔ˘Û›·Û˘, Ë ÚÔÛÔ¯‹ Î·È Ë Û˘ÌÌÂÙÔ¯‹ ÙˆÓ ·È‰ÈÒÓ. Á) ªÂ ÙËÓ ÔÏÔÎϋڈÛË ÙÔ˘ ÚÔÁÚ¿ÌÌ·ÙÔ˜, Ú·ÁÌ·ÙÔÔÈ‹ıËÎ·Ó Û˘Ó·ÓÙ‹ÛÂȘ ÙˆÓ ÂÈÛÙËÌfiÓˆÓ ÙÔ˘ ∫.À.¶.∫. Ì ٷ ̤ÏË ÙÔ˘ √ÈÎÔÏÔÁÈÎÔ‡ ∂ÚÁ·ÛÙËÚ›Ô˘ Î·È ÂÎÚÔÛÒÔ˘˜ ÙˆÓ

ÊÔÚ¤ˆÓ, Ì ÛÙfi¯Ô ÙËÓ ÂÎÙ›ÌËÛË Ù˘ Û˘ÓÔÏÈ΋˜ ÂÌÂÈÚ›·˜.

∞ÔÙÂϤÛÌ·Ù· ¶Ú·ÁÌ·ÙÔÔÈ‹ıËÎ·Ó ·ÚÔ˘ÛÈ¿ÛÂȘ ·Ó¿ Ù̷̋ Û οı ‰ËÌÔÙÈÎfi Û¯ÔÏÂ›Ô Î·È ÛÙ· ‰‡Ô Á˘ÌÓ¿ÛÈ· Ù˘ ÂÚÈÔ¯‹˜ (Û‡ÓÔÏÔ ·ÚÔ˘ÛÈ¿ÛÂˆÓ 120 Î·È 28, ·ÓÙ›ÛÙÔȯ·).

∏ ·ÍÈÔÏfiÁËÛË Ù˘ ·ÔÙÂÏÂÛÌ·ÙÈÎfiÙËÙ·˜ ÙˆÓ ·ÚÔ˘ÛÈ¿ÛÂˆÓ ¤ÁÈÓ Ì 3 ÙÚfiÔ˘˜: 1. ™ÙÔ Û‡ÓÔÏÔ ÙˆÓ ·È‰ÈÒÓ Ù˘ ∂ã-™∆ã ‰ËÌÔÙÈÎÔ‡ (Ó=363) ¯ÔÚËÁ‹ıËÎ·Ó ÌÂÙ¿ ÙȘ ·ÚÔ˘ÛÈ¿ÛÂȘ ÂÚˆÙËÌ·ÙÔÏfiÁÈ· ÁÓÒÛˆÓ, Ì ··ÓÙ‹ÛÂȘ ÛˆÛÙfi-Ï¿ıÔ˜, Ì ÛÎÔfi ÙËÓ ÂÎÙ›ÌËÛË ÙÔ˘ ÁÓˆÛÙÈÎÔ‡ ÙÔ˘˜ ÂÈ¤‰Ô˘ ÛÙȘ ıÂÌ·ÙÈΤ˜ ÂÓfiÙËÙ˜ ¢È·ÙÚÔÊ‹ / ∞ÁÁ›˙ˆ-∞Ó·Ó¤ˆ-¶›Óˆ. ™ÙËÓ Î·Ù·ÓÔÌ‹ (∂ÈÎfiÓ· 1) Ê·›ÓÂÙ·È fiÙÈ Ë ‰È·ÌfiÚʈÛË ÙÔ˘ ÁÓˆÛÙÈÎÔ‡

¢ËÌÔÙÈο∫·Ù¿ÏÏËÏÔ ÂÚȯfiÌÂÓÔ33,3%56,3%9,4%1%-™ËÌ·ÓÙÈÎfi73,7%25,3%1,1%--∂ӉȷʤÚÔÓ46,9%45,8%6,3%1%-ÃÚ‹ÛÈÌÔ69,5%28,4%2,1%--°˘ÌÓ¿ÛÈ·∫·Ù¿ÏÏËÏÔ ÂÚȯfiÌÂÓÔ47,4%36,8%15,8%--™ËÌ·ÓÙÈÎfi66,7%33,3%---∂ӉȷʤÚÔÓ60%35%5%--ÃÚ‹ÛÈÌÔ76,2%23,8%----

¶·ÚÔ˘Û›·ÛË ∂Í·ÈÚÂÙÈο ¶Ôχ

¢ËÌÔÙÈο™·Ê‹˜39,2%41,2%18,6%1,0%-∑ˆÓÙ·Ó‹23,7%51,5%16,5%8,2%-∂˘¤ÏÈÎÙË22,1%46,3%21,1%9,5%1,1%°˘ÌÓ¿ÛÈ·™·Ê‹˜57,1%33,3%9,5%--∑ˆÓÙ·Ó‹45,0%35%20,0%--∂˘¤ÏÈÎÙË45,5%18,2%31,8%4,5%--

ÌÂÙ¿ Î·È ÙȘ ·ÚÔ˘ÛÈ¿ÛÂȘ (ÚÔ¸¿Ú¯Ô˘Û˜ Î·È Ó¤Â˜ ÁÓÒÛÂȘ) ‚Ú›ÛÎÂÙ·È Û Â›Â‰Ô ÈηÓÔÔÈËÙÈÎfi ¤ˆ˜

¿ÚÈÛÙÔ (91,5% Î·È 78,0% ÁÈ· ÙȘ ‰˘Ô ÂÓfiÙËÙ˜ ·ÓÙ›ÛÙÔȯ·). ¶·Ú·ÙËÚÂ›Ù·È Î·Ï‡ÙÂÚÔ Â›Â‰Ô ÁÓÒÛˆÓ

ÛÙËÓ ÂÓfiÙËÙ· Ù˘ ‰È·ÙÚÔÊ‹˜, ÙÔ ÔÔ›Ô ı· ÌÔÚÔ‡ÛÂ

Ó· ·Ô‰Ôı› ÛÙË Û˘¯ÓfiÙÂÚË ÚÔÛ¤ÁÁÈÛË ÙÔ˘ ı¤Ì·ÙÔ˜ ·fi ÙÔ Û¯ÔÏÈÎfi Î·È ÔÈÎÔÁÂÓÂÈ·Îfi ÂÚÈ‚¿ÏÏÔÓ.

2. ªÂ ÛÎÔfi ÙËÓ ÂÎÙ›ÌËÛË Ù˘ ¿ÌÂÛ˘ ·ÔÙÂÏÂÛÌ·ÙÈÎfiÙËÙ·˜ ÙˆÓ ·ÚÔ˘ÛȿۈÓ, ‰ÈÂÚ¢ӋıËΠË

ÌÂÙ·ÙfiÈÛË ÁÓÒÛˆÓ, Ì ¯ÔÚ‹ÁËÛË ·Ó¿ÏÔÁˆÓ ÂÚˆ-

ÙËÌ·ÙÔÏÔÁ›ˆÓ Û ·ÓÙÈÚÔÛˆ¢ÙÈÎfi ‰Â›ÁÌ· (200/363, 55%) ·È‰ÈÒÓ Ù˘ ∂ã Î·È ™∆ã ‰ËÌÔÙÈÎÔ‡,

ÚÈÓ Î·È ÌÂÙ¿ ÙË ‰ÈÂÓ¤ÚÁÂÈ· ÙˆÓ ·ÚÔ˘ÛȿۈÓ.

Ÿˆ˜ Ê·›ÓÂÙ·È ÛÙËÓ ∂ÈÎfiÓ· 2, ·Ú·ÙËÚÂ›Ù·È ÌÂÙ·ÙfiÈÛË ÙÔ˘ ‰Â›ÁÌ·ÙÔ˜ ÚÔ˜ ÙËÓ Î·ÙËÁÔÚ›· ÙˆÓ 1617 ÛˆÛÙÒÓ ··ÓÙ‹ÛˆÓ, Ô˘ ·ÓÙÈÚÔÛˆ‡ÂÈ ÙËÓ

¿ÚÈÛÙË Â›‰ÔÛË. ∏ ÌÂÙ·ÙfiÈÛË ·˘Ù‹ Â›Ó·È ÛÙ·ÙÈÛÙÈο ÛËÌ·ÓÙÈ΋ (p<0,01).

3. ∞ÍÈÔÏÔÁ‹ıËÎ·Ó ÔÈ ·ÚÔ˘ÛÈ¿ÛÂȘ ·fi ÙÔ˘˜ ÂÎ-

·È‰Â˘ÙÈÎÔ‡˜ ÙÔ˘ ‰ËÌÔÙÈÎÔ‡ Î·È ÙÔ˘ Á˘ÌÓ·Û›Ô˘ ÌÂ

ÙË ¯ÔÚ‹ÁËÛË ÂÚˆÙËÌ·ÙÔÏÔÁ›Ô˘ (¶›Ó·Î˜ 1,2,3). ªÂ ‚¿ÛË Ù· ·ÔÙÂϤÛÌ·Ù·:

I. ∆Ô ÂÚȯfiÌÂÓÔ ÙˆÓ ·ÚÔ˘ÛÈ¿ÛÂˆÓ ÎÚ›ıËÎÂ

ÂÍ·ÈÚÂÙÈο ¤ˆ˜ Ôχ ηٿÏÏËÏÔ ·Ó¿ ËÏÈÎȷ΋ ÔÌ¿‰· ·fi 89,6% ÙˆÓ ÂÎ·È‰Â˘ÙÈÎÒÓ ÛÙ· ‰ËÌÔÙÈο Î·È 84,2% ÛÙ· Á˘ÌÓ¿ÛÈ·. ∂›Û˘, ÙÔ ı¤Ì· ÙˆÓ ·ÚÔ˘-

ÛÈ¿ÛÂˆÓ ·ÍÈÔÏÔÁ‹ıËΠˆ˜ ÛËÌ·ÓÙÈÎfi, ¯Ú‹ÛÈÌÔ Î·È

ÂӉȷʤÚÔÓ Û ·ÓÙ›ÛÙÔÈ¯Ô ‚·ıÌfi, ·fi ÙË Û˘ÓÙÚÈ-

ÙÈ΋ ÏÂÈÔ„ËÊ›· ÙˆÓ ÂÎ·È‰Â˘ÙÈÎÒÓ (¶›Ó·Î·˜ 1).

II. √ ÙÚfiÔ˜ ·ÚÔ˘Û›·Û˘ ·fi ÙÔ˘˜ ÔÌÈÏËÙ¤˜

ÂÎÙÈÌ‹ıËΠ·fi ÙÔ˘˜ ÂÎ·È‰Â˘ÙÈÎÔ‡˜ ˆ˜ Ôχ ¤ˆ˜ ÂÍ·ÈÚÂÙÈο Û·Ê‹˜, ˙ˆÓÙ·Ófi˜ Î·È Â˘¤ÏÈÎÙÔ˜ (¶›Ó·Î·˜ 2).

III. ∏ ·ÍÈÔÏfiÁËÛË Ù˘ Û˘ÌÂÚÈÊÔÚ¿˜ Ù˘ Ù¿Í˘ ÂÎÙÈÌ‹ıËΠ̠‚¿ÛË ÙÔÓ ‚·ıÌfi ÚÔÛÔ¯‹˜ Î·È Û˘ÌÌÂ-

ÙÔ¯‹˜, Ô˘ ıˆڋıËÎ·Ó ·ÚÎÂÙ¿ ¤ˆ˜ Ôχ ÈηÓÔÔÈ-

ËÙÈΤ˜ ·fi ÙÔ Û‡ÓÔÏÔ Û¯Â‰fiÓ ÙˆÓ ÂÎ·È‰Â˘ÙÈÎÒÓ (¶›Ó·Î·˜ 3). ¶·Ú·ÙËÚ‹ıËΠÌÈ· ‰È·ÊÔÚ¿ ÛÙÔ ‚·ıÌfi

Û˘ÌÌÂÙÔ¯‹˜ ÌÂٷ͇ ÙˆÓ ·È‰ÈÒÓ ÙÔ˘ ‰ËÌÔÙÈÎÔ‡ ηÈ

ÙÔ˘ Á˘ÌÓ·Û›Ô˘, Ô˘ fï˜ ‰ÂÓ ÌÔÚ› Ó· ·Ô‰Ôı›

ÛÙËÓ ¤ÏÏÂÈ„Ë ÚÔÛÔ¯‹˜ ‹ ÂӉȷʤÚÔÓÙÔ˜, ·ÏÏ¿ ı·

(16), ÂÓÒ Ô ÚfiÏÔ˜ Ù˘ ÚˆÙÔ‚¿ıÌÈ·˜ ÊÚÔÓÙ›-

˘Á›·˜ Û Â›Â‰Ô ÎÔÈÓfiÙËÙ·˜ ¤¯ÂÈ ·Ó·ÁÓˆÚÈÛı› ˆ˜ ȉȷ›ÙÂÚ· ÛËÌ·ÓÙÈÎfi˜ ÁÈ· ÙË ‚ÂÏÙ›ˆÛË Ù˘ ˘Á›·˜ ÙÔ˘ ÏËı˘ÛÌÔ‡ (17). ¶ÚÔ¸Ôı¤ÙÂÈ, fï˜, Û‡ÛÙËÌ· ˘Á›·˜ ÚÔÛ·Ó·ÙÔÏÈṲ̂ÓÔ ÛÙËÓ ÚˆÙÔ‚¿ıÌÈ· ÊÚÔÓÙ›‰·, ηٿÏÏËÏË ÂÎ·›‰Â˘ÛË Î·È ¯ÚfiÓÔ, ÒÛÙ ӷ ηٷÓÔ‹ÛÔ˘Ó ÔÈ Â·ÁÁÂÏ̷ٛ˜ ˘Á›·˜ ÙȘ ·Ó¿ÁΘ ˘Á›·˜ Ù˘ ÂοÛÙÔÙ ÎÔÈÓfiÙËÙ·˜, Ó· ıÂÌÂÏÈÒÛÔ˘Ó Û¯¤ÛÂȘ ÂÌÈÛÙÔÛ‡Ó˘ Î·È Ó· ÚÔ·Á¿ÁÔ˘Ó ÙËÓ ÎÔÈÓÔÙÈ΋ Û˘ÌÌÂÙÔ¯‹. ¶·Ú¿ÏÏËÏ·, Ù· ̤ÏË Ù˘ ÎÔÈÓfiÙËÙ·˜ ¯ÚÂÈ¿˙ÔÓÙ·È Û˘ÛÙËÌ·ÙÈ΋ ÂÓı¿ÚÚ˘ÓÛË Î·È ‰˘Ó·ÙfiÙËÙ·, ÒÛÙ ӷ ÌÔÚ¤ÛÔ˘Ó ÂÓÂÚÁ¿ Ó· Û˘ÌÌÂÙ¤¯Ô˘Ó Î·È Ó· ÌËÓ Â›Ó·È ·ıËÙÈÎÔ› ‰¤ÎÙ˜ ·ÔʿۈÓ.

™ÙËÓ ∂ÏÏ¿‰·, ÔÈ Â·ÁÁÂÏ̷ٛ˜ ˘Á›·˜ ‰ÂÓ

¤¯Ô˘Ó ÂÎ·›‰Â˘ÛË Û¯ÂÙÈ΋ Ì ÙËÓ ÚÔ·ÁˆÁ‹ Ù˘

˘Á›·˜ Î·È ‰ÂÓ ÌÔÚÔ‡Ó Â‡ÎÔÏ· Ó· ·ÔÛÙ·ÛÈÔÔÈË-

ıÔ‡Ó ·fi ÙÔÓ ·Ú·‰ÔÛÈ·Îfi ÙÔ˘˜ ÚfiÏÔ, ÂÓÒ Ù· ̤ÏË

Ù˘ ÎÔÈÓfiÙËÙ·˜, ›Ù ÁÈ·Ù› ¤¯Ô˘Ó Û˘ÓËı›ÛÂÈ Â›Ù ÁÈ·Ù› ̤¯ÚÈ ÙÒÚ· ‰ÂÓ Â›¯·Ó ¿ÏÏË ÂÈÏÔÁ‹, Â›Ó·È ÂÚÈÛÛfiÙÂÚÔ ·ıËÙÈÎÔ› ‰¤ÎÙ˜ ·ÔÊ¿ÛÂˆÓ Î·È ÏËÚÔÊÔÚÈÒÓ

¢ËÌÔÙÈοªÂ ÚÔÛÔ¯‹15,5%45,4%34,0%5,2%-ªÂ Û˘ÌÌÂÙÔ¯‹15,3%38,8%34,7%11,2%-°˘ÌÓ¿ÛÈ·ªÂ ÚÔÛÔ¯‹35%25%40%--ªÂ Û˘ÌÌÂÙÔ¯‹15%25%20%35%5%-

¢ÈÂÚ‡ÓËÛË Ù˘ ÂÊ·ÚÌÔÁ‹˜ Ù˘ ÓÔÌÔıÂÛ›·˜

ÁÈ· ÙËÓ

ÎÔÈÓÒÓ

ÙÚfiÊÈÌ·

∞. µ·ÛÈÏÔÔ‡ÏÔ˘1, ∂. ™ÙÚÔ˘Ì‹2, ¡.°. ¶··‰fiÔ˘ÏÔ˜1, µ. ∫·Ú·ı¿ÓÔ˜2

¶ÂÚ›ÏË„Ë

∂ÈÛ·ÁˆÁ‹: ∏ ı¤ÛÈÛË ÓÔÌÔıÂÛ›·˜ ·fi ÙËÓ ∂˘Úˆ·˚΋ ŒÓˆÛË Û¯ÂÙÈο Ì ÙËÓ ÂÈÛ‹Ì·ÓÛË ÙˆÓ ÙÚÔʛ̈Ó

ÛÙԯ‡ÂÈ ÛÙËÓ Â›Ù¢ÍË ÂÓfi˜ ˘„ËÏÔ‡ ÂÈ¤‰Ô˘ ÚÔÛÙ·Û›·˜ Ù˘ ˘Á›·˜ Î·È ÛÙË ‰È·ÛÊ¿ÏÈÛË ÙÔ˘ ‰ÈηÈÒ-

Ì·ÙÔ˜ Ô˘ ¤¯Ô˘Ó Î·È ÔÈ ·ÏÏÂÚÁÈÎÔ› ηٷӷψ٤˜ ÛÙËÓ ÂÓË̤ڈÛË. ™ÎÔfi˜ ·˘Ù‹˜ Ù˘ ÌÂϤÙ˘ ‹Ù·Ó Ô

¤ÏÂÁ¯Ô˜ Î·È Ë ·ÍÈÔÏfiÁËÛË Ù˘ ÂÈÛ‹Ì·ÓÛ˘ Û˘ÁÎÂÎÚÈÌ¤ÓˆÓ ·ÏÏÂÚÁÈÔÁfiÓˆÓ Î·È ·Ú·ÁÒÁˆÓ ÙÔ˘˜ Û 198

ÂÈÏÂÁ̤ӷ ÙÚfiÊÈÌ· (ÌÈÛÎfiÙ·, ÛÔÎÔϿ٘ ˘Á›·˜ Î·È Á¿Ï·ÎÙÔ˜, „ˆÌ› Û˘Û΢·Ṳ̂ÓÔ) Ù˘ ÂÏÏËÓÈ΋˜ ·ÁÔÚ¿˜, ηْ ÂÊ·ÚÌÔÁ‹ Ù˘ ÈÛ¯‡Ô˘Û·˜ ÓÔÌÔıÂÛ›·˜ Î·È ÙˆÓ ÚÔÏËÙÈÎÒÓ Ì¤ÙÚˆÓ ÁÈ· ÙËÓ ·ÔÊ˘Á‹ ÂÈÌfiÏ˘ÓÛ˘ ÙˆÓ ÚÔ˚fiÓÙˆÓ Î·Ù¿ ÙËÓ ·Ú·ÁˆÁÈ΋ ‰È·‰Èηۛ·.

ÀÏÈÎfi Î·È Ì¤ıÔ‰ÔÈ: ∞Ó·Ï˘ÙÈ΋ ‰ÈÂÚ‡ÓËÛË Î·È Î·Ù·ÁÚ·Ê‹

ÈÛ¯‡Ô˘Û·˜ ÓÔÌÔıÂÛ›·˜ ÁÈ· ÙËÓ ÂÈÛ‹Ì·Ó-

ÛË ·ÏÏÂÚÁÈÔÁfiÓˆÓ. ∞ÍÈÔÏfiÁËÛË ÙˆÓ ÂÙÈÎÂÙÒÓ ÂÈÏÂÁÌ¤ÓˆÓ ÙÚÔʛ̈Ó

·ÊÔÚ¿ ÙËÓ ÂÊ·ÚÌÔÁ‹ ÙˆÓ Î·ÓfiÓˆÓ ·fi ÙȘ ‚ÈÔÌ˯·ÓÈΤ˜ ÌÔÓ¿‰Â˜, ηıÒ˜ Î·È ÙˆÓ Ì¤ÙÚˆÓ

ÌÂ

ÂÚˆÙËÌ·ÙÔÏÔÁ›Ô˘ ηÈ

·ÏÏÂÚÁÈÔÁfiÓˆÓ

∞ÔÙÂϤÛÌ·Ù·: ∆· ÙÚÔÊÈο ·ÏÏÂÚÁÈÔÁfiÓ· Ô˘ ÌÂÏÂÙ‹ıËÎ·Ó ·Ó·ÁÚ¿ÊÔÓÙ·Ó ÛÙȘ ÂÙÈΤÙ˜ Ì ÔÏÏÔ‡˜ ‰È·ÊÔÚÂÙÈÎÔ‡˜ ÙÚfiÔ˘˜ (7 ÁÈ· ÙÔ ÛÈÙ¿ÚÈ, 29 ÁÈ· ÙÔ Á¿Ï·, 6 ÁÈ· ÙÔ ·‚Áfi, 8 ÁÈ· ÙÔ˘˜ ÍËÚÔ‡˜ ηÚÔ‡˜ ‰¤Ó‰ÚˆÓ, 2 ÁÈ· ÙÔ ·Ú¿ÈÎÔ ÊÈÛÙ›ÎÈ, 5 ÁÈ· ÙË ÛfiÁÈ·), ÂÓÒ Û˘¯Ó‹ ‹Ù·Ó Î·È Ë ¯Ú‹ÛË Ù¯ÓÈÎÒÓ fiÚˆÓ Î·È ÚÔÏËÙÈ΋˜ ÂÈÛ‹Ì·ÓÛ˘ ÁÈ· ÙË ‰‹ÏˆÛË Ù˘ Èı·Ó‹˜ ·ÚÔ˘Û›·˜ ÙÔ˘˜.

ÂÓÈ·›Ô˜

‰˘ÛÎÔÏÂ‡Ô˘Ó ÙÔÓ ·ÏÏÂÚÁÈÎfi ηٷӷψً Ó· ‚ÚÂÈ Î·È Ó· ÂÓÙ¿ÍÂÈ ÛÙÔ ‰È·ÈÙÔÏfiÁÈÔ ÙÔ˘ ÙÚfiÊÈÌ· ·ÛÊ·Ï‹ ·fi ÙȘ ÂÓ ÏfiÁˆ ηÙËÁÔڛ˜.

ÎÏÂȉȿ: ∂ÏÏËÓÈ΋ ·ÁÔÚ¿, ÂÈÛ‹Ì·ÓÛË, ÂÙÈΤÙ˜, ÙÚÔÊÈÎfi ·ÏÏÂÚÁÈÔÁfiÓÔ, ÓÔÌÔıÂÛ›·.

Application of the legislation on allergen labelling for selected food products in the Greek market

∞. Vassilopoulou1, ∂. Stroumpi2, ¡.G. Papadopoulos1, V. Karathanos2

Abstract

Introduction: Food labelling legislation has been established by the European Union (EU) for the protection of the health of consumers, in particular those who have food allergies, and to guarantee their right to be reliably informed about the food they consume. The aim of this study was to evaluate the labelling of food products available in the Greek market for certain allergens and their derivatives in 198 selected foods (biscuits, dark chocolate, milk, and packaged bread), with respect to the application of the EU legislation and the precautionary measures taken to avoid cross-contamination during production and sale.

Methods: The EU legislation on food labelling was reviewed in detail. Its application on selected food products was assessed by a detailed record of the terms used on packages to describe common allergens (milk, egg, wheat, peanuts, tree-nuts, soya). A standard questionnaire was used to evaluate the precautionary measures taken by the manufacturers to avoid cross contamination.

Results: Food allergens and their derivatives were recorded in a variety of ways on food packaging labels (7 for wheat, 29 for milk, 6 for egg, 8 for tree-nuts, 2 for peanuts and 5 for soya). The frequent use of complex terms to describe food allergens and the extensive use of precautionary labelling (65.66%) makes it impossible for the consumer to recognise a specific allergen. Companies report inability to avoid crosscontamination during production.

Conclusion: The use of complicated, non-specific terminology and precautionary labelling in the majority of products sold in the Greek market make it difficult to characterise a product as “allergen free”. It is

1 Allergology Research Center & Department of Allergology, 2nd University Department, “P. & A. Kyriakou” Children’s Hospital, Athens, Greece

2 Department of Nutrition, Harokopio University, Athens, Greece

Correspondence: Emilia Vassilopoulou evassil@allergy.gr

Allergology Research Center & Department of Allergology, 2nd University Department, “P. & A. Kyriakou” Children’s Hospital, Athens, Greece

almost impossible for the patient with food allergy to find and safely consume commercial products from the categories selected for evaluation.

Key words: Food allergen, food label, Greek market, labelling, legislation.

‰ÂÓ Â›Ó·È Û·Ê‹˜. øÛÙfiÛÔ, ηٿ ÙË ‰È¿ÚÎÂÈ·

ÙˆÓ ÙÂÏÂ˘Ù·›ˆÓ ‰ÂηÂÙÈÒÓ, Ë ÙÚÔÊÈ΋ ·ÏÏÂÚ-

Á›· ¤¯ÂÈ ·Ó·‰Âȯı› ˆ˜ ¤Ó· ÛÔ‚·Úfi Úfi‚ÏËÌ·

‰ËÌfiÛÈ·˜ ˘Á›·˜, Ì ·˘ÍË̤ÓË Â›ÙˆÛË (1).

¢Â‰ÔÌ¤ÓˆÓ ÙˆÓ ÂӉ¯Ô̤ӈ˜ ·ÂÈÏËÙÈÎÒÓ ÁÈ·

ÙË ˙ˆ‹ Û˘ÓÂÂÈÒÓ ÙˆÓ ÙÚÔÊÈÎÒÓ ·ÏÏÂÚÁÈÒÓ, Ù· ·ÏÏÂÚÁÈο ¿ÙÔÌ· ÛÙËÚ›˙ÔÓÙ·È Û ÌÂÁ¿ÏÔ ÔÛÔÛÙfi ÛÙȘ ‰›·ÈÙ˜ ·ÔÊ˘Á‹˜. ªÈ· ·˘ÛÙËÚ‹ ÚÔÛÎfiÏÏËÛË Û ‰›·ÈÙ· ·ÔÊ˘Á‹˜ Â›Ó·È ÙÔ ÛËÌ·ÓÙÈÎfiÙÂÚÔ ÚÔÏËÙÈÎfi ̤ÙÚÔ Î·È

ÛÙÔÓ ·fiÏ˘ÙÔ ·ÔÎÏÂÈÛÌfi ÙˆÓ

Î·È ÔÈ ÔÈÎÔÁ¤ÓÂȤ˜ ÙÔ˘˜ ˘Ô¯ÚÂÔ‡ÓÙ·È

ÙˆÓ

Û˘ÛÙ·ÙÈÎÒÓ Ô˘ ÂÌÂÚȤ¯ÔÓÙ·È ÛÙ· ÂÂÍÂÚÁ·-

Ṳ̂ӷ ÙÚfiÊÈÌ·. ø˜ Û˘Ó¤ÂÈ·, Ë Ù˘¯·›· ηٷӿ-

ψÛË ÙÚÔÊ›ÌˆÓ Ì ÎÚ˘Ì̤ӷ ·ÏÏÂÚÁÈÔÁfiÓ·

¤¯ÂÈ ·Ԃ› ÔÏϤ˜ ÊÔÚ¤˜ ÌÔÈÚ·›· (2).

°È’ ·˘ÙfiÓ ÙÔÓ ÏfiÁÔ, Â›Ó·È ÂÍ·ÈÚÂÙÈο ÛËÌ·-

ÓÙÈÎfi ÁÈ· ÙÔÓ ·ÏÏÂÚÁÈÎfi ηٷӷψً Ù· ÂÌÔ-

ÚÈο ÙÚfiÊÈÌ· Ó· ¤¯Ô˘Ó ·ÎÚÈ‚‹ Î·È ·Ó·ÌÊÈÛ‚‹-

ÙËÙË ÂÈÛ‹Ì·ÓÛË. ™Â ¯ÒÚ˜ ÂÎÙfi˜ ∂˘Úˆ·˚΋˜ ŒÓˆÛ˘, ·Ú’

fiÏÔ Ô˘ ¤¯Ô˘Ó ·Ó·Ù˘¯ı› ‰È·ÊÔÚÂÙÈΤ˜ ÓÔ-

ÌÔıÂۛ˜ Î·È Ô‰ËÁ›Â˜ ·fi ‰È¿ÊÔÚÔ˘˜ ÂıÓÈÎÔ‡˜

Î·È ‰ÈÂıÓ›˜ ÔÚÁ·ÓÈÛÌÔ‡˜, ÔÏϤ˜ ÊÔÚ¤˜ ˘¿Ú¯Ô˘Ó ÔÌÔÈfiÙËÙ˜. ™ÙË ¡. ∑ËÏ·Ó‰›·, ÙÔ 2002, Ù· ÚfiÙ˘· ÙÚÔÊ›ÌˆÓ ·Ó·Ê¤ÚÔ˘Ó fiÙÈ ˘¿Ú¯Ô˘Ó ÔÎÙÒ ‚·ÛÈο ·ÏÏÂÚÁÈÔÁfiÓ· (ı·Ï·ÛÛÈÓ¿, Á¿Ï·, ÊÈÛÙ›ÎÈ·, ÍËÚÔ› ηÚÔ›, ÛÔ˘Û·ÌfiÛÔÚÔÈ, ÛfiÁÈ·, ÛÈÙËÚ¿ Î·È ·‚Á¿), Ù· ÔÔ›· ı· Ú¤ÂÈ Ó· ÂÈÛËÌ·›ÓÔÓÙ·È

¿Óˆ ÛÙȘ ÂÙÈΤÙ˜ ÙˆÓ ÙÚÔʛ̈Ó, ·ÓÂÍ·Úًو˜ ÔÛfiÙËÙ·˜ (3). ™ÙËÓ ∞ÌÂÚÈ΋, Û‡Ìʈӷ Ì ÙÔÓ ÓfiÌÔ ÚÔÛÙ·Û›·˜ ηٷӷψÙÒÓ (4) ÁÈ· ÙËÓ ÂÈÛ‹Ì·ÓÛË

ÁfiÓ·, ·ÎfiÌ· Î·È fiÙ·Ó ·˘Ù¿ ¯ÚËÛÈÌÔÔÈÔ‡ÓÙ·È ˆ˜ ·ÚÒÌ·Ù·, ÚfiÛıÂÙ· Î·È ¯ÚˆÛÙÈΤ˜ (5). ∏ ·ÚÔ‡Û· ÌÂϤÙË ·ÔÛÎÔ› ÛÙÔÓ ¤ÏÂÁ¯Ô Î·È ÙËÓ ·ÍÈÔÏfiÁËÛË Ù˘ Â› ÙÔ˘ ·ÚfiÓÙÔ˜ ÂÈÛ‹Ì·ÓÛ˘ ÂÈÏÂÁÌ¤ÓˆÓ ·ÏÏÂÚÁÈÔÁfiÓˆÓ ÛÙËÓ ÂÏÏËÓÈ΋ ·ÁÔÚ¿, ÁÓˆÛÙÒÓ ÁÈ· ÙË Û˘¯Ó‹ ÚfiÎÏËÛË ·ÏÏÂÚÁÈÎÒÓ ·ÓÙȉڿÛˆÓ, ΢ڛˆ˜ Û ·È‰È¿ Ó·ڋ˜ ËÏÈΛ·˜, ηıÒ˜ Î·È ÙˆÓ ·Ú·ÁÒÁˆÓ ÙÔ˘˜, Û ÂÈÏÂÁ̤ӷ ÙÚfiÊÈÌ· (ÛÔÎÔϿ٘ ˘Á›·˜ Î·È Á¿Ï·ÎÙÔ˜, ÌÈÛÎfiÙ·, „ˆÌ› Û˘Û΢·Ṳ̂ÓÔ), ·fi ÏÂ˘Ú¿˜: - ÓÔÌÔıÂÛ›·˜ (ÂÏÏËÓÈ΋˜ Î·È Â˘Úˆ·˚΋˜) - ¤Ú¢ӷ˜ ·ÁÔÚ¿˜ Û 2 ÌÂÁ¿Ï· ηٷÛÙ‹Ì·Ù· ÙÚÔÊ›ÌˆÓ - ÚÔÏËÙÈÎÒÓ Ì¤ÙÚˆÓ ÙˆÓ ‚ÈÔÌ˯·ÓÈÒÓ, ÚÔ˜ ·ÔÊ˘Á‹ ÂÈÌfiÏ˘ÓÛ˘ ÙˆÓ ÚÔ˚fiÓÙˆÓ

™ÎÔfi˜ Â›Ó·È Ë ‰ÈÂÚ‡ÓËÛË Ù˘ ÈÛ¯‡Ô˜ ÙˆÓ Ì¤ÙÚˆÓ Ô˘ Ï·Ì‚¿ÓÔÓÙ·È ÁÈ· ÙËÓ ·ÛÊ¿ÏÂÈ· ÙˆÓ ·ÏÏÂÚÁÈÎÒÓ Î·Ù·Ó·ÏˆÙÒÓ, ηıÒ˜ Î·È Ù˘ ‰È·ıÂÛÈÌfiÙËÙ·˜ ÚÔ˚fiÓÙˆÓ Â˘Ú›·˜ ηٷӿψÛ˘ ÁÈ· ÙÔ˘˜ Û˘ÁÎÂÎÚÈ̤ÓÔ˘˜ ·ÛıÂÓ›˜.

ÀÏÈÎfi Î·È Ì¤ıÔ‰ÔÈ

¢ÈÂÚ‡ÓËÛË ÈÛ¯‡Ô˘Û·˜ ÓÔÌÔıÂÛ›·˜ ÁÈ· ÙËÓ ÂÈÛ‹Ì·ÓÛË ·ÏÏÂÚÁÈÔÁfiÓˆÓ ÛÙËÓ ÂÏÏËÓÈ΋ ·ÁÔÚ¿

∏ ÈÛ¯‡Ô˘Û· ÓÔÌÔıÂÛ›· ÛÙËÓ ∂ÏÏ¿‰· ÁÈ· ÙËÓ ÂÈÛ‹Ì·ÓÛË ÙÚÔÊÈÎÒÓ ·ÏÏÂÚÁÈÔÁfiÓˆÓ Â›Ó·È ÎÔÈÓ‹ Ì ÙËÓ Â˘Úˆ·˚΋. ™ÙÔ Ï·›ÛÈÔ Ù˘ ·ÚÔ‡Û·˜ ÌÂϤÙ˘, Ë ÓÔÌÔıÂÛ›· ‰ÈÂÚ¢ӋıËΠ̤ۈ Ù˘ Â›ÛËÌ˘ ÈÛÙÔÛÂÏ›‰·˜ Ù˘ Â˘Úˆ·˚΋˜ ÓÔÌÔıÂÛ›·˜ (6), ·ÏÏ¿ Î·È ÙÔ˘ ∂ÓÈ·›Ô˘ ºÔÚ¤· ∂ϤÁ¯Ô˘ ∆ÚÔÊ›ÌˆÓ (∂º∂∆).

ŒÏÂÁ¯Ô˜ ÂÊ·ÚÌÔÁ‹˜ ÓÔÌÔıÂÙÈÎÒÓ Ú˘ıÌ›ÛÂˆÓ Û ÂÈÏÂÁ̤ӷ ÚÔ˚fiÓÙ· ∏ ·ÍÈÔÏfiÁËÛË Ù˘ ÂÊ·ÚÌÔÁ‹˜ Ù˘ ÓÔÌÔıÂÛ›·˜ Û ÚÔ˚fiÓÙ· Ù˘ ÂÏÏËÓÈ΋˜ ·ÁÔÚ¿˜ ¤ÁÈÓ ÁÈ· ÎÔÈÓ¿ ·ÏÏÂÚÁÈÔÁfiÓ·, ˘‡ı˘Ó· ÁÈ· ÚfiÎÏËÛË ·ÏÏÂÚÁÈÎÒÓ ·ÓÙȉڿÛÂˆÓ Î˘Ú›ˆ˜ Û ·ÏÏÂÚÁÈο ·È‰È¿ (7), ηıÒ˜ Î·È ‚¿ÛÂÈ ÙˆÓ ÎÏÈÓÈÎÒÓ ÂÚÈÛÙ·ÙÈÎÒÓ Ô˘ ·Ó·Ê¤ÚÔÓÙ·È ÛÙÔ ∞ÏÏÂÚÁÈÔÏÔÁÈÎfi Ù̷̋ ÙÔ˘ ¡ÔÛÔÎÔÌ›Ԣ ¶·›‰ˆÓ ∞ıËÓÒÓ “¶. & ∞. ∫˘ÚÈ·ÎÔ‡” . ∏ ÂÈÏÔÁ‹ ÙˆÓ ˘fi ÌÂϤÙË ÚÔ˚fiÓÙˆÓ ¤ÁÈÓ Ì ‚¿ÛË ÁÓˆÛÙ¤˜ ÚÔÙÈÌ‹ÛÂȘ ·ÙfiÌˆÓ Ó·ڋ˜ ËÏÈΛ·˜, fiˆ˜ Â›Ó·È ÔÈ ÛÔÎÔϿ٘ ˘Á›·˜ Î·È Á¿Ï·ÎÙÔ˜, Ù· ÌÈÛÎfiÙ· Î·È Ù· Û˘Û΢·Ṳ̂ӷ „ˆÌÈ¿. ∏ ¤Ú¢ӷ ·ÁÔÚ¿˜ Ú·ÁÌ·ÙÔÔÈ‹ıËΠ۠2 ÌÂÁ¿Ï· ÔÏ˘Î·Ù·ÛÙ‹Ì·Ù· ÙÚÔʛ̈Ó, ηٿ ÙÔ ¯ÚÔÓÈÎfi ‰È¿ÛÙËÌ· √ÎÙˆ‚Ú›Ô˘-ª·˝Ô˘ 2007, fiÔ˘ ηٷÁÚ¿ÊËΠ̠ÏÂÙÔ̤ÚÂÈ· Ë Û‡ÛÙ·ÛË ÙˆÓ ÂÈÏÂÁÌ¤ÓˆÓ ÙÚÔʛ̈Ó, fiˆ˜ ·˘Ù‹ ·Ó·ÊÂÚfiÙ·Ó ÛÙËÓ ÂÙÈΤٷ ÙÔ˘˜.

∏ ÛÙ‹ÏË ππ ˘Ô‰ËÏÒÓÂÈ Ù· ·ÏÏÂÚÁÈÔÁfiÓ· Ô˘ ÌÔÚ› Ó· ˘¿Ú¯Ô˘Ó Û ¿ÏÏ· ÚÔ˚fiÓÙ· ÁÈ· Ù· ÔÔ›· ¯ÚËÛÈÌÔÔÈÂ›Ù·È Ô ›‰ÈÔ˜

ÂÍÔÏÈÛÌfi˜, Û ‰È·ÊÔÚÂÙÈ΋ ¯ÚÔÓÈ΋ ÛÙÈÁÌ‹.

∏ ÛÙ‹ÏË πππ ˘Ô‰ËÏÒÓÂÈ ·Ó ˘¿Ú¯Ô˘Ó ÔÔÈ·‰‹ÔÙ ·ÏÏÂÚÁÈÔÁfiÓ· ÛÙÔ Ï¿ÓÔ Û·˜.

™˘ÌÏËÚÒÛÙ ٷ ÎÂÏÈ¿ Ì ¤Ó· ¡∞π ‹ √Ãπ ηÈ, fiÙ·Ó Ú¤ÂÈ, Ì ÙÔ fiÓÔÌ· ÙÔ˘ Û˘ÛÙ·ÙÈÎÔ‡. ªËÓ ·Ê‹ÛÂÙ ¿‰ÂÈ· ÎÂÏÈ¿.

™Ù‹ÏË π™Ù‹ÏË ππ™Ù‹ÏË πππ

™˘ÛÙ·ÙÈο¶·ÚfiÓ ¶·ÚfiÓ Û ¿ÏÏ· ÚÔ˚fiÓÙ· Ô˘¶·ÚfiÓ ÛÙÔ ›‰ÈÔ

ÛÙÔ ÚÔ˚fiÓÚÔ¤Ú¯ÔÓÙ·È ·fi ÙËÓ ›‰È· ‚ÈÔÌ˯·ÓÈÎfi Ï¿ÓÔ

ÁÚ·ÌÌ‹ ·Ú·ÁˆÁ‹˜

°ÂÓÈο

ºÈÛÙ›ÎÈ ‹ ·Ú¿ÁˆÁ¿ ÙÔ˘

∫·ÚÔ› ‰¤ÓÙÚˆÓ (·Ì‡Á‰·Ï·, ηڇ‰È·,

οÛÈÔ˘˜, ÊÔ˘ÓÙÔ‡ÎÈ·, Î.·.) Î·È ·Ú¿ÁˆÁ¿ ÙÔ˘˜

™Ô˘Û¿ÌÈ ‹ ·Ú¿ÁˆÁ¿ ÙÔ˘

°¿Ï· ‹ ·Ú¿ÁˆÁ¿ ÙÔ˘

∞‚Á¿ ‹ ·Ú¿ÁˆÁ¿ ÙÔ˘˜

æ¿ÚÈ· ‹ ·Ú¿ÁˆÁ¿ ÙÔ˘˜

√ÛÙÚ·ÎÔÂȉ‹ ‹ ·Ú¿ÁˆÁ¿ ÙÔ˘˜

™fiÁÈ· ‹ ·Ú¿ÁˆÁ¿ Ù˘, .¯. ÏÂÎÈı›ÓË

™ÈÙ¿ÚÈ ‹ ·Ú¿ÁˆÁ¿ ÙÔ˘, .¯. ·Ï‡ÚÈ

™Ô˘ÏÊ›‰Â˜, .¯. ˆ˜ Ê˘ÛÈÎfi Û˘ÛÙ·ÙÈÎfi

·Ì˘ÏÔ‡¯Ô˘ ÙÚÔÊ›ÌÔ˘, fiˆ˜ ·Ù¿Ù·, ‹

ˆ˜ Û˘ÛÙ·ÙÈÎfi ˘ÏÈÎfi Û˘Û΢·Û›·˜ (cellophane)

ÕÏÏ· Ô˘ ıˆÚÔ‡ÓÙ·È ¯Ú‹ÛÈÌ·

Œ¯ÂÙ ‰È·‰Èηۛ˜ ·ÔÊ˘Á‹˜ Ù˘ ÂÈÌfiÏ˘ÓÛ˘ ÙÔ˘ ÚÔ˚fiÓÙÔ˜ Ì ·ÏÏÂÚÁÈÔÁfiÓ· Ô˘ ‰ÂÓ Â›Ó·È ·ÚfiÓÙ· ÛÙÔ ÚÔ˚fiÓ, ·ÏÏ¿ ›ӷÈ

ÛËÌÂȈ̤ӷ ÛÙȘ ÛًϘ ππ Î·È πππ; ¡∞π√Ãπ

¶·Ú·Î·ÏÒ ÂÈÛ˘Ó¿„Ù ÙËÓ ÂÙÈΤٷ ÂÓfi˜ ¤ÙÔÈÌÔ˘ ÚÔ˚fiÓÙÔ˜ Û ·˘Ù‹ ÙË ÊfiÚÌ·. ∞Ó ÁÈ· ÔÔÈÔ‰‹ÔÙ ÏfiÁÔ ˘¿ÚÍÔ˘Ó ·ÏÏ·Á¤˜

ÛÙÔ ÚÔ˚fiÓ, ›ÛÙ ˘‡ı˘ÓÔÈ ÁÈ· ÙËÓ ÂÓË̤ڈÛË ÙˆÓ ‰Â‰ÔÌ¤ÓˆÓ Û·˜, ·ÏÏ¿ Î·È ÁÈ· ÙËÓ ¿ÌÂÛË ÂÓË̤ڈۋ Ì·˜.

¢È‡ı˘ÓÛË ÚÔÌËıÂ˘Ù‹: ∆ÚfiÔ˜ Â·Ê‹˜ Ì ÙÔÓ ÚÔÌËıÂ˘Ù‹:

ÀÔÁÚ·Ê‹∏ÌÂÚÔÌËÓ›·

∞ÎÔÏÔ‡ıËÛ ÂÈÎÔÈÓˆÓ›· (Â› ÙfiÔ˘ Â›ÛÎÂ„Ë ‹ ÙËÏÂʈÓÈ΋ ÂÈÎÔÈÓˆÓ›·) Ì 3 ‚ÈÔÌ˯·Ó›Â˜ ÙÚÔʛ̈Ó, ·fi ÙȘ

Ôԛ˜ ÚÔ¤Ú¯ÔÓÙ·Ó Ù· Û˘ÁÎÂÎÚÈ̤ӷ ÚÔ˚fiÓÙ·. ∏ ·ÍÈÔÏfiÁËÛË ÙˆÓ Ì¤ÙÚˆÓ Ô˘ Ï·Ì‚¿ÓÔÓÙ·È Î·Ù¿ ÙËÓ ·Ú·ÁˆÁ‹ ¤ÁÈÓ ÌÂ Û˘ÁÎÂÎÚÈ̤ÓË ÊfiÚÌ· ηٷÁÚ·Ê‹˜ ·ÏÏÂÚÁÈÔÁfiÓˆÓ Û˘ÛÙ·ÙÈÎÒÓ ÁÈ· ÚÔÌËıÂ˘Ù¤˜ Î·È ·Ú·ÁˆÁÔ‡˜ ÙÚÔÊ›ÌˆÓ (¶›Ó·Î·˜ 1) (8). ªÂ ·˘Ù‹ ‰ÈÂÚ¢ӋıËÎÂ Ë ‡·ÚÍË Èı·ÓÒÓ “ÎÚ˘ÊÒÓ” ·ÏÏÂÚÁÈÔÁfiÓˆÓ ÛÙ· ÚÔ˚fiÓÙ· Î·È Ë Èı·Ó‹ ÂÈÌfiÏ˘ÓÛ‹ ÙÔ˘˜ ·fi Ù˘¯·›· ÚfiÛÌÈÍË

™Ù·ÙÈÛÙÈ΋ ·Ó¿Ï˘ÛË ∆· ‰Â‰Ô̤ӷ ηٷÁÚ¿ÊËÎ·Ó Î·È ·Ó·Ï‡ıËÎ·Ó Ì ¯Ú‹ÛË ÙÔ˘ ÚÔÁÚ¿ÌÌ·ÙÔ˜ Microsoft Excel. ∫·Ù·ÚÙ›ÛÙËÎ·Ó ÔÛÔÛÙÈ·›ÔÈ ›Ó·Î˜ ÁÈ· ÙËÓ ·ÚÔ˘Û›· ‹ ‰˘Ó·Ù‹ ·ÚÔ˘Û›· ¤Î·ÛÙÔ˘ ·ÏÏÂÚÁÈÔÁfiÓÔ˘ ¯ˆÚÈÛÙ¿ ÛÙ· ˘fi

2.

ÓÙ·È Â˘Ú¤ˆ˜ ÛÙËÓ ÂÏÏËÓÈ΋ ·ÁÔÚ¿

1. ∆È ÁÓˆÚ›˙ÂÙ ÁÈ· ÙË ÓÔÌÔıÂÛ›· fiÛÔÓ ·ÊÔÚ¿ ÙËÓ ÂÈÛ‹Ì·ÓÛË

·ÏÏÂÚÁÈÔÁfiÓˆÓ;

2. ¶·›ÚÓÂÙ οÔÈ· Û˘ÁÎÂÎÚÈ̤ӷ ̤ÙÚ· ÁÈ· ÙËÓ

·ÏÏÂÚÁÈÔÁÔÓÈÎfiÙËÙ·;

3. ¶Ò˜ ηı·Ú›˙ÂÙ ÙË ÁÚ·ÌÌ‹ ·Ú·ÁˆÁ‹˜;

4. À¿Ú¯ÂÈ Î¿ÔÈÔ ÚÔ˚fiÓ Ô˘ Ó· ¤¯ÂÈ Í¯ˆÚÈÛÙ‹ ÁÚ·ÌÌ‹;

5. ¶fiÛÔ ·ÛÊ·Ï‹ Â›Ó·È Ù· ÚÔ˚fiÓÙ· Û·˜; £· Û˘ÓÈÛÙÔ‡Û·Ù ÙËÓ Î·Ù·Ó¿ÏˆÛ‹ ÙÔ˘˜ Û ¿ÙÔÌ· Ì ·ÏÏÂÚÁ›Â˜;

·Ú¿ÁˆÁ¿ ÙÔ˘˜ Â›Ó·È ·ÚfiÓÙ· Î·È Ù· ÙÚfiÊÈÌ· ˆ-

ÏÔ‡ÓÙ·È ÚÔÛ˘Û΢·Ṳ̂ӷ, ηıÒ˜ Î·È fiÙ·Ó Ù· ·Ï-

ÏÂÚÁÈÔÁfiÓ· ¯ÚËÛÈÌÔÔÈÔ‡ÓÙ·È ˆ˜ ÚfiÛıÂÙ· Û ‰È·-

χÙ˜, ·ÚÒÌ·Ù· ‹ ·ÏÎÔÔÏÔ‡¯· ÔÙ¿ ηٿ ÙËÓ ÂÂ-

ÍÂÚÁ·Û›· ÙÚÔʛ̈Ó. ∏ √‰ËÁ›· 2003/89/ EC (11) ÁÈ·

ÙËÓ ÂÈÛ‹Ì·ÓÛË ÂÊ·ÚÌfiÛÙËΠÛÙ· ÎÚ¿ÙË Ì¤ÏË Ù˘

∂˘Úˆ·˚΋˜ ŒÓˆÛ˘ ÙÔ 2004, ηٷÚÁÒÓÙ·˜ ÙÔ˘˜ η-

ÓfiÓ˜ ÂÈÛ‹Ì·ÓÛ˘ ÙÚÔÊ›ÌˆÓ ÙÔ˘ 1996 (9,10), fiÔ˘

›Û¯˘Â Ô Î·ÓfiÓ·˜ ÙÔ˘ 25% (12), ηıÒ˜ Î·È ¿ÏÏÔ˘˜ ÙÚfi-

Ô˘˜ ηٷÁÚ·Ê‹˜. °È· ·Ú¿‰ÂÈÁÌ·, ˘‹Ú¯Â Ë ‰˘Ó·-

ÙfiÙËÙ· ηٷÁÚ·Ê‹˜ οÔÈˆÓ Û˘ÛÙ·ÙÈÎÒÓ ÌfiÓÔ ˆ˜

ηÙËÁÔÚ›·, .¯. Ê˘ÙÈο ¤Ï·È·. ªÂ ÙÔÓ ·ÚfiÓÙ· ÓfiÌÔ, ··ÈÙÂ›Ù·È Ë ·ÎÚÈ‚‹˜ ˘fi‰ÂÈÍË Ù˘ ËÁ‹˜ fiÏˆÓ ÙˆÓ

·ÏÏÂÚÁÈÔÁfiÓˆÓ Û˘ÛÙ·ÙÈÎÒÓ, ÒÛÙÂ, ÁÈ· ·Ú¿‰ÂÈÁÌ·,

fiÙ·Ó ¤Ó· Ê˘ÙÈÎfi ¤Ï·ÈÔ ÂÚȤ¯ÂÈ ÊÈÛÙÈΤϷÈÔ, ·˘Ùfi Ó·

‰È¢ÎÚÈÓ›˙ÂÙ·È ÛÙËÓ ÂÙÈΤٷ. ¶·ÚÔÌÔ›ˆ˜, Ë ËÁ‹ ÂÓfi˜

Ê˘ÛÈÎÔ‡ ·ÚÒÌ·ÙÔ˜, .¯. ¤Ó·˜ ÍËÚfi˜ ηÚfi˜, ı· Ú¤-

ÂÈ Ó· ÂÈÛËÌ·›ÓÂÙ·È Û·ÊÒ˜ Î·È Ó· ÌËÓ ·Ó·Ê¤ÚÂÙ·È

Ì ÁÂÓÈÎÔ‡˜ fiÚÔ˘˜ fiˆ˜ “Ê˘ÛÈÎfi ¿ÚˆÌ·” . ™ÙÔ ·-

Ú¿ÚÙËÌ· πππ· Ù˘ √‰ËÁ›·˜ 2003/89/ EC, ηıÔÚ›˙ÔÓÙ·È

Â›Û˘ Ù· ‰Ò‰Âη ·ÏÏÂÚÁÈÔÁfiÓ· ÙÚfiÊÈÌ· Î·È Û˘ÛÙ·-

ÙÈο ÙÚÔÊ›ÌˆÓ Ô˘ Ú¤ÂÈ ··Ú·›ÙËÙ· Ó· ÂÈÛËÌ·›-

ÓÔÓÙ·È Î·È ÛÙ· ÔÔ›· ÂÚÈÏ·Ì‚¿ÓÔÓÙ·È ÙÔ Á¿Ï·, ÙÔ ·‚Áfi, Ù· ÛÈÙËÚ¿, ÔÈ ÍËÚÔ› ηÚÔ› Î·È ÙÔ „¿ÚÈ (11).

™‡Ìʈӷ Ì ÙËÓ √‰ËÁ›· ·˘Ù‹, ‰›‰ÂÙ·È Ë ‰˘Ó·ÙfiÙËÙ· ÌÈ·˜ ÌÂÙ·‚·ÙÈ΋˜ ÂÚÈfi‰Ô˘ ‰È¿ÚÎÂÈ·˜ ÂÓfi˜ ¤ÙÔ˘˜ ¤ˆ˜ ÙËÓ Ï‹ÚË ÂÊ·ÚÌÔÁ‹ Ù˘, ÒÛÙ ÔÈ ·Ú·Û΢·ÛÙ¤˜ ÙÚÔÊ›ÌˆÓ Ó· Ú·ÁÌ·ÙÔÔÈ‹ÛÔ˘Ó ÙȘ ··Ú·›ÙËÙ˜ ·ÏÏ·Á¤˜ ÛÙȘ ÂÙÈΤÙ˜ (11). ∆· ÚÔ˚fiÓÙ· Ô˘ ·Ú‹¯ıËÛ·Ó ÌÂÙ¿ ÙËÓ 25Ë ¡ÔÂÌ‚Ú›Ô˘ 2005

‰ÂÓ ÂÈÙÚ¤ÂÙ·È Ó· ˆÏÔ‡ÓÙ·È ¯ˆÚ›˜ ÛˆÛÙ‹ ÂÈÛ‹-

Ì·ÓÛË, ÂÓÒ Ù· ÚÔ˚fiÓÙ· Ô˘ ›¯·Ó ‹‰Ë ·Ú·¯ı›

ÚÈÓ ÙËÓ ·Ú·¿Óˆ ËÌÂÚÔÌËÓ›· ÌÔÚÔ‡Ó Ó· ˆ-

ÏÔ‡ÓÙ·È Ì¤¯ÚÈ Ù¤ÏÔ˘˜ ÙˆÓ ·ÔıÂÌ¿ÙˆÓ (11). ∆¤ÏÔ˜, Û‡Ìʈӷ Ì ÙËÓ Ô‰ËÁ›·, “ÙÔ Û˘ÛÙ·ÙÈÎfi ı·

Ú¤ÂÈ Ó· ÂÈÛËÌ·›ÓÂÙ·È ÛÙËÓ ÂÙÈΤٷ Ì ۷ʋ ηÈ

·ÎÚÈ‚‹ ÙÚfiÔ Î·È Ë ÂÈÛ‹Ì·ÓÛË ‰ÂÓ Â›Ó·È ··Ú·›ÙËÙË fiÙ·Ó ÙÔ fiÓÔÌ· ÙÔ˘ ÚÔ˚fiÓÙÔ˜ ˘Ô‰ËÏÒÓÂÈ Û·ÊÒ˜

ÌÂϤÙË ·ÏÏÂÚÁÈÔÁfiÓˆÓ Û˘ÛÙ·ÙÈÎÒÓ ÛÙ· ÂÈÏÂÁ̤ӷ ÚÔ˚fiÓÙ· √ ·Î·ıfiÚÈÛÙÔ˜ ÙÚfiÔ˜ ·Ó·ÁÚ·Ê‹˜ ÙˆÓ ÙÚÔÊ›ÌˆÓ ÛÙȘ ÂÙÈΤÙ˜ ·fi ÙË ÓÔÌÔıÂÛ›· ·Ê‹ÓÂÈ ÂÚÈıÒÚÈ· ·Û¿ÊÂÈ·˜ Î·È ÚÔ‚ÏË̿وÓ. ™ÙÔÓ ¶›Ó·Î· 3, ·Ó·Ê¤ÚÔÓÙ·È fiÏÔÈ ÔÈ ÙÚfiÔÈ ·Ó·ÁÚ·Ê‹˜ ÙˆÓ ˘fi ÂͤٷÛË ·ÏÏÂÚÁÈÔÁfiÓˆÓ ÛÙ· ÚÔ˚fiÓÙ· Ô˘ Û˘ÌÂÚÈÂÏ‹ÊıËÛ·Ó ÛÙË ÌÂϤÙË.

™ÙËÓ ÏÂÈÔÓfiÙËÙ· ÙˆÓ ÂÚÈÙÒÛˆÓ, ÙÔ ÛÈÙ¿ÚÈ Î·È Ù· ·Ú¿ÁˆÁ¿ ÙÔ˘ ·Ó·Ê¤ÚÔÓÙ·Ó ˆ˜ “ÛÈÙ¿Ï¢ÚÔ” (89 ÊÔÚ¤˜), “·Ï‡ÚÈ Û›ÙÔ˘” (39 ÊÔÚ¤˜) ‹ ÛÈÙ¿ÚÈ (10 ÊÔÚ¤˜). ™˘ÓÔÏÈο, Ù· ÛÈÙËÚ¿ ‚Ú¤ıËÎ·Ó Î·Ù·ÁÂÁÚ·Ì̤ӷ Ì 45 ‰È·ÊÔÚÂÙÈÎÔ‡˜ ÙÚfiÔ˘˜, fiˆ˜ “ÁÏÔ˘Ù¤ÓË” (8 ÊÔÚ¤˜), “‚‡ÓË” (12 ÊÔÚ¤˜), “Natural Oat Bran” (3 ÊÔÚ¤˜), “ÚÔ˙‡ÌÈ” (9 ÊÔÚ¤˜).

¶›Ó·Î·˜ 3. ∆ÚfiÔÈ ‰‹ÏˆÛ˘ ÎÔÈÓÒÓ ·ÏÏÂÚÁÈÔÁfiÓˆÓ ÛÙ· ˘fi ÌÂϤÙË ÚÔ˚fiÓÙ· Ù˘ ÂÏÏËÓÈ΋˜ ·ÁÔÚ¿˜, fiˆ˜ ·˘ÙÔ› ·Ó¢ڤıËÛ·Ó ÛÙȘ ÂÙÈΤÙ˜ ÂÈÛ‹Ì·ÓÛ˘ ÙˆÓ Û˘ÛÙ·ÙÈÎÒÓ

∫ÔÈÓ¿ ·ÏÏÂÚÁÈÔÁfiÓ· ÙÚfiÊÈÌ· ∆ÚfiÔ˜ ·Ó·ÁÚ·Ê‹˜ ÙÔ˘˜ ÛÙȘ ÂÙÈΤÙ˜ ÙˆÓ ˘fi ÌÂϤÙË ÙÚÔʛ̈Ó

™ÈÙ¿ÚÈÛÈÙ¿ÚÈ, ·Ï‡ÚÈ Û›ÙÔ˘/ ÛÈÙ·ÚÈÔ‡, ÚˆÙ½Ó˜ Û›ÙÔ˘, ·Ï‡ÚÈ Û›Î·Ï˘, ‚‡ÓË, ¿Ì˘ÏÔ, ÚÔ˙‡ÌÈ °¿Ï·Á¿Ï·, ÔÚfi˜ Á¿Ï·ÎÙÔ˜, ÛÙÂÚ¿ Á¿Ï·ÎÙÔ˜, ÚÔ˚fiÓÙ· Á¿Ï·ÎÙÔ˜, ÚˆÙ½Ó˜ Á¿Ï·ÎÙÔ˜, ·Ê·Ï·ÙˆÌ¤ÓË ÛÎfiÓË Á¿Ï·ÎÙÔ˜, ˙·¯·ÚÔ‡¯Ô Á¿Ï·, ÁÈ·Ô‡ÚÙÈ, Ù˘Ú›, ÔÚfi˜ ÚˆÙ½Ó˘ Á¿Ï·ÎÙÔ˜, Ï·ÎÙfi˙Ë, ÏÈ·Ú¿ Á¿Ï·ÎÙÔ˜, ·Û‚¤ÛÙÈÔ, ‚Ô‡Ù˘ÚÔ/ ‚Ô‡Ù˘ÚÔ ·ÁÂÏ¿‰Ô˜/ ¿Ó˘‰ÚÔ ‚Ô‡Ù˘ÚÔ, Ù˘ÚfiÁ·Ï·, ‚¿ÊÏ·, Îڤ̷ Á¿Ï·ÎÙÔ˜, ÎÂÊ›Ú, ÛÂÚÌ¤ÙÈ, ÚfiÛıÂÙÔ ˘„ËÏ‹˜ Û˘ÁΤÓÙÚˆÛ˘ ÚˆÙ½Ó˘, ˘ÙÈ¿, ·Ï‡ÚÈ ˘„ËÏ‹˜ Û˘ÁΤÓÙÚˆÛ˘ ÚˆÙ½Ó˘, ڷϛӷ, ηڷ̤Ϸ, η˙½ÓË, Ï·ÎÙÈÎfi Ô͇, Ï·ÎÙ·Ï‚Ô˘Ì›ÓË/ Ï·ÎÙÔÛÊ·ÈÚ›ÓË ∞‚Áfi·‚Áfi, ·‚Áfi Û ÛÎfiÓË, ÚˆÙ½Ó˜ ·‚ÁÔ‡, ·Ï‚Ô˘Ì›ÓË, ÏÂÎÈı›ÓË, ·ÛÚ¿‰È

•ËÚÔ› ηÚÔ›ÍËÚÔ› ηÚÔ›, ÊÔ˘ÓÙÔ‡ÎÈ·, ·Ì‡Á‰·Ï·, ÊÔ˘ÓÙÔ˘Îfi·ÛÙ·, ‚¿ÊÏ·, ηڇ‰È·, ¿ÚˆÌ· ÊÔ˘ÓÙÔ‡ÎÈ, ÔÏÙfi˜ ÍËÚÒÓ Î·ÚÒÓ

ºÈÛÙ›ÎÈ ·Ú¿ÈÎÔÊÈÛÙ›ÎÈ ·Ú¿ÈÎÔ,

ÚÔ¤Ï¢Û˘

™˘ÛÙ·ÙÈο ÙÚÔÊ›ÌˆÓ ∞ÚÈıÌfi˜ ÚÔ˚fiÓÙˆÓ

¿ÁÓˆÛÙ˘ ÚÔ¤Ï¢Û˘ ÛÙ· ÔÔ›· ·Ó¢ڤıËÛ·Ó

ÏfiÁˆ ÂÏÏÈÔ‡˜ ÂÈÛ‹Ì·ÓÛ˘ Ù· ÂÓ ÏfiÁˆ Û˘ÛÙ·ÙÈο

Õڈ̷/ ·ÚˆÌ·ÙÈΤ˜ ‡Ï˜70

ª·ÁÈ¿/ Ì·ÁÈ¿ Óˆ‹43

§ÂÎÈı›ÓË20

µÔ‡Ù˘ÚÔ11

µÔ‡Ù˘ÚÔ Û˘Ì˘Îӈ̤ÓÔ9

ºÒÛÊÔÚÔ˜6

∞Û‚¤ÛÙÈÔ6

ºˆÛÊÔÚÈÎfi ·Û‚¤ÛÙÈÔ2

µÔ‡Ù˘ÚÔ ˙·¯·ÚÔÏ·ÛÙÈ΋˜1

º˘ÙÈÎfi/¿ ¤Ï·ÈÔ/·76

º˘ÙÈÎfi/¿ ÏÈ·Úfi/¿33

º˘ÙÈÎfi ÏÈ·Úfi ˘‰ÚÔÁÔӈ̤ÓÔ/ÌÂÚÈÎÒ˜27

À‰ÚÔÁÔӈ̤ÓÔ Ê˘ÙÈÎfi ¤Ï·ÈÔ ‹ ÏÈ·Ú‹ ‡ÏË14 ¶›Ó·Î·˜ 5. ∆ÚfiÔÈ ÚÔÏËÙÈ΋˜ ÂÈÛ‹Ì·ÓÛ˘ ÛÙ· ˘fi ÌÂϤÙË

Á¿Ï· Î·È Ù· ·Ú¿ÁˆÁ¿ ÙÔ˘ ·Ó·Ê¤ÚÔÓÙ·Ó Î˘Ú›ˆ˜ ˆ˜ “ÔÚfi˜ Á¿Ï·ÎÙÔ˜” ‹ ˆ˜ “Á¿Ï·”. ¶·ÚfiÏ· ·˘-

Ù¿, Ë ·ÚÔ˘Û›· ÙÔ˘ ‰ËÏÒıËΠ25 ÊÔÚ¤˜ Ì ÙÔÓ fiÚÔ

Ï·ÎÙfi˙Ë. ™˘ÓÔÏÈο ηÙÂÁÚ¿ÊËÛ·Ó 29 ‰È·ÊÔÚÂÙÈÎÔ›

fiÚÔÈ, οÔÈÔÈ ·fi ÙÔ˘˜ ÔÔ›Ô˘˜ ·Ê‹ÓÔ˘Ó ÂÚÈıÒ-

ÚÈ· ·ÚÂÍËÁ‹ÛÂˆÓ Î·È ÌË ·Ó·ÁÓÒÚÈÛ˘ Ù˘ ·ÚÔ˘Û›·˜ ÙÔ˘, fiˆ˜ ÔÈ fiÚÔÈ Ï·ÎÙfi˙Ë, ·Û‚¤ÛÙÈÔ, ‚Ô‡Ù˘ÚÔ, ‚¿ÊÏ·, Îڤ̷ Á¿Ï·ÎÙÔ˜, ÎÂÊ›Ú, ÛÂÚÌ¤ÙÈ, ÚfiÛıÂÙÔ ˘„ËÏ‹˜ Û˘ÁΤÓÙÚˆÛ˘ ÚˆÙ½Ó˘, ˘ÙÈ¿, ·Ï‡ÚÈ ˘„ËÏ‹˜ Û˘ÁΤÓÙÚˆÛ˘ ÚˆÙ½Ó˘, ڷϛӷ, ηڷ̤Ϸ, η˙½ÓË, Ï·ÎÙÈÎfi Ô͇, Ï·ÎÙ·Ï‚Ô˘Ì›ÓË/ Ï·ÎÙÔÛÊ·ÈÚ›ÓË.

∆Ô ·‚Áfi Î·È Ù· ·Ú¿ÁˆÁ¿ ÙÔ˘ ηٷÁÚ¿ÊËÎ·Ó Û˘ÓÔÏÈο Ì 6 ‰È·ÊÔÚÂÙÈÎÔ‡˜ ÙÚfiÔ˘˜, Ì ÂÈÎÚ·Ù¤-

ÛÙÂÚÔ˘˜ ÙÔ˘˜ fiÚÔ˘˜ ·‚Áfi, ÛÎfiÓË ·‚ÁÔ‡, ÚˆÙ½Ó˜ ·‚ÁÔ‡, ·ÛÚ¿‰È, ·ÏÏ¿ Î·È ·Ï‚Ô˘Ì›ÓË Î·È ÏÂÎÈı›ÓË. ∆· ÊÈÛÙ›ÎÈ· ·Ó·Ê¤ÚÔÓÙ·Ó Ì ÙÔ˘˜ fiÚÔ˘˜ ÊÈÛÙ›ÎÈ· Î·È ·Ú·¯›‰Â˜.

∏ ÛfiÁÈ· ‰ËψÓfiÙ·Ó Ì ÙÔ˘˜ fiÚÔ˘˜ ÛfiÁÈ·, ÏÂÎÈı›ÓË ÛfiÁÈ·˜ (127 ÊÔÚ¤˜) Î·È ·Ï‡ÚÈ ÛfiÁÈ·˜/ÛÔÁȿϢÚÔ (20 ÊÔÚ¤˜).

∆¤ÏÔ˜, ÔÈ Î·ÚÔ› ‰¤Ó‰ÚˆÓ ·Ó·Ê¤ÚÔÓÙ·Ó Î˘Ú›ˆ˜ Ì ÙÔÓ ÁÂÓÈÎfi fiÚÔ ÍËÚÔ› ηÚÔ› (93 ÊÔÚ¤˜) Î·È ÏÈÁfiÙÂÚÔ Ì ·Ó·ÊÔÚ¿ ÙÔ˘ Û˘ÁÎÂÎÚÈ̤ÓÔ˘ ›‰Ô˘˜ ÙÔ˘ ÂÌÂÚȯfiÌÂÓÔ˘ ηÚÔ‡, fiˆ˜ ÊÔ˘ÓÙÔ‡ÎÈ (39 ÊÔÚ¤˜) Î·È ·Ì‡Á‰·Ï· (28 ÊÔÚ¤˜).

∂ӉȷʤÚÔ˘Û· ‰È·›ÛÙˆÛË ·ÔÙ¤ÏÂÛ ÙÔ ÁÂÁÔÓfi˜ fiÙÈ ÛÙȘ ÂÙÈΤÙ˜ ÙˆÓ ÚÔ˚fiÓÙˆÓ Û˘¯Ó¿ ·Ó·Ê¤ÚÔÓÙ·Ó ÛÙ· Û˘ÛÙ·ÙÈο Â› ̤ÚÔ˘˜ Û‡ÓıÂÙ· ˘ÏÈο ¿ÁÓˆÛÙ˘ Û‡ÛÙ·Û˘, ¯ˆÚ›˜ ÂÚ·ÈÙ¤Úˆ ·Ó¿Ï˘ÛË (¶›Ó·Î·˜ 4), fiˆ˜: - “‚¿ÊÏ·” Û ¤Ó· ÚÔ˚fiÓ, Ù˘ ÔÔ›·˜ Ë Èı·Ó‹ Û‡ÛÙ·ÛË, fiˆ˜ ηٷÁÚ¿ÊËΠ۠¿ÏÏÔ ÚÔ˚fiÓ Ù˘ ›‰È·˜ ÂÙ·ÈÚ›·˜, ›ӷÈ: ·Ï‡ÚÈ Û›ÙÔ˘, ˙¿¯·ÚË, Á¿Ï· ¿·¯Ô, Ê˘ÙÈο ¤Ï·È·, Á·Ï·Îو̷ÙÔÔÈËÙ‹˜: ÏÂÎÈı›-

ÙÚfiÊÈÌ·

∫·Ì›· ÚÔÏËÙÈ΋ ÂÈÛ‹Ì·ÓÛË34,34%

∆Ô ÚÔ˚fiÓ ÌÔÚ› Ó· ÂÚȤ¯ÂÈ ›¯ÓË ·fi49,98%

¶Èı·ÓfiÓ Ó· ÂÚȤ¯ÂÈ ›¯ÓË/ ›¯ÓË ·fi7,57%

¶·Ú·Û΢¿˙ÂÙ·È/ ·Ú¿ÁÂÙ·È

Û ÂÚÁÔÛÙ¿ÛÈÔ Ô˘ ¯ÚËÛÈÌÔÔÈ›6,06%

∂Ó‰¤¯ÂÙ·È Ó· ÂÚȤ¯ÔÓÙ·È ›¯ÓË ·fi1,51%

∂Ӊ¯fiÌÂÓË ·ÚÔ˘Û›·0,50%

ÓË ÛfiÁÈ·˜ (∂322), ·Ï¿ÙÈ, ‚·ÓÈÏÏ›ÓË, ¿ÚˆÌ·, ‰È·Îfi-

ÛÌËÛË: ˙¿¯·ÚË, ÛÈÙ¿ÚÈ, Î·Î¿Ô Û ÛÎfiÓË, ÊÔÈÓÈΤϷÈÔ, Ì¿˙· ηοÔ

“Ì·ÁÈ¿/Ì·ÁÈ¿ Óˆ‹”, Ë ÔÔ›· Èı·ÓfiÓ Â›Ó·È Ì‡-

ÎËÙ·˜ ·ÓÂÙ˘Á̤ÓÔ˜ Û Á¿Ï·, ÂÓÒ ÌÔÚ› Ó· ÂÚȤ¯ÂÈ ›¯ÓË ÛÈÙËÚÒÓ (‚‡Ó˘) (13) - “‚Ô‡Ù˘ÚÔ/‚Ô‡Ù˘ÚÔ ˙·¯·ÚÔÏ·ÛÙÈ΋˜/‚Ô‡Ù˘ÚÔ

ÙÔ ÔÔ›Ô ÌÔÚ› Ó· Â›Ó·È ˙ˆÈ΋˜ ‹ Ê˘ÙÈ΋˜ ÚÔ¤Ï¢Û˘ Î·È Ó· ÂÚȤ¯ÂÈ ÚˆÙ½Ó˜ Á¿Ï·ÎÙÔ˜ (14) - “ÏÂÎÈı›ÓË”, Ë ÔÔ›· ÌÔÚ› Ó· Â›Ó·È ÚˆÙ½ÓË

‹ ÛfiÁÈ·˜ (9) - “·Û‚¤ÛÙÈÔ”, “ÊÒÛÊÔÚÔ˜”, “ʈÛÊÔÚÈÎfi ·Û‚¤ÛÙÈÔ”, Ô˘ Èı·ÓÒ˜ ÚÔ¤Ú¯ÔÓÙ·È ·fi Á¿Ï· (15) - “Ê˘ÙÈο ¤Ï·È·”, ÛÙ· ÔÔ›· ·Ó‹ÎÔ˘Ó ÙÔ ÂÏ·ÈfiÏ·‰Ô, ÙÔ ÛÔÁȤϷÈÔ, ÙÔ ËÏȤϷÈÔ, ÙÔ ÛË۷̤ϷÈÔ ‹ ηÈ

¿ÏÏ· ¤Ï·È· ÍËÚÒÓ Î·ÚÒÓ, fiˆ˜ ÙÔ ÊÈÛÙÈΤϷÈÔ (1).

¶ÚÔÏËÙÈ΋ ÂÈÛ‹Ì·ÓÛË ·ÏÏÂÚÁÈÔÁfiÓˆÓ ÛÂ

ÙÚfiÊÈÌ· Ù˘ ÂÏÏËÓÈ΋˜ ·ÁÔÚ¿˜

™ÙÔ 65% ÙˆÓ ÚÔ˚fiÓÙˆÓ Ô˘ ÌÂÏÂÙ‹ıËηÓ

˘‹Ú¯Â ÚÔÏËÙÈ΋ ÂÈÛ‹Ì·ÓÛË Ù˘ ·ÚÔ˘Û›·˜ ·ÏÏÂÚÁÈÔÁfiÓˆÓ. ™¯Â‰fiÓ Û fiÏ· ·Ó·ÊÂÚfiÙ·Ó fiÙÈ ÂÚȤ-

¯Ô˘Ó ‹ ÌÔÚ› Ó· ÂÚȤ¯Ô˘Ó ÛÈÙËÚ¿ ‹ ÚÔ˚fiÓÙ· ÙÔ˘˜ (196), Á¿Ï· ‹ ÚÔ˚fiÓÙ· ÙÔ˘ (192) Î·È Î·ÚÔ‡˜ ‰¤Ó‰ÚˆÓ ‹ ÚÔ˚fiÓÙ· ÙÔ˘˜ (190). ¶ÂÚÈÛÛfiÙÂÚ· ·fi 2/3

ÂÚȤ¯Ô˘Ó ‹ ÌÔÚ› Ó· ÂÚȤ¯Ô˘Ó ÛfiÁÈ· ‹ ÚÔ˚fiÓÙ· Ù˘ (144) Î·È ÛÔ˘Û¿ÌÈ (126). ∆¤ÏÔ˜, ÂÚ›Ô˘ Ù· ÌÈÛ¿

ÌÔÚ› Ó· ÂÚȤ¯Ô˘Ó ·‚Á¿, ÂÓÒ 26 ÚÔ˚fiÓÙ· ÌÔÚ›

Ó· ÂÚȤ¯Ô˘Ó ÊÈÛÙ›ÎÈ· ‹ ÚÔ˚fiÓÙ· ÙÔ˘˜. ∏ Èı·Ó‹ ·ÚÔ˘Û›· ·ÏÏÂÚÁÈÔÁfiÓÔ˘ ÛÙ· ÚÔ˚fiÓÙ·

η˜

Ó· ηٷÁÚ¿ÊÔÓÙ·È ¯ˆÚÈÛÙ¿, ÌÂÙ¿ ÙÔÓ Î·Ù¿ÏÔÁÔ ÙˆÓ

Û˘ÛÙ·ÙÈÎÒÓ Î·È ÛÙÔ Ù¤ÏÔ˜ Ó· ·Ó·Ê¤ÚÂÙ·È Ë ÚÔÏË-

ÙÈ΋ ÂÈÛ‹Ì·ÓÛË. π‰·ÓÈ΋ ¿ÓÙˆ˜ ı· ‹Ù·Ó Ë ¯Ú‹-

ÛË Îˆ‰ÈÎÔÔÈËÌ¤ÓˆÓ ¯ÚˆÌ¿ÙˆÓ ‹ Û˘Ì‚fiÏˆÓ Ô˘

Ó· ‰ËÏÒÓÔ˘Ó ÙËÓ ·ÚÔ˘Û›· Û˘ÁÎÂÎÚÈ̤ÓÔ˘ ·ÏÏÂÚ-

ÁÈÔÁfiÓÔ˘ (1).

¢˘ÛÙ˘¯Ò˜, ÛÙËÓ ·ÚÔ‡Û· ÌÂϤÙË ‰ÂÓ Î·Ù·Ê¤Ú·-

Ì ӷ Û˘ÏϤÍÔ˘Ì ÏËÚÔÊÔڛ˜ ÁÈ· fiÏ· Ù· ÚÔ˚fi-

ÓÙ· ÙˆÓ ÂÈÏÂÁÌ¤ÓˆÓ Î·ÙËÁÔÚÈÒÓ. ∫·È ·˘Ùfi ÁÈ·Ù› ÔÈ

ÂÙ·Èڛ˜ ·‰˘Ó·ÙÔ‡Û·Ó Ó· Ì·˜ ·Ú¿Û¯Ô˘Ó ‰Â›ÁÌ·Ù·

ÙˆÓ Û˘Û΢·ÛÈÒÓ ÙÔ˘˜, ÔfiÙÂ Ë Î·Ù·ÁÚ·Ê‹ ÙˆÓ Û˘-

ÛÙ·ÙÈÎÒÓ ¤ÁÈÓ ·¢ı›·˜ ·fi Ù· Ú¿ÊÈ· ÙˆÓ Î·Ù·-

ÛÙËÌ¿ÙˆÓ ÙÚÔʛ̈Ó. ∞Ó·fiÊ¢ÎÙ· ·ÓÙÈÌÂÙˆ›Û·-

Ì ʷÈÓfiÌÂÓ· ÚÔηٿÏ˄˘ Î·È Î·¯˘Ô„›·˜ ·fi

ÙÔ˘˜ ηٷÛÙË̷ٿگ˜ ηٿ ÙËÓ Î·Ù·ÁÚ·Ê‹. ∂›-

Û˘, ‰ÂÓ ¤ÁÈÓ ·Ô‰ÂÎÙfi ÙÔ ·›ÙËÌ· ÁÈ· Â›Û΄Ë

ÛÙÔÓ ¯ÒÚÔ ·Ú·ÁˆÁ‹˜ ÙˆÓ ‚ÈÔÌ˯·ÓÈÒÓ ÙÚÔʛ̈Ó

8. Food standards Agency [Webpage, Internet]. http://www. food.gov.uk/

9. Official Journal of the European Communities [Webpage, Internet]. Regulation (EC) No 178/2002/EC of the European Parliament and of the Council of 28 January 2002, laying down the general principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in matters of food safety; 2002: http://eur-lex.europa.eu/pri/en/oj/ dat/2002/l_031/l_03120020201en00010024.pdf

10. Official Journal of the European Union [Webpage, Internet]. Commission communication in the framework of the implementation of the directive 2001/95/EC of the European Parliament and of the Council of 3 December 2001 on general product safety; 2001: http://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:C:2006: 171:0023:0026:EN:PDF

11. Official Journal of the European Union [Webpage, Internet]. Directive 2003/89/EC of the European Parliament and of the Council of 10 November 2003 amending Directive 2000/13/EC as regards indication of the ingredients present in foodstuffs; 2003: http://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2003: 308:0015:0018:EN:PDF.

ηٿ ÙËÓ ·Ú·ÁˆÁ‹. ™˘ÌÂÚ·ÛÌ·ÙÈο, ÛÙ· Ï·›ÛÈ· Ù˘ ÌÂϤÙ˘ ·˘-

‰È·ÈÛÙÒÛ·Ì fiÙÈ, ·Ú¿ ÙȘ ÓÔÌÔıÂÙÈΤ˜ Ú˘ıÌ›ÛÂȘ, ··ÈÙÔ‡ÓÙ·È ÂÚ·ÈÙ¤Úˆ ÚÔÛ¿ıÂȘ ÙfiÛÔ ÁÈ·

ÙËÓ ÂÊ·ÚÌÔÁ‹ ÙˆÓ ÚÔÙÂÈÓfiÌÂÓˆÓ Ì¤ÙÚˆÓ fiÛÔ Î·È

ÁÈ· οÔȘ ·ÏÏ·Á¤˜ ÛÙÔÓ ÙÚfiÔ ÂÈÛ‹Ì·ÓÛ˘ ÙˆÓ

Û˘ÛÙ·ÙÈÎÒÓ ÛÙËÓ ÂÙÈΤٷ ÙˆÓ ÙÚÔʛ̈Ó, ÒÛÙ ӷ ‰È·ÛÊ·Ï›˙ÂÙ·È Ë Ì¤ÁÈÛÙË

µÈ‚ÏÈÔÁÚ·Ê›·

1. Van Hengel AJ. Declaration of allergens on the label of food products purchased on the European market. Trends in Food Science and Technology 2007;18:96-100.

2. Bock SA, Mun~oz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol 2001;107:191-193.

3. Food Standards Australia New Zealand [Webpage, Internet]. Australia New Zealand Food Standards Code; 2002: http://www.foodstandards.gov.au/thecode/

4. US Food and Drug Administration, Center for Food Safety and Applied Nutrition [Webpage, Internet]. Food Allergen Labelling and Consumer Protection Act of 2004; 2004: http://www.cfsan.fda.gov/~dms/alrgact.html

5. Boden M, Dadswell R, Hattersley S. Review of statutory and voluntary labelling of food allergens. Proc Nutr Soc 2005;64:475-480.

6. Gateway to the European Union [Webpage, Internet]. http://europa.eu/

7. Niggemann B, Beyer K. Diagnosis of food allergy in children: toward a standardization of food challenge. J Pediatr Gastroenterol Nutr 2007;45:399-404.

12. Official Journal of the European Communities [Webpage, Internet]. Directive 2000/13/EC of the European Parliament and of the Council of 20 March 2000 on the approximation of the laws of the Member States relating to the labelling, presentation and advertising of foodstuffs; 2000: http://eur-lex.europa.eu/LexUriServ/LexUriServ. do?uri=OJ:L:2000:109:0029:0042:EN:PDF

13. Canadian Food Inspection Agency [Webpage, Internet]. Yeast production and use in food industry. http://www. inspection.gc.ca/

14. University of Guelph, Canada [Webpage, Internet]. Butter manufacture - Overview of the butter making process; http://www.foodsci.uoguelph.ca/dairyedu/butter. html

15. Eastridge ML. Major advances in applied dairy cattle nutrition. J Dairy Sci 2006;89:1311-23.

16. UK Food Standards Agency [Webpage, Internet]. Nut Allergy Labelling - Report of Research into the Consumer Response; 2002: http://www.foodstandards.gov.uk/ multimedia/pdfs/nutallergyresearch.pdf

17. Laitinen K, Isolauri E. Allergic infants: growth and implications while on exclusion diets. Nestle Nutr Workshop Ser Pediatr Program 2007;60:157-167; discussion 167-169.

18. Mills EN, Valovirta E, Madsen C, Taylor SL, Vieths S, Anklam E, et al. Information provision for allergic consumers - where are we going with food allergen labelling? Allergy 2004;59:1262-1268.

19. Said M, Weiner JM. “May contain traces of...”: hidden food allergens in Australia. Med J Aust 2004;181:183-184.

20. Crevel R. Industrial dimensions of food allergy. Proc Nutr Soc 2005;64:470-474.

µ’

¶·ÓÂÈÛÙËÌ›Ô˘ ∞ıËÓÒÓ,

¡ÔÛÔÎÔÌÂ›Ô ¶·›‰ˆÓ

“¶. & ∞. ∫˘ÚÈ·ÎÔ‡”, ∞ı‹Ó·

AÏÏËÏÔÁÚ·Ê›·:

°ÂÒÚÁÈÔ˜ ∆ÛfiÏ·˜

geotsol@otenet.gr

µ’ ¶·È‰È·ÙÚÈ΋ ∫ÏÈÓÈ΋

¶·ÓÂÈÛÙËÌ›Ô˘ ∞ıËÓÒÓ

¡ÔÛÔÎÔÌÂ›Ô ¶·›‰ˆÓ “¶. & ∞. ∫˘ÚÈ·ÎÔ‡”, ∞ı‹Ó·

™ÙÔÌ·ÙÈΤ˜

¤ÍÂȘ ÂÎÙfi˜ ‰È·ÙÚÔÊ‹˜: Ë Â›‰Ú·Û‹ ÙÔ˘˜ ÛÙËÓ ˘Á›·

°. ∆ÛfiÏ·˜

¶ÂÚ›ÏË„Ë: √ÚÈṲ̂Ó˜ ÛÙÔÌ·ÙÈΤ˜ Û˘Ó‹ıÂȘ ÂÎÙfi˜ ‰È·ÙÚÔÊ‹˜ ¤¯Ô˘Ó Û˘Û¯ÂÙÈÛı› Ì ÚԂϋ̷ٷ ˘Á›·˜, ȉȷ›ÙÂÚ· Ì ÔÚıÔ‰ÔÓÙÈΤ˜ ·ÓˆÌ·Ï›Â˜. √ ıËÏ·ÛÌfi˜ ‰·ÎÙ‡ÏÔ˘, Û˘ÓËı¤ÛÙÂÚ· ÙÔ˘ ·ÓÙ›¯ÂÈÚ·, ‹ È›Ï·˜, Ô˘ Û˘¯Ó¿ ·Ú¯›˙Ô˘Ó ÓˆÚ›˜ ÛÙË ‚ÚÂÊÈ΋ ËÏÈΛ·, Û˘Ì‚¿ÏÏÔ˘Ó ÛÙËÓ ËÚÂÌ›· ÙÔ˘ ‚Ú¤ÊÔ˘˜, ÂÓÒ ˘¿Ú¯Ô˘Ó ÂӉ›ÍÂȘ fiÙÈ Ë È›Ï· ÚÔÛٷهÂÈ ·fi ÙÔ Û‡Ó‰ÚÔÌÔ ÙÔ˘ ·ÈÊÓ›‰ÈÔ˘ ‚ÚÂÊÈÎÔ‡ ı·Ó¿ÙÔ˘. ¶ÚԂϋ̷ٷ ·Ó·Î‡ÙÔ˘Ó fiÙ·Ó ÔÈ ¤ÍÂȘ ·˘Ù¤˜ ·Ú·Ù›ÓÔÓÙ·È Î·È È‰È·›ÙÂÚ· ÌÂÙ¿ ÙËÓ ËÏÈΛ· ÙˆÓ 6 ¤ˆ˜ 8 ¯ÚfiÓˆÓ, ÔfiÙ ·Ú·ÙËÚÔ‡ÓÙ·È Î·È Ù· ϤÔÓ ÛÔ‚·Ú¿ ÚԂϋ̷ٷ ·fi ÙÔ ÛÙÔÌ·ÙÔÁÓ·ıÈÎfi Û‡ÛÙËÌ·. ∂Âȉ‹, fï˜, ÛÙËÓ ÏÂÈÔÓfiÙËÙ· ÙˆÓ ÂÚÈÙÒÛÂˆÓ ÔÈ Û˘Ó‹ıÂȘ ·˘Ù¤˜ ‰È·ÎfiÙÔÓÙ·È ¤ÁηÈÚ· ·fi Ù· ›‰È· Ù· ·È‰È¿, ı· Ú¤ÂÈ Ó· ηıËÛ˘¯¿˙ÔÓÙ·È ÔÈ ÁÔÓ›˜ Î·È Ó· ÙÔ˘˜ ÙÔÓ›˙ÂÙ·È fiÙÈ Ë ¿ÛÎËÛË ›ÂÛ˘ ÛÙÔ ·È‰› ÚÔÎÂÈ̤ÓÔ˘ Ó· ‰È·Îfi„ÂÈ ÙË Û˘Ó‹ıÂÈ·, fi¯È ÌfiÓÔ ‰ÂÓ ˆÊÂÏ›, ·ÏÏ¿ ÂÓ›ÔÙ ÂÓ‰¤¯ÂÙ·È Î·È Ó· ‚Ï¿„ÂÈ.

ÎÏÂȉȿ: ¶È›Ï·,

Non-nutritive sucking habits: their influence on children’s health

2nd Department of Paediatrics, University of Athens, “P. & A. Kyriakou” Children’s Hospital, Athens, Greece

Correspondence: Georgios Tsolas geotsol@otenet.gr

2nd Department of Paediatrics, University of Athens, “P. & A. Kyriakou” Children’s Hospital, Athens, Greece

G. Tsolas

Abstract: Certain oral habits in infants have been linked to medical conditions or adverse outcomes, especially related to orofacial structures. Most children suck their thumbs, fingers, or a pacifier at some time in their early life. These habits are very common and have a soothing and calming effect. There is also evidence that pacifiers may help reduce the risk of sudden infant death syndrome (SIDS). The only time sucking habits might be a concern is if they continue beyond the age of 6 to 8 years or affect the shape of the child’s mouth or teeth pattern. The good news is that most children stop their sucking habits before they get very far in school. This means that parents may be assured that their child will eventually stop the habit on his/her own, and they should know that putting too much pressure on their child to stop the habit may cause more harm than good.

Key words: Pacifiers, thumbs, fingers, dental effects of sucking behaviours, non-nutritive sucking habits.

ÛÂȘ ·˘Ù¤˜ Â›Ó·È Â‡ÎÔϘ ÛÙËÓ ÂÎÙ¤ÏÂÛ‹ ÙÔ˘˜, Û˘Ó¯›˙ÔÓÙ·È ÁÈ· ÌÂÁ¿ÏÔ ¯ÚÔÓÈÎfi ‰È¿ÛÙËÌ· ÌÂÙ¿ ÙË Á¤ÓÓËÛË Î·È ‰ÂÓ ÂÍ·ÚÙÒÓÙ·È ·fi ÙËÓ ›ӷ Î·È ÙËÓ ¤ÓÙ·Û‹ Ù˘. ¶Èı·ÓÔÏÔÁÂ›Ù·È fiÙÈ

¯ÚfiÓÔ ˙ˆ‹˜ ·˘Í¿ÓÂÙ·È Ë Û¯ÂÙÈ΋ Û˘¯ÓfiÙËÙ· ÙÔ˘ ıËÏ·ÛÌÔ‡ ‰·ÎÙ‡ÏÔ˘. √È ÛÙÔÌ·ÙÈΤ˜ ·˘Ù¤˜ ¤ÍÂȘ, ÔÈ Ôԛ˜ ·Ú·ÙËÚÔ‡ÓÙ·È ÛÙÔ 70-90% ÙˆÓ ‚ÚÂÊÒÓ, ıˆÚÔ‡ÓÙ·È ˆ˜ Ê˘ÛÈÔÏÔÁÈΤ˜ ÚÔÎÂÈ̤ÓÔ˘ ÁÈ· ·È‰È¿ ‚ÚÂÊÈ΋˜ ‹ ÓËȷ΋˜ ËÏÈΛ·˜, ηıÒ˜ ÚÔÛʤÚÔ˘Ó Û ·˘Ù¿ ·›ÛıËÌ· ·ÛÊ¿ÏÂÈ·˜ Î·È ËÚÂÌ›· (1). ∏ ·Ú¿Ù·Û‹ ÙÔ˘˜ ¤Ú·Ó Ù˘ ËÏÈΛ·˜ ÙˆÓ 4-5 ÂÙÒÓ ıˆÚÂ›Ù·È fiÙÈ ÂÓ‰¤¯ÂÙ·È Ó· Ô‰ËÁ‹ÛÂÈ Û ÚԂϋ̷ٷ Î·È È‰È·›ÙÂÚ· Û ÔÚıÔ‰ÔÓÙÈΤ˜ ·ÓˆÌ·Ï›Â˜. √È ¤Ú¢Ó˜ Ô˘ ·ÊÔÚÔ‡Ó ÛÙËÓ ÂȉËÌÈÔÏÔÁ›· ÙˆÓ Û˘ÓËıÂÈÒÓ ·˘ÙÒÓ ¤¯Ô˘Ó

ËÏÈ˘, ÂÓÒ ÌÂÙ¿ ÙÔÓ ÙÚ›ÙÔ

ȉ›ˆ˜ ÌÂÙ¿ ÙËÓ ËÏÈΛ· ÙˆÓ 4-5 ÂÙÒÓ, Ë ‰È·ÎÔ‹ Ù˘

‰ÂÓ Â›Ó·È Â‡ÎÔÏË. ∏ ·ÓÙÈÌÂÙÒÈÛË ÂÍ·ÚÙ¿Ù·È ·fi ÙÔ

Â¿Ó ÚfiÎÂÈÙ·È ÁÈ· ıËÏ·ÛÌfi È›Ï·˜ ‹ ‰·ÎÙ‡ÏÔ˘, η-

ıÒ˜ Î·È ·fi ÙËÓ ËÏÈΛ· ÙÔ˘ ·È‰ÈÔ‡. ¶Ú¤ÂÈ, fï˜,

¿ÓÙÔÙ ӷ ‚·Û›˙ÂÙ·È ÛÙËÓ Î·Ï‹ Û˘ÓÂÚÁ·Û›· Ì ÙÔ

·È‰› Î·È ÛÙËÓ ÂÓË̤ڈۋ ÙÔ˘ ÁÈ· Ù· ‰˘Û¿ÚÂÛÙ·

·ÔÙÂϤÛÌ·Ù· Ô˘ ÌÔÚ› Ó· ¤¯ÂÈ ·˘Ù‹ Ë Û˘Ó‹ıÂÈ·

ÛÙ· ‰fiÓÙÈ· ÙÔ˘, ÛÙÔ ¯·ÌfiÁÂÏfi ÙÔ˘, ·ÎfiÌË Î·È ÛÙ·

‰¿ÎÙ˘Ï¿ ÙÔ˘. ∂›Ó·È, Â›Û˘, ÌÂÁ¿ÏË Ë ·Í›· ÙÔ˘ Â·›-

ÓÔ˘ Î·È Ù˘ ËıÈ΋˜ ·ÓÙ·ÌÔÈ‚‹˜ ÁÈ· ÙËÓ ÚÔÛ¿ıÂÈ·

‰È·ÎÔ‹˜ Ù˘ ¤Í˘. ™Â ÔÏϤ˜ ÂÚÈÙÒÛÂȘ, Ë ¤ÁηÈ-

ÚË ‰È·ÎÔ‹ Ù˘ Û˘Ó‹ıÂÈ·˜ ÌÔÚ› Ó· ·ÎÔÏÔ˘ıËı›

·fi ·˘ÙfiÌ·ÙË ‚ÂÏÙ›ˆÛË Ù˘ ı¤Û˘ Î·È Ù˘ Û¯¤Û˘

ÙˆÓ ‰ÔÓÙÈÒÓ, ¯ˆÚ›˜ η̛· ¿ÏÏË ıÂÚ·›·.

ªÂÚÈο ·fi Ù· ̤۷ Ô˘ ÌÔÚ› Ó· ¯ÚËÛÈÌÔÔÈ-

ËıÔ‡Ó ÁÈ· ÙË ‰È·ÎÔ‹ ÙÔ˘ ıËÏ·ÛÌÔ‡ ÙÔ˘ ‰·ÎÙ‡ÏÔ˘

›ӷÈ:

°È· ÙË Ó‡ÎÙ·: Á¿ÓÙÈ· ‹ Â›‰ÂÛÌÔ˜ ÛÙÔ Â›Ì·¯Ô

‰¿ÎÙ˘ÏÔ ‹ Ì·ÎÚ‡ Ì·Ó›ÎÈ ÈÙ˙¿Ì·˜, Ú·Ì̤ÓÔ ÛÙËÓ

¿ÎÚË, ÁÈ· Ó· ÌËÓ ¤¯ÂÈ ÚfiÛ‚·ÛË ÙÔ ‰¿ÎÙ˘ÏÔ ÛÙÔ

ÛÙfiÌ·.

°È· ÙËÓ Ë̤ڷ: “‰·ÎÙ˘ÏÔÎÔ˘ÎÏ›ÙÛ˜” ηٷÛ΢-

Ì ‰È¿ÊÔÚ· ̤۷ ‹ ˙ˆÁÚ·ÊÈṲ̂Ó˜ ¿Óˆ ÛÙÔ ›‰ÈÔ ÙÔ ‰¿ÎÙ˘ÏÔ Î·È

Ì Ï·ÛÙÂÏ›ÓË.

Ë Â¿ÏÂÈ„Ë ÙÔ˘ ‰·ÎÙ‡ÏÔ˘ Ì ÈÎÚ‹ Ô˘Û›·, ÚÔÎÂÈ̤ÓÔ˘ Ó· ÌÂȈı› Ë

¢¯·Ú›ÛÙËÛË ·fi ÙËÓ ·›ÛıËÛË Ô˘ Û˘Óԉ‡ÂÈ ÙÔÓ

ıËÏ·ÛÌfi.

™ÙËÓ ÂÚ›ÙˆÛË, fï˜, ηٿ ÙËÓ ÔÔ›· Ë ·Ú·-

¿Óˆ ‰È·‰Èηۛ· ‰ÂÓ ·Ô‰ÒÛÂÈ, ÙÔ ·È‰› ÌÔÚ› Ó·

‚ÔËıËı› Ì ÙË ¯ÚËÛÈÌÔÔ›ËÛË ·ÏÒÓ ÔÚıÔ‰ÔÓÙÈ-

ÎÒÓ Ì˯·ÓË̿وÓ, ÁÈ· ˘fiÌÓËÛË Î·È ÂÍÔ˘‰ÂÙ¤ÚˆÛË

Ù˘ ¢¯·Ú›ÛÙËÛ˘, fiˆ˜ ÁÈ· ·Ú¿‰ÂÈÁÌ· ÂÓfi˜

·ÏÔ‡ ÎÈÓËÙÔ‡ Ì˯·Ó‹Ì·ÙÔ˜ Ù˘ ¿Óˆ ÁÓ¿ıÔ˘ ‹ ÌÈ·˜

ÚÔÛÙÔÌȷ΋˜ Ͽη˜, Ô˘ ı· ¯ÚËÛÈÌÔÔÈ› ÙÔ ·È‰› ÌfiÓÔ Î·Ù¿ ÙË ‰È¿ÚÎÂÈ· Ù˘ Ó‡ÎÙ·˜.

™˘ÌÂÚ¿ÛÌ·Ù·

1. √È ÛÙÔÌ·ÙÈΤ˜ Û˘Ó‹ıÂȘ ÂÎÙfi˜ ‰È·ÙÚÔÊ‹˜,

fiˆ˜ Ô ıËÏ·ÛÌfi˜ È›Ï·˜ Î·È ‰·ÎÙ‡ÏÔ˘ ‹ ‰·ÎهψÓ, ıˆÚÔ‡ÓÙ·È ˆ˜ Ê˘ÛÈÔÏÔÁÈΤ˜ ÚÔÎÂÈ̤ÓÔ˘ ÁÈ· Ù· ‚Ú¤ÊË Î·È Ù· ÌÈÎÚ¿ Ó‹È·.

2. ∏ Û˘Û¯¤ÙÈÛ‹ ÙÔ˘˜ Ì ÙËÓ ÂÌÊ¿ÓÈÛË ÔÚıÔ‰ÔÓÙÈ-

ÚÔ‚ÏËÌ¿ÙˆÓ Â›Ó·È ‰Â‰Ô̤ÓË. ∞˘Ù¿, fï˜, Â›Ó·È Î·Ù¿ ηÓfiÓ· ·˘ÙÔ·Ó·ÛÙÚ¤„ÈÌ· ÛÙ· ·È‰È¿ Ù·

ÔÔ›· ··ÏÏ¿ÛÛÔÓÙ·È ÙˆÓ ¤ÍÂÒÓ ÙÔ˘˜ ÚÈÓ ·fi ÙËÓ

ËÏÈΛ· ÙˆÓ 3-4 ÂÙÒÓ. ¶Úfi‚ÏËÌ·, Û˘ÓÂÒ˜, ·ÔÙÂÏ› Ë ·Ú¿Ù·Û‹ ÙÔ˘˜ ¤Ú·Ó Ù˘ ËÏÈΛ·˜ Ë ÔÔ›· ·ÓÙÈ-

ÛÙÔȯ› ÛÙËÓ ÂÚ›Ô‰Ô Ù˘ ÌfiÓÈÌ˘ Ô‰ÔÓÙÔÊ˘˝·˜.

™ÙËÓ ÙÂÏÂ˘Ù·›· ·˘Ù‹ ÂÚ›ÙˆÛË, ÔÈ ·ÓˆÌ·Ï›Â˜ ÛÙË

Û‡ÁÎÏÂÈÛË Â›Ó·È ‚·Ú‡ÙÂÚ˜ Î·È ı· ··ÈÙËı›, Èı·Ófiٷٷ, ÔÚıÔ‰ÔÓÙÈ΋ ıÂÚ·›· ÁÈ· ÙËÓ ·ÔηٿÛÙ·Û‹ ÙÔ˘˜.

3. √ ıËÏ·ÛÌfi˜ È›Ï·˜ ˘ÂÚÙÂÚ› ¤Ó·ÓÙÈ ÙÔ˘ ıËÏ·ÛÌÔ‡ ‰·ÎÙ‡ÏÔ˘, ΢ڛˆ˜ ÂÂȉ‹ ÙÔ ·È‰› ··ÏÏ¿ÛÛÂÙ·È ·fi ·˘Ù‹Ó ¢ÎÔÏfiÙÂÚ·. ÀÔÓÔ̇ÂÈ, fï˜, ÙÔÓ ÂÈÙ˘¯‹ ÌËÙÚÈÎfi ıËÏ·ÛÌfi Â¿Ó ¯ÚËÛÈÌÔÔÈËı› ÛÙÔÓ ÚÒÙÔ Ì‹Ó· Ù˘ ˙ˆ‹˜, ÂÓÒ ·˘Í¿ÓÂÈ Î·È

1. Davidson L. Thumb and finger sucking. Pediatr Rev 2008;29:207-208.

2. Nowak AJ, Warren JJ. Infant oral health and oral habits. Pediatr Clin North Am 2000;47:1043-1066.

3. Adair SM. Pacifier use in children: a review of recent literature. Pediatr Dent 2003;25:449-458.

4. Bishara SE, Warren JJ, Broffitt B, Levy SM. Changes in the prevalence of non-nutritive sucking patterns in the first 8 years of life. Am J Orthod Dentofacial Orthop 2006;130:31-36.

5. Bishara S, Larsson E. Finger habits: Their effects and their treatments - part 1. Dent Assist 2007; 76:14-16, 18.

6. Bishara S, Larsson E. Finger habits: Their effects and their treatments - part 2. Dent Assist 2007:76:16-18, 20, 22.

1

∞’ ¶·È‰È·ÙÚÈ΋ ∫ÏÈÓÈ΋,

µÂÓÈ˙¤ÏÂÈÔ °ÂÓÈÎfi

¡ÔÛÔÎÔÌ›Ô, ∏Ú¿ÎÏÂÈÔ,

∫Ú‹ÙË

2 ∞ÏÏÂÚÁÈÔÏÔÁÈÎfi ∆̷̋,

µ’ ¶·È‰È·ÙÚÈ΋ ∫ÏÈÓÈ΋

¶·ÓÂÈÛÙËÌ›Ô˘ ∞ıËÓÒÓ, ¡ÔÛÔÎÔÌÂ›Ô ¶·›‰ˆÓ

“¶. & ∞. ∫˘ÚÈ·ÎÔ‡”, ∞ı‹Ó·

AÏÏËÏÔÁÚ·Ê›·:

µ·ÛÈÏÈ΋ ∞ÁÁÂÏ¿ÎÔ˘ vaagge3@yahoo.gr

°Ô‡ÚÓ˜ ∆Â̤ÓÔ˘˜ 71500, ∏Ú¿ÎÏÂÈÔ, ∫Ú‹ÙË

M·ÛÙÔ΢ÙÙ¿ÚˆÛË ÛÙ· ·È‰È¿: ÂÚÈÁÚ·Ê‹ ‰‡Ô ÂÚÈÙÒÛˆÓ

µ. ∞ÁÁÂÏ¿ÎÔ˘1, ª. ∫Ô˘ÙÏ‹2, ¡. ¶··‰fiÔ˘ÏÔ˜2, ∂. ª·ÓÔ˘Û¿Î˘2, ¶. •Â··‰¿ÎË2, π. ÷ڈӛÙË1, º. ™·ÍÒÓË-¶··ÁˆÚÁ›Ô˘2

¶ÂÚ›ÏË„Ë: ∏ Ì·ÛÙÔ΢ÙÙ¿ÚˆÛË Â›Ó·È ÌÈ· ·Û˘Ó‹ıÈÛÙË ÓfiÛÔ˜ Ô˘ ¯·Ú·ÎÙËÚ›˙ÂÙ·È ·fi ÙËÓ ¿ıÚÔÈÛË ÌÂÁ¿ÏÔ˘ ·ÚÈıÌÔ‡ Ì·ÛÙÔ΢ÙÙ¿ÚˆÓ Û ‰È¿ÊÔÚÔ˘˜ ÈÛÙÔ‡˜ ÙÔ˘ ÛÒÌ·ÙÔ˜. ∏ ÎÏÈÓÈ΋ ÂÈÎfiÓ· ÂÍ·ÚÙ¿Ù·È ·fi ÙË ‰È·ÛÔÚ¿ ÙˆÓ Ì·ÛÙÔ΢ÙÙ¿ÚˆÓ ÛÂ Û˘ÁÎÂÎÚÈ̤ӷ fiÚÁ·Ó· Î·È ÙËÓ ¤ÎÎÚÈÛË ÌÂÛÔÏ·‚ËÙÒÓ ·fi Ù· Ì·ÛÙÔ·ÙÙ·Ú·. ∆Ô ‰¤ÚÌ· Â›Ó·È Ô ÈÛÙfi˜ Ô˘ ÚÔÛ‚¿ÏÏÂÙ·È Û˘¯ÓfiÙÂÚ· ÛÙ· ·È‰È¿ Î·È ÌÔÚ› Ó· Â›Ó·È Ë ÌfiÓË ÂΉ‹ÏˆÛË Ù˘ ÓfiÛÔ˘. √È ÂÓ‹ÏÈΘ Û˘Ó‹ıˆ˜ ·ÚÔ˘ÛÈ¿˙Ô˘Ó Û˘ÛÙËÌ·ÙÈ΋ Ì·ÛÙÔ΢ÙÙ¿ÚˆÛË Î·È ¤¯Ô˘Ó ‚·Ú‡ÙÂÚË ¤ÎÊÚ·ÛË Ù˘ ÓfiÛÔ˘. ¶ÂÚÈÁÚ¿ÊÔÓÙ·È ‰‡Ô ·ÁfiÚÈ·, ËÏÈΛ·˜ 7 ÌËÓÒÓ Î·È 13 ÂÙÒÓ, Ì ‰È·ÊÔÚÂÙÈΤ˜ ÌÔÚʤ˜ ‰ÂÚÌ·ÙÈ΋˜ Ì·ÛÙÔ΢ÙÙ¿ÚˆÛ˘. ∆Ô ‚Ú¤ÊÔ˜ ·ÚÔ˘Û›·Û ·fi ÙËÓ ËÏÈΛ· ÙˆÓ 3 ÌËÓÒÓ Î·ÊÂÙȤ˜ ÎËÏȉԂϷÙȉ҉ÂȘ ‚Ï¿‚˜ ÛÙÔ ‰¤ÚÌ·, ¯ˆÚ›˜ ¿ÏÏ· ÎÏÈÓÈο ÛËÌ›· ÂÎÙfi˜ ·fi ·ÓËÛ˘¯›· Î·È ÎÓËÛÌfi. ∏ ÙÚÈ‚‹ ÙˆÓ ‚Ï·‚ÒÓ ‰ËÌÈÔ˘ÚÁÔ‡Û ÂÚ˘ıÚfiÙËÙ· Î·È ÔÌÊfi (ıÂÙÈÎfi ÛËÌÂ›Ô Darier). ∏ ‚ÈÔ„›· ‰ÂÚÌ·ÙÈ΋˜ ‚Ï¿‚˘ ¤‰ÂÈÍ ÌÂÁ¿Ï˜ ·ıÚÔ›ÛÂȘ Ì·ÛÙÔ΢ÙÙ¿ÚˆÓ ÂÚÈ·ÁÁÂȷο, ÂÈÎfiÓ· Û˘Ì‚·Ù‹ Ì ÎËÏȉԂϷÙÈ‰Ò‰Ë ÌÔÚÊ‹ ‰ÂÚÌ·ÙÈ΋˜ Ì·ÛÙÔ΢ÙÙ¿ÚˆÛ˘. ∆Ô 13 ÂÙÒÓ ·ÁfiÚÈ ÚÈÓ ·fi 6 ̋Ә ›¯Â ·Ú¯›ÛÂÈ Ó· ·ÚÔ˘ÛÈ¿˙ÂÈ ÂÂÈÛfi‰È· Ì ·Ó·Ó¢ÛÙÈ΋ ‰˘Û¯¤ÚÂÈ·, ÂÎÓ¢ÛÙÈÎfi Û˘ÚÈÁÌfi, ÂÈÁ·ÛÙÚ·ÏÁ›·, ÂÚ˘ıÚfiÙËÙ· ÎÔÚÌÔ‡, ·ÁÁÂÈÔÔ›‰ËÌ· ÚÔÛÒÔ˘, ÎÓËÛÌfi Î·È ÙÒÛË Ù˘ ·ÚÙËÚȷ΋˜ ›ÂÛ˘. ¢ÂÓ ˘‹Ú¯·Ó ‰ÂÚÌ·ÙÈΤ˜ ‚Ï¿‚˜. ∏ ‚ÈÔ„›· ‰¤ÚÌ·ÙÔ˜ ¤‰ÂÈÍ ¿ıÚÔÈÛË Ì·ÛÙÔ΢ÙÙ¿ÚˆÓ ÂÚÈ·ÁÁÂȷο, ÂÓÒ Ô ¤ÏÂÁ¯Ô˜ ÁÈ· Û˘ÛÙËÌ·ÙÈ΋ Ì·ÛÙÔ΢ÙÙ¿ÚˆÛË ‹Ù·Ó ·ÚÓËÙÈÎfi˜. ™ÙÔ ·ÁfiÚÈ Ù¤ıËΠ‰È¿ÁÓˆÛË ‰È¿¯˘Ù˘ ‰ÂÚÌ·ÙÈ΋˜ Ì·ÛÙÔ΢ÙÙ¿ÚˆÛ˘.

Mastocytosis in children: a report of two cases

1 1st Department of Paediatrics, “Venizelio” General Hospital, Heraklion, Crete

2 Allergology Clinic, 2nd Department of Paediatrics, “P. & A. Kyriakou” Childrens’ Hospital, University of Athens, Athens

Correspondence: Vassiliki Aggelakou vaagge3@yahoo.gr Gournes Temenous 71500, Heraklion, Crete

V. Aggelakou1, M. Koutli2, N. Papadopoulos2, E. Manoussakis2, P. Xepapadaki2, I. Charoniti1, F. Saxoni-Papageorgiou2

Abstract: Mastocytosis is an uncommon disease in infants and children. It is characterized by aggregates of large numbers of mast cells in several body tissues. The clinical manifestations depend on the dispersion of mast cells in specific organs and the secretion of mast cell mediators. Skin is the tissue usually affected in children and dermal manifestations may be the only presenting feature of the disease. Adults usually present with systemic mastocytosis and are more often affected by the more severe forms of the disease. Two cases of cutaneous mastocytosis in childhood of different types are presented. A 7 month-old male infant had first presented at the age of three months, with brownish maculopapular cutaneous lesions. There were no other clinical signs, apart from jitteriness and pruritus. The Darier sign was positive. Biopsy of the lesion revealed large perivascular aggregates of mast cells, which were compatible with maculopapular cutaneous mastocytosis. A 13 year-old boy presented with episodes of respiratory distress, expiratory wheezing, epigastric pain, flushing, facial angioedema, pruritus and lowered blood pressure. No apparent cutaneous lesions were reported and the Darier sign was negative. Skin biopsy revealed perivascular mast cell aggregates, while examination for systemic mastocytosis was negative. The diagnosis was made of diffuse cutaneous mastocytosis.

Key words: Mastocytosis, cutaneous mastocytosis, diffuse cutaneous mastocytosis, urticaria pigmentosa, children.

∆Ô 2000, ÔÈ Valent Î·È Û˘Ó. ÚfiÙÂÈÓ·Ó Ù·ÍÈÓfiÌËÛË Ù˘ Ì·ÛÙÔ΢ÙÙ¿ÚˆÛ˘ ‚¿ÛÂÈ Ó¤ˆÓ ‰È·ÁÓˆÛÙÈÎÒÓ ÎÚÈÙËÚ›ˆÓ, Ë ÔÔ›· ¤ÁÈÓ ·Ô‰ÂÎÙ‹ ·fi ÙÔÓ ¶·ÁÎfiÛÌÈÔ √ÚÁ·ÓÈÛÌfi ÀÁ›·˜ (¶›Ó·Î˜ 1 Î·È 2) (1,2). ∆· Ì·ÛÙÔ·ÙÙ·Ú· ·ıÚÔ›˙ÔÓÙ·È Î˘Ú›ˆ˜ ÛÙÔÓ Û˘Ó‰ÂÙÈÎfi ÈÛÙfi, Á‡Úˆ ·fi Ù· ÂÚÈÊÂÚÈο Ó‡ڷ Î·È Ù· ·ÈÌÔÊfiÚ· Î·È ÏÂÌÊÈο ·ÁÁ›·, ˘fi ÙËÓ Â›‰Ú·ÛË Î˘ÙÙ·ÚÔÎÈÓÒÓ (ÈÓÙÂÚÏ¢ΛÓ˜ 1,4,5,6,9,10,15) Î·È ÙÔ˘ ·Ú¿ÁÔÓÙ· ÙˆÓ ·Ú¯¤ÁÔÓˆÓ Î˘ÙÙ¿ÚˆÓ SCF (stem cell factor), Ô˘ Â›Ó·È Ô Î‡ÚÈÔ˜ ·˘ÍËÙÈÎfi˜ ·Ú¿ÁÔÓÙ·˜ ÙˆÓ Ì·ÛÙÔ΢ÙÙ¿ÚˆÓ. √ SCF ‰È·ÊÔÚÔÔÈ›

¶›Ó·Î·˜ 1. ∆·ÍÈÓfiÌËÛË Ù˘ Ì·ÛÙÔ΢ÙÙ¿ÚˆÛ˘

ÛÌÈÔ √ÚÁ·ÓÈÛÌfi ÀÁ›·˜ (¶√À)

¢ÂÚÌ·ÙÈ΋ Ì·ÛÙÔ΢ÙÙ¿ÚˆÛË

1. ∫ËÏȉԂϷÙȉ҉˘ ‰ÂÚÌ·ÙÈ΋ Ì·ÛÙÔ΢ÙÙ¿ÚˆÛË ‹ ÌÂÏ·Á¯ÚˆÌ·ÙÈ΋ ÎÓ›‰ˆÛË (urticaria pigmentosa) (70-90%)

2. ¢È¿¯˘ÙË ‰ÂÚÌ·ÙÈ΋ Ì·ÛÙÔ΢ÙÙ¿ÚˆÛË (1-3%)

3. ªÔÓ‹Ú˜ Ì·ÛÙÔ·Ùو̷ (10-30%)

4. ∂Í·ÓıËÌ·ÙÈ΋ ÎËÏȉ҉˘ ÙËÏ·ÁÁÂÈÂÎÙ·Û›· (Ôχ Û¿ÓÈ·)

∫·ÏÔ‹ı˘ Û˘ÛÙËÌ·ÙÈ΋ Ì·ÛÙÔ΢ÙÙ¿ÚˆÛË

1. ™˘ÛÙËÌ·ÙÈ΋, ‚Ú·‰Â›·˜ ÂͤÏÈ͢, Ì·ÛÙÔ΢ÙÙ¿ÚˆÛË

2. ª·ÛÙÔ΢ÙÙ¿ÚˆÛË ·ÔÎÏÂÈÛÙÈο ÛÙÔÓ Ì˘ÂÏfi ÙˆÓ ÔÛÙÒÓ

™˘ÛÙËÌ·ÙÈ΋ Ì·ÛÙÔ΢ÙÙ¿ÚˆÛË, ÌÂ Û˘ÓÔ‰fi ·ÈÌ·ÙÔÏÔÁÈ΋

‰È·Ù·Ú·¯‹ Ô˘ ‰ÂÓ Û¯ÂÙ›˙ÂÙ·È Ì ٷ Ì·ÛÙÔ·ÙÙ·Ú·

1. ™˘ÛÙËÌ·ÙÈ΋ Ì·ÛÙÔ΢ÙÙ¿ÚˆÛË Ì ÔÍ›· Ì˘ÂÏÔÁÂÓ‹ Ï¢¯·ÈÌ›·

2. ™˘ÛÙËÌ·ÙÈ΋ Ì·ÛÙÔ΢ÙÙ¿ÚˆÛË ÌÂ Ì˘ÂÏÔ¸ÂÚÏ·ÛÈÎfi

Û‡Ó‰ÚÔÌÔ

3. ™˘ÛÙËÌ·ÙÈ΋ Ì·ÛÙÔ΢ÙÙ¿ÚˆÛË ÌÂ Ì˘ÂÏÔ‰˘ÛÏ·ÛÙÈÎfi

Û‡Ó‰ÚÔÌÔ

4. ™˘ÛÙËÌ·ÙÈ΋ Ì·ÛÙÔ΢ÙÙ¿ÚˆÛË Ì ¯ÚfiÓÈ· Ì˘ÂÏÔÌÔÓÔ΢Ù-

Ù·ÚÈ΋ Ï¢¯·ÈÌ›·

5. ™˘ÛÙËÌ·ÙÈ΋ Ì·ÛÙÔ΢ÙÙ¿ÚˆÛË Ì ÌË-Hodgkin ϤÌʈ̷

6. ™˘ÛÙËÌ·ÙÈ΋ Ì·ÛÙÔ΢ÙÙ¿ÚˆÛË Ì ˘ÂÚˈÛÈÓÔÊÈÏÈÎfi Û‡Ó‰ÚÔÌÔ

∫·ÎÔ‹ı˘ Û˘ÛÙËÌ·ÙÈ΋ Ì·ÛÙÔ΢ÙÙ¿ÚˆÛË

§Â˘¯·ÈÌ›· ·fi Ì·ÛÙÔ·ÙÙ·Ú·

™¿ÚΈ̷ ·fi Ì·ÛÙÔ·ÙÙ·Ú·

∂͈‰ÂÚÌ·ÙÈÎfi Ì·ÛÙÔ·Ùو̷

Ù· Ì·ÛÙÔ·ÙÙ·Ú· ·fi Ù· ÔÏ˘‰‡Ó·Ì· CD34+ ·Ú-

¯¤ÁÔÓ· ·ÙÙ·Ú·, Ù· ÔÔ›· ÂÎÊÚ¿˙Ô˘Ó ÙÔÓ ˘Ô‰Ô¯¤· ÙÔ˘ SCF, c-KIT (3). ªÂϤÙ˜ ÙˆÓ ÙÂÏÂ˘Ù·›ˆÓ

¯ÚfiÓˆÓ ¤‰ÂÈÍ·Ó fiÙÈ ÙÔ˘Ï¿¯ÈÛÙÔÓ ÔÚÈṲ̂Ó˜ ÌÔÚʤ˜

Û˘ÛÙËÌ·ÙÈ΋˜ Ì·ÛÙÔ΢ÙÙ¿ÚˆÛ˘, Ì ¤Ó·ÚÍË Î˘Ú›ˆ˜ ÌÂÙ¿ Ù· 20 ¯ÚfiÓÈ· ˙ˆ‹˜, ÔÊ›ÏÔÓÙ·È Û ‰ÈÂÁÂÚÙÈΤ˜ ÌÂÙ·ÏÏ¿ÍÂȘ ÛÙÔÓ ˘Ô‰Ô¯¤· c-KIT, Ì ·ÚÈ· ÌÂÙ¿ÏÏ·ÍË ÙËÓ D816V (2,3). ∆Ô ÎÏÈÓÈÎfi Ê¿ÛÌ· Ù˘

Ì·ÛÙÔ΢ÙÙ¿ÚˆÛ˘ ÂÚÈÏ·Ì‚¿ÓÂÈ ÙËÓ Ï‹ÚË ·Ô˘Û›· Û˘ÌÙˆÌ¿ÙˆÓ Ì¤¯ÚÈ ÙËÓ ·ÚÔ˘Û›· ÛÔ‚·ÚÒÓ ÂΉËÏÒÛˆÓ. ∫‡ÚÈÔ ¯·Ú·ÎÙËÚÈÛÙÈÎfi Ù˘ ÓfiÛÔ˘ Â›Ó·È Ë ¤ÎÎÚÈÛË ÌÂÛÔÏ·‚ËÙÒÓ ·fi Ù· Ì·ÛÙÔ·ÙÙ·Ú·, ˘fi ÙËÓ Â›‰Ú·ÛË ‰È·ÊfiÚˆÓ ·Ú·ÁfiÓÙˆÓ, Ô˘ Ô‰ËÁ› Û ÔÈΛϘ ÂΉËÏÒÛÂȘ (¶›Ó·Î˜ 3 Î·È 4). ∆· ·È‰È¿ Û˘Ó‹ıˆ˜ ÂÌÊ·Ó›˙Ô˘Ó ‰ÂÚÌ·ÙÈ΋ Ì·ÛÙÔ΢ÙÙ¿ÚˆÛË Î·È Î˘Ú›ˆ˜ ÙËÓ ÎËÏȉԂϷÙÈ‰Ò‰Ë ÌÔÚÊ‹, Ô˘ ÎÏ·ÛÈο ÔÓÔÌ¿˙ÂÙ·È ÌÂÏ·Á¯ÚˆÌ·ÙÈ΋ ÎÓ›‰ˆÛË. ÷ڷÎÙËÚÈÛÙÈÎfi Î·È ‰È·ÁÓˆÛÙÈÎfi ÛËÌÂ›Ô Ù˘ ‰ÂÚÌ·ÙÈ΋˜ Ì·ÛÙÔ΢ÙÙ¿ÚˆÛ˘ Â›Ó·È ÙÔ ÛËÌ›Ô

Darier, ÙÔ ÔÔ›Ô Û˘Ó›ÛÙ·Ù·È ÛÙË ‰ËÌÈÔ˘ÚÁ›· ÂÚ˘ıÚfiÙËÙ·˜ Î·È ÔÌÊÔ‡ ÛÙ· fiÚÈ· Ù˘ ‰ÂÚÌ·ÙÈ΋˜ ·ÏÏÔ›ˆÛ˘, ÌÂÙ¿ ·fi Ì˯·ÓÈ΋ ÙÚÈ‚‹ Ù˘ (5). √È ÂÓ‹ÏÈΘ Û˘¯Ó¿ ¿Û¯Ô˘Ó ·fi Û˘ÛÙËÌ·ÙÈ΋ Ì·ÛÙÔ΢ÙÙ¿ÚˆÛË.

ªÂ›˙ÔÓ·*¶ÔÏ˘ÂÛÙȷΤ˜ ‰ÈËı‹ÛÂȘ ·fi Ì·ÛÙÔ·ÙÙ·Ú·

ÛÙÔÓ Ì˘ÂÏfi ÙˆÓ ÔÛÙÒÓ ‹ Û ¿ÏÏÔ fiÚÁ·ÓÔ ÂÎÙfi˜

ÙÔ˘ ‰¤ÚÌ·ÙÔ˜ (>15 ‰ÈËı‹ÛÂȘ)

∂Ï¿ÛÛÔÓ·*1.ª·ÛÙÔ·ÙÙ·Ú· Ì ·ÓÒÌ·ÏË ÌÔÚÊÔÏÔÁ›·

ÛÙÔÓ Ì˘ÂÏfi ‹ ¿ÏÏÔ fiÚÁ·ÓÔ ÂÎÙfi˜ ÙÔ˘ ‰¤ÚÌ·ÙÔ˜ (>25%)

2.ªÂÙ¿ÏÏ·ÍË D816V ÛÙÔ Îˆ‰ÈÎfiÓÈÔ 816 ÙÔ˘ c-KIT Û fiÚÁ·ÓÔ ÂÎÙfi˜ ·fi ÙÔ ‰¤ÚÌ·†

3.ª·ÛÙÔ·ÙÙ·Ú· Ì ¤ÎÊÚ·ÛË CD2, CD25 ‹ Î·È Ù· ‰‡Ô ÛÙÔÓ Ì˘ÂÏfi ÙˆÓ ÔÛÙÒÓ

4.∆Ú˘Ù¿ÛË ÔÚÔ‡ >20 ng/mL (‰ÂÓ ıˆÚÂ›Ù·È ÎÚÈÙ‹ÚÈÔ Û ·ÛıÂÓ›˜ Ì ̷ÛÙÔ΢ÙٿوÛË

ÌÂ Û˘ÓÔ‰fi ·ÈÌ·ÙÔÏÔÁÈ΋ ‰È·Ù·Ú·¯‹)

* ¢È¿ÁÓˆÛË

Û˘ÛÙËÌ·ÙÈ΋˜ Ì·ÛÙÔ΢ÙÙ¿ÚˆÛ˘ Ù›ıÂÙ·È ÌÂ

ÙÔ˘Ï¿¯ÈÛÙÔÓ ¤Ó· Ì›˙ÔÓ Î·È ¤Ó· ¤Ï·ÛÛÔÓ ÎÚÈÙ‹ÚÈÔ ‹ ÙÚ›· ÂÏ¿ÛÛÔÓ· ÎÚÈÙ‹ÚÈ·

ÌËÓÒÓ ÚÔÛ‹Ïı ÛÙÔ Â͈ÙÂÚÈ-

È·ÙÚÂ›Ô ÏfiÁˆ ÂÌÊ¿ÓÈÛ˘ ηÊÂÙÈÒÓ ÎËÏȉԂϷÙȉˆ‰ÒÓ ‚Ï·‚ÒÓ ·fi 4Ì‹ÓÔ˘, ÛÙ·‰È·Î¿

Û ̤ÁÂıÔ˜ Î·È ·ÚÈıÌfi, ÌÂ Û˘ÓÔ‰fi

·ÓËÛ˘¯›· Î·È ÎÓËÛÌfi. ∆Ô ‚Ú¤ÊÔ˜ ›¯Â Ï¿‚ÂÈ ÙÔÈ΋

·ÁˆÁ‹ Ì ÊÏÔ˘ÙÈη˙fiÓË Î·È ÂÓ˘‰¿ÙˆÛË.

ÙÔ ÌÔÓ·‰ÈÎfi ·È‰› Ê·ÈÓÔÙ˘Èο ˘ÁÈÒÓ ÁÔ-

Ó¤ˆÓ, Ì ·ÙÔÌÈÎfi ·Ó·ÌÓËÛÙÈÎfi ÂχıÂÚÔ. ∏ ۈ̷ÙÈ΋ ·‡ÍËÛË Î·È Ë „˘¯ÔÎÈÓËÙÈ΋ ÙÔ˘ ·Ó¿Ù˘ÍË ‹Ù·Ó

Û˘Ì‚·Ù¤˜ Ì ÙËÓ ËÏÈΛ· ÙÔ˘. ∞fi ÙË Ê˘ÛÈ΋ ÂͤٷÛË ‰È·ÈÛÙÒıËÎ·Ó ÎËÏȉԂϷÙȉ҉ÂȘ ηÊÂÙȤ˜ ‚Ï¿‚˜ ‰¤ÚÌ·ÙÔ˜, ÛÙËÓ ÂÚÈÔ¯‹ ÙÔ˘ ·˘¯¤Ó·, ÛÙÔÓ ÎÔÚÌfi ηÈ, ÏÈÁfiÙÂÚÔ, ÛÙ· ¿ÎÚ·, ÌÂÁ¤ıÔ˘˜ 2-10 ÂηÙÔÛÙÒÓ Î·È ˆÔÂȉԇ˜ Û¯‹Ì·ÙÔ˜, Ì ıÂÙÈÎfi ÛËÌÂ›Ô Darier (∂ÈÎfiÓ˜ 1 Î·È 2). ∏ ÂͤٷÛË ÙˆÓ ˘fiÏÔÈˆÓ

∂ÈÎfiÓ· 2. ™ËÌÂ›Ô Darier ÛÙÔ ›‰ÈÔ ‚Ú¤ÊÔ˜

Û˘ÛÙËÌ¿ÙˆÓ ‹Ù·Ó Ê˘ÛÈÔÏÔÁÈ΋. √ ÂÚÁ·ÛÙËÚÈ·Îfi˜ ¤ÏÂÁ¯Ô˜ ¤‰ÂÈÍÂ: °ÂÓÈ΋ ·›Ì·ÙÔ˜: §Â˘Î¿ ·ÈÌÔÛÊ·›ÚÈ·=15.000 Î.Î.¯. (¶=25%, §=64%, ª=7%, ∏=4%), ·ÈÌÔÛÊ·ÈÚ›ÓË=10,6 g/dl, ·ÈÌ·ÙÔÎÚ›Ù˘=32,4%, ·ÈÌÔÂÙ¿ÏÈ·=574000 K/ÌL, ¢∂∫=1,5%, ∆∫∂=9 mm (1Ë ÒÚ·). √ ‚ÈÔ¯ËÌÈÎfi˜ ¤ÏÂÁ¯Ô˜ ‹Ù·Ó Ê˘ÛÈÔÏÔÁÈÎfi˜, Ë ÙÚ˘Ù¿ÛË ÔÚÔ‡ 12 ng/ml (Ê.Ù. <14 ng/ml) Î·È ÙÔ ˘ÂÚ˯ÔÁÚ¿ÊËÌ· ÎÔÈÏ›·˜ Ê˘ÛÈÔÏÔÁÈÎfi. ™ÙË ‚ÈÔ„›·

‰ÂÚÌ·ÙÈ΋˜ ‚Ï¿‚˘ ·Ú·ÙËÚ‹ıËÎ·Ó ˘ÎÓ¤˜ ‰ÈËı‹ÛÂȘ ·fi ·ÙÙ·Ú· Ì ÈÛÙÔ¯ËÌÈÎÔ‡˜ Î·È ÈÛÙÔÏÔÁÈÎÔ‡˜

¯·Ú·ÎÙ‹Ú˜ Ì·ÛÙÔ΢ÙÙ¿ÚˆÓ ÛÙÔ ¯fiÚÈÔ, ÂÈÎfiÓ· Û˘Ì-

‚·Ù‹ Ì ÌÂÏ·Á¯ÚˆÌ·ÙÈ΋ ÎÓ›‰ˆÛË (∂ÈÎfiÓ· 3). ∆Ô

‚Ú¤ÊÔ˜ Ù¤ıËΠ۠·ÁˆÁ‹ Ì ÎÂÙÔÙÈÊ·›ÓÈÔ, Ì ̤ÙÚÈ·

·ÓÙ·fiÎÚÈÛË, Î·È ÛÙË Û˘Ó¤¯ÂÈ· Ì ÛÂÙÈÚÈ˙›ÓË, Ì η-

Ï¿ ·ÔÙÂϤÛÌ·Ù· fiÛÔÓ ·ÊÔÚ¿ ÙËÓ ·ÓËÛ˘¯›· Î·È ÙÔÓ

ÎÓËÛÌfi. ∞ÎfiÌË, ‰fiıËÎ·Ó Ô‰ËÁ›Â˜ ÛÙÔ˘˜ ÁÔÓ›˜ ÁÈ·

·ÔÊ˘Á‹ ÂÎÏ˘ÙÈÎÒÓ ·Ú·ÁfiÓÙˆÓ ·ÔÎÔÎΛˆÛ˘

ÙˆÓ Ì·ÛÙÔ΢ÙÙ¿ÚˆÓ.

2Ë ÂÚ›ÙˆÛË

∞ÁfiÚÈ ËÏÈΛ·˜ 13 ÂÙÒÓ ·ÚÔ˘Û›·˙ ·fi 6Ì‹ÓÔ˘

ÂÂÈÛfi‰È· Ì ·Ó·Ó¢ÛÙÈ΋ ‰˘Û¯¤ÚÂÈ·, ÂÈÁ·ÛÙÚÈÎfi

¿ÏÁÔ˜, ÎÓËÛÌfi, ‰È¿¯˘ÙË ÂÚ˘ıÚfiÙËÙ· (flushing) ηÈ

ÌÂÚÈΤ˜ ÊÔÚ¤˜ ·ÁÁÂÈÔÔ›‰ËÌ· ÚÔÛÒÔ˘. ∆· Û˘ÌÙÒÌ·Ù· ·Ú¯Èο ‹Ù·Ó ‹È· Î·È ·˘ÙÔÂÚÈÔÚÈ˙fiÌÂÓ·, ÂÓÒ ÛÙ·‰È·Î¿ ·˘Í‹ıËÎ·Ó ÛÂ Û˘¯ÓfiÙËÙ· Î·È ‚·Ú‡ÙËÙ·. ∆· ÂÂÈÛfi‰È· ‰ÂÓ Â›¯·Ó

∂ÈÎfiÓ· 3. µÈÔ„›· ‰¤ÚÌ·ÙÔ˜ ÙÔ˘ ‚Ú¤ÊÔ˘˜ Ì ÙË ÌÂÏ·Á¯ÚˆÌ·ÙÈ΋ ÎÓ›‰ˆÛË.

‰È·ÈÛÙÒıËΠ‹È· Á·ÛÙÚ›Ùȉ· Î·È ¯ÔÚËÁ‹ıËΠıÂÚ·›· Ì ·Ó·ÛÙÔÏ›˜ Ù˘ ·ÓÙÏ›·˜ ÚˆÙÔÓ›ˆÓ ÁÈ· 3 ̋Ә. ∞fi ÙÔ ÔÈÎÔÁÂÓÂÈ·Îfi ÈÛÙÔÚÈÎfi ·Ó·Ê¤ÚÂÙ·È Á·ÛÙÚÔÔÈÛÔÊ·ÁÈ΋ ·ÏÈÓ‰ÚfiÌËÛË ÛÙÔÓ ·Ù¤Ú· ηÈ

ÙÔ˘˜ ÁÔÓ›˜ ÙÔ˘ Î·È ˘Ôı˘ÚÂÔÂȉÈÛÌfi˜, ÎÓ›‰ˆÛË ÌÂÙ¿ ·fi Ï‹„Ë Ê·ÚÌ¿ÎˆÓ Î·È ÂÚÈÔ‰Èο ·ÁÁÂÈÔÔ›‰ËÌ· ÛÙË ÌËÙ¤Ú·. ∆· ·‰¤ÚÊÈ· ÙÔ˘, 18 Î·È 5 ÂÙÒÓ, Â›Ó·È Ê·ÈÓÔÙ˘Èο ˘ÁÈ‹. √ ÂÚÁ·ÛÙËÚÈ·Îfi˜ Î·È ·Ú·ÎÏÈÓÈÎfi˜ ¤ÏÂÁ¯Ô˜, Ô˘ ÂÚÈÂϿ̂·Ó ÁÂÓÈ΋ ·›Ì·ÙÔ˜, ∆∫∂, ‚·ÛÈÎÔ‡˜ ‚ÈÔ¯ËÌÈÎÔ‡˜ ‰Â›ÎÙ˜, ı˘ÚÂÔÂȉÈΤ˜ ÔÚÌfiÓ˜, ·˘ÙÔ·ÓÙÈÛÒÌ·Ù· (·ÓÙÈı˘ÚÂÔÂȉÈο, ·ÓÙÈ˘ÚËÓÈο, ·ÓÙÈ-DNA), ·ÓÙÈÛÒÌ·Ù· ÁÈ· EBV, CMV

∂ÈÎfiÓ· 4. µÈÔ„›· ‰¤ÚÌ·ÙÔ˜ ÙÔ˘ ·ÛıÂÓÔ‡˜ Ì ÙË ‰È¿¯˘ÙË Ì·ÛÙÔ΢ÙÙ¿ÚˆÛË.

ªÂÛÔÏ·‚ËÙ¤˜ ¢Ú¿ÛÂȘ

πÛÙ·Ì›ÓË∞ÁÁÂÈԉȷÛÙÔÏ‹, ÂÚ‡ıËÌ·, Ô›‰ËÌ·, ÎÓËÛÌfi˜, ÎÓ›‰ˆÛË, ‚ÚÔÁ¯fiÛ·ÛÌÔ˜, ·˘ÍË̤ÓÔ

Á·ÛÙÚÈÎfi Ô͇, ÂÓÂÚÁÔÔ›ËÛË Ï¢ÎÔ΢ÙÙ¿ÚˆÓ

∏·Ú›ÓË√ÛÙÂÔfiÚˆÛË, ·Ó·ÛÙÔÏ‹ ‰ËÌÈÔ˘ÚÁ›·˜ ıÚfiÌ‚Ô˘, ·Ú¿Ù·ÛË PTT

∆Ú˘Ù¿ÛˢȿÛ·ÛË ÈÓˆ‰ÔÁfiÓÔ˘ Î·È ÂÓÂÚÁÔÔ›ËÛË ÎÔÏÏ·ÁÂÓ¿Û˘ Ô˘ Ô‰ËÁ› Û ηٷÛÙÚÔÊ‹

ÈÛÙÒÓ, ‚ÚÔÁ¯fiÛ·ÛÌÔ˜, ÔÛÙÂÔfiÚˆÛË

Ã˘Ì¿ÛË∆ÔÈ΋ ·Ó·ÛÙÔÏ‹ ‹Í˘, ÂÓÂÚÁÔÔ›ËÛË Ì·ÛÙÔ΢ÙÙ¿ÚˆÓ, ‰ËÌÈÔ˘ÚÁ›· Ê˘ÛÛ·Ï›‰ˆÓ (;)

∫·ı„›ÓË G Î·È ∫·Ú‚Ô͢ÂÙȉ¿ÛË ∞¶·Ú·ÁˆÁ‹ ÎÈÓ›Ó˘, Ë·ÙÈ΋ ›ÓˆÛË (;)

ŸÍÈÓ˜ ˘‰ÚÔϿۘµÏ¿‚˜ ÔÛÙÒÓ, ÔÛÙÂÔfiÚˆÛË

§Â˘ÎÔÙÚȤÓÈ· C4, D4, E4 ¶·Ú·ÙÂٷ̤ÓÔ˜ ‚ÚÔÁ¯fiÛ·ÛÌÔ˜, ·˘ÍË̤ÓË ·Ú·ÁˆÁ‹ ‚ϤÓÓ˘, ·˘ÍË̤ÓË ‰È·ÂÚ·ÙfiÙËÙ· Î·È Û˘Û·ÛÙÈÎfiÙËÙ· ·ÁÁ›ˆÓ

¶ÚÔÛÙ·ÁÏ·Ó‰›ÓË D2

¶·Ú¿ÁÔÓÙ·˜ ÂÓÂÚÁÔÔ›ËÛ˘

∞ÁÁÂÈԉȷÛÙÔÏ‹, ‚ÚÔÁ¯fiÛ·ÛÌÔ˜, ¯ËÌÂÈÔÙ·Í›· Ô˘‰ÂÙÂÚÔʛψÓ

∞˘ÍË̤ÓË ‰È·ÂÚ·ÙfiÙËÙ· ·ÁÁ›ˆÓ, ‚ÚÔÁ¯fiÛ·ÛÌÔ˜, ¯ËÌÂÈÔÙ·Í›· Î·È ÂÓÂÚÁÔÔ›ËÛË ÙˆÓ ·ÈÌÔÂÙ·Ï›ˆÓ (PAF)Ï¢ÎÔ΢ÙÙ¿ÚˆÓ TNF¢ËÌÈÔ˘ÚÁ›· ÊÏÂÁÌÔÓ‹˜

IL-3¶ÔÏÏ·Ï·ÛÈ·ÛÌfi˜ Ì·ÛÙÔ΢ÙÙ¿ÚˆÓ

IL-4, IL-13¶·Ú·ÁˆÁ‹ IgE, ·Ú·ÁˆÁ‹ ‚ϤÓÓ˘

IL-5¶·Ú·ÁˆÁ‹ Î·È ÂÓÂÚÁÔÔ›ËÛË ËˆÛÈÓÔʛψÓ

Î·È ÈÔ‡˜ Ë·Ù›Ùȉ·˜, Ï‹ÚË ¤ÏÂÁ¯Ô Û˘ÌÏËÚÒÌ·-

ÙÔ˜, ‰ÔÎÈÌ·Û›· ·˘ÙfiÏÔÁÔ˘ ÔÚÔ‡, ·ÓÔÛÔÛÊ·ÈÚ›Ó˜, ·ÎÙÈÓÔÁÚ·Ê›· ıÒڷη, ˘ÂÚ˯ÔÁÚ¿ÊËÌ· ÎÔÈÏ›·˜

Î·È ÔÈÛÔÊ·ÁÔÁÚ¿ÊËÌ·, ‹Ù·Ó Ê˘ÛÈÔÏÔÁÈÎfi˜. ∏ ÙÚ˘-

Ù¿ÛË ÔÚÔ‡ ‹Ù·Ó 4 ng/ml. ∏ pHÌÂÙÚ›· ÔÈÛÔÊ¿ÁÔ˘

¤‰ÂÈÍ ÌÂÙÚ›Ô˘ ‚·ıÌÔ‡ Á·ÛÙÚÔÔÈÛÔÊ·ÁÈ΋ ·ÏÈÓ‰ÚfiÌËÛË, ÂÓÒ ÛÙËÓ ÂÓ‰ÔÛÎfiËÛË ÙÔ˘ ·ÓÒÙÂÚÔ˘ Â-

ÙÈÎÔ‡ ‰È·ÈÛÙÒıËΠ‰È¿‚ÚˆÛË ÛÙËÓ Î·Ú‰ÈÔÔÈÛÔ-

Ê·ÁÈ΋ Û˘Ì‚ÔÏ‹, ηıÒ˜ Î·È ‹ÈÔ Ô›‰ËÌ· Î·È ÂÚ˘ıÚfiÙËÙ· ÛÙÔ ÛÒÌ· Î·È ÙÔ ¿ÓÙÚÔ ÙÔ˘ ÛÙÔÌ¿¯Ô˘. √È

‚ÈÔ„›Â˜ Ô˘ ÂÏ‹ÊıËÛ·Ó ‹Ù·Ó Ê˘ÛÈÔÏÔÁÈΤ˜. ŒÁÈÓÂ

‚ÈÔ„›· ˘ÁÈÔ‡˜ ‰¤ÚÌ·ÙÔ˜, ÛÙËÓ ÔÔ›· ‚Ú¤ıËΠ‰È¿Ù·ÛË ·ÁÁ›ˆÓ, Ì ‰ÈfiÁΈÛË ÙˆÓ ÂÓ‰ÔıËÏÈ·ÎÒÓ Î˘ÙÙ¿-

ÚˆÓ Î·È ·‡ÍËÛË ÙÔ˘ ·ÚÈıÌÔ‡ ÙˆÓ Ì·ÛÙÔ΢ÙÙ¿ÚˆÓ

ÂÚÈ·ÁÁÂȷο (∂ÈÎfiÓ· 4). ∆Ô ÛÈÓıËÚÔÁÚ¿ÊËÌ·

ÔÛÙÒÓ ‹Ù·Ó Ê˘ÛÈÔÏÔÁÈÎfi. ∏ ÂͤٷÛË ÙÔ˘ Ì˘ÂÏÔ‡

ÙˆÓ ÔÛÙÒÓ ¤‰ÂÈÍ ·˘ÍË̤ÓË Î˘ÙÙ·ÚÔ‚Ú›ıÂÈ·, ÌÂ Ê˘-

ÛÈÔÏÔÁÈΤ˜ fiϘ ÙȘ ΢ÙÙ·ÚÈΤ˜ ÛÂÈÚ¤˜ Î·È ¯ˆÚ›˜ ·ÚÔ˘Û›· Ì·ÛÙÔ΢ÙÙ¿ÚˆÓ. ™ÙÔÓ Ì˘ÂÏfi ‰ÂÓ ·ÓȯÓ‡ıËΠÌÂÙ¿ÏÏ·ÍË ÛÙÔ ÂÍfiÓÈÔ 17 ÙÔ˘ ÁÔÓȉ›Ô˘ c-KIT. ªÂ Ù· ·ÓˆÙ¤Úˆ ‰Â‰Ô̤ӷ, Ù¤ıËÎÂ Ë ‰È¿ÁÓˆÛË Ù˘ ‰È¿¯˘Ù˘ ‰ÂÚÌ·ÙÈ΋˜ Ì·ÛÙÔ΢ÙÙ¿ÚˆÛ˘. √ ·ÛıÂÓ‹˜

¤Ï·‚ ‰È¿ÁÓˆÛË ‰È¿¯˘Ù˘ ‰ÂÚÌ·ÙÈ΋˜ Ì·ÛÙÔ΢ÙÙ¿ÚˆÛ˘, ηıfiÛÔÓ ‰ÂÓ ÏËÚÔ‡Û ٷ ÎÚÈÙ‹ÚÈ· ÁÈ· ÙË

‰È¿ÁÓˆÛË Ù˘ Û˘ÛÙËÌ·ÙÈ΋˜ Ì·ÛÙÔ΢ÙÙ¿ÚˆÛ˘ (¶›Ó·Î·˜ 2). ∆¤ıËΠ۠ıÂÚ·›· Ì Ï‚ÔÛÂÙÈÚÈ˙›ÓË Î·È Ú·ÓÈÙȉ›ÓË, ÂÊԉȿÛıËΠ̠·‰ÚÂÓ·Ï›ÓË ·˘ÙfiÌ·Ù˘

ËÏÈΛ· Î·È ÛÙËÓ ÙÚ›ÙË Ì ٤ٷÚÙË ‰ÂηÂÙ›· Ù˘ ˙ˆ‹˜. ¶ÂÚ›Ô˘ Ù· 2/3 ÙˆÓ ·ÛıÂÓÒÓ Ì ̷ÛÙÔ΢ÙÙ¿ÚˆÛË Â›Ó·È ·È‰È¿. ∏ Ì·ÛÙÔ΢ÙÙ¿ÚˆÛË ‰ÂÓ Â›Ó·È

ÎÏËÚÔÓÔÌÈ΋ ÓfiÛÔ˜ Î·È Ë Û˘¯ÓfiÙËÙ· ÔÈÎÔÁÂÓÔ‡˜ ηٷÓÔÌ‹˜ Â›Ó·È ÂÚ›Ô˘ 11% (8). ∏ ¤Ó·ÚÍË ÛÙËÓ ·È‰È΋ ËÏÈΛ· ‹ ÛÙËÓ ÂÓ‹ÏÈÎÔ ˙ˆ‹ ‰È·Ê¤ÚÂÈ ˆ˜ ÚÔ˜

ÙËÓ ÎÏÈÓÈ΋ ¤ÎÊÚ·ÛË, ÙËÓ ÔÚ›·, ÙËÓ ·Ó‡ÚÂÛË ÌÂÙ·ÏÏ¿ÍÂˆÓ ÛÙÔÓ ˘Ô‰Ô¯¤· c-Kit Î·È ÙËÓ ÚfiÁÓˆÛË. ∆Ô 80% ÙˆÓ ·ÛıÂÓÒÓ Ì ̷ÛÙÔ΢ÙÙ¿ÚˆÛË ¤¯ÂÈ

ÚÔÛ‚ÔÏ‹ ÙÔ˘ ‰¤ÚÌ·ÙÔ˜ Î·È ÌfiÓÔ ÙÔ 20% ÙˆÓ ·ÛıÂÓÒÓ ÌÂ Û˘ÛÙËÌ·ÙÈ΋ Ì·ÛÙÔ΢ÙÙ¿ÚˆÛË ‰ÂÓ ¤¯ÂÈ ‰ÂÚÌ·ÙÈΤ˜ ÂΉËÏÒÛÂȘ (7). ∏ ‰ÂÚÌ·ÙÈ΋ Ì·ÛÙÔ΢ÙÙ¿ÚˆÛË (¢ª) Â›Ó·È Ë ÌfiÓË ÂΉ‹ÏˆÛË Û¯Â‰fiÓ ÛÙÔ Û‡ÓÔÏÔ ÙˆÓ ·Û¯fiÓÙˆÓ ·È‰ÈÒÓ.

∏ Û˘¯ÓfiÙÂÚË ÌÔÚÊ‹ ¢ª Â›Ó·È Ë ÎËÏȉԂϷÙȉ҉˘ ÌÔÚÊ‹, Ô˘ ÎÏ·ÛÈο ÔÓÔÌ¿˙ÂÙ·È ÌÂÏ·Á¯ÚˆÌ·ÙÈ΋ ÎÓ›‰ˆÛË (ª∫) Î·È ·ÊÔÚ¿ ÙÔ 70-90% ÙˆÓ ÂÚÈÙÒÛÂˆÓ ¢ª (8-10). √È ‚Ï¿‚˜ ÛÙ· ·È‰È¿, Û ۯ¤ÛË

Ì ÙÔ˘˜ ÂÓ‹ÏÈΘ, Â›Ó·È ÂÚÈÛÛfiÙÂÚÔ ÌÂÏ·Á¯ÚˆÌ·ÙÈΤ˜ Î·È ÏÈÁfiÙÂÚÔ ÂÚ˘ıÚ¤˜ ÎËÏ›‰Â˜, ‚Ï·Ù›‰Â˜, ϿΘ

‹

fi˙ÔÈ ÔÈΛÏÔ˘ ÌÂÁ¤ıÔ˘˜ (̤ÛË ‰È¿ÌÂÙÚÔ˜ 5 mm ηÈ

̤ÁÈÛÙË 15 mm) Î·È Ì ÂÓÙfiÈÛË Î˘Ú›ˆ˜ ÛÙÔÓ ÎÔÚÌfi

Û¿ÓÈ· ¤ˆ˜ ηıfiÏÔ˘ ÛÙȘ ·Ï¿Ì˜, Ù· ¤ÏÌ·Ù·, ÙÔ ÚfiÛˆÔ Î·È ÙÔ ÙÚȯˆÙfi Ù˘ ÎÂÊ·Ï‹˜ (7-10). ∆Ô

™˘˙‹ÙËÛË

ÛËÌÂ›Ô Darier Â›Ó·È ıÂÙÈÎfi ÛÙÔ Û‡ÓÔÏÔ Û¯Â‰fiÓ ÙˆÓ ·ÛıÂÓÒÓ Ì ¢ª. √ ÎÓËÛÌfi˜ Â›Ó·È ÙÔ ÈÔ Û˘¯Ófi Û‡Ìو̷ Ù˘ ª∫ Î·È ÔÈΛÏÏÂÈ Û ¯ÚÔÓÈfiÙËÙ· Î·È ¤ÓÙ·ÛË (8-10). ∆Ô flushing ÂÌÊ·Ó›˙ÂÙ·È ÌÂÙ¿ ·fi ˙ÂÛÙfi ‹ ÎÚ‡Ô

Û·ÓÈfiÙÂÚ· οÔÈ· ÙÚÔÊ‹ ‹ Ê¿ÚÌ·ÎÔ, ÂÓÒ Û ÌÂÁ¿-

ÏÔ ÔÛÔÛÙfi ·Ú¤ÌÂÈÓ ·‰È¢ÎÚ›ÓÈÛÙÔ (14).

∏ Û˘¯ÓfiÙËÙ· Ù˘ ·ÙÔ›·˜ ÛÙÔ˘˜ ·ÛıÂÓ›˜ Ì ̷-

ÛÙÔ΢ÙÙ¿ÚˆÛË Â›Ó·È ›‰È· Ì ÙÔ˘ ÁÂÓÈÎÔ‡ ÏËı˘ÛÌÔ‡, ÂÓÒ Ë Û˘¯ÓfiÙËÙ· Ù˘ ·Ó·Ê˘Ï·Í›·˜ Â›Ó·È ÌÂÁ·-

χÙÂÚË ÛÙË Ì·ÛÙÔ΢ÙÙ¿ÚˆÛË. °ÂÓÈο, ÔÈ ·ÛıÂÓ›˜ ÌÂ

·ÙÔ›· Î·È Ì·ÛÙÔ΢ÙÙ¿ÚˆÛË Î¿ÓÔ˘Ó ÛÔ‚·ÚfiÙÂÚ˜

·ÓÙȉڿÛÂȘ, Û ۯ¤ÛË Ì ·˘ÙÔ‡˜ Ô˘ ¿Û¯Ô˘Ó ÌfiÓÔ

·fi Ì·ÛÙÔ΢ÙÙ¿ÚˆÛË (15).

∏ ‰È¿ÁÓˆÛË Ù˘ ÓfiÛÔ˘ Â›Ó·È ÈÔ Â‡ÎÔÏË fiÙ·Ó

˘¿Ú¯Ô˘Ó ‰ÂÚÌ·ÙÈΤ˜ ‚Ï¿‚˜ Î·È ıÂÙÈÎfi ÛËÌ›Ô

Darier, ÂÓÒ ··ÈÙÂ›Ù·È ÌÂÁ¿ÏÔ˜ ‚·ıÌfi˜ ˘Ô„›·˜ Ù˘

‰È¿ÁÓˆÛ˘ ·fi ÙÔÓ ÎÏÈÓÈÎfi ÁÈ·ÙÚfi fiÙ·Ó ·˘Ù¿ ·Ô˘-

ÛÈ¿˙Ô˘Ó. ™Ù· ·È‰È¿ Ì ¢ª ¯ˆÚ›˜ ¿ÏÏ· ÎÏÈÓÈο Â˘Ú‹Ì·Ù·, Ë ‰È¿ÁÓˆÛË Ù›ıÂÙ·È Ì ÙË ‚ÈÔ„›· ‰¤ÚÌ·ÙÔ˜

Î·È ‰ÂÓ ··ÈÙÂ›Ù·È ÂÚ·ÈÙ¤Úˆ ¤ÏÂÁ¯Ô˜. ŸÌˆ˜, fiÙ·Ó

˘¿Ú¯Ô˘Ó ÎÏÈÓÈο ÛËÌ›·, fiˆ˜ ÏÂÌÊ·‰ÂÓÈ΋ ‰Èfi-

ÁΈÛË ‹ ÛÏËÓÔÌÂÁ·Ï›·, Û˘ÛÙËÌ·ÙÈο Û˘ÌÙÒÌ·Ù·

Î·È Ë ÓfiÛÔ˜ ÂÌÊ·Ó›˙ÂÙ·È ÌÂÙ¿ ÙËÓ ËÏÈΛ· ÙˆÓ 5 ÂÙÒÓ,

Ú¤ÂÈ Ó· Á›ÓÂÙ·È Ï‹Ú˘ ¤ÏÂÁ¯Ô˜ ÁÈ· ÙÔÓ ·ÔÎÏÂÈÛÌfi ™ª. √ ¤ÏÂÁ¯Ô˜ ÂÚÈÏ·Ì‚¿ÓÂÈ Ì¤ÙÚËÛË Ù˘ ÙÚ˘-

Ù¿Û˘ ÔÚÔ‡, ‚ÈÔ„›· Ì˘ÂÏÔ‡ ÙˆÓ ÔÛÙÒÓ, ÛÈÓıËÚÔ-

ÁÚ¿ÊËÌ· ÔÛÙÒÓ Î·È ·Ó›¯Ó¢ÛË Ù˘ ÌÂÙ¿ÏÏ·Í˘

D816V ÛÙÔÓ c-Kit (13). ÕÏϘ ÂÚÁ·ÛÙËÚȷΤ˜ ‹ ÂÓ‰ÔÛÎÔÈΤ˜ ÂÍÂÙ¿ÛÂȘ ··ÈÙÔ‡ÓÙ·È Î·Ù¿ ÂÚ›ÙˆÛË. ∏ Ì·ÛÙÔ΢ÙÙ¿ÚˆÛË Ú¤ÂÈ Ó· ·ÔÎÏ›ÂÙ·È ÛÂ

·ÛıÂÓ›˜ Ì Â·Ó·Ï·Ì‚·ÓfiÌÂÓ· ÂÂÈÛfi‰È· ȉÈÔ·ıÔ‡˜ ·Ó·Ê˘Ï·Í›·˜ (14,15).

∏ ıÂÚ·›· Â›Ó·È Û˘Ìو̷ÙÈ΋, Ì ʿÚ̷η

ÂÎÏÔÁ‹˜ Ù· H1 ·ÓÙÈÈÛÙ·ÌÈÓÈο, fiˆ˜ Ë ˘‰ÚÔ͢˙›ÓË, ·ÏÏ¿ Î·È Ù· ÓÂfiÙÂÚ·, fiˆ˜ Ë ÛÂÙÈÚÈ˙›ÓË, Ë Ï‚ÔÛÂÙÈÚÈ˙›ÓË, Ë ÏÔÚ·Ù·‰›ÓË ‹ Ë ‰ÂÛÏÔÚ·Ù·‰›ÓË. ∆Ô ÎÂ-

ÙÔÙÈÊ·›ÓÈÔ Ê·›ÓÂÙ·È Ó· ˘ÔÏ›ÂÙ·È ÙˆÓ ·ÓÙÈÈÛÙ·-

ÌÈÓÈÎÒÓ ÛÙÔÓ ¤ÏÂÁ¯Ô ÙˆÓ Û˘ÌÙˆÌ¿ÙˆÓ (16). ∏

ÚÔÛı‹ÎË ∏2 ·ÓÙÈÈÛÙ·ÌÈÓÈÎÒÓ, fiˆ˜ Ë Ú·ÓÈÙȉ›ÓË

‹ Ë ÛÈÌÂÙȉ›ÓË, Â›Ó·È ¯Ú‹ÛÈÌË fiÙ·Ó ˘¿Ú¯Ô˘Ó Û˘ÌÙÒÌ·Ù· ·fi ˘ÂÚ¤ÎÎÚÈÛË Á·ÛÙÚÈÎÔ‡ ÔͤԘ. ∆Ô

¯ÚˆÌÔÁÏ˘ÎÈÎfi Ó¿ÙÚÈÔ ·fi ÙÔ ÛÙfiÌ· ¤¯ÂÈ ¯ÔÚËÁËı› Ì ηϿ ·ÔÙÂϤÛÌ·Ù· Û ·ÛıÂÓ›˜ Ì ‰È·ÚÚÔ˚Τ˜

ÎÂÓÒÛÂȘ, ΈÏÈÎÔÂȉ‹ ÎÔÈÏȷο ¿ÏÁË, Ì˘ÔÛÎÂÏÂÙÈο ¿ÏÁË ‹ ÎÂÊ·Ï·ÏÁ›· (16). ™Â ·ÛıÂÓ›˜ Ì ª∫ ‹

Ì·ÛÙÔ΢ÙÙÒÌ·Ù· ¤¯Ô˘Ó ¯ÔÚËÁËı› ÙÔÈο ÛÙÂÚÔÂȉ‹, Ì ηϿ ·ÔÙÂϤÛÌ·Ù· (16,17). √È ·ÛıÂÓ›˜ ÌÂ

Ì·ÛÙÔ΢ÙÙ¿ÚˆÛË Î·È ÈÛÙÔÚÈÎfi ·Ó·Ê˘Ï·Í›·˜ Ú¤-

ÂÈ ÔˆÛ‰‹ÔÙ ӷ Â›Ó·È ÂÊԉȷṲ̂ÓÔÈ Ì ·‰ÚÂÓ·Ï›ÓË ·˘ÙfiÌ·Ù˘ ¤Á¯˘Û˘, ÎÔÚÙÈÎÔÂȉ‹ Î·È ·ÓÙÈÈÛÙ·ÌÈÓÈο ÁÈ· Ó· ·ÓÙÈÌÂÙˆ›˙Ô˘Ó ¤ÁηÈÚ· Ù˘¯fiÓ ÂÂÈÛfi‰ÈÔ. √È ·ÛıÂÓ›˜ ÌÂ Û˘Ìو̷ÙÈ΋ Ì·ÛÙÔ΢ÙÙ¿ÚˆÛË Ú¤ÂÈ Ó· ·ÔʇÁÔ˘Ó ÁÓˆÛÙÔ‡˜ ÂÎÏ˘ÙÈÎÔ‡˜ ·Ú¿ÁÔÓÙ˜ ·ÔÎÔÎΛˆÛ˘ ÙˆÓ Ì·ÛÙÔ΢ÙÙ¿ÚˆÓ

Ó· Á›ÓÂÈ ÛÙÔÓ Î›Ó‰˘ÓÔ ·fi ÙË ¯ÔÚ‹ÁËÛË

¤ÏÂÁ¯Ô Î·È ·fi ÙË ¯ÔÚ‹ÁËÛË ·Ó·ÈÛıË-

Ê·ÚÌ¿ÎˆÓ ÛÙË ‰È¿ÚÎÂÈ· ¯ÂÈÚÔ˘ÚÁÈ΋˜ Â¤Ì‚·Û˘ ‹ ÂÓ‰ÔÛÎfiËÛ˘, Û ·ÛıÂÓ›˜ Ì ̷ÛÙÔ΢ÙÙ¿ÚˆÛË. ∫¿ÔÈÔÈ Û˘ÁÁÚ·Ê›˜ ÚÔÙ›ÓÔ˘Ó ÙËÓ ÂÓ‰Ô‰ÂÚÌÈ΋ ‰ÔÎÈÌ·Û›· Ì ÙÔ Ê¿ÚÌ·ÎÔ Ô˘ ÚfiÎÂÈÙ·È Ó·

¯ÔÚËÁËı› ÚÈÓ ·fi ÙË ¯ÂÈÚÔ˘ÚÁÈ΋ Â¤Ì‚·ÛË (7).

∏ ¤Ó·ÚÍË ıÂÚ·›·˜ Ì ·ÓÙÈÈÛÙ·ÌÈÓÈο ÚÈÓ ·fi ÙËÓ

Â¤Ì‚·ÛË Â›Ó·È ·ÔÙÂÏÂÛÌ·ÙÈ΋ (7).

™˘ÌÂÚ·ÛÌ·ÙÈο, Ë Ì·ÛÙÔ΢ÙÙ¿ÚˆÛË Â›Ó·È Û¿ÓÈ·, ·È‰È·ÙÚÈ΋ ΢ڛˆ˜, ÓfiÛÔ˜ Ô˘ ¯·Ú·ÎÙËÚ›˙ÂÙ·È

·fi ¿ıÚÔÈÛË ÙˆÓ Ì·ÛÙÔ΢ÙÙ¿ÚˆÓ ÛÙÔ ‰¤ÚÌ·. ™˘-

¯ÓfiÙÂÚË Â›Ó·È Ë ÎËÏȉԂϷÙȉ҉˘ ÌÔÚÊ‹ ‹ Ë ÌÂÏ·Á¯ÚˆÌ·ÙÈ΋ ÎÓ›‰ˆÛË. ∏ ‰È¿¯˘ÙË ‰ÂÚÌ·ÙÈ΋ Ì·-

ÛÙÔ΢ÙÙ¿ÚˆÛË, ȉȷ›ÙÂÚ· ¯ˆÚ›˜ ‰ÂÚÌ·ÙÈΤ˜ ‚Ï¿‚˜, Â›Ó·È ÂÍ·ÈÚÂÙÈο Û¿ÓÈ·. √È ÂÚÈÛÛfiÙÂÚ˜ ÂÚÈÙÒÛÂȘ ·È‰È·ÙÚÈ΋˜ ¢ª Â›Ó·È ÌË Û˘Ìو̷ÙÈΤ˜, ÌÂ

1. Valent P, Sperr W, Schwartz L, Horny HP. Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms. J Allergy Clin Immunol 2004; 114:3-11.

2. Valent P. Diagnostic evaluation and classification of mastocytosis. Immunol Allergy Clin N Am 2006;26:515-534.

3. Carter MC, Metcalfe DD. Pediatric mastocytosis. Arch Dis Child 2002;86:315-319.

4. Alto W, Clarcq L. Cutaneous and systemic manifestations of mastocytosis. Am Fam Physician 1999;59:3047-3054, 3059-3060.

5. Surjushe A, Jindal S, Gote P, Saple DG. Darier’s sign. Indian J Dermatol Venereol Leprol 2007;73:363-364.

6. Hartmann K, Bruns BS, Henz MB. Mastocytosis: Review of clinical and experimental aspects. J Investig Dermatol Symp Proc 2001;6:143-147.

7. Brockow K. Urticaria pigmentosa. Immunol Allergy Clin N Am 2004;24:287-316.

8. Ben-Amitai D, Matzker A, Cohen HA. Paediatric cutaneous mastocytosis: A review of 180 patients. Isr Med Assoc J 2005;7:320-322.

9. Kiszewski AE, Dura ã n-Mckinster C, Orozco-Covarrubias L, Gutiérrez-Castrellfin P, Ruiz-Maldonado R. Cutaneous mastocytosis in children: a clinical analysis of 71 cases. J Eur Acad Dermatol Venereol 2004;18:285-290.

10. Akoglu G, Erkin G, Cakir B, Boztepe G, Sahin S, Karaduman A, et al. Cutaneous mastocytosis: demographic aspects and clinical features of 55 patients. J Eur Acad Dermatol Venereol 2006;20:969-973.

11. Roy J, Metry DW, Hicks J, Morgan AJ, Heptulla R. An unusual presentation of mastocytosis: Unilateral swelling of the vulva. Pediatr Dermatol 2005;22:554-557.

12. Conrad H, Gausche-Hill M, Burbulys D. A 6-month old

with total body flushing and a macular-papular lesion. Pediatr Emerg Care 2007;23:321-323.

13. Shaffer HC, Parsons DJ, Peden DB, Morrell D. Recurrent syncope and anaphylaxis as presentation of systemic mastocytosis in a pediatric patient: case report and literature review. J Am Acad Dermatol 2006;54(5 Suppl):S210-213.

14. Brockow K, Jofer C, Behrendt H, Ring J. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy 2008;63: 226-232.

15. Greenhawt M, Akin C. Mastocytosis and allergy. Curr Opin Allergy Clin Immunol 2007;7:387-392.

16. Heide R, Tank B, Oranje A. Mastocytosis in childhood. Pediatr Dermatol 2002;19:375-381.

17. Valent P, Akin C, Escribano L, Födinger M, Hartmann K, Brockow K, et al. Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest 2007;37:435-453.

ª. ª·˘Ú›ÎÔ˘ ª. Kalliora, ª. Mavrikou

∞ÁfiÚÈ ËÏÈΛ·˜ 3,5 ÂÙÒÓ ÂÈÛ‹¯ıË ÏfiÁˆ ˘„ËÏÔ‡

˘ÚÂÙÔ‡ ·fi 24ÒÚÔ˘, ¯ˆÚ›˜ Û˘ÓÔ‰¿ Û˘ÌÙÒÌ·Ù·, Î·È ‰È·ÈÛو̤Ó˘ ·‡ÍËÛ˘ Ù˘ ·ÏηÏÈ΋˜

ʈÛÊ·Ù¿Û˘ (ALP): 3621U/L Û ÂÚÁ·ÛÙËÚÈ·Îfi

¤ÏÂÁ¯Ô. ¶ÚÔ ‰‡Ô ‚‰ÔÌ¿‰ˆÓ ·Ó·Ê¤ÚÂÙ·È ÂÌ‡ÚÂÙÔ ‰È¿ÚÎÂÈ·˜ 7 ËÌÂÚÒÓ ÌÂ Û˘ÌÙÒÌ·Ù· ·fi ÙÔ ·ÓÒÙÂÚÔ ·Ó·Ó¢ÛÙÈÎfi. ∂χıÂÚÔ ·ÙÔÌÈÎfi Î·È ÔÈ-

ÎÔÁÂÓÂÈ·Îfi ÈÛÙÔÚÈÎfi.

∫·Ù¿ ÙËÓ ÎÏÈÓÈ΋ ÂͤٷÛË, ÏËÓ ˆÙ›Ùȉ·˜ ηÈ

Ë·ÙÔÛÏËÓÔÌÂÁ·Ï›·˜ ~2 cm, ‰ÂÓ ‰È·ÈÛÙÒıËηÓ

¿ÏÏ· ·ıÔÏÔÁÈο Â˘Ú‹Ì·Ù·.

∂ÚÁ·ÛÙËÚÈ·Îfi˜ ¤ÏÂÁ¯Ô˜: ALP (3381U/L).

πÛÔ¤Ó˙˘Ì· ALP: Ë·ÙÈÎfi: L1 = 61,6%, L2 = (-), ÂÓÙÂÚÈÎfi = (-), ÔÛÙÈÎfi = 11,5, µ2 = 26,9%, (Ë ÈÛÔÌÔÚÊ‹ µ2 Â›Ó·È ÔÛÙÈ΋˜ ÚÔ¤Ï¢Û˘ Î·È Â›Ó·È

Û˘¯Ófi ‡ÚËÌ· Û ·È‰È¿ Ì ‚·ÚÈ¿ ›ˆÛË). °ÂÓÈ΋ ·›Ì·ÙÔ˜, µ/à ¤ÏÂÁ¯Ô˜, °ÂÓÈ΋ Ô‡ÚˆÓ: Ê˘ÛÈÔÏÔÁÈΤ˜ ÙÈ̤˜.

Abs M. pneumoniae (-), Abs CMV (-), Abs Toxoplasma (-), ÂÚËÙÔ˚Ô› (-), ·‰ÂÓÔ˚Ô› (-).

Abs (EBV-VCA) IgG (+), (EBV-VCA) IgM (+).

¶·Ú·ÎÏÈÓÈÎfi˜ ¤ÏÂÁ¯Ô˜: ÀÂÚ˯ÔÁÚ¿ÊËÌ· ÎÔÈÏ›·˜: ª¤ÁÂıÔ˜ Ûϋӷ ·˘ÍË̤ÓÔ Î·Ù¿ 1,5 cm ÂÚ›Ô˘ (ÂÈÌ‹Î˘ ¿ÍÔÓ·˜ ·˘ÙÔ‡ 10,94 cm). ªÂÚÈÎÔ›

ÌÂÛÂÓÙ¤ÚÈÔÈ ÏÂÌÊ·‰¤Ó˜ ~1 cm ÛÙË ‰ÂÍÈ¿ ÎÔÈÏ›·.

¶ÔÚ›·-ŒÎ‚·ÛË: ÃÔÚËÁ‹ıËΠ·ÌÔ͢ÎÈÏÏ›ÓË

ÏfiÁˆ ˆÙ›Ùȉ·˜. ∞˘Ú¤ÙËÛ ÙÔ ‰Â‡ÙÂÚo 24ˆÚÔ.

™Ù·‰È·Î¿ ÌÂÈÒıËÎ·Ó ÔÈ ÙÈ̤˜ Ù˘ ALP, ÌÂ Ê˘ÛÈÔÏÔÁÈ΋ ÙÈÌ‹ (220 U/L) Û 2 ̋Ә. ¶Èı·Ó¤˜ ‰È·ÁÓÒÛÂȘ: 1.

kagoris@in.gr

1st Department of Paediatrics, “P. & A. Kyriakou” Children’s Hospital, Athens, Greece

Correspondence: Maria Kalliora kagoris@in.gr

1st Department of Paediatrics, “P. & A. Kyriakou” Children’s Hospital, Athens, Greece

¶·È‰È·ÙÚÈ΋ ∫ÏÈÓÈ΋,

¶·ÓÂÈÛÙ‹ÌÈÔ ∫Ú‹Ù˘

∞ÏÏËÏÔÁÚ·Ê›·:

∂ÌÌ·ÓÔ˘‹Ï °·Ï·Ó¿Î˘ emmgalan@med.uoc.gr

¶·È‰È·ÙÚÈ΋ ∫ÏÈÓÈ΋

¶·ÓÂÈÛÙËÌ›Ô˘ ∫Ú‹Ù˘

Department of Paediatrics, University of Crete

Correspondence:

Emmanouil Galanakis

emmgalan@med.uoc.gr

Department of Paediatrics, University of Crete

K·Ù¢ı˘ÓÙ‹ÚȘ ÁÚ·Ì̤˜ 2008

∂. °·Ï·Ó¿Î˘

Guidelines 2008

E. Galanakis

√‰ËÁ›Â˜ ÁÈ· ÙËÓ ÚfiÏË„Ë Ù˘ ÌÂÙ¿‰ÔÛ˘

Ù˘ Ïԛ̈͢ HIV ·fi ÙË ÌËÙ¤Ú· ÛÙÔ ·È‰›.

™ÙÔ Pediatrics ÙÔ˘ ¡ÔÂÌ‚Ú›Ô˘ (2008:122:112734) ·Ú·Ù›ıÂÓÙ·È ÔÈ Ô‰ËÁ›Â˜ (ˆ˜ Policy Statement) Ù˘ ∞ÌÂÚÈηÓÈ΋˜ ∞η‰ËÌ›·˜ ¶·È‰È·ÙÚÈ΋˜ (American Academy of Pediatrics, AAP) ÁÈ· ÙËÓ ÚfiÏË„Ë Ù˘ ÌÂÙ¿‰ÔÛ˘ ÙÔ˘ ÈÔ‡ Ù˘ ·ÓıÚÒÈÓ˘ ·ÓÔÛÔ·ÓÂ¿ÚÎÂÈ·˜ ·fi ÙË ÌËÙ¤Ú· ÛÙÔ ·È‰› (ÂÚÈÁÂÓÓËÙÈ΋ ÌÂÙ¿‰ÔÛË ‹ οıÂÙË ÌÂÙ¿‰ÔÛË). √È Ô‰ËÁ›Â˜ Û˘ÓÔ„›˙ÔÓÙ·È ÛÙÔÓ

ηıÔÏÈÎfi ¤ÏÂÁ¯Ô ÙˆÓ ÂÁ·ˆÓ, ÌÂÙ¿ ·fi ÂÓË̤ڈÛË, Ì›· ‹ Î·È ‰˘Ô ÊÔÚ¤˜ ηٿ ÙË ‰È¿ÚÎÂÈ· Ù˘

·ËÛ˘, ·ÏÏÈÒ˜ ηٿ ÙÔÓ ÙÔÎÂÙfi ÛÙË ÌËÙ¤Ú·

‹/Î·È ÛÙÔ ÓÂÔÁÓfi (Ì ÌÂıfi‰Ô˘˜ Ù·¯Â›·˜ ·Ó›¯Ó¢Û˘, ·ÔÙÂϤÛÌ·Ù· Û 20-60 min). ÀÂÓı˘Ì›˙ÂÙ·È fiÙÈ Ë ÚÔÏËÙÈ΋ ·ÁˆÁ‹ Ì ·ÓÙÈ-ÚÂÙÚÔ˚ο Û¯‹Ì·Ù· ÚÈÓ, ηٿ Î·È ÌÂÙ¿ ÙÔÓ ÙÔÎÂÙfi

Â›Ó·È ÂÍ·ÈÚÂÙÈο ·ÔÙÂÏÂÛÌ·ÙÈ΋ Î·È ¤¯ÂÈ ·ÏÏ¿ÍÂÈ ‰Ú·ÛÙÈο ÙË Ê˘ÛÈ΋ ÔÚ›· Ù˘ οıÂÙ˘ ÌÂÙ¿‰ÔÛ˘. √ÌÔ›ˆ˜ ˘ÂÓı˘Ì›˙ÂÙ·È fiÙÈ Ë Ïԛ̈ÍË Ù˘ ÌËÙ¤Ú·˜ ·fi HIV ·ÔÙÂÏ› ·ÓÙ¤Ó‰ÂÈÍË

¿ÚÓËÛ˘ ÛÙÔÓ ¤ÏÂÁ¯Ô HIV, ˆÛÙfiÛÔ Ê·›ÓÂÙ·È Ó· ·Ú·ÌÂÚ›˙ÂÙ·È ÛÙ·‰È·Î¿ Ë ‰˘ÛΛÓËÙË ÚÔ¸fiıÂÛË Ù˘ ÂÓËÌÂڈ̤Ó˘ ¤ÁÁÚ·Ê˘ Û˘Ó·›ÓÂÛ˘. ™Â ¿ÏÏË

Û‡ÛÙ·ÛË (Statement) ÙÔ˘ ∞ÌÂÚÈηÓÈÎÔ‡ ∫ÔÏÂÁ›Ô˘ π·ÙÚÒÓ (American College of Physicians, ACP), ÚÔ‰ËÌÔÛÈÂ˘Ì¤ÓË ÛÙÔ Annals of Internal Medicine (30 ¡ÔÂÌ‚Ú›Ô˘ 2008), ÚÔÙ›ÓÂÙ·È Ì¿ÏÈÛÙ· ¤ÏÂÁ¯Ô˜ ÚÔ˘Ù›Ó·˜ Û fiÏÔ˘˜ ÙÔ˘˜ ·ÛıÂÓ›˜ 13-64 ÂÙÒÓ (¿Ú· Î·È ÛÙÔ˘˜ ÂÊ‹‚Ô˘˜) Ô˘ οÓÔ˘Ó È·ÙÚÈΤ˜ ÂÍÂÙ¿ÛÂȘ ÁÈ· ¿ÏÏÔ ÏfiÁÔ.

ÙÔ˘ Pediatrics (¡Ô¤Ì‚ÚÈÔ˜ 2008:122:1142-52), ·Ú·Ù›ıÂÓÙ·È ÔÈ Ô‰ËÁ›Â˜ (ˆ˜ Clinical Report) Ù˘ ∞ÌÂÚÈηÓÈ΋˜ ∞η‰ËÌ›·˜ ¶·È‰È·ÙÚÈ΋˜ (American Academy of Pediatrics, AAP) ÁÈ· ÙËÓ ÚfiÏË„Ë Ù˘ Ú·¯›Ùȉ·˜. ™‡Ìʈӷ Ì ÙȘ Ô‰ËÁ›Â˜ ·˘Ù¤˜, Û ÂÚÈÙÒÛÂȘ ·ÓÂ·ÚÎÔ‡˜ Ï‹„˘ ‚ÈÙ·Ì›Ó˘ D Ì ÙËÓ ÙÚÔÊ‹ Î·È ÌÂȈ̤Ó˘ ¤ÎıÂÛ˘ ÛÙÔ ËÏÈ·Îfi ʈ˜, Ú¤ÂÈ Ó· ÂÍ·ÛÊ·Ï›˙ÂÙ·È Ë ÂÏ¿¯ÈÛÙË ÔÛfiÙËÙ· ÙˆÓ 400 IU ‚ÈÙ·Ì›Ó˘ D ËÌÂÚËÛ›ˆ˜ Û fiÏ· Ù· ‚Ú¤ÊË, ·È‰È¿ Î·È ÂÊ‹‚Ô˘˜. π‰È·›ÙÂÚË ¤ÌÊ·ÛË ‰›‰ÂÙ·È ÛÙ· ıËÏ¿˙ÔÓÙ· ‚Ú¤ÊË ‹‰Ë ·fi ÙȘ ÚÒÙ˜ Ë̤Ú˜ Ù˘ ˙ˆ‹˜ Î·È ÛÙÔ˘˜ ÂÊ‹‚Ô˘˜ Ô˘ ‰ÂÓ ÙÚ¤ÊÔÓÙ·È ÛˆÛÙ¿. ∏ ÙÚ¤¯Ô˘Û· Û‡ÛÙ·ÛË ·˘Í¿ÓÂÈ ÙËÓ ÂÏ¿¯ÈÛÙË ËÌÂÚ‹ÛÈ· ÚfiÛÏË„Ë ·fi 200 IU Û 400 IU. √È Ô‰ËÁ›Â˜ ˘ÂÓı˘Ì›˙Ô˘Ó fiÙÈ ÔÏϤ˜ ÚfiÛÊ·Ù˜ ÌÂϤÙ˜ ˘Ô‰ÂÈÎÓ‡Ô˘Ó Â˘ÂÚÁÂÙÈ΋ ‰Ú¿ÛË Ù˘ ‚ÈÙ·Ì›Ó˘ D ÛÙËÓ ·ÔÙÂÏÂÛÌ·ÙÈ΋ ÂÁÁÂÓ‹ ·ÓÔÛ›·, ηıÒ˜ Î·È Î·Ù¿ ÙÔ˘ ‰È·‚‹ÙË Î·È ÙÔ˘ ηÚΛÓÔ˘. ∆Ô Pediatrics ›¯Â ÊÈÏÔÍÂÓ‹ÛÂÈ Ôχ ÚfiÛÊ·Ù· Î·È Û˘ÛÙ¿ÛÂȘ ÁÈ· ÙËÓ ·ÓÂ¿ÚÎÂÈ· Ù˘ ‚ÈÙ·Ì›Ó˘ D Û ·È‰È¿ ·fi ÙË Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society, ∏¶∞ (Pediatrics 2008;122:398-417).

√‰ËÁ›Â˜ ÁÈ· ÙË Ê˘ÛÈ΋ ¿ÛÎËÛË ÙˆÓ ·È‰ÈÒÓ Û ËÏÂÎÙÚÔÓÈ΋ ‰ËÌÔÛ›Â˘ÛË ÛÙÔÓ ‰ÈÎÙ˘·Îfi ÙfiÔ ÙÔ˘ Department of Health and Human Services ÙˆÓ ∏¶∞ (http://www.health.gov/ paguidelines/default.aspx, 8 √ÎÙˆ‚Ú›Ô˘ 2008). √È Ô‰ËÁ›Â˜ Â›Ó·È ÏÂÙÔÌÂÚ›˜ Î·È ·ÊÔÚÔ‡Ó

fiϘ ÙȘ ËÏÈ˘ ¿Óˆ ÙˆÓ 6 ÂÙÒÓ Î·È ·¢ı‡ÓÔ-

ÓÙ·È Î˘Ú›ˆ˜ Û Â·ÁÁÂÏ̷ٛ˜ ˘Á›·˜, ·ÏÏ¿ ηÈ

ÛÙÔ Â˘Ú‡ ÎÔÈÓfi. °È· Ù· ·È‰È¿ Î·È ÙÔ˘˜ ÂÊ‹-

‚Ô˘˜, ÔÈ Ô‰ËÁ›Â˜ Û˘ÓÔ„›˙ÔÓÙ·È Û ÙÔ˘Ï¿¯ÈÛÙÔÓ

1 ÒÚ· ۈ̷ÙÈ΋˜ ¿ÛÎËÛ˘ ËÌÂÚËÛ›ˆ˜ (Ë ¿ÛÎË-

ÛË Ó· Â›Ó·È Î·Ù¿ÏÏËÏË ÁÈ· ÙËÓ ËÏÈΛ·, ¢¯¿ÚÈ-

ÛÙË Î·È Ó· ¤¯ÂÈ ÔÈÎÈÏ›·), Ì ¤ÌÊ·ÛË ÛÙËÓ ·Â-

Úfi‚È· ¿ÛÎËÛË Î·È Û ÙÔ˘Ï¿¯ÈÛÙÔÓ ÙÚȘ ‚‰ÔÌ·‰È·›ˆ˜ ÈÔ ¤ÓÙÔÓË ¿ÛÎËÛË ÁÈ· ÙËÓ ÂÓ‰˘Ó¿ÌˆÛË

ÙÔ˘ Ì˘ÔÛÎÂÏÂÙÈÎÔ‡.

∏ ‚ÚÂÊÈ΋ ıÓËÛÈÌfiÙËÙ· ÛÙËÓ ∂ÏÏ¿‰· Î·È ·ÏÏ·¯Ô‡. ∂ӉȷʤÚÔÓÙ· Û˘ÁÎÚÈÙÈο ÛÙÔȯ›· ÁÈ· ÙË ‚ÚÂÊÈ΋ ıÓËÛÈÌfiÙËÙ· Û ÔÏϤ˜ ¯ÒÚ˜ ·ÁÎÔÛÌ›ˆ˜ ·ÚÔ˘ÛÈ¿ÛıËÎ·Ó ÚfiÛÊ·Ù· ·fi ÙÔ CDC (Centers for Disease Control and Prevention) ÙˆÓ

∏¶∞ (ÈÛÙÔÛÂÏ›‰· http://www.cdc.gov/nchs/data/ databriefs/db09.htm, ‚Ï Î·È http//www.medscape. com/viewarticle/582117). ¶ÚÒÙ˜ ÛÙËÓ Ù·ÍÈÓfi-

ÌËÛË ¤Ú¯ÔÓÙ·È Ë ™ÈÁηÔ‡ÚË, ÙÔ ÃÔÓÁÎ-∫ÔÓÁÎ

Î·È Ë π·ˆÓ›· (2,0-2,8 ı¿Ó·ÙÔÈ ‚ÚÂÊÒÓ ·Ó¿ 1000 ˙ÒÓÙ· ÓÂÔÁÓ¿). ∏ ∂ÏÏ¿‰·, Ì 4,1 ı·Ó¿ÙÔ˘˜ ‚ÚÂÊÒÓ ·Ó¿ 1000 ˙ÒÓÙ· ÓÂÔÁÓ¿, ʤÚÂÙ·È ÈÔ Î¿Ùˆ ·fi ¯ÒÚ˜ Ì ·Ú·‰ÔÛȷο ¯·ÌËÏ‹ ıÓËÛÈÌfiÙËÙ·, fiˆ˜ ÔÈ ÛηӉÈÓ·‚ÈΤ˜ (™Ô˘Ë‰›· 3,1, ¡ÔÚ‚ËÁ›· 3,2, ºÈÓÏ·Ó‰›· 3,3), ·ÏÏ¿ ÈÛÔ‚·ıÌ› Ì ÙË

°ÂÚÌ·Ó›·, ÙËÓ πÙ·Ï›· Î·È ÙËÓ √ÏÏ·Ó‰›· Î·È ÚÔËÁÂ›Ù·È Ù˘ ∞˘ÛÙÚ·Ï›·˜ Î·È ÙÔ˘ πÛÚ·‹Ï (4,5), Ù˘

∞ÁÁÏ›·˜ Î·È √˘·Ï›·˜ (5,0) ÙÔ˘ ∫·Ó·‰¿ (5,3) ηÈ

ÙˆÓ ∏¶∞ (6,9). ∆· ÛÙÔȯ›· ·˘Ù¿ ‚·Û›˙ÔÓÙ·È ÛÂ

‰Â‰Ô̤ӷ ÙÔ˘ 2004 Î·È ÙÔÓ›˙ÂÙ·È fiÙÈ ·ÏÏ·Á¤˜ ·Ú·ÙËÚÔ‡ÓÙ·È ¯ÚfiÓÔ Ì ÙÔ ¯ÚfiÓÔ. ¶ÂÚÈÛÛfiÙÂÚ· Û˘ÁÎÚÈÙÈο Î·È ‰È·¯ÚÔÓÈο ‰Â‰Ô̤ӷ ·Ú¤¯ÔÓÙ·È

Ù· ∏ӈ̤ӷ ŒıÓË Û ÂΉfiÛÂȘ fiˆ˜ Ë ËÏÂÎÙÚÔÓÈ΋ http://www.un.org/esa/population/ publications/wpp2006/WPP2006_Highlights_ rev.pdf.

∂ÚÁ·ÛÙ‹ÚÈÔ π·ÙÚÈ΋˜

°ÂÓÂÙÈ΋˜ ¶·ÓÂÈÛÙËÌ›Ô˘

∞ıËÓÒÓ, ¡ÔÛÔÎÔÌ›Ô

¶·›‰ˆÓ “∞Á›· ™ÔÊ›·”,

∞ı‹Ó·

AÏÏËÏÔÁÚ·Ê›·:

™ÔÊ›· ∫›ÙÛÈÔ˘-∆˙¤ÏË

skitsiou@med.uoa.gr

∂ÚÁ·ÛÙ‹ÚÈÔ π·ÙÚÈ΋˜

°ÂÓÂÙÈ΋˜ ¶·ÓÂÈÛÙËÌ›Ô˘

∞ıËÓÒÓ,

¡ÔÛÔÎÔÌÂ›Ô ¶·›‰ˆÓ

“∞Á›· ™ÔÊ›·”, £Ë‚ÒÓ Î·È §Â‚·‰Â›·˜, 11527 ∞ı‹Ó·

Department of Medical Genetics, Medical School, University of Athens, “Aghia Sofia” Children’s Hospital, Athens, Greece

Correspondence: Sophia Kitsiou-Tzeli skitsiou@med.uoa.gr

Department of Medical Genetics, Medical School, University of Athens, “Aghia Sofia” Children’s Hospital, Thivon & Levadias St., 11257 Athens, Greece

πÛÙÔÛÂÏ›‰Â˜ ÁÂÓÂÙÈ΋˜

∂. °È·ÓÓ¿ÙÔ˘, ™. ∫›ÙÛÈÔ˘-∆˙¤ÏË

Genetics Sites

E. Giannatou, S. Kitsiou-Tzeli

∏ ÈÛÙÔÛÂÏ›‰· Ù˘ ∂˘Úˆ·˚΋˜ ∂Ù·ÈÚ›·˜

ÙÔ˘ ∞ÓıÚÒÔ˘ - http://www.eshg.org ∏ ÈÛÙÔÛÂÏ›‰· www.eshg.org ·ÔÙÂÏ› ÙÔÓ Â›ÛËÌÔ ‰È·‰ÈÎÙ˘·Îfi ÙfiÔ Ù˘ ∂˘Úˆ·˚΋˜ ∂Ù·ÈÚ›·˜ °ÂÓÂÙÈ΋˜ ÙÔ˘ ∞ÓıÚÒÔ˘.

ÂÓı¿ÚÚ˘ÓÛË Ó¤ˆÓ ÂÈÛÙËÌfiÓˆÓ Î·È ÛÙË ÌÂÙ¿‰ÔÛË Ù˘ Ù¯ÓÔÁÓˆÛ›·˜ ÛÂ

ÁÂÓÂÙÈÎÒÓ È·ÙÚÈÎÒÓ ˘ËÚÂÛÈÒÓ ÛÙȘ ·Ó·Ù˘ÛÛfiÌÂÓ˜ Â˘Úˆ·˚Τ˜ ¯ÒÚ˜. ™ÙȘ ‰Ú·ÛÙËÚÈfiÙËÙ˜ Ù˘ ∂Ù·ÈÚ›·˜ ÂÚÈÏ·Ì‚¿ÓÔÓÙ·È Ë ÔÚÁ¿ÓˆÛË ÙÔ˘ ÂÙ‹ÛÈÔ˘ European Human Genetics Conference Î·È Ë ¤Î‰ÔÛË ÙÔ˘ ·Ó·ÁÓˆÚÈṲ̂ÓÔ˘ ·ÚÔ˘˜ ÂÚÈÔ‰ÈÎÔ‡ European Journal of Human Genetics. ™ÙËÓ Î·ÙËÁÔÚ›· “ª·ı‹Ì·Ù·” (ESHG Courses) ·Ú¤¯ÔÓÙ·È ÂÈϤÔÓ ÏËÚÔÊÔڛ˜ Û¯ÂÙÈο Ì ÂÎ·È‰Â˘ÙÈο ÛÂÌÈÓ¿ÚÈ· Ô˘ ‰ÈÔÚÁ·ÓÒÓÂÈ Ë ∂Ù·ÈÚ›· Û ‰È¿ÊÔÚ˜ Â˘Úˆ·˚Τ˜ ¯ÒÚ˜ Î·È ·ÊÔÚÔ‡Ó ÛÙË ªÔÚȷ΋ °ÂÓÂÙÈ΋, ∫ÏÈÓÈ΋ °ÂÓÂÙÈ΋, °ÂÓÂÙÈ΋ ÙÔ˘ ∫·ÚΛÓÔ˘, ∫˘ÙÙ·ÚÔÁÂÓÂÙÈ΋, °ÂÓÂÙÈ΋ ™˘Ì‚Ô˘Ï¢ÙÈ΋, ¢˘ÛÌÔÚÊÔÏÔÁ›·, µÈÔÏËÚÔÊÔÚÈ΋ Î·È ™Ù·ÙÈÛÙÈ΋ °ÂÓÂÙÈ΋. ™ÙËÓ Î·ÙËÁÔÚ›· “™˘Ó¤‰ÚÈ·” Á›ÓÂÙ·È ·Ó·ÊÔÚ¿ ÛÙÔ ÂÙ‹ÛÈÔ Û˘Ó¤‰ÚÈÔ Ù˘ ∂Ù·ÈÚ›·˜, Ì ÂÚÈÏ‹„ÂȘ ÙˆÓ ·Ó·ÎÔÈÓÒÛˆÓ-‰È·Ï¤ÍˆÓ, fiˆ˜ Î·È ÛÂ Û˘Ó¤‰ÚÈ· ÚÔËÁÔ‡ÌÂÓˆÓ ÂÙÒÓ. ™ÙËÓ Î·ÙËÁÔÚ›· “¶ÏËÚÔÊÔڛ˜ ÁÈ· ∞ÛıÂÓ›˜” (Patient Information) ÌÔÚ› ηÓ›˜ Ó· ‚ÚÂÈ ÂÓËÌÂÚˆÙÈο Ê˘ÏÏ¿‰È· ¯Ú‹ÛÈÌ· ÁÈ· ·ÛıÂÓ›˜, ÔÈÎÔÁ¤ÓÂȘ, ·ÏÏ¿ Î·È ÁÈ·ÙÚÔ‡˜, Ô˘ ‰›ÓÔ˘Ó ÏËÚÔÊÔڛ˜ Û¯ÂÙÈο Ì ٷ ÁÂÓÂÙÈο ÙÂÛÙ, ÙËÓ ·ÌÓÈÔ·Ú·Î¤ÓÙËÛË, ÙË Ï‹„Ë ÙÚÔÊÔ‚Ï¿ÛÙ˘, ÙÔ˘˜ ÙÚfiÔ˘˜ ÎÏËÚÔÓÔÌÈÎfiÙËÙ·˜ Î.¿. √È ÏËÚÔÊÔڛ˜ ·˘Ù¤˜ ¤¯Ô˘Ó ÛÙfi¯Ô Ó· ·Ó·‰Â›ÍÔ˘Ó ÙȘ ÂÈÛÙËÌÔÓÈΤ˜, ·ÏÏ¿ Î·È ÙȘ ÎÔÈÓˆÓÈΤ˜ Î·È „˘¯ÔÏÔÁÈΤ˜ ‰È·ÛÙ¿ÛÂȘ Ù˘ ÁÂÓÂÙÈ΋˜ Î·È ÙˆÓ ÁÂÓÂÙÈÎÒÓ ·Ó·Ï‡ÛˆÓ.

- http://www.acmg.net

∏ ÈÛÙÔÛÂÏ›‰· www.acmg.net ·ÔÙÂÏ› ÙÔÓ ‰È·‰ÈÎÙ˘·Îfi ÙfiÔ ÙÔ˘ ∞ÌÂÚÈηÓÈÎÔ‡ ∫ÔÏÂÁ›Ô˘ π·ÙÚÈ΋˜ °ÂÓÂÙÈ΋˜. ∆Ô ∫ÔϤÁÈÔ È‰Ú‡ıËΠÙÔ

1991 Î·È ÛÙfi¯Ô ÙÔ˘ ¤¯ÂÈ ÙË ‰È¿ÁÓˆÛË, ·ÓÙÈÌÂÙÒ-

ÈÛË Î·È ÚfiÏË„Ë ÙˆÓ ÁÂÓÂÙÈÎÒÓ ÓÔÛË̿وÓ, ÚÔˆıÒÓÙ·˜ ÙËÓ ·Ó¿Ù˘ÍË Î·È ÙËÓ ÂÊ·ÚÌÔÁ‹

ÙˆÓ ˘ËÚÂÛÈÒÓ Ù˘ ÁÂÓÂÙÈ΋˜. ™ÙËÓ ÚÔÛ¿ıÂÈ¿ ÙÔ˘ ·˘Ù‹, ̤ÏË ÙÔ˘ ∫ÔÏÂÁ›Ô˘ -ÎÏÈÓÈÎÔ› ηÈ

ÌÔÚÈ·ÎÔ› ÁÂÓÂÙÈÛÙ¤˜, ΢ÙÙ·ÚÔÁÂÓÂÙÈÛÙ¤˜, ÁÂÓÂ-

ÙÈÎÔ› Û‡Ì‚Ô˘ÏÔÈ Î·È ‚ÈÔ¯ËÌÈÎÔ›- ·Ú¤¯Ô˘Ó ˘ËÚÂۛ˜ ÂÈÛÙËÌÔÓÈ΋˜ ÂÓË̤ڈÛ˘ Î·È ÚÔÙ¿ÛÂȘ ÂÎ·›‰Â˘Û˘ ÁÈ· fiÛÔ˘˜ È·ÙÚÔ‡˜ ¿ÏÏÔ˘˜ ÂÈ-

‹ ¿ÏÏÔ˘˜ ÂÈÛÙ‹ÌÔÓ˜ ÂÈı˘ÌÔ‡Ó Ó·

ÙÔ Û‡Ó‰ÚÔÌÔ ÙÔ˘ ‡ıÚ·˘ÛÙÔ˘ Ã-¯ÚˆÌÔÛÒÌ·ÙÔ˜ Î·È Ë ÈÓÔ΢ÛÙÈ΋ ÓfiÛÔ˜, ·ÏÏ¿ Î·È Ô‰ËÁ›Â˜ ÁÈ· ÓÔÛ‹Ì·Ù· Ô˘ ¯ÚÂÈ¿˙ÔÓÙ·È

ÁÂÓÂÙÈ΋ ÂÎÙ›ÌËÛË ‹ Û˘Ì‚Ô˘Ï¢ÙÈ΋. ∂›Û˘, ÛÙËÓ ›‰È· ηÙËÁÔÚ›· ‚Ú›ÛÎÂÙ·È Î·È ÙÔ Â›ÛËÌÔ ÂÚÈÔ‰ÈÎfi ÙÔ˘ ∫ÔÏÂÁ›Ô˘, ÙÔ Genetics in Medicine. ™Ùfi¯Ô˜ ÙÔ˘ ÂÚÈÔ‰ÈÎÔ‡ Â›Ó·È Ë ÂÊ·ÚÌÔÁ‹ ÙˆÓ

ÂÈÙ¢ÁÌ¿ÙˆÓ Ù˘ ÁÂÓÂÙÈ΋˜ ÛÙËÓ È·ÙÚÈ΋ Ú·ÎÙÈ΋.

∏ ÈÛÙÔÛÂÏ›‰· ÙÔ˘ March of Dimes - http://www.marchofdimes.com

∏ ÈÛÙÔÛÂÏ›‰· www.marchofdimes.com ·ÔÙÂÏ› ÙÔÓ ‰È·‰ÈÎÙ˘·Îfi ÙfiÔ ÙÔ˘ ÌË ÎÂÚ‰ÔÛÎÔÈÎÔ‡ ÔÚÁ·ÓÈÛÌÔ‡ March of Dimes, Ô˘ ȉڇıËΠÙÔ 1938. ∞ÔÛÙÔÏ‹ ÙÔ˘ ÔÚÁ·ÓÈÛÌÔ‡ Â›Ó·È Ë ‚ÂÏÙ›ˆÛË Ù˘ ˘Á›·˜ ÙˆÓ ‚ÚÂÊÒÓ Ì ÙËÓ ÚfiÏË„Ë

ÙˆÓ Û˘ÁÁÂÓÒÓ ·ÓˆÌ·ÏÈÒÓ, Ù˘ ÚÔˆÚfiÙËÙ·˜ Î·È Ù˘ ÂÚÈÁÂÓÓËÙÈ΋˜ ıÓËÛÈÌfiÙËÙ·˜, ̤ۈ Ù˘ ¤Ú¢ӷ˜, Ù˘ ÚÔÒıËÛ˘ Ù˘ ÔÚÁ¿ÓˆÛ˘ ÎÔÈÓˆÓÈÎÒÓ ˘ËÚÂÛÈÒÓ Î·È Ù˘ ÂÎ·›‰Â˘Û˘.

™ÙËÓ Î·ÙËÁÔÚ›· “∂Á΢ÌÔÛ‡ÓË Î·È ¡ÂÔÁÓfi” (Pregnancy & Newborn) Î·È ÛÙËÓ ˘ÔηÙËÁÔÚ›· “°ÂÓÂÙÈ΋ Î·È Û˘ÁÁÂÓ›˜ ·ÓˆÌ·Ï›Â˜” ·Ú¤¯ÔÓÙ·È ¯Ú‹ÛÈ̘ ÏËÚÔÊÔڛ˜ ÁÈ· ·ÛıÂÓ›˜, ÔÈÎÔÁ¤ÓÂȘ, ·ÏÏ¿ Î·È ÁÈ·ÙÚÔ‡˜, ÁÈ· Ù· Û˘¯ÓfiÙÂÚ· ÁÂÓÂÙÈο ÓÔÛ‹Ì·Ù· Î·È Û‡Ó‰ÚÔÌ·. ™ÙËÓ ›‰È·

ÁÂÓÂÙÈÎÔ‡ ÂϤÁ¯Ô˘. ∆¤ÏÔ˜, ··ÓÙÒÓÙ·È ÂÚˆÙ‹Ì·Ù· fiˆ˜ “Û ÔÈÔ˘˜ ·¢ı‡ÓÂÙ·È Ë °ÂÓÂÙÈ΋ ™˘Ì‚Ô˘Ï¢ÙÈ΋», «ÙÈ ı· ·ÍÈÔÏÔÁËı› ηٿ ÙË ‰È¿ÚÎÂÈ· Ù˘ ÂͤٷÛ˘ ·fi ÙÔÓ ÎÏÈÓÈÎfi ÁÂÓÂÙÈÛÙ‹”, Î.¿. ∏ ÈÛÙÔÛÂÏ›‰· ÙÔ˘ ∂˘Úˆ·˚ÎÔ‡

ÙˆÓ DNA-¢È·ÁÓˆÛÙÈÎÒÓ ∂ÚÁ·ÛÙËÚ›ˆÓhttp://www.eddnal.com

∏ ÈÛÙÔÛÂÏ›‰· www.eddnal.com ·ÔÙÂÏ› ÙÔÓ ‰È·‰ÈÎÙ˘·Îfi ÙfiÔ ÙÔ˘ ∂˘Úˆ·˚ÎÔ‡ ∫·Ù·ÏfiÁÔ˘ ÙˆÓ DNA-¢È·ÁÓˆÛÙÈÎÒÓ ∂ÚÁ·ÛÙËÚ›ˆÓ (European Directory of DNA Diagnostic Laboratories, EDDNAL). O EDDNAL ·ÔÙÂÏ› ÌË ÎÂÚ‰ÔÛÎÔÈÎfi ÔÚÁ·ÓÈÛÌfi, ¯ÚËÌ·ÙÔ‰ÔÙÔ‡ÌÂÓÔ ·fi ÙËÓ ∂˘Úˆ·˚΋ ∂ÈÙÚÔ‹. ø˜ ·ÔÛÙÔÏ‹ ¤¯ÂÈ ÙË ‰È¿‰ÔÛË ÏËÚÔÊÔÚÈÒÓ ÌÂٷ͇ ÙˆÓ ÂÈÛÙËÌfiÓˆÓ Ô˘ ·Û¯ÔÏÔ‡ÓÙ·È Ì ÙËÓ È·ÙÚÈ΋ ÁÂÓÂÙÈ΋, Û¯ÂÙÈο Ì ÙË ‰È·ıÂÛÈÌfiÙËÙ· ÙˆÓ ‰È·ÁÓˆÛÙÈÎÒÓ ·Ó·Ï‡ÛÂˆÓ Ô˘ ‚·Û›˙ÔÓÙ·È ÛÙÔ DNA ÁÈ· Û¿ÓÈ· ÁÂÓÂÙÈο ÓÔÛ‹Ì·Ù· ÛÙËÓ ∂˘ÚÒË. ¶ÚÔÛ¿ıÂÈ· ÙÔ˘ EDDNAL Â›Ó·È Ë

ÁÂÓÂÙÈÎÒÓ ÙÂÛÙ ˘„ËÏÒÓ ÚԉȷÁÚ·ÊÒÓ, ηıÒ˜ Î·È Ë ‰È¢ÎfiÏ˘ÓÛË ÙˆÓ ÂÚ¢ÓËÙÒÓ ÛÙËÓ ·Ó¿Ù˘ÍË Ó¤ˆÓ ‰È·ÁÓˆÛÙÈÎÒÓ ÌÂıfi‰ˆÓ. ¶·Ú¤¯ÔÓÙ·È ÏËÚÔÊÔڛ˜ ÁÈ· ÂÚÁ·ÛÙ‹ÚÈ· ‰È·ÁÓˆÛÙÈÎÒÓ ‹/Î·È ÂÚ¢ÓËÙÈÎÒÓ ˘ËÚÂÛÈÒÓ Ô˘ ‚Ú›ÛÎÔÓÙ·È Û ¯ÒÚ˜ Ù˘ ∂˘Úˆ·˚΋˜ ŒÓˆÛ˘. ª¤Û· ·fi ÙȘ ˘ÔηÙËÁÔڛ˜ Ù˘ ÈÛÙÔÛÂÏ›‰·˜ ·Ú¤¯ÔÓÙ·È ÂȉÈΤ˜ ÏËÚÔÊÔڛ˜ ÁÈ· Ù· ΤÓÙÚ· (˘‡ı˘ÓÔ˜ ΤÓÙÚÔ˘ Û οı ¯ÒÚ·, Ì ÛÙÔȯ›· ÂÈÎÔÈÓˆÓ›·˜), ·ÏÏ¿ Î·È Û˘Ó‰¤ÛÂȘ Ì ÈÛÙÔÛÂÏ›‰Â˜ ¿ÏÏˆÓ ‰È·‰ÈÎÙ˘·ÎÒÓ ÙfiˆÓ, Û¯ÂÙÈΤ˜ Ì DNA ‰È·ÁÓˆÛÙÈΤ˜ ÂÍÂÙ¿ÛÂȘ. ∏ ÛËÌ·Û›· Ù˘ ÈÛÙÔÛÂÏ›‰·˜ ÁÈ· ÙÔÓ ·ÛÎÔ‡ÓÙ· ·È‰›·ÙÚÔ Â›Ó·È Ôχ ÛËÌ·ÓÙÈ΋, ηıÒ˜ ÔÈ ÌÔÚȷΤ˜ ÂÍÂÙ¿ÛÂȘ ¤¯Ô˘Ó ÂÈÛ·¯ı› ÛÙËÓ Î·ıËÌÂÚÈÓ‹ Ú·ÎÙÈ΋. ∂›Ó·È ‚·ÛÈÎfi ÁÈ· ÙÔÓ ·È‰›·ÙÚÔ Ó· ¤¯ÂÈ Û¯ËÌ·Ù›ÛÂÈ ÌÈ· ·Ú¯È΋ ÚÔÛˆÈ΋ ÁÓÒÛË ÚÈÓ ·¢ı˘Óı› ÛÙÔÓ ÂȉÈÎfi ÁÂÓÂÙÈÛÙ‹, Ô ÔÔ›Ô˜ ı· ÙÔÓ Î·Ù¢ı‡ÓÂÈ ·ÛʷϤÛÙÂÚ·.

∏ ÈÛÙÔÛÂÏ›‰· ÙÔ˘ ∂ÚÁ·ÛÙËÚ›Ô˘ π·ÙÚÈ΋˜ °ÂÓÂÙÈ΋˜ ÙÔ˘ ¶·ÓÂÈÛÙËÌ›Ô˘ ∞ıËÓÒÓhttp://iatriki-genetiki.med.uoa.gr

∏ ÈÛÙÔÛÂÏ›‰· http://iatriki-genetiki.med.uoa.gr ·ÔÙÂÏ› ÙÔÓ ‰È·‰ÈÎÙ˘·Îfi ÙfiÔ ÙÔ˘ ∂ÚÁ·ÛÙËÚ›Ô˘ π·ÙÚÈ΋˜ °ÂÓÂÙÈ΋˜ ÙÔ˘ ¶·ÓÂÈÛÙËÌ›Ô˘ ∞ıËÓÒÓ, Ô˘ ¤¯ÂÈ ¤‰Ú· ÙÔ ÃˆÚ¤ÌÂÈÔ ∂Ú¢ÓËÙÈÎfi ∂ÚÁ·ÛÙ‹ÚÈÔ

Ì˘˚΋ ‰˘ÛÙÚÔÊ›· Duchenne / Becker, ÚÔÛˆÔˆÌÔ‚Ú·¯ÈfiÓÈÔ˜ Ì˘˚΋ ‰˘ÛÙÚÔÊ›·, ÓˆÙÈ·›· Ì˘˚΋ ·ÙÚÔÊ›·, Û‡Ó‰ÚÔÌ· Prader Willi & Angelman, Û‡Ó‰ÚÔÌÔ ¯ÚˆÌÔÛÒÌ·ÙÔ˜ ‡ıÚ·˘ÛÙÔ˘ Ã, ¤ÏÂÁ¯Ô˜ ÌÈÎÚÔÂÏÏÂÈÌÌ¿ÙˆÓ ¯ÚˆÌÔÛÒÌ·ÙÔ˜ À), ηıÒ˜ Î·È Û·Ê‹ ÂÚÈÁÚ·Ê‹ ÙˆÓ Û¯ÂÙÈÎÒÓ ÁÂÓÂÙÈÎÒÓ ÓÔÛË̿وÓ. ™ÙËÓ ›‰È· ηÙËÁÔÚ›· Î·È ÛÙËÓ ˘ÔηÙËÁÔÚ›· “∂͈ÙÂÚÈο π·ÙÚ›·” Á›ÓÂÙ·È ·Ó·ÊÔÚ¿ ÛÙ· ÂÍÂȉÈÎÂ˘Ì¤Ó· π·ÙÚ›· °ÂÓÂÙÈ΋˜ Ô˘ Ú·ÁÌ·ÙÔÔÈÔ‡ÓÙ·È ÛÙÔÓ ¯ÒÚÔ ÙÔ˘ ∂ÚÁ·ÛÙËÚ›Ô˘, fiˆ˜ Â›Ó·È Ù· π·ÙÚ›· °ÂÓÂÙÈ΋˜ ™˘Ì‚Ô˘Ï¢ÙÈ΋˜, ∫ÏÈÓÈ΋˜ °ÂÓÂÙÈ΋˜ Î·È ™˘Ì‚Ô˘Ï¢ÙÈ΋˜ ∫‡ËÛ˘, ‰›ÓÔÓÙ·˜ ¯Ú‹ÛÈ̘ ηÙ¢ı‡ÓÛÂȘ Û ÂӉȷÊÂÚfiÌÂÓÔ˘˜ ÁÈ·ÙÚÔ‡˜, ·ÏÏ¿ Î·È Û ·ÛıÂÓ›˜ ‹ ÔÈÎÔÁ¤ÓÂȘ Ì ÁÂÓÂÙÈÎfi ÓfiÛËÌ·.

ηÙËÁÔÚ›· “¢ËÌÔÛȇÛÂȘ” Ô ·È‰›·ÙÚÔ˜ ÌÔÚ› Ó· ÂÓËÌÂÚˆı›

ÁÈ·

∏ ALP Â›Ó·È ¤Ó·˜ ¢·›ÛıËÙÔ˜ ‰Â›ÎÙ˘ Ë·-

ÙÈ΋˜ ‹ ÔÛÙÈ΋˜ ‚Ï¿‚˘ ÛÙ· ·È‰È¿ Î·È ÙÔ˘˜

ÂÓ‹ÏÈΘ. ™Ù· ·È‰È¿ ¤¯ÂÈ ·Ó·ÊÂÚı› ÌÈ· ηٿ-

ÛÙ·ÛË Ô˘ ¯·Ú·ÎÙËÚ›˙ÂÙ·È ·fi ·ÚÔ‰È΋ ·Ï-

Ï¿ ÛËÌ·ÓÙÈ΋ ·‡ÍËÛË Ù˘ ALP, Ì ·Ô˘Û›· ÂÚ-

Á·ÛÙËÚÈ·ÎÒÓ Î·È ÎÏÈÓÈÎÒÓ Â˘ÚËÌ¿ÙˆÓ Ë·ÙÈ-

΋˜ ‹ ÔÛÙÈ΋˜ ÓfiÛÔ˘. ∏ ηٿÛÙ·ÛË ·˘Ù‹ ÂÚÈ-

ÁÚ¿ÊÂÙ·È ˆ˜ ηÏÔ‹ı˘ ·ÚÔ‰È΋ ˘ÂÚʈÛÊ·-

Ù·Û·ÈÌ›· Ù˘ ‚ÚÂÊÈ΋˜ Î·È ·È‰È΋˜ ËÏÈΛ·˜. ∆· ÎÚÈÙ‹ÚÈ· ‰È¿ÁÓˆÛ˘, Û‡Ìʈӷ Ì ÙÔ˘˜

Kraut et al., (1985) ›ӷÈ:

1. ∏ÏÈΛ· ÌÈÎÚfiÙÂÚË ÙˆÓ 5 ÂÙÒÓ

2. ¶ÔÈÎÈÏ›· ÎÏÈÓÈÎÒÓ Û˘Ìو̿وÓ

3. ∞Ô˘Û›· ÎÏÈÓÈÎÒÓ Î·È ÂÚÁ·ÛÙËÚÈ·ÎÒÓ Â˘ÚËÌ¿ÙˆÓ ÔÛÙÈ΋˜ ‹ Ë·ÙÈ΋˜ ÓfiÛÔ˘

4. ∞‡ÍËÛË ·ÌÊÔÙ¤ÚˆÓ ÙˆÓ ÈÛÔÂÓ˙‡ÌˆÓ (Ë·ÙÈÎfi Î·È ÔÛÙÈÎfi) ALP

5. º˘ÛÈÔÏÔÁÈΤ˜ ÙÈ̤˜ ALP ÂÓÙfi˜ 4 ÌËÓÒÓ (1,2).

√ ·ÛıÂÓ‹˜ Ì·˜ ‰ÂÓ Â›¯Â ÎÏÈÓÈο Î·È ÂÚÁ·ÛÙËÚȷο Â˘Ú‹Ì·Ù· Ë·ÙÈ΋˜ ‹ ÔÛÙÈ΋˜ ‚Ï¿‚˘. √ Ë·ÙÈÎfi˜ ¤ÏÂÁ¯Ô˜ ‹Ù·Ó Ê˘ÛÈÔÏÔÁÈÎfi˜.

¶·Ú·ıÔÚÌfiÓË, ‚ÈÙ·Ì›ÓË D, ·ÎÙÈÓÔÁÚ·Ê›· Ì·-

ÎÚÒÓ ÔÛÙÒÓ: Ê˘ÛÈÔÏÔÁÈο Â˘Ú‹Ì·Ù·. ¶ÚÔËÁ‹-

ıËΠÏԛ̈ÍË ·fi Èfi Epstein Barr Î·È Â›¯Â Ê˘-

ÛÈÔÏÔÁÈΤ˜ ÙÈ̤˜ ALP Û 2 ̋Ә (3).

∏ ·ÈÙÈÔÏÔÁ›· Ù˘ ηÏÔ‹ıÔ˘˜ ·ÚÔ‰È΋˜ ˘ÂÚʈÛÊ·Ù·Û·ÈÌ›·˜ ·Ú·Ì¤ÓÂÈ ·‰È¢ÎÚ›ÓÈ-

ÛÙË. £ÂˆÚÂ›Ù·È fiÙÈ ÔÈ ÈÔ›, fiˆ˜ ·‰ÂÓÔ˚Ô›, ÁÚ›˘, ÚÔÙ·˚Ô›, ÂÚËÙÔ˚Ô›, ÂÚ˘ıÚ¿˜, ÈÏ·Ú¿˜, Epstein Barr Î·È echo ·›˙Ô˘Ó ÛËÌ·ÓÙÈÎfi ÚfiÏÔ. ∂›Û˘, ¿ÏϘ ÏÔÈÌÒÍÂȘ, fiˆ˜ ÏÔÈÌÒÍÂȘ ÙÔ˘ Ô˘ÚÔÔÈËÙÈÎÔ‡ Î·È ·Ó·Ó¢ÛÙÈÎÔ‡, Èı·ÓfiÓ Ó· Û¯ÂÙ›˙ÔÓÙ·È Ì ÙËÓ Î·Ù¿ÛÙ·ÛË ·˘Ù‹ (2,3,4).

∏ ·ıÔÁ¤ÓÂÈ· Ù˘ ηÏÔ‹ıÔ˘˜ ·ÚÔ‰È΋˜ ˘ÂÚʈÛÊ·Ù·Û·ÈÌ›·˜ Ê·›ÓÂÙ·È Ó· Â›Ó·È ÔÏ˘-

·Ú·ÁÔÓÙÈ΋. ¢È¿ÊÔÚÔÈ Ì˯·ÓÈÛÌÔ› ¤¯Ô˘Ó ÂÓÔ¯ÔÔÈËı›, fiˆ˜ ·‡ÍËÛË Ù˘ ALP ÏfiÁˆ Ù˘

Û˘ÛÛÒÚ¢Û˘ ÙˆÓ ÌÂÙ·‚ÔÏÈÙÒÓ Ù˘ ‚ÈÙ·Ì›Ó˘ D (25-OH D3), ÌÂȈ̤ÓË Î¿ı·ÚÛË Ù˘ ALP ·fi ÙÔ Ï¿ÛÌ·, Èı·ÓfiÓ ÏfiÁˆ ÈÔÁÂÓÔ‡˜ Ïԛ̈͢ ‹ ˘ÂÚ‚ÔÏÈ΋˜ Û˘ÛÛÒÚ¢Û˘ ÛÈ·ÏÈÎÒÓ ÔͤˆÓ ÙÔ˘ Ë·ÙÈÎÔ‡ ÈÛÔÂÓ˙‡ÌÔ˘ (3,5).

∏ ηÏÔ‹ı˘ ·ÚÔ‰È΋ ˘ÂÚʈÛÊ·Ù·Û·ÈÌ›· Ù›ÓÂÈ Ó· ¤¯ÂÈ ÌÈ· Âԯȷ΋ ηٷÓÔÌ‹, ΢ڛˆ˜ ÙÔ ÊıÈÓfiˆÚÔ Î·È ÙÔÓ ¯ÂÈÌÒÓ·, ÂÔ¯¤˜ ηٿ ÙȘ Ôԛ˜ ÔÈ ÈÒÛÂȘ Â›Ó·È ÈÔ Û˘¯Ó¤˜ (6). ∏ ηÏÔ‹ı˘ ·ÚÔ‰È΋ ˘ÂÚʈÛÊ·Ù·Û·ÈÌ›· ı· Ú¤ÂÈ Ó· Ï·Ì‚¿ÓÂÙ·È ˘’ fi„Ë ·Ú¯Èο ÛÙË ‰È·ÊÔÚÈ΋ ‰È¿ÁÓˆÛË Ù˘ ·‡ÍËÛ˘ ALP ¯ˆÚ›˜ ÂÌÊ·Ó‹ ·ÈÙ›· Û ·È‰È¿ <5 ÂÙÒÓ, ÒÛÙ ӷ

1. Carroll, AJ, Coakley JC. Transient hyperphosphatasaemia: an important condition to recognize. J Paediatr Child Health 2001;37:359-362.

2. Stein P, Rosalki SB, Foo AY, Hjelm M. Transient hyperphosphatasemia of infancy and early childhood: clinical and biochemical features of 21 cases and literature review. Clin Chem 1987;33:313-318.

3. Eboriadou M, Skouli G, Panagopoulou P, Haidopoulou K, Makedou A, Varlamis G. Acute laryngotracheobronchitis and associated transient hyperphosphatasemia: a new case of transient hyperphosphatasemia in early childhood. J Paediatr Child Health 2006;42:149-150.

4. Suzuki M, Okazaki T, Nagai T, Töro K, Sétonyi P. Viral infection of infants and children with benign transient hyperphosphatasemia. FEMS Immunol Med Microbiol 2002;33:215-218.

5. Crofton PM. What is the cause of benign transient hyperphosphatasemia? A study of 35 cases. Clin Chem 1988;34:335-340.

6. Behúlova ã D, Bzdúch V, Holesova ã D, Vasilenkova ã A, Ponec J. Transient hyperphosphatasemia of infancy and childhood: study of 194 cases. Clin Chem 2000;46:1868-1869.

∏

ÚÔ˜ ÙÔ˘˜ ∫ÚÈÙ¤˜ Ù˘ “¶·È‰È·ÙÚÈ΋˜”

ÚÔÛ¤ÊÂÚ·Ó ÙËÓ ›ڷ Î·È ÙÔÓ ¯ÚfiÓÔ ÙÔ˘˜ ÁÈ· Ó· ÂÍ·ÛÊ·Ï›ÛÔ˘Ó ÙÂÎÌËÚȈ̤Ó˜ Î·È ·ÓÙÈÎÂÈÌÂÓÈΤ˜ ·ÍÈÔÏÔÁ‹ÛÂȘ ÁÈ· ÙȘ ÂÈÛÙËÌÔÓÈΤ˜ ÂÚÁ·Û›Â˜ Ô˘ ‰ËÌÔÛȇıËÎ·Ó Î·Ù¿ ÙÔ ¤ÙÔ˜ 2008.

√ ¢È¢ı˘ÓÙ‹˜ ™‡ÓÙ·Í˘

∫ˆÓÛÙ·ÓÙ›ÓÔ˜ ™ÙÂÊ·Ó›‰Ë˜

∫ÚÈÙ¤˜ ÙˆÓ ÂÚÁ·ÛÈÒÓ Ô˘ ‰ËÌÔÛȇıËÎ·Ó ÛÙÔÓ ÙfiÌÔ 71 ÙÔ˘ ¤ÙÔ˘˜ 2008

∞ı·Ó·Û¤Ï˘ ™ˆÙ‹Ú˘

∞ı·Ó·ÛÈ¿‰Ô˘-¶ÈÂÚÔÔ‡ÏÔ˘ º·Ó‹

∞Ó‰Ú¤Ô˘ ∞ϤͷӉÚÔ˜

∞Ó‰ÚÔÓ›ÎÔ˘ ™Ù˘ÏÈ·Ó‹

∞ÙÙÈÏ¿ÎÔ˜ ∞¯ÈÏϤ·˜

µ·˙·›Ô˘ ∞Ó‰ÚÈ·Ó‹

µ¿Ô˜ °ÂÒÚÁÈÔ˜

µ·Ú‚·Ú‹ÁÔ˘-ºÚ›Ì· ∞Ó·ÛÙ·Û›·

µÏ·¯Ô··‰ÔÔ‡ÏÔ˘ ∂Ï›‰·

µÔ‡‰Ú˘ ∫ˆÓÛÙ·ÓÙ›ÓÔ˜

°·Ï·Ó¿Î˘ ∂ÌÌ·ÓÔ˘‹Ï

°·ÚÔ‡ÊË-∫Ô‡ÙÛ· ∞Ó·ÛÙ·Û›·

°ÂˆÚÁ·ÎfiÔ˘ÏÔ˜ ¢ËÌ‹ÙÚÈÔ˜

°ÂˆÚÁÔ‡ÏË ∂ϤÓË

°È·ÓÓ·ÎÔ‡ÏÈ· ª·›ÚË

¢ÂÏËÁÂÒÚÔÁÏÔ˘ ∂˘ı‡ÌÈÔ˜

¢È·Ì·ÓÙ‹ ∂ÏÈÛ¿‚ÂÙ

¢ÚfiÛÔ˘-∞Á·Î›‰Ô˘ µ·ÛÈÏÈ΋

∑·ÊÂÈÚ›Ô˘ ¢ËÌ‹ÙÚÈÔ˜

£ˆÌ·˚‰Ô˘ ¢¿ÊÓË-§ˆÚ¤Ù·

∫·Ó·Î¿-Gantenbein ÃÚÈÛÙ›Ó·

∫·Ó¿ÚÈÔ˘ ª·Ú›·

∫·ÛÛÈÔ‡-¶ÚÔ‡ÓÙ˙Ô˘ ∫˘Úȷ΋

∫·Ù˙ËÏ¿Î˘ ¡ÈÎfiÏ·Ô˜

∫·ÙÛ·ÚÔ‡-¶ÂÎÙ·Û›‰Ë ∂˘ÛÙ·ı›·

∫·ÙÙ¿Ì˘ ∞ÓÙÒÓ˘

∫·Ê¿ÙÔ˜ ∞ÓÙÒÓ˘

∫·ÊÚ›ÙÛ· ¶·Ó·ÁÈÒÙ·

∫›ÙÛÈÔ˘-∆˙¤ÏË ™ÔÊ›·

∫ÔÏ·˚Ù˘ °ÂÚ¿ÛÈÌÔ˜

∫ÔÏÏÈfi˜ ∫ˆÓÛÙ·ÓÙ›ÓÔ˜

∫fiÛÛ˘‚· §˘‰›·

∫ÚÈÙÛ¤ÏË ∂ϤÓË

∫ÒÛÙ·ÏÔ˜ ÃÚ‹ÛÙÔ˜

∫ˆÛÙ·Ú›‰Ô˘ ™Ù·˘ÚԇϷ

ª·Ï·Ì›ÙÛË-¶Ô‡¯ÓÂÚ ∞ÚÈ¿‰ÓË

ª·ÓÙ·‰¿Î˘ ∂ÏȉÔÊfiÚÔ˜

ª·ÛÙÚÔÁÈ¿ÓÓË ƒ›Ù·

ªÔÛ¯fi‚Ë ª·Ú›·

ª¿Î· ª·ÚÁ·Ú›Ù·

ªÈÙÛÒÚË ª·Ú›·

ª˘ÚÈÔÎÂÊ·ÏÈÙ¿Î˘ ¡ÈÎfiÏ·Ô˜

¡ÈÎÔÏ¿Ô˘-¶··Ó·ÁÈÒÙÔ˘ ∞ÏÂͿӉڷ

¡ÙÔ˘ÓÙÔ˘Ó¿Î˘ ∂Ï¢ı¤ÚÈÔ˜-™Ù·‡ÚÔ˜

™·ÍÒÓË-¶··ÁˆÚÁ›Ô˘ ºˆÙÂÈÓ‹ ™·Ú·Ê›‰Ë˜ ∫ÔÛÌ¿˜

™ÂÚ‚ÈÙ˙fiÁÏÔ˘ ª·Ú›Ó·

™È·ÌÔÔ‡ÏÔ˘-ª·˘Ú›‰Ô˘ ∞ÓÙÈÁfiÓË

™ÈÁ¿Ï·˜ πˆ¿ÓÓ˘

™›‰Ë µ·ÛÈÏÈ΋

™ÈÒÌÔ˘ ∞ÈηÙÂÚ›ÓË

™ËÏÈÔÔ‡ÏÔ˘ ÷ڿ

™ËÏÈÒÙË-°Îڤη µ·ÛÈÏÈ΋

™Ô‡ÏÔ˘ µ¿Ó·

™Ù·ÌÔÁÈ¿ÓÓÔ˘-ª·˘ÚÔÂȉ‹ §¤Ï·

™ÙÂȷοÎË

Akbulut T.177

Antoniadou I.210

Attilakos A.210

Augoustides-Savvopoulou P.291

Baka M.296

Bouhoutsou D.296

Castellsagué X.345

Del Torso S.92

Diamante E.291

Doganis D.296

Douladiris N.296

Drossou-Agakidou V.291

EDIG consortium383

Florakis D.345

Fuentes-Lugo D.96

Hadjipanyidis A.92

Ioannou H.P.291

Kallergi C.296

Katsarou E.210

Kosmidis S.296

Kotsis V.186

Lang H.87

Mastroyianni S.210

Nadalin S.87

Nicholson A.J.92

Nunez D.A.162

Park F.177

Ponce-Rivera M.96

Pourtsidis A.296

Prassouli A. 210

Radtke A.87

Sarafidou J.210

Saxoni-Papageorgiou F.296

Skardoutsou A.210

Sotiropoulos G.C.87

Stabouli S.186

Synodinou M.296

Trimis G.345

Tsampoura Z.291

Van Esso D.92

Varvoutsi M.296

Vasilatou-Kosmidis H.296

Voudris K.210

∞ÁÁÂÏ¿ÎÔ˘ µ.49, 54, 317, 486

∞ÁÁÂÏÔÔ‡ÏÔ˘ ƒ.271

∞˚‚¿˙Ë ¢.219

∞˚‚¿˙˘ µ.219

∞ÏÂÍ·Ó‰Ú¿ÙÔ˜ Ã.301

∞Ó·ÁÓˆÛÙ¿ÙÔ˘ ¡.403

∞ÓıÚ·ÎfiÔ˘ÏÔ˜ ª.µ.231

∞ÓÙ¿ÚË µ.135

∞ÓÙˆÓÈ¿‰Ô˘-∫Ô˘Ì¿ÙÔ˘ π. 426, 469

∞ÓÙˆÓ›ÙÛË ª.215

∞Ó˘Ê·ÓÙ¿Î˘ ∫.317

∞ÚÁ˘ÚÔÔ‡ÏÔ˘-¶·Ù¿Î· ¶.219

∞ÛÎËÙ‹ µ.75, 311 ∞ÙÙÈÏ¿ÎÔ˜ ∞. 426 ∞˘ÁÂÓ¿ÎË ∞.60 µ·ÚÏ¿Ì˘ °.135, 215, 417 µ·ÚÏ¿Ì˘ ™.215 µ·ÛÈÏÂÈ¿‰Ë˜ Õ.219 µ·ÛÈÏÔÔ‡ÏÔ˘ ∞. 475 µ·ÛÈÏÔÔ‡ÏÔ˘ µ.383

µÂÏÈÛÛ·Ú›Ô˘ µ.383

µÂÏÈÛÛ·Ú›Ô˘ π.ª.37 µ›‰Ú· ¡.361

µÏ·¯¿ÎË °.192

µÏ·¯Ô··‰ÔÔ‡ÏÔ˘ ∂.277

µÏ¿¯Ô˜ ∞.390

µÚ¿ÓË √.141

°·Ï·Ó¿Î˘ ∂.171, 248, 324, 404, 494 °·ÏÏ¿-µÔ˘Ì‚Ô˘Ú¿ÎË ∞.263

°ÂÚÌ·Ó¿Î˘ π.238, 403, 417

°ÂˆÚÁÈÔÔ‡ÏÔ˘-ª›¯· ¶. 434, 449

°È·Ï·Ì¿ ∂.219

°È·ÓÓ¿ÎË ª.37

°È·ÓÓ·ÎÔÔ‡ÏÔ˘ Ã.238

°È·ÓÓ·ÎÔ‡ÏÈ· ª.361

°È·ÓÓ¿ÙÔ˘ ∂. 497 °Ô˘ÚÙ˙ÂÏ›‰Ë˜ ¶.311 ¢ÂÌÂÚÙ˙›‰Ô˘ µ.141 ¢ËÌÔÔ‡ÏÔ˘ ∞.355 ¢ËÌÔÔ‡ÏÔ˘ ∞ÈÎ. 469

¢ÈÔÌ‹‰Ô˘˜ ª.251 ¢ÔÏÈ·Ó›ÙË ª.376 ¢Ô‡‰· ∂.368

¢Ú·ÎˆÓ¿Î˘ °.60

∑·Ú‰·‚¿ °.219

∑ÂÚ‚Ô˘‰¿ÎË ∞. 449 ∑‹‚·-¶ÂÙÚÔÔ‡ÏÔ˘ ª.376

∑‹ÎÔ˜ ¢.251

∑ÔÏÒÙ· ∞ÈÎ. 469

∏Ï›· ™.49

∏ÏÈÔ‰ÚÔÌ›ÙË ∑. 469

£ÂÔ‰ÔÛ›Ô˘ ª.251

£ˆÌ·˝‰Ë˜ ∆.219

£ˆÌ·˝‰Ô˘ §.407, 458

£ˆÌ¿˜ ¢.277

ÿÌ‚ÚÈÔ˜ °.141

∫·‚·ÏÈÒÙ˘ π.301

∫·‰fiÁÏÔ˘ ¡.128

∫·ÏÏÈÒÚ· ª. 493

∫·ÏÌ·ÓÙ‹ ª.403

∫·Ó·‚¿Î˘ ∂.224, 383

∫¿ÓÙ˙ÈÔ˘ ∫.141

∫·Ú·ÁÈ¿ÓÓË ¶.18

∫·Ú·ı¿ÓÔ˜ µ. 475

∫·Ú·Ì·ÍfiÁÏÔ˘ ¢.301

∫·Ú·Ó¿ÛÈÔ˘ ∫.376

∫·Úfi΢ ∞.148

∫·ÙÛ·Ú¿Î˘ π.60

∫·Ê¿ÙÔ˜ ∞.24, 70, 157

∫·ÊÂÙ˙‹˜ ¢. 37, 441

∫›ÙÛÈÔ˜ ∫.128

∫›ÙÛÈÔ˘-∆˙¤ÏË ™.224, 235, 255, 383, 497

∫Ï·‰›ÙÔ˘ ª.60

∫Ô˚Ó¿ÎË ™.361

∫fiÎÔÚË ∂.49, 54, 192, 317

∫ÔÏ·˝Ù˘ °.383

∫ÔÏȷϤÍË ∞.255

∫ÔÓÙÔÁÈ¿ÓÓË ª.361

∫ÔÓÙfiÔ˘ÏÔ˜ ∂.42

∫ÔڷοÎË ∂.238

∫ÔÚÌ¿˜ °. 441

∫Ô˘ÁÈÔ˘ÌÔ˘Ù˙¿Î˘ °.331

∫Ô‡ÚÙ˘ ∞.215

∫Ô‡ÛÙ· ∂.123

∫Ô˘ÙÏ‹ ª. 486

∫Ô˘ÙÛ·˘Ù›ÎË Ã.247

∫ÚÈÙÛ¤ÏË ∂. 441

∫˘ÚÈfiÔ˘ÏÔ˜ °.148

∫ˆÓÛÙ·ÓÙfiÔ˘ÏÔ˜ A. 441

∫ˆÓÛÙ·ÓÙÔ˘Ï¿ÎË ∂. 441

∫ÒÛÙ· ∫.128

∫ˆÛÙ¿ÎÔ˘ ∫.383

∫ÒÛÙ·ÏÔ˜ Ã.64, 116

§·‚Ú¿ÓÔ˜ °.271

§¿ÁÁ·ÚË µ.383

§Â‚ÂÓÙfiÔ˘ÏÔ˜ °.224

§ÈÓ·Ú‰¿Î˘ ª.24

§Ô˘›˙Ô˘ ∞. 441

ª·ÁηӿÚË º.361

ª·Î¤‰Ô˘ ∫.215

ª¿Î˘ ∞.390, 399

ª·Ï·ıÚ¿ÎË ª.60

ª·ÓÔ˘Ú¿ ∞.238

ª·ÓÔ˘Û¿Î˘ ∂. 486

ª¿ÓÙ˙ÈÔ˘ ∂.247

ª·ÓÙÔ‡‰Ë˜ ™. 458

ª·ÓÒÏ· ∞.399

ª¿ÚÁ·ÚË ∞. 469

ª·ÚÁ¿ÚË ª.∫.238

ª·ÚΤ·˜ ¡.323

ª·ÛÙÚÔÁÈ¿ÓÓË ™.311

ª·˘Ú›Î· ¶. 469

ª·˘Ú›ÎÔ˘ ª.

∞.141

™.105

ª.135

ª·˙ÔÔ‡ÏÔ˘-∫˘Úηӛ‰Ô˘ ∂.283 ª¿ÎˆÛË ™.49 ª·ÚÙÛfiη˜ Ã.™.409

∫.361 ªÂÚÙÛÈ¿˜ °.24

¢.383

π.355

∂.219

¡.243, 247 ¡Â¿Ú¯Ô˘ ∞.60 ¡›Î·˜ π.311

¡.18 ¡ÈˆÙ¿Î˘ °.49, 54, 192

∞.1

°.247

™.128

π.141

π·ÙÚÈ΋˜ Î·È ¢È·ÙÚÔÊ‹˜24

√ÚÁ·ÓÔ‡ ª.54

¶¿‚Ë ∂.148

¶¿Ì·ÓÔ˜ ∞.105

¶·ÓÙÂÏÈ¿‰Ë˜ Ã.42

¶·ÓÙÈΛ‰Ô˘ ª.141

¶··Á·ÚÔ˘Ê¿Ï˘ ∫.165

¶··ÁÈ¿ÓÓ˘ I. 417

¶··ÁÈ·ÓÓÔÔ‡ÏÔ˘ √.301

¶··‰¿Î˘ µ.277

¶··‰¿ÎÔ˘-§·ÁÔÁÈ¿ÓÓË ™.376

¶··‰ËÌËÙÚ›Ô˘ ∞.1

¶··‰fiÔ˘ÏÔ˜ ¡.37, 76, 475, 486

¶··‰ÔÔ‡ÏÔ˘ ∞.434, 449

¶··‰ÔÔ‡ÏÔ˘ ª.128

∂.135

°.247

∞.123

∫.243

£.141

¶.317

π.323

∂.42

∞.135

∞. 426, 469

™·‚‚›‰Ô˘ ∞.238

™·˚Ù¿Î˘ ∂.238

™·ÎÂÏÏ¿Ú˘ °.355

™·Ï·‚Ô‡Ú· ∫.255

™·ÍÒÓË-¶··ÁˆÚÁ›Ô˘ º.37, 486

™·Ú·ÓÙÔÔ‡ÏÔ˘ ∞ÈÎ.301

™·Úȉ¿Î˘ π.60

™·ÚÚ‹ ∫.24

™ËÊÈ·ÓÔ‡ ¶.165

™È·ÌÔÔ‡ÏÔ˘-ª·˘Ú›‰Ô˘ ∞.201, 399

™È¯ÏÈÌ›ÚË ¶.201

™ÎÈ·‰¿˜ ∫.165

™Ô˘Ì¿ÎË ∂.383

™ËÏÈÔÔ‡ÏÔ˘ £. 441

™‡ÚÔÁÏÔ˘ ∫.141

™Ù·Ì·Ù¿ÎË ∞.317

™ÙÂÊ·Ó¿ÎË ™.304

™ÙÂÊ·Ó›‰Ë˜ ∫.75, 173, 311, 327

™ÙÚ›ÓÙ˙˘ ¡.383

™ÙÚÔ˘Ì‹ ∂. 475

™ˆÊÚÔÓ¿ ™.361

∆·‚Ï·‰¿ÎË £.60

∆·ÎÔ‡‰·˜ ¢.141

∆·¿ÎË °.243

∆·ÛÈÔÔ‡ÏÔ˘ µ.376

∆˙ËÙËÚ›‰Ô˘ ª.42

∆˙›ÓË ∂. 469

∆˙ÈÊ‹ º.255

∆˙Ô‡ÊË ª.201

∆ÔÎ̷Λ‰Ë˜ ™.368

∆Ô˘ÓÈÛÛ›‰Ô˘ ¢. 441

∆Ô‡ÛÔ˘Ï˘ ¢.368

∆Û·Ô‡ÛË Ã.399

∆ÛÈ¿ÓÙ˘ π.383

∆ÛÈ¿ÓÙÔ˘ µ.148

∆ÛÈ¿ÙÛÈÔ˘ √.301

∆ÛÈÏÈÌÈÁοÎË ∞.304

∆ÛÈÔ‡Ú˘ π.128

∆Û›ÙÛÈη ∞. 441, 500

∆ÛfiÏ·˜ °. 482

∆ÛÔÏÈ¿ ª.37

∆ÛÔ˘Ì¿Î·˜ ∫. 449 º·ÚÌ¿ÎË ∞-∂.361

ºÈÏÈÔÔ‡ÏÔ˘ ∞. 441

ºÈÏ›Ô˘ √.376

ºÏ¤‚· ∞.135

ºÔ‡ÓÙ˙ËÏ· Œ.219 ºÚ¤ÛÎÔ˘ ∞. 441 ºÚ˘Û›Ú· Œ.224 ºˆÙ›Ô˘ ∫.165 ÷ÏÈ¿ÛÔ˜ ¡.390, 399 ÷ڛÛ˘ °.355 ÷ڈӛÙË π.54, 486 ÷Ù˙Ë·ı·Ó·Û›Ô˘ Ã.123, 317 ÷Ù˙ˉ¿ÎË ∂.238 ÛÙÔÁÏÔ˘ ∞.215 ÃÚÈÛÙÈ·Ó¿Î˘ ∂.π.243 ÃÚÈÛÙÔÁÈÒÚÁÔ˜ ™.383 ÃÚÈÛÙfi‰Ô˘ÏÔ˜ ∞.368 æÒÓË ™.224

∂˘ÚÂÙ‹ÚÈÔ Ï¤ÍˆÓ-ÎÏÂȉÈÒÓ ÙÔ˘ ∆fiÌÔ˘ 71

AIS345

Amino acids291

Behavioural problems210

Biliary atresia87

Blood pressure186 Cellular296

Childhood obesity92, 96

Childhood overweight96

Children210

CIN 2/3345

CMV Ïԛ̈ÍË135 EBV135

Enteral feeding tolerance291

Epidemiology92

Essential hypertension186 FGFR349

Gene therapy177

Genetic disease177

Genital warts345

Growth reference96

Growth standard96

Gs ÚˆÙ½ÓË317

Gs· ÌÂÙ·ÏÏ¿ÍÂȘ317 HPV345

Human papilloma virus 11162

Human papilloma virus 6162

Humoral296

Idiopathic generalized epilepsy210 Immunity296

Larynx162

Left ventricular mass index186

Liver failure87

Liver insufficiency87

Liver transplantation87

Living donor liver transplantation87

Lymphoma296

Management92

NADP-·Ó·ÁˆÁ¿ÛË192

Paediatric transplant programme87

Paediatrics177

Papilloma162

Parenteral nutrition291

Plasma citrulline291

PRES311

Preterm neonates291

Prevention92

Quadrivalent vaccine345

Recovery296

Small intestine291

Split liver87

Split techniques87

VaIN 2/3345

VIN 2/3345

Viral vectors177

Voice disorders162

Well-controlled seizures210

‚ÈÙ·Ì›Ó˘ µ1254 ∞ÓÔÛÔÊ·ÈÓfiÙ˘Ô˜135 ∞ÓÙ·ÏÏ·Á‹ ·ÂÚ›ˆÓ18 ∞ÓÙÈÌÂÙÒÈÛË235 ∞ÓÙÈÌÂÙÒÈÛË ·¯˘Û·ÚΛ·˜376 ∞ÓÙÈÚÔÛˆ¢ÙÈÎfi ÂıÓÈÎfi ‰Â›ÁÌ·70

∞ÓÙÈÛÙ¿ıÌÈÛË ‰fiÛ˘271 ∞ÓÙ›¯ÂÈÚ·˜482 ∞ÔÎÏÂÈÛÙÈο ¯ÔÚÙÔÊ¿ÁÔÈ54 ∞ÚÁÈÓ›ÓË116 ∞Ú¯·›· ÈÛÙÔÚ›· Ù˘ È·ÙÚÈ΋˜283 ÕÙ˘Ë Ïԛ̈ÍË37 ∞˘ÍËÙÈ΋ ÔÚÌfiÓË49, 123, 128

B

µÚ¤ÊË54, 331 µÚԢΤÏψÛË399

° °¿Ï·Ù· ˘„ËÏ‹˜ ‰È·ÙÚÔÊÈ΋˜ ·Í›·˜116 °·ÛÙÚÂÓÙÂÚ›Ùȉ·301 °ÂÓÂÙÈ΋1, 105 °ÂÓÂÙÈ΋ ηıÔ‰‹ÁËÛË1 °ÂÓÂÙÈ΋ Û˘Ì‚Ô˘Ï¢ÙÈ΋235 °ÏÔ˘Ù·Ì›ÓË116 °ÓˆÛÙÈΤ˜ ÏÂÈÙÔ˘ÚÁ›Â˜426 ¢

¢¿ÎÙ˘ÏÔ482

¢¿ÛηÏÔÈ219 ¢Â›ÎÙ˘ Ì¿˙·˜ ÛÒÌ·ÙÔ˜368

¢Â›ÎÙ˘ ˘ÁÈÂÈÓ‹˜ ‰È·ÙÚÔÊ‹˜24

¢ÂÚÌ·ÙÈ΋ Ì·ÛÙÔ΢ÙÙ¿ÚˆÛË486

¢È·‰Èηۛ· ·fiÊ·Û˘383

¢È·‰ÈÎÙ˘·Îfi˜ ÂıÈÛÌfi˜434

¢È·‰›ÎÙ˘Ô441, 449

¢È·˙Â¿ÌË42

¢È·ÙÚÔÊ‹24, 54, 361

¢È·ÙÚÔÊ‹ ‚Ú¤ÊÔ˘˜116

¢È·ÙÚÔÊ‹ ·È‰ÈÒÓ157

¢È¿¯˘ÙË ‰ÂÚÌ·ÙÈ΋ Ì·ÛÙÔ΢ÙÙ¿ÚˆÛË486

¢ÈÂÚ‡ÓËÛË201

¢ÈfiÁΈÛË390

¢ÈÛÎÔÂȉ‹˜ ·ÙÂÏÂÎÙ·Û›·60

¢È-˘ÔÎÂÈÌÂÓÈÎfi˜ ÓÔ˘˜331 ¢ª™376

¢˘Û·Ó¿ÏÔÁÔ ÎÔÓÙfi ·Ó¿ÛÙËÌ·49

∂

“∂ıÈÛÌfi˜” ÛÙÔ ‰È·‰›ÎÙ˘Ô441

∂ÏÏËÓÈ΋ ·ÁÔÚ¿ 475

∂Ì‚fiÏÈ·148

ŒÌ‚Ú˘·331

∂Ó·ÏÏ·ÎÙÈΤ˜ ıÂÚ·›˜355

∂ÓÙÂÚÔ¿ıÂÈ·64

∂ÈÛ‹Ì·ÓÛË475

∂ÙÈΤÙ˜475

∂Ê˂›·434, 441

ŒÊË‚ÔÈ361

ŒÊ˂Ԙ60

∏

◊‚Ë128

∏ıÈο ‰ÈÏ‹ÌÌ·Ù·383

∏ÏÂÎÙÚÔÓÈÎÔ› ˘ÔÏÔÁÈÛÙ¤˜ 449

◊Ê·ÈÛÙÔ˜283

£

£ÚÂÙÈο Û˘ÛÙ·ÙÈο157

£ÚÔÌ‚ÔÂÓÈ΋ ÔÚʇڷ399

π

π·ÙÚÈ΋ ÁÂÓÂÙÈ΋283

πÓ҉˘ ‰˘ÛÏ·Û›· ÔÛÙÒÓ317

∫

∫·Ì‡Ï˜ ·Ó¿Ù˘Í˘70

∫¿ÓÈÛÌ·219

∫·Ú‰È·ÁÁÂȷο ÓÔÛ‹Ì·Ù·215

∫·Ú‰ÈÔÏÔÁÈÎfi˜ ¤ÏÂÁ¯Ô˜417

∫·ÚÓÈÙ›ÓË116

∫·Ù¿¯ÚËÛË ‰È·‰ÈÎÙ‡Ô˘441

∫·Ù¢ı˘ÓÙ‹ÚȘ Ô‰ËÁ›Â˜417

∫ÏÈÓÈο ÎÚÈÙ‹ÚÈ·224

∫ÏÈÓÈ΋ ÁÂÓÂÙÈ΋271

∫ÏÈÓÈ΋ ¤Î‚·ÛË135

∫ÔÈÓfiÙËÙ·469

∫˘Ùfi¯ÚˆÌ·-b5-·Ó·ÁˆÁ¿ÛË192

§

§ÂÌÊ·‰¤Ó˜390

§ÂÌÊ·‰ÂÓÔ¿ıÂÈ·243 §Â˘ÎÔÂÁÎÂÊ·ÏÔ¿ıÂÈ·311 §Èȉ·ÈÌÈÎfi ÚÔÊ›Ï215 §ÈÔÚˆÙ½Ó˜24 §ÔÈÌÒÍÂȘ301 ª ª·ÁÓËÙÈ΋ ÙÔÌÔÁÚ·Ê›· ÂÁÎÂÊ¿ÏÔ˘311 ª·ıËÙ¤˜219 ª·ÎÚÔıÚÂÙÈο ÛÙÔȯ›·368 ª·ÛÙÔ΢ÙÙ¿ÚˆÛË 486 ªÂı·ÈÌÔÛÊ·ÈÚÈÓ·ÈÌ›·192 ªÂÏ·Á¯ÚˆÌ·ÙÈ΋ ÎÓ›‰ˆÛË486 ªÂÛÔÁÂȷ΋ ‰›·ÈÙ·361 ªÂÙ·‚ÔÏÈÎfi Û‡Ó‰ÚÔÌÔ24 ªÂÙ·ÌfiÛ¯Â˘ÛË ‹·ÙÔ˜141 ªËÓÈÁÁÈÙȉfiÎÔÎÎÔ˜ Ù‡Ô˘ C148 ªÈÎÚÔÏÈı›·ÛË277 ªÈÙÔ¯ÔÓ‰Úȷο ÓÔÛ‹Ì·Ù·1 ªÔÚȷ΋ ‰È¿ÁÓˆÛË105 ªÏ ÙÔ˘ ÌÂı˘ÏÂÓ›Ô˘192 ª˘ÎfiÏ·ÛÌ· 37 ª˘ÎÔÏ·ÛÌ·ÙÈ΋ Ó¢ÌÔÓ›·60 ¡ ¡ÂÎÚˆÙÈ΋ ÏÂÌÊ·‰ÂÓ›Ùȉ·243 ¡ÂÔÁÓ¿331 ¡ÂÔÁÓfi64 ¡ÂÊÂÏÔÔÈË̤ÓË ·‰ÚÂÓ·Ï›ÓË231 ¡ÂÊÚÈ΋ ·ÓÂ¿ÚÎÂÈ·311 ¡ÔÌÔıÂÛ›·475 ¡fiÛÔ˜ Kikuchi-Fujimoto243 ¡Ô˘ÎÏÂÔÙ›‰È·116 √

√ÁÎÔÁÔÓ›‰È·255 √‰ËÁ›Â˜ ‰È·ÙÚÔÊ‹˜376 √ÈÎÔÓÔÌÈ΋ ·ÍÈÔÏfiÁËÛË148 √§§ ·È‰È΋˜ ËÏÈΛ·˜255 √Í›· ‚ÚÔÁ¯ÈÔÏ›Ùȉ·231 √Í›· Ï·Ú˘ÁÁÔÙÚ·¯ÂÈÔ‚ÚÔÁ¯›Ùȉ·231 √Í›· Ï¢¯·ÈÌ›·263 √͢ÁfiÓˆÛË18 √ÚıÔ‰ÔÓÙÈΤ˜ ·ÓˆÌ·Ï›Â˜482 ŸÚ¯ÂȘ277

¶·È‰›417 ¶·È‰È¿37, 70, 141, 263, 301, 311, 361, 449, 486 ¶·È‰È·ÙÚÈ΋105

¶·È‰È΋ ÂÈÏË„›·426

¶·È‰È΋ ËÏÈΛ·201, 390

¶·È‰È΋ ·¯˘Û·ÚΛ·368, 376

¶·Ú¿ÁÔÓÙ˜ ÎÈÓ‰‡ÓÔ˘449

¶·ÚÂÌ‚¿ÛÂȘ376

¶·¯˘Û·ÚΛ·24, 70, 157

¶ÂÚÈ‚¿ÏÏÔÓ469

¶ÂÚÈÙÔÌ‹355

¶ÂÚÈÊÂÚÈ΋ ÚÒÈÌË ‹‚Ë317

¶È›Ï· 482

¶ÈÛÙÔÔ›ËÛË ˘Á›·˜417

¶Ó¢ÌÔÓÈfiÎÔÎÎÔ˜148

¶ÔÏ˘·ÎfiÚÂÛÙ· ÏÈ·Ú¿ Ôͤ·116

¶ÔÏ˘Û˘ÛÙËÌ·ÙÈο ÓÔÛ‹Ì·Ù·1

¶Ú‚ÈÔÙÈο116

¶ÚÔ‚ÈÔÙÈο116

¶ÚÔÁÂÓÓËÙÈ΋ ‰È¿ÁÓˆÛË235, 383

¶ÚÔÁÂÓÓËÙÈÎfi˜ ¤ÏÂÁ¯Ô˜238

¶ÚfiÏË„Ë215

¶ÚÔʇϷÍË ˘ÚÂÙÈÎÒÓ Û·ÛÌÒÓ42

¶ÚÒÙÔ ÂÂÈÛfi‰ÈÔ ·‡ÚÂÙˆÓ Û·ÛÌÒÓ201

ƒ

ƒÔÙ·˚fi˜301 ™

™›‰ËÚÔ˜116

™ÎÂÏÂÙÈ΋ ‰˘ÛÏ·Û›·49 ™·ÛÌÔ›311 ™ÙÔÌ·ÙÈΤ˜ ¤ÍÂȘ ÂÎÙfi˜ ‰È·ÙÚÔÊ‹˜482

™˘ÁÁÂÓ›˜ ηډÈÔ¿ıÂȘ238

™˘ÁÁÂÓ‹˜ ·ÌÊÔÙÂÚfiÏ¢ÚÔ˜

Ú·È‚Ô˚ÔÔ‰›·283 ™˘ÌÂÚÈÊÔÚ¿426

™˘Ó·ÈÛıËÌ·ÙÈΤ˜ ·ÓÙȉڿÛÂȘ383

™˘Ó‰ÚÔÌÈ΋ ·¯˘Û·ÚΛ·224

™‡Ó‰ÚÔÌÔ Bardet-Biedl224

™‡Ó‰ÚÔÌÔ McCune-Albright317

™‡Ó‰ÚÔÌÔ Prader-Willi123

™‡Ó‰ÚÔÌÔ Turner123, 235

™‡Ó‰ÚÔÌÔ ·ÈÊÓ›‰ÈÔ˘ ‚ÚÂÊÈÎÔ‡ ı·Ó¿ÙÔ˘304

™‡Ó‰ÚÔÌÔ ˘ÔÏ·ÛÙÈ΋˜

·ÚÈÛÙÂÚ‹˜ ηډȿ˜238

™˘Ó‰˘·Ṳ̂ÓË ·ÓÂ¿ÚÎÂÈ· ÔÚÌÔÓÒÓ128 ™˘ÛÙ¿ÛÂȘ235 ™˘ÛÙ¿ÛÂȘ ∞ÌÂÚÈηÓÈ΋˜

∞η‰ËÌ›·˜ ¶·È‰È·ÙÚÈ΋˜304 ™¯ÔÏÈ΋ ÂÙÔÈÌfiÙËÙ·458 ™ˆÌ·ÙÈ΋ ¿ÛÎËÛË157

∆

∆ÂÏÈÎfi ·Ó¿ÛÙËÌ·128 ∆ÚÔÊÈÎfi ·ÏÏÂÚÁÈÔÁfiÓÔ475 À

À¤ÚÙ·ÛË311 ÀÔıÚ„›·70 ÀÔ¯ÔÓ‰ÚÔÏ·Û›·49 À„›Û˘¯ÓÔ˜

Ì ٷϷÓÙÒÛÂȘ18 ⁄„Ô˜-ÛÙfi¯Ô˜128 º º›ÌˆÛË355 º˘ÛÈ΋ ‰Ú·ÛÙËÚÈfiÙËÙ·368 º˘ÛÈ΋ ηٿÛÙ·ÛË368 à ÃÔÚÙÔÊ·Á›·54 ÃÚfiÓÈ· ‰È¿ÚÚÔÈ·64 ÃÚfiÓÈ· ÓÂÊÚÈ΋ ·ÓÂ¿ÚÎÂÈ·123 ÃÚfiÓÈ· ÓÔÛ‹Ì·Ù·157 ÃÚfiÓÈÔ˜ ‚‹¯·˜37 ÃÚˆÌÔÛˆÌÈΤ˜ ·ÓˆÌ·Ï›Â˜255 ÃÚˆÌÔÛˆÌÈΤ˜ ‰È·Ù·Ú·¯¤˜263

æ æ˘¯ÔÏÔÁÈ΋ Á¤ÓÓËÛË331

17 π·ÓÔ˘·Ú›Ô˘ 2009

æ˘¯È΋ ·ÓıÂÎÙÈÎfiÙËÙ· ÛÙËÓ ·È‰È΋ & ∂ıÓÈÎfi ÿ‰Ú˘Ì·

ÂÊË‚È΋ ËÏÈΛ· ∂Ú¢ÓÒÓ, ∞ı‹Ó·

¶ÏËÚÔÊÔڛ˜: Era Ltd

∆ËÏ.: 210-3634944

Fax: 210-3631690

E-mail: info@era.gr

19 π·ÓÔ˘·Ú›Ô˘ 2009 19Ë ∂ÈÛÙËÌÔÓÈ΋ ∏ÌÂÚ›‰· Ì ı¤Ì·: •ÂÓԉԯ›Ô

∂›Î·ÈÚ· £¤Ì·Ù· ÛÙËÓ ¶·È‰È·ÙÚÈ΋ “Makedonia

√ÚÁ¿ÓˆÛË: º. ∞ı·Ó·ÛÈ¿‰Ô˘ Palace”, ¶ÏËÚÔÊÔڛ˜: Global Events £ÂÛÛ·ÏÔÓ›ÎË

TËÏ.: 2310-247743, 4

Fax: 2310-247746

E-mail: info@globalevents.gr

Website: www.globalevents.gr

28-30 π·ÓÔ˘·Ú›Ô˘ 2009 35th British Paediatric Neurology Association Birmingham, Annual Conference England, UK

National Motorcycle Museum, Solihull

¶ÏËÚÔÊÔڛ˜: BPNA Secretariat, Bridge House, Harrow Road, Bolton, BL1 4NH

∆ËÏ.: 01204 492888

Fax: 01204 493003

E-mail: info@bpna.org.uk

Website: www.bpna.org.uk/2009/

20-22 ª·ÚÙ›Ô˘ 2009 2Ô ∂ÓÙ·ÙÈÎfi ™ÂÌÈÓ¿ÚÈÔ ÛÙËÓ ∂ÊË‚È΋ π·ÙÚÈ΋ ∞ı‹Ó·

•ÂÓÔ‰Ô¯Â›Ô N.J.V. ATHENS PLAZA, ™‡ÓÙ·ÁÌ·

√ÚÁ¿ÓˆÛË: ªÔÓ¿‰· ∂ÊË‚È΋˜ ÀÁ›·˜ (ª.∂.À.), µã ¶·È‰È·ÙÚÈ΋ ∫ÏÈÓÈ΋ ¶·ÓÂÈÛÙËÌ›Ô˘ ∞ıËÓÒÓ,

¡ÔÛÔÎÔÌÂ›Ô ¶·›‰ˆÓ «¶. & ∞. ∫˘ÚÈ·ÎÔ‡»

¶ÏËÚÔÊÔڛ˜: °Ú·ÌÌ·Ù›· Ù˘ ª.∂.À., ¡ÔÛÔÎÔÌÂ›Ô ¶·›‰ˆÓ «¶. & ∞. ∫˘ÚÈ·ÎÔ‡», ªÂÛÔÁ›ˆÓ 24, °Ô˘‰‹, ∆.∫. 115 27

TËÏ.: 210-7710824, 213-2009806

E-mail: info@youth-health.gr Website: www.youth-health.gr

3-5 ∞ÚÈÏ›Ô˘ 2009 1Ô ¶·ÓÂÏÏ‹ÓÈÔ ™˘Ó¤‰ÚÈÔ °ÓˆÛÈ·ÎÒÓ Ã·ÚÔÎfiÂÈÔ

™˘ÌÂÚÈÊÔÚÈÛÙÈÎÒÓ ¶ÚÔÛÂÁÁ›ÛÂˆÓ ¶·ÓÂÈÛÙ‹ÌÈÔ, Û ¶·È‰È¿ Î·È ∂Ê‹‚Ô˘˜ ∞ı‹Ó·

√ÚÁ¿ÓˆÛË: ∂ÏÏËÓÈ΋ ∂Ù·ÈÚ›· ŒÚ¢ӷ˜

Ù˘ ™˘ÌÂÚÈÊÔÚ¿˜

¶ÏËÚÔÊÔڛ˜: Ibis El Greco ∞.∂., Î. ª·Ú›· §Â‚¤ÓÙË

∆ËÏ.: 2810-301711

Fax: 2810-301689, 301683

E-mail: mleventi@ibiselgreco.gr

Website: www.childCBTconf2009.gr, www.ibiselgreco.com

15-17 ∞ÚÈÏ›Ô˘ 2009

European Surgical Institute: Minimally Invasive Norderstedt, Techniques in Paediatric Surgery Germany

¶ÏËÚÔÊÔڛ˜: European Surgical Institute

∆ËÏ.: 49-0-4-052-973-200

Fax: 49-0-4-052-973-209

E-mail: info@esi-online.de

20-24 ∞ÚÈÏ›Ô˘ 2009

Annual Course of the European Society for ∫¤Ú΢ڷ, Pediatric Neurosurgery ∂ÏÏ¿‰·

Corfu Chandris Hotel

¶ÏËÚÔÊÔڛ˜: Erasmus Conferences Tours & Travel S.A.

∆ËÏ.: 210.7257693

Fax: 210.7257532

E-mail: info@erasmus.gr

Website: http://www.erasmus.gr/

15-17 ª·˝Ô˘ 2009 6Ô ¶·ÓÂÏÏ‹ÓÈÔ ™˘Ó¤‰ÚÈÔ ¶·È‰Ô„˘¯È·ÙÚÈ΋˜ ∞›ÁÏË ∑·›Ԣ, √ÚÁ¿ÓˆÛË: ¶·È‰Ô„˘¯È·ÙÚÈ΋ ∂Ù·ÈÚ›· ∂ÏÏ¿‰Ô˜, ∞ı‹Ó·

ŒÓˆÛË æ˘¯È¿ÙÚˆÓ ¶·È‰ÈÒÓ Î·È ∂Ê‹‚ˆÓ

¶ÏËÚÔÊÔڛ˜: ∫∂°ª ∆Ô˘ÚÈÛÙÈΤ˜ & ™˘Ó‰ÚȷΤ˜

∂ȯÂÈÚ‹ÛÂÈ, Congress World - ª. ¶···Ó·ÁÈÒÙÔ˘

∆ËÏ.: 210-7210052, 7210001

Fax: 210-7210051

E-mail: info@congressworld.gr Website: www.congressworld.gr

21-24 ª·˝Ô˘ 2009

2nd International Congress on ADHD Vienna, Austria

¶ÏËÚÔÊÔڛ˜: Congress and Exhibition Office

CPOHANSER Service, Zum Ehrenhain 34, 22885 Barsbüttel, Germany

∆ËÏ.: +49-40-670 88 20

Fax: +49-40-670 32 83

E-mail: adhd2009@cpo-hanser.de Website: www.cpo-hanser.de, www.adhd-congress.org

3-6 πÔ˘Ó›Ô˘ 2009

4-6 πÔ˘Ó›Ô˘ 2009

9-13 πÔ˘Ó›Ô˘ 2009

11-13 πÔ˘Ó›Ô˘ 2009

42nd Annual Meeting of the European Society Budapest, Hungary for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN)

¶ÏËÚÔÊÔڛ˜: Vanda Williamson, 12, rue de la Croix-Faubin, 75557 Paris Cedex 11, France

Tel: +33 (0)1 44 64 15 15, Fax: +33 (0)1 44 64 15 24

E-mail: espghan@colloquium.fr Website: www.espghan.org

21st Annual Meeting of the European Academy of Vilnius, Lithuania

Childhood Disability

¶ÏËÚÔÊÔڛ˜: AIM Group - Conbaltas UAB, Konstitucijos av.15 / Kernavés 5, LT-09319 Vilnius, Lithuania

∆ËÏ.: + 370 5 212 0004, Fax: + 370 5 212 00 13

E-mail: info@eacd2009.com Website: www.eacd2009.com

27th Annual Meeting of the European Society for Brussels, Belgium

Paediatric Infectious Diseases - ESPID 2009

¶ÏËÚÔÊÔڛ˜: Liraz Bregman

∆ËÏ.: 41-229-080-488, Fax: 41-227-322-850

E-mail: espid@kenes.com

3rd International Symposium on Childhood, Frankfurt, Germany

Adolescent and Young Adult

Non Hodgkin Lymphoma

¶ÏËÚÔÊÔڛ˜: Alfred Reiter, MD

∆ËÏ.: 49-641-9943420, Fax: 49-641-9943429

E-mail: alfred.reiter.@paediat.med.uni-giessen.de

17-20 πÔ˘Ó›Ô˘ 2009 20th Congress of the European Society of Pediatric Verona, Italy and Neonatal Intensive Care (ESPNIC)

¶ÏËÚÔÊÔڛ˜: KENES International,

1-3 Rue de Chantepoulet, PO Box 1726,

CH-1211 Geneva 1 Switzerland

∆ËÏ.: + 41 22 908 0488

Fax: + 41 22 732 2850

E-mail: espnic@kenes.com

Website: www.kenes.com/espnic

19-21 πÔ˘Ó›Ô˘ 2009 47Ô ¶·ÓÂÏÏ‹ÓÈÔ ¶·È‰È·ÙÚÈÎfi ™˘Ó¤‰ÚÈÔ

Minoa Palace

¶ÏËÚÔÊÔڛ˜: AC&C Professional Congress Organiser, Hotel, ÷ÓÈ¿

¶ÈÂÚ›·˜ 1∞, 144 51 ªÂÙ·ÌfiÚʈÛË ∞ÙÙÈ΋˜

∆ËÏ.: 210 6889 130

Fax: 210 6844 777

E-mail: pedcongress@acnc.gr

Website: www.acnc.gr

21-26 πÔ˘Ó›Ô˘ 2009 5th World Congress of Paediatric Cardiology Cairns, QLD, and Cardiac Surgery Australia

¶ÏËÚÔÊÔڛ˜: ICMS Pty Ltd

∆ËÏ.: 61-396-820-244

Fax: 61-396-820-288

E-mail: pccs2009@icms.com.au

Mohammed Shuweikhat, 10 ÂÙÒÓ, ™·Ô˘‰È΋ ∞Ú·‚›· ¶·È‰› Ì ÌÂÚÈ΋ fiÚ·ÛË “∆· Ù˘ÊÏ¿ ·È‰È¿ ˙ˆÁÚ·Ê›˙Ô˘Ó” , ÕÓÓ· §·Ô˘Ù¿ÚË-°ÎÚÈÙ˙¿Ï·, ∞ı‹Ó· 2006

Mohammed Shuweikhat, 10 years old, Saudi Arabia Partially blind child

“Blind children paint”, Anna Laoutari-Gritzala, Athens 2006

Turn static files into dynamic content formats.

Create a flipbook